<SEC-DOCUMENT>0001104659-25-001821.txt : 20250108
<SEC-HEADER>0001104659-25-001821.hdr.sgml : 20250108
<ACCEPTANCE-DATETIME>20250108063000
ACCESSION NUMBER:		0001104659-25-001821
CONFORMED SUBMISSION TYPE:	PRE 14A
PUBLIC DOCUMENT COUNT:		6
CONFORMED PERIOD OF REPORT:	20250107
FILED AS OF DATE:		20250108
DATE AS OF CHANGE:		20250108

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Cyclacel Pharmaceuticals, Inc.
		CENTRAL INDEX KEY:			0001130166
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		IRS NUMBER:				911766850
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		PRE 14A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-50626
		FILM NUMBER:		25516526

	BUSINESS ADDRESS:	
		STREET 1:		200 CONNELL DRIVE
		STREET 2:		SUITE 1500
		CITY:			BERKELEY HEIGHTS
		STATE:			NJ
		ZIP:			07922
		BUSINESS PHONE:		908-517-7330

	MAIL ADDRESS:	
		STREET 1:		200 CONNELL DRIVE
		STREET 2:		SUITE 1500
		CITY:			BERKELEY HEIGHTS
		STATE:			NJ
		ZIP:			07922

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	XCYTE THERAPIES INC
		DATE OF NAME CHANGE:	20001218
</SEC-HEADER>
<DOCUMENT>
<TYPE>PRE 14A
<SEQUENCE>1
<FILENAME>tm252001-1_pre14a.htm
<DESCRIPTION>PRE 14A
<TEXT>
<html>
  <head>
    <title>tm252001-1_pre14a - none - 6.5937945s</title>
  </head>
  <body style="margin-left:auto;margin-right:auto;width:595.31pt;">
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:27.85pt;min-height:706pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">UNITED STATES</font>
          <br >
          <font style="letter-spacing:-0.2pt;">SECURITIES AND EXCHANGE COMMISSION</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:2pt; text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">WASHINGTON, D.C. 20549</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:18.5pt; text-align:center; width:456pt;">
          <div style="margin-left: 38.158%; margin-right: 38.158%; margin-top: 0pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
        </div>
        <div style="margin-top:16pt; text-align:center; width:456pt; line-height:16pt;font-weight:bold;font-size:14pt;">
          <font style="letter-spacing:-0.28pt;">SCHEDULE 14A</font><font style="font-weight:normal;letter-spacing:0.28pt;"> </font>
        </div>
        <div style="margin-top:12pt; text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Proxy Statement Pursuant to Section&#160;14(a) of the </font>
          <br >
          <font style="letter-spacing:-0.2pt;">Securities Exchange Act of 1934 </font>
          <br >
          <font style="letter-spacing:-0.2pt;">(Amendment No.&#8199;&#8199;)</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Filed by the Registrant &#9746; </font>
        </div>
        <div style="margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Filed by a Party other than the Registrant &#9744; </font>
        </div>
        <div style="margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Check the appropriate box: </font>
        </div>
        <div style=" float:left; line-height:12pt; margin-top:8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#9746;</font>
          <br >
        </div>
        <div style=" margin-top:8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Preliminary Proxy Statement </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#9744;</font>
          <br >
        </div>
        <div style=" margin-top:8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <!--blacklining:none;-->
          <font style="font-weight:bold;letter-spacing:-0.2pt;">Confidential, for Use of the Commission Only (as permitted by Rule&#160;14a-6(e)(2))</font><font style="letter-spacing:0.2pt;"> </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#9744;</font>
          <br >
        </div>
        <div style=" margin-top:8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Definitive Proxy Statement </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#9744;</font>
          <br >
        </div>
        <div style=" margin-top:8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Definitive Additional Materials </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#9744;</font>
          <br >
        </div>
        <div style=" margin-top:8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Soliciting Material under Rule&#160;14a-12 </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-top:12pt; text-align:center; width:456pt; line-height:16pt;font-weight:bold;font-size:14pt;">
          <font style="letter-spacing:-0.28pt;">CYCLACEL PHARMACEUTICALS, INC. </font>
        </div>
        <div style="margin-top:1.167pt; width:456pt;">
          <div style="margin-left: 0pt; width: 456pt; margin-top: 0pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
        </div>
        <div style="margin-top:4pt; text-align:center; width:456pt; line-height:10pt;font-size:8pt;">
          <font style="letter-spacing:0.16pt;">(Name of Registrant as Specified In Its Charter) </font>
        </div>
        <div style="margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#8199;</font>
        </div>
        <div style="margin-top:2.5pt; width:456pt;">
          <div style="margin-left: 0pt; width: 456pt; margin-top: 0pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
        </div>
        <div style="margin-top:2pt; text-align:center; width:456pt; line-height:10pt;font-size:8pt;">
          <font style="letter-spacing:0.16pt;">(Name of Person(s) Filing Proxy Statement, if other than the Registrant) </font>
        </div>
        <div style="margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Payment of Filing Fee (Check the appropriate box): </font>
        </div>
        <div style=" float:left; line-height:12pt; margin-top:8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#9746;</font>
          <br >
        </div>
        <div style=" margin-top:8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">No fee required. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#9744;</font>
          <br >
        </div>
        <div style=" margin-top:8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Fee paid previously with preliminary materials. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#9744;</font>
          <br >
        </div>
        <div style=" margin-top:8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Fee computed on table in exhibit required by Item&#160;25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11.</font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:3pt;margin-left:69.66pt;width:456pt;">
        <div style="position:relative;text-align:center; width:456pt;">
          <img src="lg_cyclacel-4clr.jpg" alt="[MISSING IMAGE: lg_cyclacel-4clr.jpg]" height="107" width="261" >
        </div>
        <div style="margin-top:10.4pt; text-align:center; width:456pt; line-height:11.5pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Cyclacel Pharmaceuticals, Inc. </font>
          <br >
          <font style="letter-spacing:-0.2pt;">200 Connell Drive, Suite 1500 </font>
          <br >
          <font style="letter-spacing:-0.2pt;">Berkeley Heights, New Jersey 07922</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; text-align:center; width:456pt; line-height:11.5pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">SPECIAL MEETING OF STOCKHOLDERS </font>
          <br >
          <font style="letter-spacing:-0.2pt;">TO BE HELD ON FEBRUARY [&#8199;&#8199; ], 2025</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">January [&#8199;&#8199;], 2025 </font>
        </div>
        <div style="margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Dear Stockholders of Cyclacel Pharmaceuticals, Inc.: </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">You are cordially invited to a Special Meeting of Stockholders (the &#8220;Special Meeting&#8221;) of Cyclacel Pharmaceuticals, Inc. (the &#8220;Company&#8221; or &#8220;Cyclacel&#8221;) to be held on February [&nbsp;&nbsp;&nbsp;], 2025, beginning at [10:00] a.m. Eastern Time. This Special Meeting will be a &#8220;virtual meeting&#8221; of stockholders, which will be conducted exclusively via online audio-only broadcast. You will be able to participate in the Special Meeting, vote your shares and submit your questions during the meeting via the Internet by visiting </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">www.virtualshareholdermeeting.com/[</font><font style=" white-space:pre; text-decoration:underline #000000 solid;letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">]</font><font style="letter-spacing:0.2pt;">. The Special Meeting will be held in virtual format only. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">On January&#160;2, 2025, the Company entered into a Securities Purchase Agreement (the &#8220;Purchase Agreement&#8221;) with David E. Lazar, pursuant to which he agreed to acquire (i)&#160;1,000,000 shares of Series&#160;C Convertible Preferred Stock (&#8220;Series&#160;C Preferred Stock&#8221;) of the Company at a price of $1.00 per share and (ii)&#160;upon approval of the Nasdaq Proposal (as defined below), 2,100,000 shares of Series&#160;D Preferred Stock (&#8220;Series&#160;D Preferred Stock&#8221; and, together with the Series&#160;C Preferred Stock, the &#8220;Preferred Stock&#8221;) of the Company at a price of $1.00 per share, for aggregate gross proceeds of $3.1&#160;million. Each share of Series&#160;C Preferred Stock is convertible into 2.65 shares of the Company&#8217;s common stock, par value $0.001 per share (&#8220;Common Stock&#8221;), and each share of Series&#160;D Preferred Stock is convertible into 110 shares of Common Stock. In no event will the Series&#160;C Preferred Stock be convertible into Common Stock in a manner that would result in Mr.&#160;Lazar or his transferees or their affiliates holding more than the lower of (i)&#160;the maximum&#160;percentage of the number of shares of Common Stock outstanding immediately after giving effect to the issuance of shares of Common Stock issuable upon conversion of the Preferred Stock that can be issued to the holder without requiring a vote of the stockholders of the Company under the rules and regulations of The Nasdaq Stock Market (&#8220;Nasdaq&#8221;); and (ii)&#160;5% of the number of shares of Common Stock outstanding immediately before the original issue date (the &#8220;Series&#160;C Ownership Limitation&#8221;), prior to the date that the Company&#8217;s stockholders approve the issuance of shares of Common Stock to Mr.&#160;Lazar upon conversion of the Preferred Stock. In addition, prior to a Fundamental Transaction (as defined below), in no event will the Series&#160;D Preferred Stock be convertible into Common Stock in a manner that would result in Mr.&#160;Lazar or his transferees or their affiliates holding more than the lower of (i)&#160;the maximum&#160;percentage of the number of shares of the Common Stock outstanding immediately after giving effect to the issuance of shares of Common Stock issuable upon conversion of the Preferred Stock that can be issued to the Holder without requiring a vote of the stockholders of the Company under the rules and regulations of Nasdaq; and, (ii)&#160;49.99% of the number of shares of the Common Stock outstanding immediately before the original issue date (the &#8220;Series&#160;D Ownership Limitation). The term &#8220;Fundamental Transaction,&#8221; as used herein means when (i)&#160;the Corporation effects any merger of the Company with or into another entity and the Company is not the surviving entity, (ii)&#160;any tender offer or exchange offer (whether by the Company or by another individual or entity, and approved by the Company) is completed pursuant to which holders of Common Stock are permitted to tender or exchange their shares of Common Stock for other securities, cash or property and the holders of at least 50% of the Common Stock accept such offer, or (iii)&#160;the Company effects any reclassification of the Common Stock or any compulsory share exchange pursuant to which the Common Stock is effectively converted into or exchanged for other securities, cash or property (other than as a result of a subdivision or combination of shares of Common Stock). The certificate of designations for each of the </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;margin-bottom:35.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Series&#160;C Preferred Stock and Series&#160;D Preferred Stock further provides that even following a vote of the stockholders of the Company in accordance with the rules and regulations of the trading market on which the Common Stock trades on such date and applicable securities laws to approve the removal of the Ownership Limitation, the Company shall not effect any conversion of the Preferred Stock, and a holder of the Preferred Stock shall not have the right to convert any portion of the Preferred Stock, to the extent that, after giving effect to the conversion, such holder (together with any other shares of Common Stock otherwise held by such holder(s) or their affiliates) would beneficially own the number of shares of Common Stock, which would be in excess of any statutory threshold pursuant to which the acquisition of such shares would trigger a compulsory offer requirement under applicable federal or state tender offer rules for the holder and its affiliates to make a tender offer for all the shares of the Company. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Under the applicable Nasdaq rules and the Purchase Agreement, in the absence of stockholder approval, we may not issue shares of Common Stock to Mr.&#160;Lazar upon conversion of the Series&#160;C Preferred Stock, and Mr.&#160;Lazar may not vote shares of the Series&#160;C Preferred Stock, in each case, in excess of the Ownership Limitation. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In the Purchase Agreement, we agreed to call a meeting of stockholders for purposes of soliciting approval of the issuance of all the shares of Common Stock upon conversion of the Preferred Stock pursuant to the terms of the Purchase Agreement and an amendment to the Certificate of Designations for the Series&#160;C Preferred Stock (the &#8220;Series&#160;C Preferred Certificate of Designations&#8221;) in order to remove the Series&#160;C Ownership Limitation. Furthermore, the issuance of shares of our Common Stock to David Lazar upon the conversion of the Preferred Stock would result in a &#8220;change of control&#8221; under applicable rules of The Nasdaq Capital Market (&#8220;Nasdaq&#8221;). We are therefore also seeking approval from stockholders for the &#8220;change of control&#8221; that would result under Nasdaq rules upon the issuance of Common Stock to David Lazar upon conversion of the Preferred Stock. In addition, pursuant to the Purchase Agreement, we agreed to call a meeting of stockholders for purposes of an amendment to our Amended and Restated Certificate of Incorporation, as amended (the &#8220;Certificate&#8221;), to effect a reverse stock split of our issued and outstanding shares of Common Stock, at a ratio of between 1:4 and 1:16 (the &#8220;Reverse Stock Split Amendment&#8221;), an amendment to the Certificate to increase the number of authorized shares of Common Stock from 100,000,000 shares to 250,000,000 shares (the &#8220;Share Increase Amendment&#8221;), which number would not be adjusted as a result of the Reverse Stock Split Amendment, and of an amendment to the Cyclacel Pharmaceuticals, Inc. 2018 Equity Incentive Plan, as amended (the &#8220;2018 Plan&#8221;), to reserve an additional 500,000 shares of Common Stock for issuance thereunder (the &#8220;Plan&#160;Amendment&#8221;), which number would not be adjusted as a result of the Reverse Stock Split Amendment. Accordingly, we are calling this Special Meeting in order to solicit approval from stockholders for these proposals. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">If the issuance of the Common Stock upon conversion of the Series&#160;C Preferred Stock and the removal of the Series&#160;C Ownership Limitation with respect to the Series&#160;C Preferred Stock are approved by our stockholders, Mr.&#160;Lazar (or his transferee) will become a significant stockholder, owning approximately 19.06% of our Common Stock (based on the conversion of all shares of the Preferred Stock that are expected to be issued to Mr.&#160;Lazar pursuant to the Purchase Agreement). We expect that our Common Stock will continue to be listed on Nasdaq provided that we can regain compliance with Nasdaq&#8217;s continued listing requirements, and the Company will continue as a public reporting company under the rules of the Securities and Exchange Commission (the &#8220;SEC&#8221;). </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">In addition, on January&#160;2, 2025, the Company entered into a Warrant Exchange Agreement (the &#8220;Exchange Agreement&#8221;) with Armistice Capital Master Fund&#160;Ltd. (the &#8220;Holder&#8221;) of certain existing warrants (the &#8220;Exchanged Warrants&#8221;) to purchase an aggregate of 24,844,725 shares of Common Stock. The Exchanged Warrants were originally issued (i)&#160;pursuant to a securities purchase agreement, dated as of April&#160;30, 2024 by and between the Company and the Holder and (ii)&#160;pursuant to a warrant exercise and reload agreement dated November&#160;13, 2024 by and between the Company and the Holder. Pursuant to the Exchange Agreement, on the closing date and subject to approval of the Warrant Exchange Issuance Proposal (as defined below), the Company agreed to exchange with the Holder the Exchanged Warrants for (i)&#160;an aggregate of 24,844,725 shares of Common Stock (the &#8220;New Shares&#8221;) and (ii)&#160;$1,100,000 (collectively, the &#8220;Exchange&#8221;). To the extent the Holder would otherwise beneficially own in excess of any beneficial ownership limitation applicable to the Holder after giving effect to the Exchange, the Exchanged Warrants shall be exchanged for a number of New Shares issuable to the Holder without violating the beneficial ownership </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;margin-bottom:35.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">limitation and the remainder of the Holder&#8217;s Exchanged Warrants shall be issued as pre-funded warrants to purchase the number of shares of Common Stock equal to the number of shares of Common Stock in excess of the beneficial ownership limitation. The closing is expected to take place substantially concurrently with the date of the approval of the Warrant Exchange Issuance Proposal, subject to the approval of the Nasdaq Proposal. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In light of the foregoing, the Special Meeting has been called by the Board of Directors to submit to stockholders for approval of the following matters: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:7.3pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">1.</font>
          <br >
        </div>
        <div style=" margin-top:7.3pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">The approval of (i)&#160;the issuance to Mr.&#160;Lazar, our interim Chief Executive Officer, of the Common Stock upon conversion of the Preferred Stock, and (ii)&#160;an amendment of the Series&#160;C Preferred Stock Certificate of Designations removing the Series&#160;C Ownership Limitation, for purposes of Nasdaq Listing Rules 5635(b), (c)&#160;and (d). We refer to this proposal as the &#8220;Nasdaq Proposal&#8221; or &#8220;Proposal 1.&#8221;; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:7.3pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">2.</font>
          <br >
        </div>
        <div style=" margin-top:7.3pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">The approval of the issuance of shares of Common Stock in connection with the Exchange Agreement, for purposes of Nasdaq Listing Rule&#160;5635(d). We refer to this proposal as the &#8220;Warrant Exchange Issuance Proposal&#8221; or &#8220;Proposal 2.&#8221;; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:7.31pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">3.</font>
          <br >
        </div>
        <div style=" margin-top:7.31pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">The approval of an amendment to the Certificate to effect a reverse stock split at a ratio not less than 1:4 and not more than 1:16, or the &#8220;Reverse Stock Split,&#8221; such ratio and the implementation and timing of such Reverse Stock Split to be determined in the discretion of our Board of Directors (the &#8220;Reverse Stock Split Proposal&#8221;). We refer to this proposal as the &#8220;Reverse Stock Split Proposal&#8221; or &#8220;Proposal 3.&#8221;; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:7.31pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">4.</font>
          <br >
        </div>
        <div style=" margin-top:7.31pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">The approval of an amendment to the Certificate to increase the number of authorized shares of Common Stock from 100,000,000 shares to 250,000,000 shares, which number would not be adjusted as a result of the Reverse Stock Split Amendment, if such amendment is approved. We refer to this proposal as the &#8220;Share Increase Proposal&#8221; or &#8220;Proposal 4.&#8221;; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:7.3pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">5.</font>
          <br >
        </div>
        <div style=" margin-top:7.3pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">The approval of an amendment to the Cyclacel Pharmaceuticals, Inc. 2018 Equity Incentive Plan, as amended to reserve an additional 500,000 shares of Common Stock for issuance thereunder, which number would not be adjusted as a result of the Reverse Stock Split Amendment, if such amendment is approved. We refer to this proposal as the &#8220;2018 Plan&#160;Amendment Proposal&#8221; or &#8220;Proposal 5.&#8221;; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:7.3pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">6.</font>
          <br >
        </div>
        <div style=" margin-top:7.3pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">The approval of the adjournment of the Special Meeting, if necessary, if a quorum is present, to solicit additional proxies if there are not sufficient votes to approve any of the above Proposals. We refer to this proposal as the &#8220;Adjournment Proposal&#8221; or &#8220;Proposal 6.&#8221; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The proxy statement attached to this letter provides you with more specific information concerning the Special Meeting, the Purchase Agreement, the Exchange Agreement, the transactions contemplated by the Purchase Agreement and the Exchange Agreement, the Reverse Stock Split Amendment, the Share Increase Amendment, the Plan&#160;Amendment, and other related matters, including information as to how to cast your vote. We encourage you to read the entire proxy statement, the Purchase Agreement, the Series&#160;C Preferred Stock Certificate of Designation, the Series&#160;D Preferred Stock Certificate of Designation and the Exchange Agreement, copies of which were previously filed as Exhibits&#160;10.1, 3.1, 3.2 and 10.5, respectively, to the Company&#8217;s Current Report on Form 8-K filed with the SEC on January&#160;6, 2025, and the other appendices to the proxy statement carefully and in their entirety. The proposals being presented for approval of our stockholders are more fully described in the Proxy Statement accompanying this Notice. Please refer to the Proxy Statement for further information with respect to the business to be transacted at the Special Meeting. No other matters will be considered at the Special Meeting. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Your vote is important. The close of business on January&#160;6, 2025 has been fixed as the record date for the determination of stockholders of the Company entitled to notice of, and to vote at, the Special Meeting. Only stockholders of record at the close of business on January&#160;6, 2025 are entitled to notice of, and to vote at, the Special Meeting and any adjournments or postponements thereof. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Enclosed is a proxy that will entitle you to vote your shares on the matters presented at the Special Meeting, even if you are unable to attend. Please mark the proxy to indicate your vote, date and sign the </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;margin-bottom:35.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;height:660pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">proxy and return it in the enclosed envelope as soon as possible for receipt prior to the Special Meeting, or follow the instructions in the accompanying proxy materials to vote via the internet. Regardless of the number of shares you own, please be sure you are represented at the Special Meeting either by attending virtually or by returning your proxy or voting on the internet as soon as possible. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">On behalf of Cyclacel Pharmaceuticals, Inc., I thank you for your ongoing interest and investment in our company. </font>
        </div>
        <div style="margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Sincerely, </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">David Lazar </font> <br ><font style="letter-spacing:0.2pt;">Interim Chief Executive Officer</font></div>
      </div>
      <div style="margin-top:2.00000000000002pt;margin-bottom:35.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:11.5pt;font-weight:bold;color:#FC0014;">
          <font style="letter-spacing:-0.2pt;">PRELIMINARY PROXY MATERIALS FILED PURSUANT TO RULE 14a-6(a) </font>
          <br >
          <font style="letter-spacing:-0.2pt;">SUBJECT TO COMPLETION</font><font style="font-weight:normal;color:#000000;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="position:relative;margin-top:10pt; text-align:center; width:456pt;">
          <img src="lg_cyclacel-4clr.jpg" alt="[MISSING IMAGE: lg_cyclacel-4clr.jpg]" height="107" width="261" >
        </div>
        <div style="margin-top:13.72pt; text-align:center; width:456pt; line-height:11.5pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Cyclacel Pharmaceuticals, Inc.</font>
          <br >
          <font style="letter-spacing:-0.2pt;">200 Connell Drive, Suite 1500</font>
          <br >
          <font style="letter-spacing:-0.2pt;">Berkeley Heights, New Jersey 07922</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; text-align:center; width:456pt; line-height:11.5pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">NOTICE OF SPECIAL MEETING OF STOCKHOLDERS </font>
          <br >
          <font style="letter-spacing:-0.2pt;">TO BE HELD ON FEBRUARY [ ], 2025</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">January [&#8199;&#8199;], 2025 </font>
        </div>
        <div style="margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Dear Stockholders of Cyclacel Pharmaceuticals, Inc.: </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The Board of Directors (the &#8220;Board&#8221;) of Cyclacel Pharmaceuticals, Inc., a Delaware corporation (the &#8220;Company&#8221;), has called for a Special Meeting of stockholders (the &#8220;Special Meeting&#8221;), to be held on February [&#8199;&#8199;], 2025, beginning at [10:00] a.m. Eastern Time. This Special Meeting will be a &#8220;virtual meeting&#8221; of stockholders, which will be conducted exclusively via online audio-only broadcast. You will be able to participate in the Special Meeting, vote your shares and submit your questions during the meeting via the Internet by visiting </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">www.virtualshareholdermeeting.com/</font>&#8203;<font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">[ &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;]</font><font style="letter-spacing:0.2pt;">. The Special Meeting will be held in virtual format only. The Special Meeting has been called for the following purposes: </font></div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.01pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">1.</font>
          <br >
        </div>
        <div style=" margin-top:6.01pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">The approval of (i)&#160;the issuance to Mr.&#160;Lazar, our interim Chief Executive Officer, of the Common Stock upon conversion of the Preferred Stock, and (ii)&#160;an amendment of the Series&#160;C Preferred Stock Certificate of Designations removing the Series&#160;C Ownership Limitation, for purposes of Nasdaq Listing Rules 5635(b), (c)&#160;and (d). We refer to this proposal as the &#8220;Nasdaq Proposal&#8221; or &#8220;Proposal 1.&#8221;; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.01pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">2.</font>
          <br >
        </div>
        <div style=" margin-top:6.01pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">The approval of the issuance of shares of Common Stock in connection with the Exchange Agreement, for purposes of Nasdaq Listing Rule&#160;5635(d). We refer to this proposal as the &#8220;Warrant Exchange Issuance Proposal&#8221; or &#8220;Proposal 2.&#8221;; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.01pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">3.</font>
          <br >
        </div>
        <div style=" margin-top:6.01pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">The approval of an amendment to the Certificate to effect a reverse stock split at a ratio not less than 1:4 and not more than 1:16, or the &#8220;Reverse Stock Split,&#8221; such ratio and the implementation and timing of such Reverse Stock Split to be determined in the discretion of our Board (the &#8220;Reverse Stock Split Proposal&#8221;). We refer to this proposal as the &#8220;Reverse Stock Split Proposal&#8221; or &#8220;Proposal 3.&#8221;; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.91pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">4.</font>
          <br >
        </div>
        <div style=" margin-top:5.91pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">The approval of an amendment to the Certificate to increase the number of authorized shares of Common Stock from 100,000,000 shares to 250,000,000 shares, which number would not be adjusted as a result of the Reverse Stock Split Amendment, if such amendment is approved. We refer to this proposal as the &#8220;Share Increase Proposal&#8221; or &#8220;Proposal 4.&#8221;; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.91pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">5.</font>
          <br >
        </div>
        <div style=" margin-top:5.91pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">The approval of an amendment to the Cyclacel Pharmaceuticals, Inc. 2018 Equity Incentive Plan, as amended (the &#8220;2018 Plan&#8221;) to reserve an additional 500,000 shares of Common Stock for issuance thereunder, which number would not be adjusted as a result of the Reverse Stock Split Amendment, if such amendment is approved. We refer to this proposal as the &#8220;2018 Plan Amendment Proposal&#8221; or &#8220;Proposal 5.&#8221;; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.91pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">6.</font>
          <br >
        </div>
        <div style=" margin-top:5.91pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">The approval of the adjournment of the Special Meeting, if necessary, if a quorum is present, to solicit additional proxies if there are not sufficient votes to approve any of the above Proposals. We refer to this proposal as the &#8220;Adjournment Proposal&#8221; or &#8220;Proposal 6.&#8221; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-left:20pt; margin-top:7.92pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">No other matters will be considered at the Special Meeting. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;margin-bottom:35.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;height:660pt;margin-left:69.66pt;width:456pt;">
        <div style="text-indent:20pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Pursuant to the Company&#8217;s Second Amended and Restated Bylaws, as amended (the &#8220;Bylaws&#8221;), the Board has fixed the close of business on January&#160;6, 2025, as the record date for determination of the stockholders entitled to vote at the Special Meeting and any adjournments or postponements thereof. </font><font style="font-weight:bold;letter-spacing:-0.2pt;">Please complete, sign and submit your proxy, which is solicited by the Board, as soon as possible so that your shares can be voted at the Special Meeting in accordance with your instructions. You can ensure that your shares are voted at the Special Meeting by voting via the internet or by completing, signing and returning the enclosed proxy.</font><font style="letter-spacing:0.2pt;"> If you do attend the Special Meeting, you may then withdraw your proxy and vote your shares at the meeting. In any event, you may revoke your proxy prior to its exercise. Shares represented by proxies that are returned properly signed but unmarked will be voted in favor of proposals made by us. </font>
        </div>
        <div style="margin-top:8pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">This Notice of Special Meeting of Stockholders, Proxy Statement and the proxy card are available online at: https://annualgeneralmeetings.com/[&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;].</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">BY ORDER OF THE BOARD OF DIRECTORS, </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">David Lazar </font> <br ><font style="letter-spacing:0.2pt;">Interim Chief Executive Officer</font></div>
      </div>
      <div style="margin-top:2.00000000000002pt;margin-bottom:35.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a><a name="TOC">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">SPECIAL MEETING OF STOCKHOLDERS</font>
        </div>
        <div style="margin-top:6pt; text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">PROXY STATEMENT</font>
        </div>
        <div style="margin-top:6pt; text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Table of Contents</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <table style="width:456pt;height:587.5pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:8pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:432.33pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3.5pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt;text-align:center;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Page </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:1.917pt 0pt 0.5pt 0pt; width:432.33pt;white-space:normal;text-align:left;">
              <div style="margin-left:10pt; text-indent:-10pt;">
                <a href="#tINRT"><font style="letter-spacing:0.2pt;">IMPORTANT NOTICE REGARDING THE AVAILABILITY OF PROXY MATERIALS FOR THE SPECIAL MEETING OF STOCKHOLDERS TO BE HELD ON FEBRUARY [&#8199;&#8199;], 2025 </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.0550000000000015pt;width:0pt;">&#8203;</td>
            <td style="padding:1.917pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:1.917pt 0pt 0.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tINRT">1</a></font> <a href="#tINRT"></a></td>
            <td style="padding:0pt;padding-left:0.0550000000000015pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:432.33pt;text-align:left;">
              <div style="white-space:nowrap;">
                <a href="#tQAAA"><font style="letter-spacing:0.2pt;">QUESTIONS AND ANSWERS ABOUT THE SPECIAL MEETING </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.0550000000000015pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tQAAA">2</a></font> <a href="#tQAAA"></a></td>
            <td style="padding:0pt;padding-left:0.0550000000000015pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:432.33pt;text-align:left;">
              <div style="margin-left:10pt;">
                <a href="#tWITP"><font style="letter-spacing:0.2pt;">What is the purpose of the Special Meeting? </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.0550000000000015pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tWITP">2</a></font> <a href="#tWITP"></a></td>
            <td style="padding:0pt;padding-left:0.0550000000000015pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:432.33pt;text-align:left;">
              <div style="margin-left:10pt;">
                <a href="#tWIET"><font style="letter-spacing:0.2pt;">Who is entitled to vote at the Special Meeting? </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.0550000000000015pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tWIET">2</a></font> <a href="#tWIET"></a></td>
            <td style="padding:0pt;padding-left:0.0550000000000015pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:432.33pt;text-align:left;">
              <div style="margin-left:10pt;">
                <a href="#tHDIV"><font style="letter-spacing:0.2pt;">How do I vote? </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.0550000000000015pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tHDIV">2</a></font> <a href="#tHDIV"></a></td>
            <td style="padding:0pt;padding-left:0.0550000000000015pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:432.33pt;text-align:left;">
              <div style="margin-left:10pt;">
                <a href="#tWSMI"><font style="letter-spacing:0.2pt;">What shares may I vote? </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.0550000000000015pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tWSMI">3</a></font> <a href="#tWSMI"></a></td>
            <td style="padding:0pt;padding-left:0.0550000000000015pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.167pt 0pt 0.5pt 0pt; width:432.33pt;text-align:left;">
              <div style="margin-left:20pt; text-indent:-10pt;">
                <a href="#tWITD"><font style="letter-spacing:0.2pt;">What is the difference between holding shares as a stockholder of record and as a beneficial </font>
                  <br >
                  <font style="letter-spacing:0.2pt;">owner? </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.0550000000000015pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tWITD">3</a></font> <a href="#tWITD"></a></td>
            <td style="padding:0pt;padding-left:0.0550000000000015pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:432.33pt;text-align:left;">
              <div style="margin-left:10pt;">
                <a href="#tWCAQ"><font style="letter-spacing:0.2pt;">What constitutes a quorum at the Special Meeting? </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.0550000000000015pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tWCAQ">3</a></font> <a href="#tWCAQ"></a></td>
            <td style="padding:0pt;padding-left:0.0550000000000015pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:432.33pt;text-align:left;">
              <div style="margin-left:10pt;">
                <a href="#tWVIR"><font style="letter-spacing:0.2pt;">What vote is required to approve each proposal? </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.0550000000000015pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tWVIR">3</a></font> <a href="#tWVIR"></a></td>
            <td style="padding:0pt;padding-left:0.0550000000000015pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:432.33pt;text-align:left;">
              <div style="margin-left:10pt;">
                <a href="#tWITE"><font style="letter-spacing:0.2pt;">What is the effect of abstentions and broker non-votes? </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.0550000000000015pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tWITE">4</a></font> <a href="#tWITE"></a></td>
            <td style="padding:0pt;padding-left:0.0550000000000015pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:432.33pt;text-align:left;">
              <div style="margin-left:10pt;">
                <a href="#tMICM"><font style="letter-spacing:0.2pt;">May I change my vote? </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.0550000000000015pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tMICM">4</a></font> <a href="#tMICM"></a></td>
            <td style="padding:0pt;padding-left:0.0550000000000015pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:432.33pt;text-align:left;">
              <div style="margin-left:10pt;">
                <a href="#tWIPF"><font style="letter-spacing:0.2pt;">Who is paying for this proxy solicitation? </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.0550000000000015pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tWIPF">4</a></font> <a href="#tWIPF"></a></td>
            <td style="padding:0pt;padding-left:0.0550000000000015pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:432.33pt;text-align:left;">
              <div style="margin-left:10pt;">
                <a href="#tAIET"><font style="letter-spacing:0.2pt;">Am I entitled to dissenters&#8217; rights? </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.0550000000000015pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tAIET">4</a></font> <a href="#tAIET"></a></td>
            <td style="padding:0pt;padding-left:0.0550000000000015pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:432.33pt;text-align:left;">
              <div style="margin-left:10pt;">
                <a href="#tHCIF"><font style="letter-spacing:0.2pt;">How can I find out the results of the voting at the Special Meeting? </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.0550000000000015pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tHCIF">4</a></font> <a href="#tHCIF"></a></td>
            <td style="padding:0pt;padding-left:0.0550000000000015pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:432.33pt;text-align:left;">
              <div style="margin-left:10pt;">
                <a href="#tISAT"><font style="letter-spacing:0.2pt;">If stockholders approve the proposals, will we remain a public company? </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.0550000000000015pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tISAT">4</a></font> <a href="#tISAT"></a></td>
            <td style="padding:0pt;padding-left:0.0550000000000015pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.167pt 0pt 0.5pt 0pt; width:432.33pt;white-space:normal;text-align:left;">
              <div style="margin-left:20pt; text-indent:-10pt;">
                <a href="#tWITE1"><font style="letter-spacing:0.2pt;">What is the effect to us and our other stockholders of having David Lazar as our largest stockholder? </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.0550000000000015pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tWITE1">4</a></font> <a href="#tWITE1"></a></td>
            <td style="padding:0pt;padding-left:0.0550000000000015pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.167pt 0pt 0.5pt 0pt; width:432.33pt;white-space:normal;text-align:left;">
              <div style="margin-left:20pt; text-indent:-10pt;">
                <a href="#tDTBR"><font style="letter-spacing:0.2pt;">Does the Board recommend stockholder approval of the Nasdaq Proposal and the Warrant Exchange Issuance Proposal? </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.0550000000000015pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tDTBR">5</a></font> <a href="#tDTBR"></a></td>
            <td style="padding:0pt;padding-left:0.0550000000000015pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.167pt 0pt 0.5pt 0pt; width:432.33pt;white-space:normal;text-align:left;">
              <div style="margin-left:20pt; text-indent:-10pt;">
                <a href="#tWFDT"><font style="letter-spacing:0.2pt;">What factors did the Board consider and what were its reasons for recommending that the stockholders approve the Nasdaq Proposal? </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.0550000000000015pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tWFDT">5</a></font> <a href="#tWFDT"></a></td>
            <td style="padding:0pt;padding-left:0.0550000000000015pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.167pt 0pt 0.5pt 0pt; width:432.33pt;text-align:left;">
              <div style="margin-left:20pt; text-indent:-10pt;">
                <a href="#tWHII"><font style="letter-spacing:0.2pt;">What happens if I sell my shares of Common Stock or Preferred Stock before the Special </font>
                  <br >
                  <font style="letter-spacing:0.2pt;">Meeting? </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.0550000000000015pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tWHII">7</a></font> <a href="#tWHII"></a></td>
            <td style="padding:0pt;padding-left:0.0550000000000015pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:432.33pt;text-align:left;">
              <div style="margin-left:10pt;">
                <a href="#tHDTC"><font style="letter-spacing:0.2pt;">How do the Company&#8217;s insiders and existing stockholders intend to vote their shares? </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.0550000000000015pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tHDTC">7</a></font> <a href="#tHDTC"></a></td>
            <td style="padding:0pt;padding-left:0.0550000000000015pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:432.33pt;text-align:left;">
              <div style="white-space:nowrap;">
                <a href="#tCSCF"><font style="letter-spacing:0.2pt;">CAUTIONARY STATEMENT CONCERNING FORWARD-LOOKING INFORMATION </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.0550000000000015pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tCSCF">8</a></font> <a href="#tCSCF"></a></td>
            <td style="padding:0pt;padding-left:0.0550000000000015pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:432.33pt;text-align:left;">
              <div style="white-space:nowrap;">
                <a href="#tSOOC"><font style="letter-spacing:0.2pt;">SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.0550000000000015pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tSOOC">9</a></font> <a href="#tSOOC"></a></td>
            <td style="padding:0pt;padding-left:0.0550000000000015pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:432.33pt;text-align:left;">
              <div style="white-space:nowrap;">
                <a href="#tPTBA"><font style="letter-spacing:0.2pt;">PROPOSALS TO BE ACTED UPON AT THE SPECIAL MEETING </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.0550000000000015pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tPTBA">10</a></font> <a href="#tPTBA"></a></td>
            <td style="padding:0pt;padding-left:0.0550000000000015pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:432.33pt;text-align:left;">
              <div style="margin-left:10pt;">
                <a href="#tPN1N"><font style="letter-spacing:0.2pt;">PROPOSAL NO. 1&#8201;&#8211;&#8201;NASDAQ PROPOSAL </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.0550000000000015pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tPN1N">10</a></font> <a href="#tPN1N"></a></td>
            <td style="padding:0pt;padding-left:0.0550000000000015pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:432.33pt;text-align:left;">
              <div style="margin-left:10pt;">
                <a href="#tPN2W"><font style="letter-spacing:0.2pt;">PROPOSAL NO. 2&#8201;&#8211;&#8201;WARRANT EXCHANGE ISSUANCE PROPOSAL </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.0550000000000015pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tPN2W">15</a></font> <a href="#tPN2W"></a></td>
            <td style="padding:0pt;padding-left:0.0550000000000015pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:432.33pt;text-align:left;">
              <div style="margin-left:10pt;">
                <a href="#tPN3R"><font style="letter-spacing:0.2pt;">PROPOSAL NO. 3&#8201;&#8211;&#8201;REVERSE STOCK SPLIT PROPOSAL </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.0550000000000015pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tPN3R">17</a></font> <a href="#tPN3R"></a></td>
            <td style="padding:0pt;padding-left:0.0550000000000015pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:432.33pt;text-align:left;">
              <div style="margin-left:10pt;">
                <a href="#tPN4S"><font style="letter-spacing:0.2pt;">PROPOSAL NO. 4&#8201;&#8211;&#8201;SHARE INCREASE PROPOSAL </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.0550000000000015pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tPN4S">23</a></font> <a href="#tPN4S"></a></td>
            <td style="padding:0pt;padding-left:0.0550000000000015pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:432.33pt;text-align:left;">
              <div style="margin-left:10pt;">
                <a href="#tPN52"><font style="letter-spacing:0.2pt;">PROPOSAL NO. 5&#8201;&#8211;&#8201;2018 PLAN AMENDMENT PROPOSAL </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.0550000000000015pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tPN52">24</a></font> <a href="#tPN52"></a></td>
            <td style="padding:0pt;padding-left:0.0550000000000015pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:432.33pt;text-align:left;">
              <div style="margin-left:10pt;">
                <a href="#tPN6A"><font style="letter-spacing:0.2pt;">PROPOSAL NO. 6&#8201;&#8211;&#8201;ADJOURNMENT PROPOSAL </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.0550000000000015pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tPN6A">30</a></font> <a href="#tPN6A"></a></td>
            <td style="padding:0pt;padding-left:0.0550000000000015pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:432.33pt;text-align:left;">
              <div style="white-space:nowrap;">
                <a href="#tOTMA"><font style="letter-spacing:0.2pt;">OTHER MATTERS </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.0550000000000015pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tOTMA">31</a></font> <a href="#tOTMA"></a></td>
            <td style="padding:0pt;padding-left:0.0550000000000015pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:432.33pt;text-align:left;">
              <div style="white-space:nowrap;">
                <a href="#tSTCO"><font style="letter-spacing:0.2pt;">STOCKHOLDER COMMUNICATIONS </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.0550000000000015pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tSTCO">32</a></font> <a href="#tSTCO"></a></td>
            <td style="padding:0pt;padding-left:0.0550000000000015pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 0.5pt 0pt; width:432.33pt;text-align:left;">
              <div style="white-space:nowrap;">
                <a href="#tAPA"><font style="letter-spacing:0.2pt;">APPENDIX A: SERIES C PREFERRED STOCK CERTIFICATE OF DESIGNATIONS </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.0550000000000015pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 0.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tAPA">A-1</a></font> <a href="#tAPA"></a></td>
            <td style="padding:0pt;padding-left:0.0550000000000015pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.167pt 0pt 0.5pt 0pt; width:432.33pt;white-space:normal;text-align:left;">
              <div style="margin-left:10pt; text-indent:-10pt;">
                <a href="#tCPI"><font style="letter-spacing:0.2pt;">APPENDIX B: AMENDED AND RESTATED SERIES C PREFERRED STOCK CERTIFICATE OF DESIGNATIONS </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.0550000000000015pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tCPI">B-1</a></font> <a href="#tCPI"></a></td>
            <td style="padding:0pt;padding-left:0.0550000000000015pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">i</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a><a name="TOC2">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:530.5pt;margin-left:69.66pt;width:456pt;">
        <table style="width:456pt;height:80.5pt;margin-top:0pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:8pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #FFFFFF;padding:0pt 0pt 0.5pt 0pt; width:432.33pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:3.5pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.5pt 0pt;text-align:center;" colspan="4">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Page </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:432.33pt;text-align:left;">
              <div style="white-space:nowrap;">
                <a href="#tAPC"><font style="letter-spacing:0.2pt;">APPENDIX C: SERIES D PREFERRED STOCK CERTIFICATE OF DESIGNATIONS </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.0550000000000015pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tAPC">C-1</a></font> <a href="#tAPC"></a></td>
            <td style="padding:0pt;padding-left:0.0550000000000015pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.167pt 0pt 0.833pt 0pt; width:432.33pt;text-align:left;">
              <div style="margin-left:10pt; text-indent:-10pt;">
                <a href="#tAPD"><font style="letter-spacing:0.2pt;">APPENDIX D: FORM OF CERTIFICATE OF AMENDMENT TO EFFECT REVERSE STOCK </font>
                  <br >
                  <font style="letter-spacing:0.2pt;">SPLIT </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.0550000000000015pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 0.833pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tAPD">D-1</a></font> <a href="#tAPD"></a></td>
            <td style="padding:0pt;padding-left:0.0550000000000015pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:432.33pt;text-align:left;">
              <div style="white-space:nowrap;">
                <a href="#tAPE"><font style="letter-spacing:0.2pt;">A</font><font style="text-transform:uppercase;letter-spacing:0.2pt;">ppendix E: Charter Amendment for the Authorized Shares Increase</font></a>
              </div>
            </td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.0550000000000015pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tAPE">E-1</a></font>
            </td>
            <td style="padding:0pt;padding-left:0.0550000000000015pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:432.33pt;text-align:left;">
              <div style="white-space:nowrap;">
                <a href="#tAPF"><font style="letter-spacing:0.2pt;">APPENDIX F: 2018 EQUITY INCENTIVE PLAN, AS AMENDED </font></a>
              </div>
            </td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt; width:3.5pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:0.0550000000000015pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:14.25pt; text-align:right; white-space:nowrap;">
              <font style="letter-spacing:0.2pt;"><a href="#tAPF">F-1</a></font>
            </td>
            <td style="padding:0pt;padding-left:0.0550000000000015pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">ii</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a><a name="tINRT">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:3pt;margin-bottom:179pt;margin-left:69.66pt;width:456pt;">
        <div style="position:relative;text-align:center; width:456pt;">
          <img src="lg_cyclacel-4clr.jpg" alt="[MISSING IMAGE: lg_cyclacel-4clr.jpg]" height="107" width="261" >
        </div>
        <div style="margin-top:17pt; text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Cyclacel Pharmaceuticals, Inc.</font>
          <br >
          <font style="letter-spacing:-0.2pt;">200 Connell Drive, Suite 1500</font>
          <br >
          <font style="letter-spacing:-0.2pt;">Berkeley Heights, New Jersey 07922</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">SPECIAL MEETING PROXY STATEMENT</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">IMPORTANT NOTICE REGARDING THE AVAILABILITY OF PROXY MATERIALS FOR THE</font>
          <br >
          <font style="letter-spacing:-0.2pt;">SPECIAL MEETING OF STOCKHOLDERS TO BE HELD ON FEBRUARY [ ], 2025</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:8pt; text-align:center; width:456pt; line-height:12pt;font-style:italic;">
          <font style="letter-spacing:0.2pt;">The Notice of Special Meeting, Proxy Statement and Proxy Card are available at: </font>
          <br >
          <font style="letter-spacing:0.2pt;">https://annualgeneralmeetings.com/[&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;]</font><font style="font-style:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">We are making these proxy materials available to you in connection with the solicitation of proxies by the Board of Directors (the &#8220;Board&#8221;) of Cyclacel Pharmaceuticals, Inc. (the &#8220;Company&#8221;) for a Special Meeting of Stockholders (the &#8220;Special Meeting&#8221;) and for any adjournment or postponement of the Special Meeting. The mailing of the notice of internet availability of these proxy materials will commence on January [&#8199;&#8199;], 2025. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">This Special Meeting will be a &#8220;virtual meeting&#8221; of stockholders, which will be conducted exclusively via online audio-only broadcast. You will be able to participate in the Special Meeting, vote your shares and submit your questions during the meeting via the Internet by visiting </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">www.virtualshareholdermeeting.com/[</font><font style=" white-space:pre; text-decoration:underline #000000 solid;letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">]</font><font style="letter-spacing:0.2pt;">. The Special Meeting will be held in virtual format only. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">In this Proxy Statement, &#8220;we,&#8221; &#8220;us,&#8221; &#8220;our,&#8221; &#8220;Cyclacel&#8221; and the &#8220;Company&#8221; refer to Cyclacel Pharmaceuticals, Inc. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">This Proxy Statement is being made available to you because you own shares of our Common Stock, par value $0.001 per share, or preferred stock, par value $0.001 per share, as of the record date, which entitles you to vote at the Special Meeting. By use of a proxy, you can vote whether or not you attend the Special Meeting. This Proxy Statement describes the matters we would like you to vote on and provides information on those matters. </font>
        </div>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">1</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a><a name="tQAAA">&#8203;</a><a name="tWITP">&#8203;</a><a name="tWIET">&#8203;</a><a name="tHDIV">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">QUESTIONS AND ANSWERS ABOUT THE SPECIAL MEETING</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">What is the purpose of the Special Meeting?</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The purpose of the Special Meeting is to hold a stockholder vote on the following matters: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:7.4pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">1.</font>
          <br >
        </div>
        <div style=" margin-top:7.4pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">The approval of (i)&#160;the issuance to Mr.&#160;Lazar, our interim Chief Executive Officer, of the Common Stock upon conversion of the Preferred Stock, and (ii)&#160;an amendment of the Series&#160;C Preferred Stock Certificate of Designations removing the Series&#160;C Ownership Limitation, for purposes of Nasdaq Listing Rules 5635(b), (c)&#160;and (d). We refer to this proposal as the &#8220;Nasdaq Proposal&#8221; or &#8220;Proposal 1.&#8221;; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:7.4pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">2.</font>
          <br >
        </div>
        <div style=" margin-top:7.4pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">The approval of the issuance of shares of Common Stock in connection with the Exchange Agreement, for purposes of Nasdaq Listing Rule&#160;5635(d). We refer to this proposal as the &#8220;Warrant Exchange Issuance Proposal&#8221; or &#8220;Proposal 2.&#8221;; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:7.4pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">3.</font>
          <br >
        </div>
        <div style=" margin-top:7.4pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">The approval of an amendment to the Certificate to effect a reverse stock split at a ratio not less than 1:4 and not more than 1:16, or the &#8220;Reverse Stock Split,&#8221; such ratio and the implementation and timing of such Reverse Stock Split to be determined in the discretion of our Board (the &#8220;Reverse Stock Split Proposal&#8221;). We refer to this proposal as the &#8220;Reverse Stock Split Proposal&#8221; or &#8220;Proposal 3.&#8221;; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:7.41pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">4.</font>
          <br >
        </div>
        <div style=" margin-top:7.41pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">The approval of an amendment to the Certificate to increase the number of authorized shares of Common Stock from 100,000,000 shares to 250,000,000 shares, which number would not be adjusted as a result of the Reverse Stock Split Amendment, if such amendment is approved. We refer to this proposal as the &#8220;Share Increase Proposal&#8221; or &#8220;Proposal 4.&#8221;; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:7.4pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">5.</font>
          <br >
        </div>
        <div style=" margin-top:7.4pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">The approval of an amendment to the Cyclacel Pharmaceuticals, Inc. 2018 Equity Incentive Plan, as amended (the &#8220;2018 Plan&#8221;) to reserve an additional 500,000 shares of Common Stock for issuance thereunder (the &#8220;Plan Amendment&#8221;), which number would not be adjusted as a result of the Reverse Stock Split Amendment, if such amendment is approved. We refer to this proposal as the &#8220;2018 Plan Amendment Proposal&#8221; or &#8220;Proposal 5.&#8221;; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:7.51pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">6.</font>
          <br >
        </div>
        <div style=" margin-top:7.51pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">The approval of the adjournment of the Special Meeting, if necessary, if a quorum is present, to solicit additional proxies if there are not sufficient votes to approve any of the above Proposals. We refer to this proposal as the &#8220;Adjournment Proposal&#8221; or &#8220;Proposal 6.&#8221; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Other than these proposals, no other proposals will be presented for a vote at the Special Meeting. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Who is entitled to vote at the Special Meeting?</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Holders of record of our Common Stock and Series&#160;C Preferred Stock as of the close of business on January&#160;6, 2025, the record date for the Special Meeting, or the Record Date, will be entitled to notice of and to vote at the Special Meeting and at any adjournments or postponements thereof. As of the Record Date, there were 11,256,133 shares of Common Stock and 1,000,000 shares of our Series&#160;C Preferred Stock outstanding and entitled to vote. Holders of our Common Stock are entitled to one&#160;(1) vote for each share of Common Stock outstanding as of the Record Date. Holders of our Series&#160;C Preferred Stock will vote together with the holders of our Common Stock on the proposals, except for the Nasdaq Proposal (Proposal 1), on an as-converted to Common Stock basis, such that the number of votes per share of Series&#160;C Preferred Stock is equal to 2.65, assuming a conversion price of $1.00 per share, which was the Nasdaq Minimum Price (as defined in Nasdaq Listing Rule&#160;5635(d)) applicable immediately before the execution and delivery of the Purchase Agreement. As of the Record Date, holders of our Series&#160;C Preferred Stock are entitled to 2.65&#160;votes for each share of Series&#160;C Preferred Stock outstanding. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">You do not need to attend the Special Meeting to vote your shares. Instead, you may vote your shares by marking, signing, dating and returning the enclosed proxy card or voting through the internet. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">How do I vote?</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">You may vote virtually at the Special Meeting, vote by proxy through the internet or vote by proxy using the enclosed proxy card. To vote through the internet, go to </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">2</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a><a name="tWSMI">&#8203;</a><a name="tWITD">&#8203;</a><a name="tWCAQ">&#8203;</a><a name="tWVIR">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">https://annualgeneralmeetings.com/[&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;] and complete an electronic proxy card. You will be asked for a Control Number, which has been provided with the Notice of Internet Availability. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Whether you plan to attend the Special Meeting or not, we urge you to vote by proxy to ensure your vote is counted. Voting by proxy will not affect your right to attend the Special Meeting and vote. If you vote via the internet or properly complete your proxy card and submit it to us in time, the &#8220;proxy&#8221; &#8203;(one of the individuals named on the proxy card) will vote your shares as you have directed. If you sign the proxy card but do not make specific choices, the proxy will vote your shares as recommended by the Board and, as to any other matters properly brought before the Special Meeting, in the sole discretion of the proxy. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">What shares may I vote?</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">You may vote all shares of Common Stock and Series&#160;C Preferred Stock of the Company that you owned as of the close of business on the Record Date. These shares include: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:8.3pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">1.</font>
          <br >
        </div>
        <div style=" margin-top:8.3pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">those held directly in your name as the </font><font style="font-style:italic;letter-spacing:0.2pt;">stockholder of record;</font><font style="letter-spacing:0.2pt;"> and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:8.3pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">2.</font>
          <br >
        </div>
        <div style=" margin-top:8.3pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:40pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">those held for you as the </font><font style="font-style:italic;letter-spacing:0.2pt;">beneficial owner</font><font style="letter-spacing:0.2pt;"> through a bank, broker or other financial intermediary at the close of business on the record date. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Each share of Common Stock is entitled to one&#160;(1) vote. The holders of our Series&#160;C Preferred Stock are entitled to 2.65 votes for each share of Series&#160;C Preferred Stock outstanding. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">What is the difference between holding shares as a stockholder of record and as a beneficial owner?</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Most stockholders hold their shares through a bank, broker or other financial intermediary rather than directly in their own name. As summarized below, there are some distinctions between shares held of record and shares held beneficially. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="font-weight:bold;letter-spacing:-0.2pt;">Stockholder of Record</font><font style="letter-spacing:0.2pt;">:&nbsp;&nbsp;&nbsp;If your shares are registered directly in your name with the Company&#8217;s transfer agent, Equiniti Trust Company, LLC, you are considered, with respect to those shares, the stockholder of record. As the stockholder of record, you have the right to grant your proxy directly to the Company or to vote your shares at the Special Meeting. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="font-weight:bold;letter-spacing:-0.2pt;">Beneficial Owner</font><font style="letter-spacing:0.2pt;">:&nbsp;&nbsp;&nbsp;If you hold shares in a stock brokerage account or through a bank or other financial intermediary, you are considered the beneficial owner of shares held in street name. Your bank, broker or other financial intermediary is considered, with respect to those shares, the stockholder of record. As the beneficial owner, you have the right to direct your bank, broker or other financial intermediary on how to vote your shares, but because you are not the stockholder of record, you may not vote these shares at the Special Meeting unless you obtain a signed proxy from the stockholder of record giving you the right to vote the shares. As a beneficial owner, you are, however, welcome to attend the Special Meeting. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">What constitutes a quorum at the Special Meeting?</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The presence in person or by proxy of the holders of one-third (33</font><font style=" position:relative; bottom:4.25pt;font-size:7.5pt;letter-spacing:0.15pt;">1/3</font><font style="letter-spacing:0.2pt;">%) of the votes represented by the outstanding Common Stock and the Series&#160;C Preferred Stock is necessary to constitute a quorum at the Special Meeting. As of the Record Date, there were 13,906,133 votes represented by outstanding shares of our Common Stock and the Series&#160;C Preferred Stock. Accordingly, the presence of the holders of at least 4,635,378 of the votes entitled to be cast at the meeting will be required to establish a quorum. Both abstentions and broker non-votes, if any, are counted as present for determining the presence of a quorum. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">What vote is required to approve each proposal?</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Assuming a quorum is present, the affirmative vote of the holders of a majority of the votes cast on the proposal by the holders of shares of Common Stock and the Series&#160;C Preferred Stock present or represented at the meeting is required for approval of Proposal Nos. 1, 2, 3, 4, 5 and 6. Abstentions and broker non-votes, if any, are not considered votes cast and therefore will have no effect on the outcome of Proposal Nos. 1, 2, 3, 4, 5 and 6. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">3</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a><a name="tWITE">&#8203;</a><a name="tMICM">&#8203;</a><a name="tWIPF">&#8203;</a><a name="tAIET">&#8203;</a><a name="tHCIF">&#8203;</a><a name="tISAT">&#8203;</a><a name="tWITE1">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">What is the effect of abstentions and broker non-votes?</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">An &#8220;abstention&#8221; occurs when a stockholder sends in a proxy with explicit instructions to decline to vote regarding a particular matter or attends the Special Meeting and elects not to vote or fails to cast a ballot. Abstentions are treated as shares present in person or by proxy and entitled to vote, so abstaining will have no effect on any proposal. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A &#8220;broker non-vote&#8221; occurs when a broker has not received voting instructions from the beneficial owner and the broker does not have discretionary authority to vote the shares because the proposal is non-routine. We believe that Proposals 1, 2 and 5 will be considered non-routine matters under applicable rules. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">May I change my vote?</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Yes. You may change your proxy instructions or revoke your proxy at any time prior to the vote at the Special Meeting. For shares held directly in your name, you may accomplish this by: (a)&#160;delivering a written notice of revocation to the Secretary of the Company or the Secretary&#8217;s designated agent bearing a later date than the proxy being revoked, (b)&#160;signing and delivering a later dated written proxy relating to the same shares, or (c)&#160;attending the Special Meeting and voting in person (although attendance at the Special Meeting will not in and of itself constitute a revocation of a proxy). For shares held in street name, you may change your vote by submitting new voting instructions to your broker, trustee or nominee. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Who is paying for this proxy solicitation?</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">We are paying for this proxy solicitation. Our officers and other regular employees may solicit proxies by mail, in person or by telephone or telecopy. These officers and other regular employees will not receive additional compensation. The Company may retain a third party proxy solicitor for the Special Meeting, whose costs, if retained, we estimate would be approximately $15,000. We will reimburse banks, brokers, nominees, custodians and fiduciaries for their reasonable out-of-pocket expenses incurred in sending the proxy materials to beneficial owners of the shares. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Am I entitled to dissenters&#8217; rights?</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">No dissenters&#8217; rights are available under the General Corporation Law of the State of Delaware, our Certificate, or our bylaws to any stockholder with respect to any of the matters proposed to be voted on at the Special Meeting. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">How can I find out the results of the voting at the Special Meeting?</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Preliminary voting results will be announced at the Special Meeting. In addition, final voting results will be published in a Current Report on Form 8-K that we expect to file within four&#160;(4) business days after the completion of the Special Meeting. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">If stockholders approve the proposals, will we remain a public company?</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Whether or not any of the proposals are approved, we will continue to remain a public company and the requirement to file our annual reports (including the audited financial statements contained therein) and other reports with the SEC, although our listing on Nasdaq may be affected if the Reverse Stock Split Proposal is not approved or if we are unable to regain and maintain compliance with the Nasdaq continued listing requirements. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">What is the effect to us and our other stockholders of having David Lazar as our largest stockholder?</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Because of Mr.&#160;Lazar&#8217;s significant ownership of our Preferred Stock and Common Stock, any transaction or arrangement between us, on the one hand, and Mr.&#160;Lazar or any of their respective affiliates, on the other hand, will need to be approved by the Board consistent with its fiduciary duties to all of our stockholders. This will entail full disclosure of any relationships, transactions or other arrangements between us and Mr.&#160;Lazar and/or their respective affiliates in our filings with the SEC. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">4</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a><a name="tDTBR">&#8203;</a><a name="tWFDT">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-indent:20pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Following the approval of the Nasdaq Proposal and the removal of the Series&#160;C Ownership Limitation from the Series&#160;C Preferred Stock and the issuance of the Series&#160;D Preferred Stock at the second closing under the Purchase Agreement, Mr.&#160;Lazar will be our largest stockholder on an as-converted basis, and he would own a majority of the outstanding shares of our Common Stock if the Preferred Stock was converted into Common Stock and we would be treated as a &#8220;controlled company&#8221; under the rules of Nasdaq. As a controlled company, we would not be required to have a majority independent Board and our Compensation Committee would no longer be required to be composed solely of independent directors. Further, if Mr.&#160;Lazar owns a majority of our Common Stock and Preferred Stock, he will then have sufficient votes to elect all of our directors and to approve any other corporate action requiring the affirmative vote of holders of a majority of the outstanding shares of our Preferred Stock and Common Stock. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Does the Board recommend stockholder approval of the Nasdaq Proposal and the Warrant Exchange Issuance Proposal?</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">After careful consideration, the Board determined that (i)&#160;the Purchase Agreement and the transactions contemplated thereby, including the issuance of all the shares of Common Stock upon conversion of the Preferred Stock to Mr.&#160;Lazar and the removal of the Series&#160;C Ownership Limitation from the Series&#160;C Preferred Stock, and (ii)&#160;the Exchange Agreement and the transactions contemplated thereby, including the issuances of the Common Stock to Armistice Capital Master Fund&#160;Ltd., are each advisable and in the best interests of the Company and its stockholders. Accordingly, the Board unanimously recommends that our stockholders vote &#8220;FOR&#8221; Proposals 1 and 2. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">What factors did the Board consider and what were its reasons for recommending that the stockholders approve the Nasdaq Proposal?</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">After careful consideration, the Board determined that the Purchase Agreement and the transactions contemplated thereby, including the issuance of all of the shares of Common Stock upon conversion of the Preferred Stock and the removal of the Series&#160;C Ownership Limitation from the Series&#160;C Preferred Stock, are advisable and in the best interests of the Company and its stockholders, and determined to recommend that our stockholders approve the matters which need to be approved in order to receive the additional $2.1&#160;million for the issuance of the Series&#160;D Preferred Stock in a second closing pursuant to the Purchase Agreement. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">In making its determination, the Board considered various factors, including: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.2pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">The immediate and long-term benefit to the Company&#8217;s financial condition of receiving an aggregate of $3.1&#160;million in cash from the sale of the Preferred Stock, in light of the Company&#8217;s current cash position and liquidity needs. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.2pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">The fact that, as previously reported, the Company received a notice from the Listing Qualifications Staff (the &#8220;Staff&#8221;) of The Nasdaq Stock Market LLC (&#8220;Nasdaq&#8221;) stating that the Company was not in compliance with Nasdaq Listing Rule&#160;5550(b)(1) requiring stockholders&#8217; equity of at least $2.5&#160;million (the &#8220;Stockholders&#8217; Equity Rule&#8221;) and after a hearing before the Nasdaq Hearings Panel, the Company was granted until December&#160;24, 2024 to regain compliance with the Stockholders&#8217; Equity Rule, which was subsequently extended to February&#160;6, 2025. If the Company is unable to regain compliance with the listing standards of the Nasdaq Capital Market by February&#160;6, 2025, the Company&#8217;s securities may be delisted from Nasdaq. We believe that the ability to raise equity by approving the Nasdaq Proposal will help to facilitate our ability to regain compliance with the Stockholders&#8217; Equity Rule. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.19pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.19pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">The likelihood of securing alternative sources of capital, of a potential public or private sale of common stock, warrants, or convertible or nonconvertible debt securities and the likely price and other terms and conditions of such sales, which revealed a low likelihood of consummation of any alternatives, as well as a significant cost of such financing, assuming it could be obtained, to the Company and the associated significant dilution to its stockholders, which the Board determined was substantially less favorable to the Company than pursuing the transactions contemplated by the Purchase Agreement. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">5</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style=" float:left; margin-left:20pt; line-height:12pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">The significant likelihood that, without the consummation of the transactions contemplated by the Purchase Agreement, the Company would pursue a liquidation and dissolution of the Company, which would likely result in the Company&#8217;s common stockholders receiving no or very little value in respect of their shares of Common Stock after payment of the liquidation preference of the Company&#8217;s outstanding preferred stock. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">The funding that Mr.&#160;Lazar has provided would allow us to explore strategic alternatives in an attempt to maximize stockholder value. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">The recent performance of the Company&#8217;s stock price on Nasdaq and the capital markets as a whole, including the Company&#8217;s inability to secure any alternative offers to finance the Company via an investment in the Company&#8217;s equity or to acquire the Company outright. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">The Company&#8217;s extensive exploration, both by the Company&#8217;s management as well as through its strategic advisors of opportunities for strategic partnership and/or investment, based on which the Board determined that the Purchase Agreement offered the best opportunity with greatest financial benefit, including after considering the risks that any such anticipated benefits could ultimately not materialize. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">The fact that we have covenanted under the Purchase Agreement to solicit approval of the proposals from our stockholders. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">The terms and conditions of the Purchase Agreement, including, among other things, the representations, warranties, covenants and agreements of the parties, the conditions to closing, the form and governance of the Company post-closing and the termination rights of the parties, taken as a whole, which the Board determined were more favorable to the Company and its stockholders than those terms and conditions which could have been negotiated with or offered by other potential strategic partners and/or investors. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">The fact that the Certificate of Designations of the Series&#160;C Preferred Stock provides that the Company will redeem the Series&#160;C Preferred Stock for the fair value (as defined in the Series&#160;C Certificate of Designation) of such shares if we do not obtain approval for the removal of the Series&#160;C Ownership Limitation after four (4)&#160;stockholder meetings. In addition, if the Company does not receive the required approvals by the second meeting of stockholders, the Company shall issue 200,000 shares to David Lazar at a purchase price per share equal to the closing price of the Common Stock on the date of the second meeting plus $0.02. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Potential risks associated with alternatives to the Purchase Agreement, including the potential impact on the price of the Common Stock and ability to generate sufficient capital to support our ongoing operations. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Potential risks associated with Mr.&#160;Lazar&#8217;s significant ownership&#160;percentage following the Closing, including the right to designate directors to the Board, which will enable him to affect the outcome of, or exert significant influence over, all matters requiring Board or stockholder approval, including the election and removal of directors and any change in control, and could have the effect of delaying or preventing a change in control of the Company or otherwise discouraging or preventing a potential acquirer from attempting to obtain control of the Company, which, in turn, could have a negative effect on the market price of the Common Stock and could impact the low trading volume and volatility of the Common Stock. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">What factors did the Board consider and what were its reasons for recommending that the stockholders approve the Warrant Exchange Issuance Proposal?</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">After careful consideration, the Board determined that the Exchange Agreement and the transactions contemplated thereby, including the issuances of the Common Stock to the holder of the Exchange Warrants, are advisable and in the best interests of the Company and its stockholders, and determined to recommend that our stockholders approve Proposal No. 2. In making its determination, the Board considered various factors, including the fact that the Exchange Agreement includes a consent permitting the Company to enter into the Purchase Agreement and the transactions contemplated thereby and extinguishes warrants to purchase 24,844,725 shares of Common Stock that provide for certain cash payments in connection with </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">6</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a><a name="tWHII">&#8203;</a><a name="tHDTC">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:280pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">fundamental transactions (as defined in such warrants) that would likely make any change of control transaction cost prohibitive. We also believe that the issuance of our Common Stock in connection with the Exchange Agreement is necessary to simplify the Company&#8217;s capital structure. We will not be able to complete the second closing of the issuance of Series&#160;D Preferred Stock for $2.1&#160;million if Proposal 2 is not approved. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">What happens if I sell my shares of Common Stock or Preferred Stock before the Special Meeting?</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The Record Date for stockholders entitled to vote at the Special Meeting is earlier than the date of the Special Meeting. If you transfer your shares of Common Stock or Series&#160;C Preferred Stock after the Record Date but before the Special Meeting, you will, unless special arrangements are made to confer the voting rights with respect to such shares to the transferee, retain your right to vote at the Special Meeting. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">How do the Company&#8217;s insiders and existing stockholders intend to vote their shares?</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">All of the Company&#8217;s current directors and executive officers are expected to vote their shares of Common Stock and Series&#160;C Preferred Stock in favor of all proposals set forth in this Proxy Statement. In addition, Armistice Capital, LLC has agreed to vote all of its shares in favor of the Nasdaq Proposal (Proposal&#160;1). On the Record Date, the Company&#8217;s current directors and executive officers were entitled to cast an aggregate of 603,349 votes (which amount is determined by applying the Ownership Limitation to shares of the Series&#160;C Preferred Stock held by Mr.&#160;Lazar) and Armistice Capital, LLC was entitled to cast an aggregate of 222,655 votes, collectively representing approximately 6.97% of the Company&#8217;s issued and outstanding voting power of the Company&#8217;s capital stock as of the Record Date. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">If Proposal 1 passes, then Mr.&#160;Lazar will be permitted to vote his shares of Series&#160;C Preferred Stock on the remaining proposals without regard to the Ownership Limitation. Accordingly, assuming Proposal 1 passed, then, the Company&#8217;s current directors and executive officers and Armistice Capital, LLC would be entitled to cast an aggregate of 2,883,654 votes on Proposals 2, 3, 4, 5 and 6, representing approximately 20.74% of the Company&#8217;s issued and outstanding voting power of the Company&#8217;s capital stock as of the Record Date. </font>
        </div>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">7</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a><a name="tCSCF">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:332pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">CAUTIONARY STATEMENT CONCERNING FORWARD-LOOKING INFORMATION</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">This Proxy Statement contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, as amended. All statements in this Proxy Statement other than statements of historical fact could be deemed forward looking including, but not limited to, statements regarding the Company&#8217;s future expectations, plans and prospects, including statements about our beliefs or current expectations of our future financial prospects, operations and corporate governance procedures following the completion of the transactions with Mr.&#160;Lazar and the approval of the proposals, as well as our current beliefs of our future prospects if the approval of the proposals does not occur, whether as a result of a failure of our stockholders to approve the Nasdaq Proposal and the Warrant Exchange Issuance Proposal or otherwise. Words such as &#8220;plans,&#8221; &#8220;expects,&#8221; &#8220;will,&#8221; &#8220;shall,&#8221; &#8220;anticipates,&#8221; &#8220;continue,&#8221; &#8220;expand,&#8221; &#8220;advance,&#8221; &#8220;believes,&#8221; &#8220;guidance,&#8221; &#8220;target,&#8221; &#8220;may,&#8221; &#8220;remain,&#8221; &#8220;project,&#8221; &#8220;outlook,&#8221; &#8220;intend,&#8221; &#8220;estimate,&#8221; &#8220;could,&#8221; &#8220;should,&#8221; and other words and terms of similar meaning and expression are intended to identify forward-looking statements, although not all forward-looking statements contain such terms. Forward-looking statements are based on management&#8217;s current beliefs and assumptions that are subject to risks and uncertainties and are not guarantees of future performance. Actual results could differ materially from those contained in any forward-looking statement as a result of various factors. Given these risks and uncertainties, you are cautioned not to place undue reliance on such forward-looking statements. For a discussion of other risks and uncertainties, and other important factors, any of which could cause the Company&#8217;s actual results to differ from those contained in the forward-looking statements, see the section titled &#8220;Risk Factors&#8221; in the Company&#8217;s Annual Report on Form 10-K for the year ended December&#160;31, 2023, filed with the SEC on March&#160;21, 2024 and in other documents filed by the Company with the SEC. All information in this Proxy Statement is as of the date of the release, and the Company undertakes no duty to update this information or to publicly announce the results of any revisions to any of such statements to reflect future events or developments, except as required by law. </font>
        </div>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">8</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a><a name="tSOOC">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:1.5pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The number of shares of Common Stock outstanding at the close of business on January&#160;6, 2025 was 11,256,133 shares. In addition, as of January&#160;6, 2025, there were 135,273 shares of 6% Convertible Exchangeable Preferred Stock outstanding, 264 shares of Series&#160;A Preferred Stock and there were 1,000,000 shares of Series&#160;C Preferred Stock outstanding. Each share of Series&#160;C Preferred Stock is convertible into 2.65 shares of Common Stock, subject to applicable ownership limitations that restrict a holder&#8217;s ability to convert in excess of designated&#160;percentages. The following table sets forth the beneficial ownership of the Common Stock, as of January&#160;6, 2025, by (a)&#160;each of our executive officers, (b)&#160;each of our directors, (c)&#160;all of our current directors and executive officers as a group and (d)&#160;each stockholder known by us to own beneficially more than 5% of our Common Stock, Preferred Stock or 6% Convertible Exchangeable Preferred Stock. Beneficial ownership is determined in accordance with Rule&#160;13d-3 under the Exchange Act. In computing the number of shares beneficially owned by a person or a group and the&#160;percentage ownership of that person or group, shares of our Common Stock subject to options and warrants currently exercisable or exercisable within 60&#160;days after January&#160;6, 2025 are deemed outstanding, but are not deemed outstanding for the purpose of computing the&#160;percentage ownership of any other person. To the knowledge of the directors and executive officers of the Company, as of January&#160;6, 2025, there are no persons and/or companies who or which beneficially own, directly or indirectly, shares representing more than 5% of the voting rights attached to all outstanding shares of the Company, other than as set forth below. Unless otherwise indicated, the address of each beneficial owner listed below is c/o&#160;Cyclacel Pharmaceuticals, Inc., 200 Connell Drive, Suite&#160;1500, Berkeley Heights, New Jersey 07922. </font>
        </div>
        <table style="width:456pt;height:161.5pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt; width:199.38pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.16pt;">Name of Beneficial Owners </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Number of</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Shares of</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Common Stock</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Beneficially</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Owned </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Percentage of</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Common Stock</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Owned </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Number of</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Shares of</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Preferred Stock</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Beneficially</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Owned </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Percentage of</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Preferred Stock</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Owned </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:199.38pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">David Lazar</font><font style=" position:relative; bottom:4.25pt;font-size:6.5pt;letter-spacing:0.15pt;">(1)</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:11.89pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:11.89pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:23.245pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; white-space:nowrap;">*</td>
            <td style="padding:0pt;padding-left:23.245pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.205pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">1,000,000</td>
            <td style="padding:0pt;padding-left:6.205pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:15.055pt;width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">88.06<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:15.055pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:199.38pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">David Natan </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:11.89pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:11.89pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:23.245pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; white-space:nowrap;">*</td>
            <td style="padding:0pt;padding-left:23.245pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.205pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:6.205pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:15.055pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">*</td>
            <td style="padding:0pt;padding-left:15.055pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:199.38pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Avraham Ben-Tzvi </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:11.89pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:11.89pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:23.245pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; white-space:nowrap;">*</td>
            <td style="padding:0pt;padding-left:23.245pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.205pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:6.205pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:15.055pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">*</td>
            <td style="padding:0pt;padding-left:15.055pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:199.38pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Paul McBarron</font><font style=" position:relative; bottom:4.25pt;font-size:6.5pt;letter-spacing:0.15pt;">(2)</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:11.89pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">17,722</td>
            <td style="padding:0pt;padding-left:11.89pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:23.245pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; white-space:nowrap;">*</td>
            <td style="padding:0pt;padding-left:23.245pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.205pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:6.205pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:15.055pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">*</td>
            <td style="padding:0pt;padding-left:15.055pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:199.38pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Spiro Rombotis</font><font style=" position:relative; bottom:4.25pt;font-size:6.5pt;letter-spacing:0.15pt;">(3)</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:11.89pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">32,769</td>
            <td style="padding:0pt;padding-left:11.89pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:23.245pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; white-space:nowrap;">*</td>
            <td style="padding:0pt;padding-left:23.245pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.205pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">1,600</td>
            <td style="padding:0pt;padding-left:6.205pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:15.055pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">*</td>
            <td style="padding:0pt;padding-left:15.055pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:199.38pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Dr.&#160;Samuel L. Barker</font><font style=" position:relative; bottom:4.25pt;font-size:6.5pt;letter-spacing:0.15pt;">(4)</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:11.89pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">8,396</td>
            <td style="padding:0pt;padding-left:11.89pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:23.245pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; white-space:nowrap;">*</td>
            <td style="padding:0pt;padding-left:23.245pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.205pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">&#8212;</td>
            <td style="padding:0pt;padding-left:6.205pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:15.055pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">*</td>
            <td style="padding:0pt;padding-left:15.055pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:2.167pt 0pt 1.5pt 0pt; width:199.38pt;white-space:normal;text-align:left;">
              <div style="margin-left:10pt; text-indent:-10pt;">
                <font style="letter-spacing:0.2pt;">Executive officers and directors as a group (6&#160;persons)</font><font style=" position:relative; bottom:4.25pt;font-size:6.5pt;letter-spacing:0.15pt;">&#65279;(5)</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:11.89pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">58,887</td>
            <td style="padding:0pt;padding-left:11.89pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:23.245pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 1.5pt 0pt; min-width:3.75pt; text-align:right; white-space:nowrap;">*</td>
            <td style="padding:0pt;padding-left:23.245pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:6.205pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 1.5pt 0pt; min-width:30.75pt; text-align:right; white-space:nowrap;">1,001,600</td>
            <td style="padding:0pt;padding-left:6.205pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:15.055pt;width:0pt;">&#8203;</td>
            <td style="padding:2.167pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:2.167pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap;">88.20<font style="position:absolute;">%</font></td>
            <td style="padding:0pt;padding-left:15.055pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="margin-top:12.5pt; width:456pt;">
          <div style="margin-left: 0pt; width: 108pt; margin-top: 0pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
        </div>
        <div style=" float:left; margin-top:8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">*</font>
          <br >
        </div>
        <div style=" margin-top:8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Less than one&#160;(1) percent of shares outstanding. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:4pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(1)</font>
          <br >
        </div>
        <div style=" margin-top:4pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Consists of 1,000,000 shares of Series&#160;C Preferred Stock held by Mr.&#160;David Lazar. Each share of Series&#160;C Preferred Stock converts into 2.65 shares of Common Stock; provided, that Mr.&#160;Lazar may not vote shares of Series&#160;C Preferred Stock representing, or convert shares of Series&#160;C Preferred Stock that would result in, Mr.&#160;Lazar or his transferees voting or holding, in excess of the Ownership Limitation. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:4pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(2)</font>
          <br >
        </div>
        <div style=" margin-top:4pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Consists of 1,905 shares of common stock and 15,817 stock options exercisable within 60&#160;days of January&#160;6, 2025, held by Mr.&#160;Paul McBarron. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:4pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(3)</font>
          <br >
        </div>
        <div style=" margin-top:4pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Consists of 6,402 shares of common stock and 26,367 stock options exercisable within 60&#160;days of January&#160;6, 2025, held by Mr.&#160;Spiro Rombotis. Does not include 46 shares of Common Stock beneficially owned by Kalliopi Rombotis, Mr.&#160;Rombotis&#8217; mother. Mr.&#160;Rombotis disclaims beneficial ownership of the foregoing shares. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:4pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(4)</font>
          <br >
        </div>
        <div style=" margin-top:4pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Consists of 66 shares of common stock, 5,704 stock options and 2,626 restricted stock&#160;units exercisable within 60&#160;days of January&#160;6, 2025, held by Dr.&#160;Samuel L. Barker. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:4pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">(5)</font>
          <br >
        </div>
        <div style=" margin-top:4pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">See footnotes 1, through and including 4.</font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">9</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a><a name="tPTBA">&#8203;</a><a name="tPN1N">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">PROPOSALS TO BE ACTED UPON AT THE SPECIAL MEETING</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style=" text-decoration:underline #000000 solid;letter-spacing:-0.2pt;">PROPOSAL NO. 1&#8201;&#8212;&#8201;NASDAQ PROPOSAL</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">General</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">We are seeking stockholder approval for (i)&#160;the issuance to Mr.&#160;Lazar, our interim Chief Executive Officer, of the Common Stock upon conversion of the Preferred Stock, and (ii)&#160;an amendment to the Series&#160;C Preferred Stock Certificate of Designations removing the Series&#160;C Ownership Limitation, for purposes of Nasdaq Listing Rules 5635(b), (c)&#160;and (d). Copies of the Series&#160;C Certificate of Designations, the amended and restated Series&#160;C Certificate of Designations removing the Series&#160;C Ownership Limitation, and the Series&#160;D Certificate of Designations are attached to this proxy statement as Appendix&#160;A, B and C, respectively. We encourage stockholders to read such amended and restated Certificate of Designations in its entirety. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">Under the Purchase Agreement, we agreed to sell to Mr.&#160;Lazar (i)&#160;1,000,000 shares of Series&#160;C Preferred Stock at a price of $1.00 per share and (ii)&#160;upon approval of the Nasdaq Proposal, 2,100,000 shares of Series&#160;D Preferred Stock at a price of $1.00 per share, for aggregate gross proceeds of $3.1&#160;million. Each share of Series&#160;C Preferred Stock is convertible into 2.65 shares of Common Stock and each share of Series&#160;D Preferred Stock is convertible into 110 shares of Common Stock. In no event will the Series&#160;C Preferred Stock be convertible into Common Stock in a manner that would result in Mr.&#160;Lazar or his transferees or their affiliates holding more than the lower of (i)&#160;the maximum&#160;percentage of the number of shares of Common Stock outstanding immediately after giving effect to the issuance of shares of Common Stock issuable upon conversion of the Preferred Stock that can be issued to the holder without requiring a vote of the stockholders of the Company under the rules and regulations of Nasdaq; and (ii)&#160;5% of the number of shares of Common Stock outstanding immediately before the original issue date (the &#8220;Series&#160;C Ownership Limitation&#8221;), prior to the date that the Company&#8217;s stockholders approve the issuance of shares of Common Stock to Mr.&#160;Lazar upon conversion of the Preferred Stock. In addition, prior to a Fundamental Transaction (as defined below), in no event will the Series&#160;D Preferred Stock be convertible into Common Stock in a manner that would result in Mr.&#160;Lazar or his transferees or their affiliates holding more than the lower of (i)&#160;the maximum&#160;percentage of the number of shares of the Common Stock outstanding immediately after giving effect to the issuance of shares of Common Stock issuable upon conversion of the Preferred Stock that can be issued to the Holder without requiring a vote of the stockholders of the Company under the rules and regulations of Nasdaq; and, (ii)&#160;49.99% of the number of shares of the Common Stock outstanding immediately before the original issue date (the &#8220;Series&#160;D Ownership Limitation&#8221;). The term &#8220;Fundamental Transaction,&#8221; as used herein means when (i)&#160;the Corporation effects any merger of the Company with or into another entity and the Company is not the surviving entity, (ii)&#160;any tender offer or exchange offer (whether by the Company or by another individual or entity, and approved by the Company) is completed pursuant to which holders of Common Stock are permitted to tender or exchange their shares of Common Stock for other securities, cash or property and the holders of at least 50% of the Common Stock accept such offer, or (iii)&#160;the Company effects any reclassification of the Common Stock or any compulsory share exchange pursuant to which the Common Stock is effectively converted into or exchanged for other securities, cash or property (other than as a result of a subdivision or combination of shares of Common Stock). The certificate of designations for each of the Series&#160;C Preferred Stock and Series&#160;D Preferred Stock further provide that even following a vote of the stockholders of the Company in accordance with the rules and regulations of the trading market on which the Common Stock trades on such date and applicable securities laws to approve the removal of the Ownership Limitations, the Company shall not effect any conversion of the Preferred Stock, and a holder of the Preferred Stock shall not have the right to convert any portion of the Preferred Stock, to the extent that, after giving effect to the conversion, such holder (together with any other shares of Common Stock otherwise held by such holder(s) or their affiliates) would beneficially own the number of shares of Common Stock, which would be in excess of any statutory threshold pursuant to which the acquisition of such shares would trigger a compulsory offer requirement under applicable federal or state tender offer rules for the holder and its affiliates to make a tender offer for all the shares of the Company. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">10</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Stockholder Approval Requirement for Purposes of Nasdaq Listing Rules 5635(b), (c)&#160;and (d)</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Pursuant to Nasdaq Listing Rule&#160;5635(b), stockholder approval is required prior to the issuance of common stock that will result in a change of control of a listed company. Because we expect that the transactions contemplated by the Purchase Agreement will constitute a change of control for purposes of Nasdaq Listing Rule&#160;5635(b), we are seeking the approval of our stockholders for the issuance to David Lazar of our shares of Common Stock issuable upon conversion of the Preferred Stock sold or to be sold pursuant to the Purchase Agreement. In addition, pursuant to Nasdaq Listing Rule&#160;5635(c), stockholder approval is required prior to issuance of securities when a stock option or purchase plan is established or materially amended or other equity compensation arrangement made or materially amended, pursuant to which shares of Common Stock may be acquired by officers, directors, employees or consultants of the Company. In connection with the signing of the Purchase Agreement, the Board of Directors appointed Mr.&#160;Lazar as interim Chief Executive Officer of the Company, effective as of the signing of the Purchase Agreement. We believe the issuance or delivery of shares of Common Stock underlying the Preferred Stock to Mr.&#160;Lazar should not be treated as equity compensation within the meaning of Rule&#160;5635(c). However, it is possible Nasdaq may deem all or a portion of any arrangement as compensatory in nature, particularly in circumstances where the value deemed received by a listed company is less than the fair value of the securities issued. Accordingly, we are seeking the approval of our stockholders for the issuance of shares of the Common Stock pursuant to the Purchase Agreement pursuant to Nasdaq Listing Rule&#160;5635(c). In addition, pursuant to Nasdaq Listing Rule&#160;5635(d), stockholder approval is required for a transaction other than a public offering involving the sale, issuance or potential issuance by an issuer of common stock (or securities convertible into or exercisable for common stock) at a price that is less than the lower of (i)&#160;the closing price immediately preceding the signing of the binding agreement or (ii)&#160;the average closing price of the common stock for the five trading days immediately preceding the signing of the binding agreement, if the number of shares of common stock (or securities convertible into or exercisable for common stock) to be issued equals to 20% or more of the common stock, or 20% or more of the voting power, outstanding before the issuance. The closing price of the Common Stock on January&#160;2, 2025, which immediately preceded the signing of the Purchase Agreement, was $0.371 per share, and the average closing price of the Common Stock for the five trading days immediately preceding the signing of the Purchase Agreement was $0.35834 per share. Because the price at which we will issue the shares of Common Stock underlying the Preferred Stock to Mr.&#160;Lazar may be deemed to be lower than $0.35834 per share, we are seeking the approval of our stockholders for the issuance of shares of the Common Stock pursuant to the Purchase Agreement pursuant to Nasdaq Listing Rule&#160;5635(d). </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Under the applicable Nasdaq rules and the Purchase Agreement, in the absence of stockholder approval, we may only issue to Mr.&#160;Lazar upon conversion of the Series&#160;C Preferred Stock such number of shares of Common Stock, equal to the lower of either, (X)&#160;the maximum&#160;percentage of the number of shares of the Common Stock outstanding immediately after giving effect to the issuance of shares of Common Stock issuable upon conversion of the Preferred Stock that can be issued to the Holder without requiring a vote of our shareholders under the rules and regulations of the Trading Market on which the Common Stock trades on such date and applicable securities laws; or, (Y)&#160;19.99% of the number of shares of the Common Stock outstanding immediately prior to the date of issuance. In addition, under the applicable Nasdaq rules and the Purchase Agreement, in the absence of stockholder approval, we may not issue to Mr.&#160;Lazar the Series&#160;D Preferred Stock. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The Purchase Agreement contains customary representations, warranties and agreements of the Company and Mr.&#160;Lazar, limitations and conditions regarding sales of the Preferred Stock or underlying Common Stock, indemnification rights and other obligations of the parties. Furthermore, the Purchase Agreement contains certain covenants, including our commitment to call a meeting of stockholders for purposes of soliciting approval (i)&#160;of an amendment to the Series&#160;C Certificate of Designations in order to remove the Series&#160;C Ownership Limitation from the Series&#160;C Preferred Stock and (ii)&#160;the issuance to Mr.&#160;Lazar, our interim Chief Executive Officer, of the Common Stock upon conversion of the Preferred Stock. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">In the Purchase Agreement, Mr.&#160;Lazar has agreed that he will not engage in or effect, directly or indirectly, any short sales involving the Company&#8217;s securities or any hedging transaction that transfers the economic risk of ownership of the Preferred Stock. Additionally, prior to the transaction, the Board </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">11</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">unanimously adopted resolutions (i)&#160;exempting Mr.&#160;Lazar&#8217;s acquisition of the Preferred Stock from Section&#160;16(b) of the Exchange Act pursuant to Rule&#160;16b-3 and (ii)&#160;granting Mr.&#160;Lazar the right to sell, assign or otherwise transfer either the Preferred Stock (as well as any Common Stock underlying any such Preferred Stock) or its rights to acquire the Preferred Stock (as well as any Common Stock underlying any such securities) pursuant to the Purchase Agreement. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">We encourage you to read the Purchase Agreement in its entirety, a copy of which was previously filed as Exhibit&#160;10.1 to the Company&#8217;s Current Report on Form 8-K filed with the SEC on January 6, 2025. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">At the Special Meeting, for purposes of complying with Nasdaq Listing Rule&#160;5635, we will ask stockholders to authorize the issuance of our Common Stock upon the conversion of the Preferred Stock, in an amount that ultimately may equal or be in excess of 20% of our Common Stock outstanding before the entry into of the Purchase Agreement and which may constitute a &#8220;change of control&#8221; under Nasdaq rules. In addition, we will ask stockholders to authorize an amendment to the Series&#160;C Preferred Stock Certificate of Designations to remove the Series&#160;C Ownership Limitation. We may also transact any other business that may properly come before the Special Meeting or at any adjournments or postponements of the Special Meeting. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In the event that we do not receive approval of the Nasdaq Proposal after holding four (4)&#160;stockholder meetings, the Series&#160;C Preferred Stock Certificate of Designations provides that the Company will redeem the Series&#160;C Preferred Stock by paying the holder the fair value of such shares. Fair value is defined in the Series&#160;C Preferred Stock Certificate of Designations as the last reported closing stock price on Nasdaq on the day of the last such stockholder meeting. Upon the redemption of the Series&#160;C Preferred Stock, the outstanding shares of Series&#160;C Preferred Stock will be deemed cancelled. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The Series&#160;C Preferred Stock Certificate of Designations attached hereto as Appendix&#160;A reflects the filing previously submitted to the Secretary of State of the State of Delaware. In the event stockholders approve this proposal, the Company will file the amended and restated Series&#160;C Preferred Stock Certificate of Designations, in the form attached hereto as Appendix&#160;B, with the Secretary of State of the State of Delaware, which will thereafter set forth the rights, privileges and terms of the Series&#160;C Preferred Stock. The Series&#160;D Preferred Stock Certificate of Designations attached hereto as Appendix&#160;C reflects the filing previously submitted to the Secretary of State of the State of Delaware. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Whether or not any of the Proposals are approved, we will continue to remain a public company and the requirement to file our annual reports (including the audited financial statements contained therein) and other reports with the SEC, although our listing on Nasdaq may be affected and we may be delisted if any of the Nasdaq Proposal, the Warrant Exchange Issuance Proposal or the Reverse Stock Split Proposal is not approved. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Because of Mr.&#160;Lazar&#8217;s significant ownership of our Common Stock upon conversion of the Preferred Stock, any transaction or arrangement between us, on the one hand, and Mr.&#160;Lazar or any of their respective affiliates, on the other hand, will need to be approved by the Board consistent with its fiduciary duties to all of our stockholders. This will entail full disclosure of any relationships, transactions or other arrangements between us and Mr.&#160;Lazar and his respective affiliates in our filings with the SEC. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Following the approval of the Nasdaq Proposal and the removal of the Series&#160;C Ownership Limitation from the Series&#160;C Preferred Stock and the issuance of the Series&#160;D Preferred Stock in a second closing under the Purchase Agreement, Mr.&#160;Lazar will be our largest stockholder, and he would own a majority of the outstanding shares of our Common Stock upon conversion of the Preferred Stock and we would be treated as a &#8220;controlled company&#8221; under the rules of Nasdaq. As a controlled company, we would not be required to have a majority independent Board and our Compensation Committee would no longer be required to be composed solely of independent directors. Further, if Mr.&#160;Lazar owns a majority of our Common Stock and our Preferred Stock, he will then have sufficient votes to elect all of our directors and to approve any other corporate action requiring the affirmative vote of holders of a majority of the outstanding shares of our Common Stock and our Preferred Stock. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Reasons for the Nasdaq Proposal</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">After careful consideration, the Board determined that the Purchase Agreement and the transactions contemplated thereby, including the issuances of the Common Stock upon conversion of the Preferred </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">12</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Stock and the removal of the Series&#160;C Ownership Limitation from the Series&#160;C Preferred Stock, are advisable and in the best interests of the Company and its stockholders, and determined to recommend that our stockholders approve Proposal No. 1. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">In making its determination, the Board considered various factors, including: </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The immediate and long-term benefit to the Company&#8217;s financial condition of receiving an aggregate of $3.1&#160;million in cash from the sale of the Preferred Stock, in light of the Company&#8217;s current cash position and liquidity needs. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The fact that, as previously reported, the Company received a notice from the Listing Qualifications Staff (the &#8220;Staff&#8221;) of The Nasdaq Stock Market LLC (&#8220;Nasdaq&#8221;) stating that the Company was not in compliance with Nasdaq Listing Rule&#160;5550(b)(1) requiring stockholders&#8217; equity of at least $2.5&#160;million (the &#8220;Stockholders&#8217; Equity Rule&#8221;) and after a hearing before the Nasdaq Hearings Panel, the Company was granted until December&#160;24, 2024 to regain compliance with the Stockholders&#8217; Equity Rule, which was subsequently extended to February&#160;6, 2025. If the Company is unable to regain compliance with the listing standards of the Nasdaq Capital Market by February&#160;6, 2025, the Company&#8217;s securities may be delisted from Nasdaq. We believe that the ability to raise equity by approving the Nasdaq Proposal will help to facilitate our ability to regain compliance with the Stockholders&#8217; Equity Rule. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The likelihood of securing alternative sources of capital, of a potential public or private sale of common stock, warrants, or convertible or nonconvertible debt securities and the likely price and other terms and conditions of such sales, revealed a low likelihood of consummation of any alternatives, as well as a significant cost of such financing, assuming it could be obtained, to the Company and the associated significant dilution to its stockholders, which the Board determined was substantially less favorable to the Company than pursuing the transactions contemplated by the Purchase Agreement. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The significant likelihood that, without the consummation of the transactions contemplated by the Purchase Agreement, the Company would pursue a liquidation and dissolution of the Company, which would likely result in the Company&#8217;s common stockholders receiving no or very little value in respect of their shares of the Common Stock after payment of the liquidation preference of the Company&#8217;s outstanding preferred stock. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The funding that Mr.&#160;Lazar has provided would allow us to explore strategic alternatives in an attempt to maximize stockholder value. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The recent performance of the Company&#8217;s stock price on Nasdaq and the capital markets as a whole, including the Company&#8217;s inability to secure any alternative offers to finance the Company via an investment in the Company&#8217;s equity or to acquire the Company outright. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">During the Company&#8217;s extensive exploration, both by the Company&#8217;s management as well as its strategic advisors of opportunities for strategic partnership and/or investment, and based on the Board&#8217;s determination that the Purchase Agreement offered the best opportunity with greatest financial benefit, including after considering the risks that any such anticipated benefits could ultimately not materialize, the Board has decided to support the proposal. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">We have covenanted under the Purchase Agreement to solicit approval of the proposals from our stockholders. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The terms and conditions of the Purchase Agreement, including, among other things, the representations, warranties, covenants and agreements of the parties, the conditions to closing, the form and governance of the Company post-closing and the termination rights of the parties, taken as a whole, which the Board determined were more favorable to the Company and its stockholders than those terms and conditions which could have been negotiated with or offered by other potential strategic partners and/or investors. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The Company will redeem the Series&#160;C Preferred Stock for the fair value (as defined in the Series&#160;C Certificate of Designation) of such shares if we do not obtain approval for the removal of the Series&#160;C Ownership Limitation after four (4)&#160;stockholder meetings. In addition, if the Company does not receive the required approvals by the second meeting of stockholders, the Company shall issue 200,000 shares of </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">13</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:320pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">common stock to David Lazar at a purchase price per share equal to the closing price of the Common Stock on the date of the second meeting plus $0.02. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Potential risks associated with alternatives to the Purchase Agreement, including the potential impact on the price of the Common Stock and ability to generate sufficient capital to support our ongoing operations. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Potential risks associated with Mr.&#160;Lazar&#8217;s significant ownership&#160;percentage following the Closing include the right to designate directors to the Board, which will enable him to affect the outcome of, or exert significant influence over, all matters requiring Board or stockholder approval, including the election and removal of directors and any change in control, and could have the effect of delaying or preventing a change in control of the Company or otherwise discouraging or preventing a potential acquirer from attempting to obtain control of the Company, which, in turn, could have a negative effect on the market price of the Common Stock and could impact the low trading volume and volatility of the Common Stock. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Vote Required</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">In order to approve this proposal, assuming that a quorum is present at the Special Meeting, the affirmative vote of a majority of the votes cast by the stockholders entitled to vote on the Nasdaq Proposal is required for the proposal to pass. Abstentions and broker non-votes, if any, will have no effect on the Nasdaq Proposal. David Lazar, who is the holder of the Series&#160;C Preferred Stock, will not be permitted to vote on this Proposal. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Recommendation of the Board of Directors</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The Board unanimously recommends that you vote &#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">FOR</font><font style="letter-spacing:0.2pt;">&#8221; Proposal No. 1 to approve the Nasdaq Proposal. </font>
        </div>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">14</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a><a name="tPN2W">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style=" text-decoration:underline #000000 solid;letter-spacing:-0.2pt;">PROPOSAL NO. 2&#8201;&#8212;&#8201;WARRANT EXCHANGE ISSUANCE PROPOSAL</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">General</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">We are seeking stockholder approval for the issuance to Armistice Capital Master Fund&#160;Ltd. (the &#8220;Holder&#8221;) of 24,844,725 shares of Common Stock pursuant to a Warrant Exchange Agreement (the &#8220;Exchange Agreement&#8221;) with the Holder. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">On January&#160;2, 2025, the Company entered into the Exchange Agreement with the Holder of certain existing warrants (the &#8220;Exchanged Warrants&#8221;) to purchase an aggregate of 24,844,725 shares of Common Stock. The Exchanged Warrants were originally issued (i)&#160;pursuant to a securities purchase agreement, dated as of April&#160;30, 2024 by and between the Company and the Holder and (ii)&#160;pursuant to a warrant exercise and reload agreement dated November&#160;13, 2024 by and between the Company and the Holder. Pursuant to the Exchange Agreement, on the closing date and subject to the receipt of approval of the Warrant Exchange Issuance Proposal, the Company agreed to exchange with the Holder the Exchanged Warrants for (i)&#160;an aggregate of 24,844,725 shares of Common Stock (the &#8220;New Shares&#8221;) and (ii)&#160;$1,100,000 (collectively, the &#8220;Exchange&#8221;). To the extent the Holder would otherwise beneficially own in excess of any beneficial ownership limitation applicable to the Holder (which is 9.99%) after giving effect to the Exchange, the Exchanged Warrants shall be exchanged for a number of New Shares issuable to the Holder without violating the beneficial ownership limitation and the remainder of the Holder&#8217;s Exchanged Warrants shall be issued as pre-funded warrants to purchase the number of shares of Common Stock equal to the number of shares of Common Stock in excess of the beneficial ownership limitation. The closing is expected to take place substantially concurrently with the date on which the approval for the Warrant Exchange Issuance Proposal is received, subject to the receipt by the Company of the approval of the Nasdaq Proposal. In addition, the Holder consented to the issuance of all securities to David Lazar and/or his affiliates pursuant to the Purchase Agreement and waived the Company&#8217;s obligation to file a registration statement with respect to the registration of the resale of the shares of Common Stock issuable upon exercise of the Exchanged Warrants and the obligation to obtain stockholder approval of the New Warrant Shares upon exercise of the Exchanged Warrants. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">In addition, the Company agreed to file a registration statement on Form S-3 (or other appropriate form if the Company is not then S-3 eligible) on or before the 75th calendar day following the closing date providing for the registration of the resale of the New Shares by the holders of the New Shares (the &#8220;Resale Registration Statement&#8221;). The Company shall use its best efforts to cause the Resale Registration Statement to become effective within 110 calendar days following the closing date (or, in the event of a &#8220;full review&#8221; by the SEC, the 125th calendar day following the closing date) and to keep the Resale Registration Statement effective at all times until no Holder owns New Shares. The Holder has also undertaken to vote in favor of Proposal No. 1. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Stockholder Approval Requirement for Purposes of Nasdaq Listing Rules 5635(b) and (d)</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Pursuant to Nasdaq Listing Rule&#160;5635(d), stockholder approval is required for a transaction other than a public offering involving the sale, issuance or potential issuance by an issuer of common stock (or securities convertible into or exercisable for common stock) at a price that is less than the lower of (i)&#160;the closing price immediately preceding the signing of the binding agreement or (ii)&#160;the average closing price of the common stock for the five&#160;(5) trading days immediately preceding the signing of the binding agreement, if the number of shares of common stock (or securities convertible into or exercisable for common stock) to be issued equals to 20% or more of the common stock, or 20% or more of the voting power, outstanding before the issuance. The closing price of the Common Stock on January&#160;2, 2025, which immediately preceded the signing of the Exchange Agreement, was $0.371 per share, and the average closing price of the Common Stock for the five&#160;(5) trading days immediately preceding the signing of the Exchange Agreement was $0.35834 per share. Because the price at which we will issue the New Shares may be deemed to be lower than $0.35834 per share, we are seeking the approval of our stockholders for the issuance of the New Shares pursuant to the Exchange Agreement pursuant to Nasdaq Listing Rule&#160;5635(d). </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">We encourage you to read the Exchange Agreement in its entirety, a copy of which was previously filed as Exhibit 10.5 to the Company&#8217;s Current Report on Form 8-K filed with the SEC on January 6, 2025. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">15</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:204pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Reasons for the Warrant Exchange Issuance Proposal</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">After careful consideration, the Board determined that the Warrant Exchange Agreement and the transactions contemplated thereby, including the issuance of the New Shares, are advisable and in the best interests of the Company and its stockholders, and determined to recommend that our stockholders approve Proposal No. 2. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">In making its determination, the Board considered various factors, including the fact that the Exchange Agreement includes a consent permitting the Company to enter into the Purchase Agreement and the transactions contemplated thereby and extinguishes warrants to purchase 24,844,725 shares of Common Stock that provide for certain cash payments in connection with fundamental transactions (as defined in such warrants) that would likely make any change of control transaction cost prohibitive. We also believe that the issuance of our Common Stock in connection with the Exchange Agreement is necessary to simplify the Company&#8217;s capital structure. We will not be able to complete the second closing of the issuance of Series&#160;D Preferred Stock for $2.1&#160;million if Proposal 2 is not approved. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Vote Required</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">In order to approve this proposal, assuming that a quorum is present at the Special Meeting, the affirmative vote of a majority of the votes cast by the stockholders entitled to vote on the Warrant Exchange Issuance Proposal is required for the proposal to pass. Abstentions and broker non-votes, if any, will have no effect on the Warrant Exchange Issuance Proposal. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">As of the Record Date, there were 11,256,133 shares of Common Stock and 1,000,000 shares of our Series&#160;C Preferred Stock outstanding and entitled to vote. Holders of our Common Stock are entitled to one&#160;(1) vote for each share of Common Stock outstanding as of the Record Date. Holders of our Series&#160;C Preferred Stock will vote together with the holders of our Common Stock on the Warrant Exchange Issuance Proposal on an as-converted to Common Stock basis, such that the number of votes per share of Series&#160;C Preferred Stock is equal to 2.65, assuming a conversion price of $1.00 per share, which was the Nasdaq Minimum Price (as defined in Nasdaq Listing Rule&#160;5635(d)) applicable immediately before the execution and delivery of the Purchase Agreement. As of the Record Date, holders of our Series&#160;C Preferred Stock are entitled to 2.65 votes for each share of Series&#160;C Preferred Stock outstanding. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Recommendation of the Board of Directors</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The Board unanimously recommends that you vote &#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">FOR</font><font style="letter-spacing:0.2pt;">&#8221; Proposal No. 2 to approve the Warrant Exchange Issuance Proposal. </font>
        </div>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">16</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a><a name="tPN3R">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style=" text-decoration:underline #000000 solid;letter-spacing:-0.2pt;">PROPOSAL NO. 3&#8201;&#8212;&#8201;REVERSE STOCK SPLIT PROPOSAL</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">General</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">We are seeking stockholder approval for an amendment to the Company&#8217;s Amended and Restated Certificate of Incorporation, as amended (the &#8220;Certificate&#8221;), authorizing a Reverse Stock Split of the issued and outstanding shares of our Common Stock, at a ratio not less than 1:4 and not more than 1:16, such ratio and the implementation and timing of such Reverse Stock Split to be determined in the discretion of our Board. The form of the proposed amendment to the Certificate (the &#8220;Reverse Split Amendment&#8221;) is attached to this proxy statement as Appendix&#160;D. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">On December&#160;31, 2024, our Board approved the proposed Reverse Stock Split, and the Reverse Split Amendment in order to effect the Reverse Stock Split, subject to stockholder approval, and directed that the Reverse Split Amendment be submitted to a vote of the Company&#8217;s stockholders at the Special Meeting. If approved by our stockholders, and if implemented by our Board, the Reverse Stock Split will become effective at the time specified in the Reverse Split Amendment, as filed with the Secretary of State of the State of Delaware. The exact ratio of the Reverse Stock Split, within the 1:4 and 1:16 range, would be determined by the Board and publicly announced by the Company prior to filing the Reverse Split Amendment. In determining the appropriate ratio for the Reverse Stock Split, our Board will consider, among other things, factors such as: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.71pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.71pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the minimum price per share requirements of The Nasdaq Capital Market; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.7pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the historical trading price and trading volume of our Common Stock; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.7pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the number of shares of our Common Stock outstanding and anticipated equity financing transactions in the future; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.7pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the then-prevailing trading price and trading volume of our Common Stock and the anticipated impact of the Reverse Stock Split on the trading market for our Common Stock; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.71pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.71pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">business developments affecting us; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.7pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">prevailing general market and economic conditions. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Background and Reasons for the Reverse Stock Split</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Our Board authorized the Reverse Stock Split of our Common Stock with the primary intent of increasing the price of our Common Stock in order to meet the price criteria for continued listing on Nasdaq. Our Common Stock is publicly traded and listed on Nasdaq under the symbol &#8220;CYCC.&#8221; Our Board believes that, in addition to increasing the price of our Common Stock, the Reverse Stock Split would make our Common Stock more attractive to a broader range of institutional and other investors. Accordingly, for these and other reasons discussed below, we believe that effecting the Reverse Stock Split is in the Company&#8217;s and our stockholders&#8217; best interests. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">On December&#160;6, 2024, we received a notice from the Listing Qualifications Staff of The Nasdaq Stock Market LLC (the &#8220;Staff&#8221;) notifying us that, based upon the closing bid price of our Common Stock, for the 30 consecutive business days prior to the notice, the Company no longer met the requirement to maintain a minimum closing bid price of $1.00 per share, as set forth in Nasdaq Listing Rule&#160;5550(a)(2). The Company was originally granted 180 calendar days, or until June&#160;4, 2025, to regain compliance with the minimum bid price rule. However, if it appears to the Staff that the Company will not be able to cure the deficiency, or if the Company is otherwise not eligible, Nasdaq would notify the Company that its securities would be subject to delisting (a &#8220;Staff Delisting Determination&#8221;). In addition, if the Company has a closing bid price of $0.10 or less for a period of ten&#160;(10) consecutive business days, Nasdaq would also issue a Staff Delisting Determination letter. In the event of either such notification, the Company may appeal the Staff&#8217;s determination to delist its securities. There can be no assurance that the Staff would grant the Company&#8217;s request for continued listing subsequent to any delisting notification. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Our Board believes that the delisting of our common stock from Nasdaq would result in decreased liquidity and/or increased volatility in our Common Stock, and a diminution of institutional investor interest in our Company. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">17</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-indent:20pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Our Board continues to believe that an increased stock price could encourage investor interest and improve the marketability of our Common Stock to a broader range of investors, and thus enhance our liquidity. Because of the trading volatility often associated with low-priced stocks, many brokerage firms and institutional investors have internal policies and practices that either prohibit them from investing in low-priced stocks or tend to discourage individual brokers from recommending low-priced stocks to their customers. Additionally, because brokers&#8217; commissions on low-priced stocks generally represent a higher&#160;percentage of the stock price than commissions on higher-priced stock, the current share price of our Common Stock may result in an investor paying transaction costs that represent a higher&#160;percentage of total share value than would be the case if our share price were higher. Our Board believes that the higher share price resulting from the Reverse Stock Split could enable institutional investors and brokerage firms with such policies and practices to invest in our common stock. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Although we expect that the Reverse Stock Split will result in an increase in the market price of our Common Stock, the Reverse Stock Split may not result in a permanent increase in the market price of our Common Stock, which is dependent on many factors, including general economic, market and industry conditions and other factors detailed from time to time in the reports we file with the SEC. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Certain Risks Associated with the Reverse Stock Split</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Unexpected factors, such as our ability to successfully accomplish our business goals, market conditions and the market perception of our business may adversely affect the market price of our Common Stock. There can be no assurance that the total market capitalization of our Common Stock after the implementation of the Reverse Stock Split will be equal to or greater than the total market capitalization before the Reverse Stock Split or that the per share market price of our Common Stock following the Reverse Stock Split will increase in proportion to the reduction in the number of shares of our Common Stock outstanding before the Reverse Stock Split. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">There can be no assurance that the market price per new share of our Common Stock after the Reverse Stock Split will remain unchanged or increase in proportion to the reduction in the number of old shares of our Common Stock outstanding before the Reverse Stock Split. For example, based on the closing price of our Common Stock on January 6, 2025 of $0.45 per share, if the Board were to implement the Reverse Stock Split and utilize a ratio of 1:4, we cannot assure you that the post-split market price of our Common Stock would remain greater than $1.00. We are aware that in many cases, the market price of a company&#8217;s shares declines after a reverse stock split is implemented. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Accordingly, the total market capitalization of our Common Stock after the Reverse Stock Split, when and if implemented, may be lower than the total market capitalization before the Reverse Stock Split. Moreover, in the future, the market price of our Common Stock following the Reverse Stock Split may not exceed or remain higher than the market price prior to the Reverse Stock Split. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Further, the liquidity of our capital stock may be harmed by the proposed Reverse Stock Split given the reduced number of shares that will be outstanding after the Reverse Stock Split, particularly if the stock price does not remain increased as a result of the Reverse Stock Split. In addition, the proposed Reverse Stock Split may increase the number of stockholders who own odd lots (less than 100 shares) of our Common Stock, creating the potential for such stockholders to experience an increase in the cost of selling their shares and greater difficulty effecting sales. If we effect the Reverse Stock Split, the resulting per-share stock price may not attract institutional investors and may not satisfy the investing guidelines of such investors and, consequently, the trading liquidity of our Common Stock may not improve. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">While the Board proposes the Reverse Stock Split to bring the price of our Common Stock back above $1.00 per share in order to meet the requirements for the continued listing of our common stock on The Nasdaq Capital Market, there is no guarantee that the price of our Common Stock will not decrease in the future, or that for any other reason our common stock will not remain in compliance with The Nasdaq Capital Market listing standards. There can be no guarantee that the closing bid price of our Common Stock will remain at or above $1.00 for ten&#160;(10) consecutive trading days, which would be required to cure our current listing standard deficiency. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">18</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Potential Effects of the Proposed Reverse Stock Split</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">If this proposal is approved and the Reverse Stock Split is effected, the Reverse Stock Split will be realized simultaneously and in the same ratio for all of our issued and outstanding shares of Common Stock. The immediate effect of the Reverse Stock Split would be to reduce the number of shares of our Common Stock outstanding and to increase the per-share trading price of our common stock. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">However, we cannot predict the effect of any reverse stock split upon the market price of our Common Stock over an extended period, and in many cases, the market value of a company&#8217;s common stock following a reverse stock split declines, in many cases, because of variables outside of a company&#8217;s control (such as market volatility, investor response to the news of a proposed reverse stock split and the general economic environment). We cannot assure you that the trading price of our Common Stock after the Reverse Stock Split will rise in inverse proportion to the reduction in the number of shares of our Common Stock outstanding as a result of the Reverse Stock Split. Also, we cannot assure you that the Reverse Stock Split would lead to a sustained increase in the trading price of our Common Stock. The trading price of our Common Stock may change due to a variety of other factors, including our operating results and other factors related to our business and general market conditions. You should also keep in mind that the implementation of a reverse stock split does not have an effect on the actual or intrinsic value of our business or a stockholder&#8217;s proportional ownership in our Company. However, should the overall value of our Common Stock decline after the proposed Reverse Stock Split, then the actual or intrinsic value of the shares of our Common Stock held by you will also proportionately decrease as a result of the overall decline in value. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="font-style:italic;letter-spacing:0.2pt;">Examples of Potential Reverse Stock Split at Various Ratios</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;The table below provides examples of reverse stock splits at various ratios up to 16-for-one, without giving effect to the treatment of fractional shares, and does not assume the issuance of shares of Common Stock upon conversion of the Preferred Stock or the issuance of Common Stock upon completion of the Warrant Exchange. The actual number of shares outstanding after giving effect to the Reverse Stock Split, if effected, will depend on the actual ratio that is determined by our Board in accordance with the Reverse Split Amendment. </font>
        </div>
        <table style="width:456pt;height:86.5pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:9pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt; width:144pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Shares outstanding</font> <br ><font style="letter-spacing:-0.16pt;">as of January&#160;6, 2025 </font></div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt; width:144pt;">
              <div style="white-space:nowrap; text-align:center;">
                <font style="letter-spacing:-0.16pt;">Reverse Stock Split Ratio </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt; width:144pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Shares outstanding</font>
                <br >
                <font style="letter-spacing:-0.16pt;">after Reverse</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Stock Split </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:144pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">11,256,133</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:144pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">4 for 1 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:144pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">2,814,033</font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:144pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">11,256,133</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:144pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">8 for 1 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:144pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">1,407,017</font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:144pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">11,256,133</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:144pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">12 for 1 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:144pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">938,011</font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:144pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">11,256,133</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:144pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">16 for 1 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:144pt;">
              <div style="text-align:center;">
                <font style="letter-spacing:0.2pt;">703,508</font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="text-indent:20pt; margin-top:7.8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The resulting decrease in the number of shares of our Common Stock outstanding could potentially adversely affect the liquidity of our Common Stock, especially in the case of larger block trades. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="font-style:italic;letter-spacing:0.2pt;">Effects on Ownership by Individual Stockholders.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;If we implement the Reverse Stock Split, the number of shares of our Common Stock held by each stockholder would be reduced by dividing the number of shares held immediately before the Reverse Stock Split by the appropriate ratio and then rounding down to the nearest whole share. We would pay cash to each stockholder in lieu of any fractional interest in a share to which each stockholder would otherwise be entitled as a result of the Reverse Stock Split, as described in further detail below. The cash amount to be paid to each stockholder would equal the stockholder&#8217;s fractional interest in one&#160;(1) share of our Common Stock to which the stockholder would otherwise be entitled, multiplied by the closing sale price of our Common Stock on The Nasdaq Capital Market on the trading day immediately prior to the effective date of the Reverse Stock Split. The Reverse Stock Split would not affect any stockholder&#8217;s&#160;percentage ownership interest in our Company or proportionate voting power, except to the extent that interests in fractional shares would be paid in cash. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="font-style:italic;letter-spacing:0.2pt;">Effect on Restricted Stock Units, Stock Options, Warrants</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;In addition, we would adjust all outstanding shares of any restricted stock&#160;units, stock options and warrants entitling the holders to purchase shares of our Common Stock as a result of the Reverse Stock Split, as required by the terms of these securities. In particular, we would reduce each security by the conversion ratio, and would increase the exercise price in accordance with the terms of each security based on Reverse Stock Split ratio (i.e., the number of shares </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">19</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">issuable under such securities would decrease by the ratio, and the exercise price per share would be multiplied by ratio). Also, we would reduce the number of shares reserved for issuance under our existing equity incentive plans proportionately based on the ratio of the Reverse Stock Split. The Reverse Stock Split would not otherwise affect any of the rights currently accruing to holders of our Common Stock, or options or warrants exercisable for our common stock. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="font-style:italic;letter-spacing:0.2pt;">Other Effects on Issued and Outstanding Shares</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;If we implement the Reverse Stock Split, the rights pertaining to the issued and outstanding shares of our Common Stock would be unchanged after the Reverse Stock Split. Each share of our Common Stock issued following the Reverse Stock Split would be fully paid and non-assessable. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Reservation of Right to Abandon the Proposed Reverse Split Amendment to our Certificate</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Our Board reserves the right not to file the Reverse Split Amendment to our Certificate without further action by our stockholders at any time before the effectiveness of the filing of the Reverse Split Amendment with the Secretary of State of the State of Delaware, even if the authority to effect the Reverse Split Amendment is approved by our stockholders at the Special Meeting. By voting in favor of the Reverse Split Amendment, you are expressly also authorizing our Board to delay, not proceed with, and abandon, the proposed Reverse Split Amendment if it should so decide, in its sole discretion, that such action is in the best interests of the Company and its stockholders. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Procedure for Effecting the Proposed Stock Split and Exchange of Stock Certificates</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">If stockholders approve this proposal and our Board does not otherwise abandon the Reverse Split Amendment contemplating the Reverse Stock Split, we will file with the Delaware Secretary of State a Certificate of Amendment to our Certificate, in the form attached to this proxy statement as Appendix&#160;D. The Reverse Stock Split will become effective at the time and on the date of filing of, or at such later time as is specified in, the Reverse Split Amendment, which we refer to as the &#8220;effective time.&#8221; Beginning at the effective time, each certificate representing shares of common stock will be deemed for all corporate purposes to evidence ownership of the number of whole shares into which the shares previously represented by the certificate were combined pursuant to the Reverse Stock Split. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Upon the Reverse Stock Split, we intend to treat stockholders holding our Common Stock in &#8220;street name,&#8221; through a bank, broker or other nominee, in the same manner as registered stockholders whose shares are registered in their names. Banks, brokers or other nominees will be instructed to effect the Reverse Stock Split for their beneficial holders holding our Common Stock in &#8220;street name.&#8221; However, these banks, brokers or other nominees may have different procedures than registered stockholders for processing the Reverse Stock Split. If you hold your shares with a bank, broker or other nominee and if you have any questions in this regard, we encourage you to contact your nominee. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Following the Reverse Stock Split, stockholders holding physical certificates must exchange those certificates for new certificates and a cash payment in lieu of any fractional shares. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The Company&#8217;s transfer agent will advise registered stockholders of the procedures to be followed to exchange certificates in a letter of transmittal to be sent to stockholders. No new certificates will be issued to a stockholder until the stockholder has surrendered the stockholder&#8217;s outstanding certificate(s), together with the properly completed and executed letter of transmittal, to the transfer agent. Any old shares submitted for transfer, whether pursuant to a sale, other disposition or otherwise, will automatically be exchanged for new shares. Stockholders should not destroy any stock certificate(s) and should not submit any certificate(s) until requested to do so. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">No Appraisal Rights</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">No appraisal rights are available under the General Corporation Law of the State of Delaware or under our Certificate, or our Amended and Restated Bylaws, as amended, with respect to the Reverse Stock Split. There may exist other rights or actions under state law for stockholders who are aggrieved by reverse stock splits generally. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">20</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Potential Anti-Takeover Effect</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Although the increased proportion of unissued authorized shares to issued shares could, under certain circumstances, have an anti-takeover effect (for example, by permitting issuances that would dilute the stock ownership of a person seeking to effect a change in the composition of the Board or contemplating a tender offer or other transaction for the combination of the Company with another company), other than with respect to the transactions contemplated by the Purchase Agreement, the Reverse Stock Split proposal is not being proposed in response to any effort of which we are aware to accumulate shares of our Common Stock or obtain control of the Company, nor is it part of a plan by management to recommend a series of similar amendments to the Board and stockholders. Other than the Reverse Stock Split proposal, the Board does not currently contemplate recommending the adoption of any other actions that could be construed to affect the ability of third parties to take over or change control of the Company. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Interests of Directors and Executive Officers</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Our directors and executive officers have no substantial interests, directly or indirectly, in the matters set forth in this proposal except to the extent of their ownership of shares of our Common Stock or Preferred Stock. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Accounting Consequences</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The Reverse Stock Split would not affect the per-share par value of our Common Stock, which would remain at $0.001 par value per share, while the number of outstanding shares of common stock would decrease in accordance with the Reverse Stock Split ratio. As a result, as of the effective time of the Reverse Stock Split, the stated capital attributable to common stock on our balance sheet would decrease, and the additional paid-in capital account on our balance sheet would increase by an offsetting amount. Following the Reverse Stock Split, the reported per-share net income or loss would be higher because there would be fewer shares of common stock outstanding, and we would adjust historical per share amounts set forth in our future financial statements. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">No Going Private Transaction</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Notwithstanding the decrease in the number of outstanding shares following the Reverse Stock Split, our Board does not intend for this transaction to be the first step in a &#8220;going private transaction&#8221; within the meaning of Rule&#160;13e-3 of the Exchange Act. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Material U.S. Federal Income Tax Consequences of the Reverse Stock Split</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The following is a summary of the material U.S. federal income tax consequences of the Reverse Stock Split to holders of our shares. This summary is based on the Internal Revenue Code of 1986, as amended, or the Code, the Treasury regulations promulgated thereunder, and administrative rulings and court decisions in effect as of the date of this document, all of which may be subject to change, possibly with retroactive effect. This summary only addresses holders who hold their shares as capital assets within the meaning of the Code and does not address all aspects of U.S. federal income taxation that may be relevant to holders subject to special tax treatment, such as financial institutions, dealers in securities, insurance companies, foreign persons and tax-exempt entities. In addition, this summary does not consider the effects of any applicable state, local, foreign or other tax laws. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">We have not sought and will not seek any ruling from the Internal Revenue Service, or the IRS, or an opinion from counsel with respect to the U.S. federal income tax consequences discussed below. There can be no assurance that the tax consequences discussed below would be accepted by the IRS or a court. The tax treatment of the Reverse Stock Split to holders may vary depending upon a holder&#8217;s particular facts and circumstances. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">We urge holders to consult with their own tax advisors as to any U.S. federal, state, local or foreign tax consequences applicable to them that could result from the Reverse Stock Split. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Except as described below with respect to cash received in lieu of fractional shares, the receipt of common stock in the Reverse Stock Split should not result in any taxable gain or loss to a holder for U.S. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">21</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:100pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">federal income tax purposes. The aggregate tax basis of the common stock received by a holder as a result of the Reverse Stock Split (including the basis of any fractional share to which a holder is entitled) will be equal to the aggregate basis of the existing common stock exchanged for such stock. A holder&#8217;s holding period for the common stock received in the Reverse Stock Split will include the holding period of the common stock exchanged therefor. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A holder who receives cash in lieu of a fractional share of common stock will be treated as first receiving such fractional share and then receiving cash in redemption of such fractional share. A holder generally will recognize capital gain or loss on such deemed redemption in an amount equal to the difference between the amount of cash received and the adjusted basis of such fractional share. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Transfer Agent and Registrar</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The transfer agent and registrar for our Common Stock is now and will remain Equiniti Trust Company, LLC. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Listing</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Our Common Stock is currently traded on The Nasdaq Capital Market under the symbol &#8220;CYCC&#8221;. The principal reason for the Reverse Stock Split is to increase the per share trading price of our Common Stock in order to help ensure a share price high enough to satisfy the $1.00 per share minimum bid price requirement for continued listing on The Nasdaq Capital Market. However, there can be no assurance that the trading price of our Common Stock would be maintained at such level or that we will be able to maintain the listing of our Common Stock on The Nasdaq Capital Market. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Required Vote</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">In order to approve this proposal, assuming that a quorum is present at the Special Meeting, the affirmative vote of a majority of the votes cast by the stockholders entitled to vote on the Reverse Stock Split Proposal is required for the proposal to pass. Abstentions and broker non-votes, if any, will have no effect on the Reverse Stock Split Proposal. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">As of the Record Date, there were 11,256,133 shares of Common Stock and 1,000,000 shares of our Series&#160;C Preferred Stock outstanding and entitled to vote. Holders of our Common Stock are entitled to one&#160;(1) vote for each share of Common Stock outstanding as of the Record Date. Holders of our Series&#160;C Preferred Stock will vote together with the holders of our Common Stock on the Reverse Stock Split Proposal on an as-converted to Common Stock basis, such that the number of votes per share of Series&#160;C Preferred Stock is equal to 2.65, assuming a conversion price of $1.00 per share, which was the Nasdaq Minimum Price (as defined in Nasdaq Listing Rule&#160;5635(d)) applicable immediately before the execution and delivery of the Purchase Agreement. As of the Record Date, holders of our Series&#160;C Preferred Stock are entitled to 2.65&#160;votes for each share of Series&#160;C Preferred Stock outstanding. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Recommendation of the Board of Directors</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The Board unanimously recommends that you vote &#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">FOR</font><font style="letter-spacing:0.2pt;">&#8221; Proposal No. 3 to approve the Reverse Stock Split.</font>
        </div>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">22</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a><a name="tPN4S">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style=" text-decoration:underline #000000 solid;letter-spacing:-0.2pt;">PROPOSAL NO. 4&#8201;&#8212;&#8201;SHARE INCREASE PROPOSAL</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">General</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Our Board has determined that it is advisable to increase our authorized Common Stock from 100,000,000 shares to 250,000,000 shares, and has voted to recommend that the stockholders adopt an amendment to our Certificate effecting the proposed increase (the &#8220;Share Increase Amendment&#8221;). The full text of the proposed Share Increase Amendment to the Certificate is attached to this proxy statement as Appendix&#160;E. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">As of January&#160;6, 2025, approximately 11,256,133 shares of our Common Stock were issued and outstanding (excluding treasury shares) and approximately an additional 259,535,512&#160;shares of Common Stock were reserved for issuance upon the conversion of certain securities (including up to 233,650,443&#160;shares of Common Stock issuable upon conversion of each existing series of our preferred stock and 24,844,725 shares of Common Stock issuable pursuant to the Warrant Exchange) and exercise of options granted under our various stock-based plans. Accordingly, assuming the reservation of all of the shares of Common Stock described above (which number, for illustration purposes, has not been adjusted as a result of the Reverse Stock Split Amendment), the Company needs 170,791,645 additional shares of Common Stock to be authorized for future issuance under the Certificate. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Our Board believes it continues to be in our best interest to have sufficient additional authorized but unissued shares of Common Stock available in order to provide flexibility for corporate action in the future. Management believes that the availability of additional authorized shares for issuance from time to time in our Board&#8217;s discretion in connection with future financings, stock splits or for other corporate purposes is desirable in order to avoid repeated separate amendments to our Certificate and the delay and expense incurred in holding special meetings of the stockholders to approve such amendments. We currently have no specific understandings, arrangements or agreements with respect to any future acquisitions that would require us to issue a material amount of new shares of our common stock. However, our Board believes that the currently available unissued shares do not provide sufficient flexibility for corporate action in the future. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">We will not solicit further authorization by vote of the stockholders for the issuance of the additional shares of Common Stock proposed to be authorized, except as required by law, regulatory authorities or rules of The Nasdaq Stock Market or any other stock exchange on which our shares may then be listed. The issuance of additional shares of Common Stock could have the effect of diluting existing stockholder earnings per share, book value per share and voting power. Our stockholders do not have any preemptive right to purchase or subscribe for any part of any new or additional issuance of our securities. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Required Vote</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In order to approve this proposal, assuming that a quorum is present at the Special Meeting, the affirmative vote of a majority of the votes cast by the stockholders entitled to vote on the Share Increase Proposal is required for the proposal to pass. Abstentions and broker non-votes, if any, will have no effect on the Share Increase Proposal. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">As of the Record Date, there were 11,256,133 shares of Common Stock and 1,000,000 shares of our Series&#160;C Preferred Stock outstanding and entitled to vote. Holders of our Common Stock are entitled to one&#160;(1) vote for each share of Common Stock outstanding as of the Record Date. Holders of our Series&#160;C Preferred Stock will vote together with the holders of our Common Stock on the Share Increase Proposal on an as-converted to Common Stock basis, such that the number of votes per share of Series&#160;C Preferred Stock is equal to 2.65, assuming a conversion price of $1.00 per share, which was the Nasdaq Minimum Price (as defined in Nasdaq Listing Rule&#160;5635(d)) applicable immediately before the execution and delivery of the Purchase Agreement. As of the Record Date, holders of our Series&#160;C Preferred Stock are entitled to 2.65&#160;votes for each share of Series&#160;C Preferred Stock outstanding. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Recommendation of the Board of Directors</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The Board unanimously recommends that you vote &#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">FOR</font><font style="letter-spacing:0.2pt;">&#8221; Proposal No. 4 to approve the Share Increase Proposal. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">23</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a><a name="tPN52">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style=" text-decoration:underline #000000 solid;letter-spacing:-0.2pt;">PROPOSAL NO. 5&#8201;&#8212;&#8201;2018 PLAN AMENDMENT PROPOSAL</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">General</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">We are requesting that you vote to approve an amendment to the Cyclacel Pharmaceuticals, Inc. 2018&#160;Equity Incentive Plan. On January&#160;5, 2025, the Board adopted a resolution approving, subject to approval by our stockholders, an amendment of the 2018 Equity Incentive Plan to increase the number of shares of Common Stock available for grant under the 2018 Plan by adding 500,000 shares. The 2018 Plan was previously approved by our stockholders at the 2018 annual meeting. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">As of January&#160;6, 2025, the equity overhang, represented by all awards outstanding plus those available for future grant under the 2018 Plan, was 2.7%. The equity overhang from all awards outstanding and shares available for issuance would be 6.8%, assuming approval of this 2018 Plan&#160;Amendment Proposal, but excluding the impact from the approvals of Proposals 1 and 2. Equity overhang was calculated in each instance above as all shares issuable upon exercise of outstanding options plus shares available for future grant divided by (a)&#160;common shares outstanding plus (b)&#160;shares in the numerator. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Key Considerations for Requesting Additional Shares</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In determining the number of shares to be authorized under the 2018 Plan, as proposed to be amended, the Board considered the following principal factors: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Number of Shares Available for Grant under Existing Plan: As of January&#160;6, 2025, 195,972 shares remained available for issuance under the 2018 Plan. Except for 13,333 shares that remained available under our 2020 Inducement Equity Incentive Plan, there were no shares available to grant under prior incentive plans. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.9pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.9pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Number of Outstanding Awards Under All Plans: As of January&#160;6, 2025, there were 118,878 outstanding stock options, which had a weighted average exercise price of $44.33 and a weighted average remaining contractual life of 7.21&#160;years, and there were 39,414 RSU awards outstanding. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Our Board, the Compensation Development Committee and management all believe that the proposed amendment of the 2018 Plan is in the best interests of, and will provide long-term advantages to, us and our stockholders and recommends approval by our stockholders. The Board believes that the number of shares of Common Stock currently available for issuance under the 2018 Plan is insufficient in view of our compensation structure and strategy. The Board has concluded that our ability to attract, retain and motivate top quality employees and directors is material to our success and would be enhanced by our continued ability to make grants under the 2018 Plan. The Board has directed that the proposal to approve the amendment of the 2018&#160;Plan be submitted to the stockholders for approval at the Special Meeting. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The following is a brief summary of the 2018 Plan, as amended by this Proposal, and is qualified in all respects by the specific language of the full text of the amended and restated 2018 Plan, a copy of which is attached as Appendix&#160;F to the Proxy Statement. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Material Features of the 2018 Plan</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="font-style:italic;letter-spacing:0.2pt;">Eligibility</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;The 2018 Plan allows us, under the direction of our Compensation and Organization Development Committee, to make grants of stock options, restricted and unrestricted stock awards and other stock-based awards to employees, consultants and directors who, in the opinion of the Compensation and Organization Development Committee, are in a position to make a significant contribution to our long-term success. The purpose of these awards is to attract and retain key individuals, further align employee and stockholder interests, and to closely link compensation with Company performance. The 2018 Plan provides an essential component of the total compensation package, reflecting the importance that we place on aligning the interests of key individuals with those of our stockholders. All employees, directors and consultants of the Company and its affiliates are eligible to participate in the 2018 Plan. As of January&#160;3, 2025, there were approximately ten&#160;(10) individuals eligible to participate. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="font-style:italic;letter-spacing:0.2pt;">Shares Available for Issuance</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;As of January&#160;3, 2025, 195,972 shares of our Common Stock were available for future awards under the 2018 Plan. In addition, if any awards granted under the 2018 Plan </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">24</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">lapse or are canceled, the shares subject to those awards will again become available for awards under the 2018 Plan. As of January&#160;3, 2025, 118,225 shares were subject to outstanding awards under the 2018 Plan. Generally, shares of Common Stock reserved for awards under the 2018 Plan that lapse or are canceled will be added back to the share reserve available for future awards. However, shares of Common Stock tendered in payment for an award or shares of Common Stock withheld for taxes will not be available again for grant. The 2018 Plan provides that no non-employee director participant may receive awards for more than an aggregate grant date fair value of $100,000 in any calendar year. If our stockholders approve this proposal, an additional 500,000 shares of our Common Stock would be available for future awards under the 2018 Plan. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="font-style:italic;letter-spacing:0.2pt;">Stock Options</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;Stock options granted under the 2018 Plan may either be incentive stock options, which are intended to satisfy the requirements of Section&#160;422 of the Internal Revenue Code of 1986, as amended, or the Code, or non-qualified stock options, which are not intended to meet those requirements. Incentive Stock Options may be granted to employees of the Company and its affiliates who are deemed to be residents of the United States for tax purposes. Non-qualified options may be granted to any employees, directors and consultants of the Company and its affiliates. The exercise price of a stock option may not be less than 100% of the fair market value of our Common Stock on the date of grant. If an incentive stock option is granted to an individual who owns more than 10% of the total combined voting power of all classes of our capital stock (or the capital stock of an affiliate of the Company), the exercise price may not be less than 110% of the fair market value of our Common Stock on the date of grant and the term of the incentive stock option may not be longer than five&#160;(5) years. Non-qualified options may not have a term longer than ten&#160;(10) years. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Award agreements for stock options include rules for exercise of the stock options after termination of service. Options may not be exercised unless they are vested, and no option may be exercised after the end of the term set forth in the award agreement. Generally, incentive stock options will be exercisable for three&#160;(3) months after termination of service for any reason other than death or total and permanent disability, and for 12&#160;months after termination of service on account of death or total and permanent disability which occurs within three&#160;(3) months of termination of service. However, options will not be exercisable if the termination of service was due to cause. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="font-style:italic;letter-spacing:0.2pt;">Restricted Stock</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;Restricted stock is common stock that is subject to restrictions, including a prohibition against transfer and a substantial risk of forfeiture, until the end of a &#8220;restricted period&#8221; during which the grantee must satisfy certain vesting conditions. If the grantee does not satisfy the vesting conditions by the end of the restricted period, the restricted stock is forfeited. During the restricted period, the holder of restricted stock has the rights and privileges of a regular stockholder, except that the restrictions set forth in the applicable award agreement apply. For example, the holder of restricted stock may vote and receive dividends on the restricted shares; but he or she may not sell the shares until the restrictions are lifted. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="font-style:italic;letter-spacing:0.2pt;">Restricted Stock Units</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;Restricted stock&#160;units are phantom shares that vest in accordance with terms and conditions established by the Board or the Compensation and Organization Development Committee and when the applicable restrictions lapse, the grantee shall be entitled to receive a payout in cash, shares or a combination thereof based on the number of restricted stock&#160;units as specified in the award agreement. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="font-style:italic;letter-spacing:0.2pt;">Other Stock-Based Awards</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;The 2018 Plan also authorizes the grant of other types of stock-based compensation including, but not limited to phantom stock awards, stock appreciation rights and stock unit awards. Our Compensation and Organization Development Committee may award such stock-based awards subject to such conditions and restrictions as it may determine however each stock appreciation right shall have an exercise price which shall not be less than the fair market value of our common stock on the date of grant and shall terminate no more than ten&#160;(10) years from the date of grant. These conditions and restrictions may include continued employment with us through a specified restricted period. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="font-style:italic;letter-spacing:0.2pt;">Plan&#160;Administration</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;In accordance with the terms of the 2018 Plan, our Board has authorized our Compensation and Organization Development Committee to administer the 2018 Plan. The Compensation and Organization Development Committee may delegate part of its authority and powers under the 2018 Plan to one or more of our directors and/or officers, but only the Compensation and Organization Development Committee can make awards to participants who are directors or executive officers of the Company. In accordance with the provisions of the 2018 Plan, our Compensation and Organization Development Committee determines the terms of awards, including: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:5.6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:5.6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">which employees, directors and consultants will be granted awards; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">25</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style=" float:left; margin-left:20pt; line-height:12pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the number of shares subject to each award; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the vesting provisions of each award; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">the termination or cancellation provisions applicable to awards; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6.1pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6.1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">all other terms and conditions upon which each award may be granted in accordance with the 2018&#160;Plan. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">In addition, our Compensation and Organization Development Committee may, in its discretion, amend any term or condition of an outstanding award provided (i)&#160;such term or condition as amended is permitted by the 2018 Plan, and (ii)&#160;any such amendment shall be made only with the consent of the participant to whom such award was made, if the amendment is adverse to the participant; and provided, further, that, without the prior approval of our stockholders, options will not be repriced, replaced or regranted through cancellation or by lowering the exercise price of a previously granted award and will not be exchanged for another type of award or cash. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="font-style:italic;letter-spacing:0.2pt;">Stock Dividends and Stock Splits</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;If our Common Stock shall be subdivided or combined into a greater or smaller number of shares or if we issue any shares of Common Stock as a stock dividend, the number of shares of our common stock deliverable upon exercise of an option or upon vesting of an award shall be appropriately increased or decreased proportionately, and appropriate adjustments shall be made in the exercise, base or purchase price per share to reflect such subdivision, combination or stock dividend. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="font-style:italic;letter-spacing:0.2pt;">Corporate Transactions</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;Upon a merger or other reorganization event, our Board, may, in its sole discretion, take any one or more of the following actions pursuant to the 2018 Plan, as to some or all outstanding awards: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">provide that all outstanding options shall be assumed or substituted by the successor corporation; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">upon written notice to a participant provide that the participant&#8217;s unexercised options will terminate immediately prior to the consummation of such transaction unless exercised by the participant; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">in the event of a merger pursuant to which holders of our common stock will receive a cash payment for each share surrendered in the merger, make or provide for a cash payment to the participants equal to the difference between the merger price times the number of shares of our common stock subject to such outstanding options, and the aggregate exercise price of all such outstanding options, in exchange for the termination of such options; </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">provide that outstanding awards shall be assumed or substituted by the successor corporation, become realizable or deliverable, or restrictions applicable to an award will lapse, in whole or in part, prior to or upon the merger or reorganization event; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">with respect to stock grants and in lieu of any of the foregoing, the Board or an authorized committee may provide that, upon consummation of the transaction, each outstanding stock grant shall be terminated in exchange for payment of an amount equal to the consideration payable upon consummation of such transaction to a holder of the number of shares of common stock comprising such award (to the extent such stock grant is no longer subject to any forfeiture or repurchase rights then in effect or, at the discretion of the Board or an authorized committee, all forfeiture and repurchase rights being waived upon such transaction). </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">However, in the event that the successor corporation refuses to assume or substitute an award: </font>
        </div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">awards consisting of options, stock appreciation rights and rights to purchase restricted stock will become fully vested and immediately exercisable, including awards that would not otherwise have become vested or exercisable; and </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:20pt; line-height:12pt; margin-top:6pt; margin-bottom:0pt; text-align:left; width:10pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">&#8226;</font>
          <br >
        </div>
        <div style=" margin-top:6pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:30pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">all other awards will become fully earned and eligible to receive a payout. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="font-style:italic;letter-spacing:0.2pt;">Amendment and Termination</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;The 2018 Plan may be amended by our stockholders. It may also be amended by our Board, provided that any amendment approved by our Board which is of a scope that requires stockholder approval as required by the rules of The Nasdaq Stock Market, in order to ensure favorable federal income tax treatment for any incentive stock options under Code Section&#160;422, or for any </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">26</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">other reason is subject to obtaining such stockholder approval. However, no such action may adversely affect any rights under any outstanding award without the holder&#8217;s consent. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="font-style:italic;letter-spacing:0.2pt;">Duration of Plan</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;The 2018 Plan will expire by its terms on March&#160;29, 2028. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Federal Income Tax Considerations</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The material federal income tax consequences of the issuance and exercise of stock options and other awards under the 2018 Plan, based on the current provisions of the Code and regulations, are as follows. Changes to these laws could alter the tax consequences described below. This summary assumes that all awards granted under the 2018 Plan are exempt from or comply with, the rules under Section&#160;409A of the Code related to nonqualified deferred compensation. </font>
        </div>
        <table style="width:456pt;margin-bottom:5pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <tr style="line-height:12pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:108pt;">
              <div style="font-weight:bold;">
                <font style="letter-spacing:-0.2pt;">Incentive Stock Option:</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:336pt;white-space:normal;">
              <font style="letter-spacing:0.2pt;">Incentive stock options are intended to qualify for treatment under Section&#160;422 of the Code. An incentive stock option does not result in taxable income to the optionee or deduction to us at the time it is granted or exercised, provided that no disposition is made by the optionee of the shares acquired pursuant to the option within two&#160;(2) years after the date of grant of the option nor within one&#160;(1) year after the date of issuance of shares to the optionee (referred to as the &#8220;ISO holding period&#8221;). However, the difference between the fair market value of the shares on the date of exercise and the option price will be an item of tax preference includible in &#8220;alternative minimum taxable income&#8221; of the optionee. Upon disposition of the shares after the expiration of the ISO holding period, the optionee will generally recognize long term capital gain or loss based on the difference between the disposition proceeds and the option price paid for the shares. If the shares are disposed of prior to the expiration of the ISO holding period, the optionee generally will recognize taxable compensation, and we will have a corresponding deduction, in the year of the disposition, equal to the excess of the fair market value of the shares on the date of exercise of the option over the option price. Any additional gain realized on the disposition will normally constitute capital gain. If the amount realized upon such a disqualifying disposition is less than fair market value of the shares on the date of exercise, the amount of compensation income will be limited to the excess of the amount realized over the optionee&#8217;s adjusted basis in the shares. </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:4.167pt 0pt 4.833pt 0pt; width:108pt;">
              <div style="font-weight:bold;">
                <font style="letter-spacing:-0.2pt;">Non-Qualified Options:</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:4.167pt 0pt 4.833pt 0pt; width:336pt;white-space:normal;">
              <div>
                <font style="letter-spacing:0.2pt;">Options otherwise qualifying as incentive stock options, to the extent the aggregate fair market value of shares with respect to which such options are first exercisable by an individual in any calendar year exceeds $100,000, and options designated as non-qualified options will be treated as options that are not incentive stock options.</font>
              </div>
              <div style="margin-top:6pt;">
                <font style="letter-spacing:0.2pt;">A non-qualified option ordinarily will not result in income to the optionee or deduction to us at the time of grant. The optionee will recognize compensation income at the time of exercise of such non-qualified option in an amount equal to the excess of the then value of the shares over the option price per share. Such compensation income of optionees may be subject to withholding taxes, and a deduction may then be allowable to us in an amount equal to the optionee&#8217;s compensation income.</font>
              </div>
              <div style="margin-top:6pt;">
                <font style="letter-spacing:0.2pt;">An optionee&#8217;s initial basis in shares so acquired will be the amount paid on exercise of the non-qualified option plus the amount of any corresponding compensation income. Any gain or loss as a result of a subsequent disposition of the shares so acquired will be capital gain or loss. </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;min-height:45pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:4.167pt 0pt 5.833pt 0pt; width:108pt;">
              <div style="font-weight:bold;">
                <font style="letter-spacing:-0.2pt;">Stock Grants:</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:4.167pt 0pt 5.833pt 0pt; width:336pt;white-space:normal;">
              <font style="letter-spacing:0.2pt;">With respect to stock grants under the 2018 Plan that result in the issuance of shares that are either not restricted as to transferability or not subject to a substantial risk of forfeiture, the grantee must generally recognize ordinary </font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">27</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <table style="width:456pt;margin-top:0pt;border-collapse: collapse;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <tr style="line-height:12pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:108pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 4.833pt 0pt; width:336pt;white-space:normal;">
              <div>
                <font style="letter-spacing:0.2pt;">income equal to the fair market value of shares received. We generally will be entitled to a deduction in an amount equal to the ordinary income recognized by the grantee.</font>
              </div>
              <div style="margin-top:6pt;">
                <font style="letter-spacing:0.2pt;">With respect to stock grants involving the issuance of shares that are restricted as to transferability and subject to a substantial risk of forfeiture, the grantee must generally recognize ordinary income equal to the fair market value of the shares received at the first time the shares become transferable or are not subject to a substantial risk of forfeiture, whichever occurs earlier. A grantee may elect to be taxed at the time of receipt of shares rather than upon lapse of restrictions on transferability or substantial risk of forfeiture, but if the grantee subsequently forfeits such shares, the grantee would not be entitled to any tax deduction, including as a capital loss, for the value of the shares on which he previously paid tax. If such election is desired, the grantee must file such election with the Internal Revenue Service within 30&#160;days of the receipt of the shares. We generally will be entitled to a deduction in an amount equal to the ordinary income recognized by the grantee. </font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:12pt;min-height:57pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:4.167pt 0pt 4pt 0pt; width:108pt;">
              <div style="font-weight:bold;">
                <font style="letter-spacing:-0.2pt;">Stock Units:</font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:4.167pt 0pt 4pt 0pt; width:336pt;white-space:normal;">
              <font style="letter-spacing:0.2pt;">The grantee recognizes no income until the issuance of the shares. At that time, the grantee must generally recognize ordinary income equal to the fair market value of the shares received. We generally will be entitled to a deduction in an amount equal to the ordinary income recognized by the grantee.</font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Plan&#160;Benefits</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Since the adoption of the 2018 Plan through January&#160;3, 2025, we have granted the following stock options and restricted stock&#160;units under the 2018 Plan to the individuals and groups listed below. In all cases, the securities underlying such equity awards were shares of our common stock. </font>
        </div>
        <table style="width:456pt;height:137.5pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="line-height:9pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:bold;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt; width:408.42pt;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:-0.16pt;">Name and Position </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:6pt;">&#8203;</td>
            <td style="border-bottom:1px solid #000000;padding:0pt 0pt 2.167pt 0pt;text-align:center;" colspan="4">
              <div style="text-align:center;">
                <font style="letter-spacing:-0.16pt;">Number of</font>
                <br >
                <font style="letter-spacing:-0.16pt;">Shares </font>
              </div>
            </td>
            <td style="padding:0pt;border-bottom:1px solid #FFFFFF; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.25pt 0pt 1.5pt 0pt; width:408.42pt;text-align:left;">
              <font style="letter-spacing:0.2pt;">Named Executive Officers: </font>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.935pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.935pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:408.42pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Spiro Rombotis </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.935pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">37,198</td>
            <td style="padding:0pt;padding-left:3.935pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:408.42pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Paul McBarron </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.935pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">22,326</td>
            <td style="padding:0pt;padding-left:3.935pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:408.42pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">All current executive officers as a group </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.935pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">59,524</td>
            <td style="padding:0pt;padding-left:3.935pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:408.42pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">All current directors who are not executive officers as a group </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.935pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">8,316</td>
            <td style="padding:0pt;padding-left:3.935pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:408.42pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Each associate of any executive officers, current directors or director nominees </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.935pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">0</td>
            <td style="padding:0pt;padding-left:3.935pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;background-color:#CCEEFF;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:408.42pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">Each other person who received or is to receive 5% of awards </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.935pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">0</td>
            <td style="padding:0pt;padding-left:3.935pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;white-space:nowrap;text-align:center;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:3.5pt 0pt 1.5pt 0pt; width:408.42pt;text-align:left;">
              <div style="white-space:nowrap;">
                <font style="letter-spacing:0.2pt;">All employees, including all current officers who are not executive officers, as a group </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt;padding-left:3.935pt;width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right; ">&#8203;</td>
            <td style="padding:3.5pt 0pt 1.5pt 0pt; min-width:21pt; text-align:right; white-space:nowrap;">89,845</td>
            <td style="padding:0pt;padding-left:3.935pt;width:0pt;">&#8203;</td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="margin-top:11.9pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">New Plan&#160;Benefits</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Other than the annual grant of stock options or restricted stock&#160;units, or any initial grant of restricted stock&#160;units to our non-employee directors, the amounts of future grants under the 2018 Plan are not determinable as awards under the 2018 Plan and will be granted at the sole discretion of the Compensation and Organization Development Committee, or other delegated persons and we cannot determine at this time either the persons who will receive awards under the 2018 Plan or the amount or types of any such awards. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">On January&#160;6, 2025, the closing market price per share of our Common Stock was $0.45, as reported by the Nasdaq Stock Market. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Required Vote</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In order to approve this proposal, assuming that a quorum is present at the Special Meeting, the affirmative vote of a majority of the votes cast by the stockholders entitled to vote on the 2018 Plan </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">28</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:432pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Amendment Proposal is required for the proposal to pass. Abstentions and broker non-votes, if any, will have no effect on the 2018 Plan&#160;Amendment Proposal. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">As of the Record Date, there were 11,256,133 shares of Common Stock and 1,000,000 shares of our Series&#160;C Preferred Stock outstanding and entitled to vote. Holders of our Common Stock are entitled to one&#160;(1) vote for each share of Common Stock outstanding as of the Record Date. Holders of our Series&#160;C Preferred Stock will vote together with the holders of our Common Stock on the 2018 Plan Amendment Proposal on an as-converted to Common Stock basis, such that the number of votes per share of Series&#160;C Preferred Stock is equal to 2.65, assuming a conversion price of $1.00 per share, which was the Nasdaq Minimum Price (as defined in Nasdaq Listing Rule&#160;5635(d)) applicable immediately before the execution and delivery of the Purchase Agreement. As of the Record Date, holders of our Series&#160;C Preferred Stock are entitled to 2.65 votes for each share of Series&#160;C Preferred Stock outstanding. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Recommendation of the Board of Directors</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The Board unanimously recommends that you vote &#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">FOR</font><font style="letter-spacing:0.2pt;">&#8221; Proposal No. 5 to approve the 2018 Plan&#160;Amendment Proposal. </font>
        </div>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">29</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a><a name="tPN6A">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:320pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style=" text-decoration:underline #000000 solid;letter-spacing:-0.2pt;">PROPOSAL NO. 6&#8201;&#8212;&#8201;ADJOURNMENT PROPOSAL</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">General</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Our stockholders are being asked to consider and vote upon an adjournment of the Special Meeting, if necessary, if a quorum is present, to solicit additional proxies if there are insufficient votes in favor of approval of any of the above Proposals. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Required Vote</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">In order to approve this proposal, assuming that a quorum is present at the Special Meeting, the affirmative vote of a majority of the votes cast by the stockholders entitled to vote on the Adjournment Proposal is required for the proposal to pass. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">As of the Record Date, there were 11,256,133 shares of Common Stock and 1,000,000 shares of our Series&#160;C Preferred Stock outstanding and entitled to vote. Holders of our Common Stock are entitled to one&#160;(1) vote for each share of Common Stock outstanding as of the Record Date. Holders of our Series&#160;C Preferred Stock will vote together with the holders of our Common Stock on the Adjournment Proposal on an as-converted to Common Stock basis, such that the number of votes per share of Series&#160;C Preferred Stock is equal to 2.65, assuming a conversion price of $1.00 per share, which was the Nasdaq Minimum Price (as defined in Nasdaq Listing Rule&#160;5635(d)) applicable immediately before the execution and delivery of the Purchase Agreement. As of the Record Date, holders of our Series&#160;C Preferred Stock are entitled to 2.65&#160;votes for each share of Series&#160;C Preferred Stock outstanding. </font>
        </div>
        <div style="margin-top:12pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Recommendation of the Board of Directors</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The Board unanimously recommends that you vote &#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">FOR</font><font style="letter-spacing:0.2pt;">&#8221; Proposal No. 6. </font>
        </div>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">30</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Helvetica, Arial, sans-serif;font-size:9pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a><a name="tOTMA">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:584pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:-0.2pt;">OTHER MATTERS</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">Management and the Board of the Company know of no matters to be brought before the Special Meeting other than as set forth herein. </font>
        </div>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">31</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Helvetica, Arial, sans-serif;font-size:9pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a><a name="tSTCO">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:528pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:-0.2pt;">STOCKHOLDER COMMUNICATIONS</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">Stockholders wishing to communicate with the Board or with an individual member of the Board may do so by writing to the Board or to the particular member of the Board, care of the Corporate Secretary by mail to our principal executive offices, Attention: Corporate Secretary. The envelope should indicate that it contains a stockholder communication. All such stockholder communications will be forwarded to the director or directors to whom the communications are addressed. </font>
        </div>
        <div style="margin-top:8pt; width:456pt; line-height:12pt;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">Berkeley Heights, New Jersey</font>
        </div>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">32</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a><a name="tAPA">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:306.9pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Appendix&#160;A</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:8pt; text-align:center; width:456pt; line-height:12pt;">
          <font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Delaware</font><font style="letter-spacing:0.2pt;"> </font>
          <br >
          <font style="letter-spacing:0.2pt;">The First State </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">I, JEFFREY W. BULLOCK, SECRETARY OF STATE OF THE STATE OF DELAWARE, DO HEREBY CERTIFY THE ATTACHED IS A TRUE AND CORRECT COPY OF THE CERTIFICATE OF DESIGNATION OF &#8220;CYCLACEL PHARMACEUTICALS, INC.&#8221;, FILED IN THIS OFFICE ON THE THIRD DAY OF JANUARY, A.D. 2025, AT 9:30 O`CLOCK A.M.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <table style="width:456pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
          <tr style="min-height:84.1pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:8pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:252pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 0.5pt 0pt; width:192pt;white-space:normal;text-align:center;">
              <div style="position:relative;text-align:center;">
                <img src="sg_jeffreywbullock-bw.jpg" alt="[MISSING IMAGE: sg_jeffreywbullock-bw.jpg]" height="83" width="166" >
              </div>
              <div style="margin-top:5pt; text-align:justify;">
                <div style="margin-left: 0pt; width: 192pt; margin-top: 0pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
              </div>
              <div style="margin-top:2pt; text-align:center; line-height:10pt;">
                <font style="letter-spacing:0.16pt;">Jeffrey W. Bullock, Secretary of State</font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <table style="width:456pt;height:94pt;margin-top:13pt;border-collapse: collapse;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <tr style="min-height:90pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 1pt 0pt; width:144pt;">
              <div style="line-height:12pt;">
                <font style="letter-spacing:0.2pt;">2579644 8100</font>
                <br >
                <font style="letter-spacing:0.2pt;">SR# 20250015033 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 4pt 0pt; width:144pt;white-space:normal;text-align:center;">
              <div style="position:relative;text-align:center;">
                <img src="lg_secretarysoffistamp-bwlr.jpg" alt="[MISSING IMAGE: lg_secretarysoffistamp-bwlr.jpg]" height="115" width="115" >
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0.5pt 1pt 0pt; width:144pt;text-align:right;">
              <div style="text-align:right; line-height:12pt;">
                <font style="letter-spacing:0.2pt;">Authentication: 202612017</font>
                <br >
                <font style="letter-spacing:0.2pt;">Date: 01-03-25</font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
          <tr style="line-height:10pt;min-height:19pt;white-space:nowrap;text-align:left;vertical-align:top;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:3.5pt 0pt 1pt 0pt; width:0pt;" colspan="7">
              <font style="letter-spacing:0.2pt;">You may verify this certificate online at corp.delaware.gov/authver.shtml</font>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;"> </font>
        </div>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A-1</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">CYCLACEL PHARMACEUTICALS, INC.</font>
        </div>
        <div style="margin-top:6pt; text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">CERTIFICATE OF DESIGNATIONS, PREFERENCES,</font>
        </div>
        <div style="margin-top:6pt; text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">RIGHTS AND LIMITATIONS</font>
        </div>
        <div style="margin-top:6pt; text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">OF</font>
        </div>
        <div style="margin-top:6pt; text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">SERIES C CONVERTIBLE PREFERRED STOCK</font>
        </div>
        <div style="margin-top:6pt; text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">PURSUANT TO SECTION 151 OF THE</font>
        </div>
        <div style="margin-top:6pt; text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">DELAWARE GENERAL CORPORATION LAW</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The undersigned, Paul McBarron, does hereby certify that: </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">1.&nbsp;&nbsp;&nbsp;He is the EVP, Finance and Chief Financial Officer of Cyclacel Pharmaceuticals, Inc., a Delaware corporation (the </font><font style="font-weight:bold;letter-spacing:-0.2pt;">&#8220;Corporation&#8221;)</font><font style="letter-spacing:0.2pt;">. </font>
        </div>
        <div style="margin-left:40pt; margin-top:8pt; width:416pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">2.&nbsp;&nbsp;&nbsp;The Corporation is authorized to issue 5,000,000 shares of preferred stock. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">3.&nbsp;&nbsp;&nbsp;The following resolutions were duly adopted by the board of directors of the Corporation (the </font><font style="font-weight:bold;letter-spacing:-0.2pt;">&#8220;Board of Directors&#8221;)</font><font style="letter-spacing:0.2pt;">: </font>
        </div>
        <div style="margin-left:40pt; text-indent:20pt; margin-top:8pt; width:416pt; line-height:12pt;">
          <font style="font-weight:bold;letter-spacing:-0.2pt;">WHEREAS</font><font style="letter-spacing:0.2pt;">, the Amended and Restated Certificate of Incorporation of the Corporation, as amended, provides for a class of its authorized capital stock known as preferred stock, consisting of 5,000,000 shares, $0.001 par value per share, issuable from time to time in one or more series; </font>
        </div>
        <div style="margin-left:40pt; text-indent:20pt; margin-top:8pt; width:416pt; line-height:12pt;">
          <font style="font-weight:bold;letter-spacing:-0.2pt;">WHEREAS</font><font style="letter-spacing:0.2pt;">, the Board of Directors is authorized to provide for the issuance of the shares of preferred stock in series and to establish, from time to time, the number of shares to be included in each such series, and to fix the number, designation, powers, preferences and rights of the shares of each such series and any qualifications, limitations or restrictions thereon; and </font>
        </div>
        <div style="margin-left:40pt; text-indent:20pt; margin-top:8pt; width:416pt; line-height:12pt;">
          <font style="font-weight:bold;letter-spacing:-0.2pt;">WHEREAS</font><font style="letter-spacing:0.2pt;">, it is the desire of the Board of Directors, pursuant to its authority as aforesaid, to fix the rights, preferences, restrictions and other matters relating to a series of the preferred stock; </font>
        </div>
        <div style="margin-left:40pt; text-indent:20pt; margin-top:8pt; width:416pt; line-height:12pt;">
          <font style="font-weight:bold;letter-spacing:-0.2pt;">NOW</font><font style="letter-spacing:0.2pt;">, </font><font style="font-weight:bold;letter-spacing:-0.2pt;">THEREFORE</font><font style="letter-spacing:0.2pt;">, </font><font style="font-weight:bold;letter-spacing:-0.2pt;">BE IT RESOLVED</font><font style="letter-spacing:0.2pt;">, that the Board of Directors does hereby provide for the issuance of a series of preferred stock to be designated the &#8220;Series&#160;C Convertible Preferred Stock&#8221; and does hereby fix and determine the number rights, preferences, restrictions and other matters relating to such series of preferred stock as follows: </font>
        </div>
        <div style="margin-top:12pt; text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">TERMS OF PREFERRED STOCK</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Section&#160;1.&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Definitions</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;For the purposes hereof, the following terms shall have the following meanings: </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="font-weight:bold;letter-spacing:-0.2pt;">&#8220;Affiliate&#8221;</font><font style="letter-spacing:0.2pt;"> means any Person that, directly or indirectly through one or more intermediaries, controls or is controlled by or is under common control with a Person, as such terms are used in and construed under Rule&#160;405 of the Securities Act. </font>
        </div>
        <div style="margin-left:40pt; margin-top:8pt; width:416pt; line-height:12pt;">
          <font style="font-weight:bold;letter-spacing:-0.2pt;">&#8220;Beneficial Ownership Limitation&#8221;</font><font style="letter-spacing:0.2pt;"> shall have the meaning set forth in </font><font style="font-weight:bold;letter-spacing:-0.2pt;">Section&#160;6(c)</font><font style="letter-spacing:0.2pt;">. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="font-weight:bold;letter-spacing:-0.2pt;">&#8220;Business Day&#8221;</font><font style="letter-spacing:0.2pt;"> means any day except any Saturday, any Sunday, any day which is a federal legal holiday in the United States or any day on which banking institutions in the State of New York are authorized or required by law or other governmental action to close. </font>
        </div>
        <div style="margin-left:40pt; margin-top:8pt; width:416pt; line-height:12pt;">
          <font style="font-weight:bold;letter-spacing:-0.2pt;">&#8220;Commission&#8221;</font><font style="letter-spacing:0.2pt;"> means the United States Securities and Exchange Commission. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="font-weight:bold;letter-spacing:-0.2pt;">&#8220;Common Stock&#8221;</font><font style="letter-spacing:0.2pt;"> means the Corporation&#8217;s common stock, par value $0.001 per share, and stock of any other class of securities into which such securities may hereafter be reclassified or changed. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="font-weight:bold;letter-spacing:-0.2pt;">&#8220;Common Stock Equivalents&#8221;</font><font style="letter-spacing:0.2pt;"> means any securities of the Corporation or its subsidiaries which would entitle the holder thereof to acquire at any time Common Stock, including, without limitation, </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A-2</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:20pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">any debt, preferred stock, rights, options, warrants or other instrument that is at any time convertible into or exercisable or exchangeable for, or otherwise entitles the holder thereof to receive, Common Stock. </font>
        </div>
        <div style="margin-left:40pt; margin-top:8pt; width:416pt; line-height:12pt;">
          <font style="font-weight:bold;letter-spacing:-0.2pt;">&#8220;Conversion Amount&#8221;</font><font style="letter-spacing:0.2pt;"> means the sum of the Stated Value at issue. </font>
        </div>
        <div style="margin-left:40pt; margin-top:8pt; width:416pt; line-height:12pt;">
          <font style="font-weight:bold;letter-spacing:-0.2pt;">&#8220;Conversion Date&#8221;</font><font style="letter-spacing:0.2pt;"> shall have the meaning set forth in </font><font style="font-weight:bold;letter-spacing:-0.2pt;">Section&#160;6(a)</font><font style="letter-spacing:0.2pt;">. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="font-weight:bold;letter-spacing:-0.2pt;">&#8220;Conversion Shares&#8221;</font><font style="letter-spacing:0.2pt;"> means, collectively, the shares of Common Stock issuable upon conversion of the shares of Preferred Stock in accordance with the terms hereof. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="font-weight:bold;letter-spacing:-0.2pt;">&#8220;Exchange Act&#8221;</font><font style="letter-spacing:0.2pt;"> means the Securities Exchange Act of 1934, as amended, and the rules and regulations promulgated thereunder. </font>
        </div>
        <div style="margin-left:40pt; margin-top:8pt; width:416pt; line-height:12pt;">
          <font style="font-weight:bold;letter-spacing:-0.2pt;">&#8220;Fundamental Transaction&#8221;</font><font style="letter-spacing:0.2pt;"> shall have the meaning set forth in </font><font style="font-weight:bold;letter-spacing:-0.2pt;">Section&#160;7(d)</font><font style="letter-spacing:0.2pt;">. </font>
        </div>
        <div style="margin-left:40pt; margin-top:8pt; width:416pt; line-height:12pt;">
          <font style="font-weight:bold;letter-spacing:-0.2pt;">&#8220;GAAP&#8221;</font><font style="letter-spacing:0.2pt;"> means United States generally accepted accounting principles. </font>
        </div>
        <div style="margin-left:40pt; margin-top:8pt; width:416pt; line-height:12pt;">
          <font style="font-weight:bold;letter-spacing:-0.2pt;">&#8220;Holder&#8221;</font><font style="letter-spacing:0.2pt;"> shall have the meaning set forth in </font><font style="font-weight:bold;letter-spacing:-0.2pt;">Section&#160;2</font><font style="letter-spacing:0.2pt;">. </font>
        </div>
        <div style="margin-left:40pt; margin-top:8pt; width:416pt; line-height:12pt;">
          <font style="font-weight:bold;letter-spacing:-0.2pt;">&#8220;Liquidation&#8221;</font><font style="letter-spacing:0.2pt;"> shall have the meaning set forth in </font><font style="font-weight:bold;letter-spacing:-0.2pt;">Section&#160;5</font><font style="letter-spacing:0.2pt;">. </font>
        </div>
        <div style="margin-left:40pt; margin-top:8pt; width:416pt; line-height:12pt;">
          <font style="font-weight:bold;letter-spacing:-0.2pt;">&#8220;New York Courts&#8221;</font><font style="letter-spacing:0.2pt;"> shall have the meaning set forth in </font><font style="font-weight:bold;letter-spacing:-0.2pt;">Section&#160;8(d)</font><font style="letter-spacing:0.2pt;">. </font>
        </div>
        <div style="margin-left:40pt; margin-top:8pt; width:416pt; line-height:12pt;">
          <font style="font-weight:bold;letter-spacing:-0.2pt;">&#8220;Notice of Conversion&#8221;</font><font style="letter-spacing:0.2pt;"> shall have the meaning set forth in </font><font style="font-weight:bold;letter-spacing:-0.2pt;">Section&#160;6(a)</font><font style="letter-spacing:0.2pt;">. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="font-weight:bold;letter-spacing:-0.2pt;">&#8220;Original Issue Date&#8221;</font><font style="letter-spacing:0.2pt;"> means the date of the first issuance of any shares of the Preferred Stock regardless of the number of transfers of any particular shares of Preferred Stock and regardless of the number of certificates which may be issued to evidence such Preferred Stock. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="font-weight:bold;letter-spacing:-0.2pt;">&#8220;Person&#8221;</font><font style="letter-spacing:0.2pt;"> means an individual or corporation, partnership, trust, incorporated or unincorporated association, joint venture, limited liability company, joint stock company, government (or an agency or subdivision thereof) or other entity of any kind. </font>
        </div>
        <div style="margin-left:40pt; margin-top:8pt; width:416pt; line-height:12pt;">
          <font style="font-weight:bold;letter-spacing:-0.2pt;">&#8220;Preferred Stock&#8221;</font><font style="letter-spacing:0.2pt;"> shall have the meaning set forth in </font><font style="font-weight:bold;letter-spacing:-0.2pt;">Section&#160;2</font><font style="letter-spacing:0.2pt;">. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="font-weight:bold;letter-spacing:-0.2pt;">&#8220;Securities Act&#8221;</font><font style="letter-spacing:0.2pt;"> means the Securities Act of 1933, as amended, and the rules and regulations promulgated thereunder. </font>
        </div>
        <div style="margin-left:40pt; margin-top:8pt; width:416pt; line-height:12pt;">
          <font style="font-weight:bold;letter-spacing:-0.2pt;">&#8220;Share Delivery Date&#8221;</font><font style="letter-spacing:0.2pt;"> shall have the meaning set forth in </font><font style="font-weight:bold;letter-spacing:-0.2pt;">Section&#160;6(b)</font><font style="letter-spacing:0.2pt;">. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="font-weight:bold;letter-spacing:-0.2pt;">&#8220;Stated Value&#8221;</font><font style="letter-spacing:0.2pt;"> shall have the meaning set forth in </font><font style="font-weight:bold;letter-spacing:-0.2pt;">Section&#160;2</font><font style="letter-spacing:0.2pt;">, as the same may be increased pursuant to Section&#160;3. </font>
        </div>
        <div style="margin-left:40pt; margin-top:8pt; width:416pt; line-height:12pt;">
          <font style="font-weight:bold;letter-spacing:-0.2pt;">&#8220;Successor Entity&#8221;</font><font style="letter-spacing:0.2pt;"> shall have the meaning set forth in </font><font style="font-weight:bold;letter-spacing:-0.2pt;">Section&#160;7(d)</font><font style="letter-spacing:0.2pt;">. </font>
        </div>
        <div style="margin-left:40pt; margin-top:8pt; width:416pt; line-height:12pt;">
          <font style="font-weight:bold;letter-spacing:-0.2pt;">&#8220;Trading Day&#8221;</font><font style="letter-spacing:0.2pt;"> means a day on which the principal Trading Market is open for business. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="font-weight:bold;letter-spacing:-0.2pt;">&#8220;Trading Market&#8221;</font><font style="letter-spacing:0.2pt;"> means any of the following markets or exchanges on which the Common Stock is listed or quoted for trading on the date in question: the Nasdaq Capital Market, the Nasdaq Global Market, the Nasdaq Global Select Market, the NYSE MKT or the New York Stock Exchange (or any successors to any of the foregoing). </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="font-weight:bold;letter-spacing:-0.2pt;">&#8220;Transfer Agent&#8221;</font><font style="letter-spacing:0.2pt;"> means Equiniti Trust Company, LLC, and any successor transfer agent of the Corporation. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Section&#160;2.&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Designation, Amount and Par Value</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;The series of preferred stock shall be designated as the Series&#160;C Convertible Preferred Stock (the &#8220;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Preferred Stock</font><font style="letter-spacing:0.2pt;">&#8221;) and the number of shares so designated shall be 1,000,000 (which shall not be subject to change without the written consent of a majority of the holders of the Preferred Stock (each, a &#8220;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Holder</font><font style="letter-spacing:0.2pt;">&#8221; and collectively, the &#8220;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Holders</font><font style="letter-spacing:0.2pt;">&#8221;)). Each share of Preferred Stock shall have a par value of$0.001 per share and a stated value equal to $1.00 (the &#8220;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Stated Value</font><font style="letter-spacing:0.2pt;">&#8221;). </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Section&#160;3.&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Dividends</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;Except for stock dividends or distributions for which adjustments are to be made pursuant to </font><font style="font-weight:bold;letter-spacing:-0.2pt;">Section&#160;7</font><font style="letter-spacing:0.2pt;">, Holders shall be entitled to receive, and the Corporation shall pay, dividends </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A-3</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">on shares of Preferred Stock equal (on an as-if-converted-to-Common-Stock basis, without regard to conversion limitations herein) to and in the same form as dividends actually paid on shares of the Common Stock when, as and if such dividends are paid on shares of the Common Stock. No other dividends shall be paid on shares of Preferred Stock. The Corporation shall not pay any dividends on the Common Stock unless the Corporation simultaneously complies with this provision. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Section&#160;4.&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Voting Rights</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;The Preferred Stock shall be counted for purposes of determining a quorum at a meeting of stockholders and shall vote on matters of the Corporation on an as-if-converted-to-Common-Stock basis, subject to the provisions of the Delaware General Corporation Law and subject to the Beneficial Ownership Limitation. Subject to the provisions of Section&#160;6(c) hereof, each share of Preferred Stock shall entitle the holder thereof to cast that number of votes per share of Preferred Stock as is equal to the Stated Value of such share of Preferred Stock divided by the Nasdaq Minimum Price (as defined in Nasdaq Listing Rule&#160;5635(d)) immediately preceding the Original Issue Date, and subject to adjustments for any stock splits, stock dividends, stock combinations, recapitalizations or other similar transactions following the date hereof). </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Section&#160;5.&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Liquidation Preference</font><font style="letter-spacing:0.2pt;">. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(a)&nbsp;&nbsp;&nbsp;In the event of any liquidation, dissolution or winding up of the Corporation, either voluntary or involuntary, subject to the rights of any existing series of preferred stock or to the rights of any series of preferred stock which may from time to time hereafter come into existence, the holders of the Preferred Stock shall be entitled to receive, prior and in preference to any distribution of any of the assets of the Corporation to the holders of Common Stock by reason of their ownership thereof, the Stated Value per share of Preferred Stock then held by them, plus declared but unpaid dividends. If, upon the occurrence of any liquidation, dissolution or winding up of the Corporation, the assets and funds thus distributed among the holders of the Preferred Stock shall be insufficient to permit the payment to such holders of the full aforesaid preferential amounts, then, subject to the rights of any existing series of preferred stock or to the rights of any series of preferred stock which may from time to time hereafter come into existence, the entire assets and funds of the Corporation legally available for distribution shall be distributed ratably among the holders of each series of preferred stock in proportion to the preferential amount each such holder is otherwise entitled to receive. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(b) &nbsp;&nbsp;&nbsp;Upon the completion of the distribution required by Section&#160;5(a) above and any other distribution that may be required with respect to the rights of any existing series of preferred stock or to the rights of any series of preferred stock which may from time to time hereafter come into existence, if assets remain in the Corporation, the remaining assets shall be distributed to the holders of the Common Stock until such time as the holders of the Common stock shall have received a return of the capital originally contributed thereby. Thereafter, if assets remain in the Corporation, all remaining assets shall be distributed to all holders of Common Stock and to each series of Preferred Stock, pro&#160;rata based on the number of shares of Common Stock held by each (assuming conversion of all such Preferred Stock into Common Stock). </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(c)&nbsp;&nbsp;&nbsp;For purposes of this Section&#160;5, a liquidation, dissolution or winding up of the Corporation shall be deemed to be occasioned by, or to include, (i)&#160;the acquisition of the Corporation by another entity by means of any transaction or series of related transactions (including, without limitation, any reorganization, merger or consolidation, but excluding any merger effected exclusively for the purpose of changing the domicile of the Corporation); or (ii)&#160;a sale of all or substantially all of the assets of the Corporation, unless the Corporation&#8217;s stockholders of record as constituted immediately prior to such acquisition or sale will, immediately after such acquisition or sale (by virtue of securities issued as consideration for the Corporation&#8217;s acquisition or sale or otherwise) hold at least fifty&#160;percent (50%) of the voting power of the surviving or acquiring entity in approximately the same relative&#160;percentages after such acquisition or sale as before such acquisition or sale. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(d) &nbsp;&nbsp;&nbsp;In any of the events specified in subsection (c)&#160;above, if the consideration received by the corporation is other than cash, its value will be deemed its fair market value. Any securities shall be valued as follows: </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A-4</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:60pt; width:396pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(i) &nbsp;&nbsp;&nbsp;Securities not subject to restrictions on free marketability: </font>
        </div>
        <div style="margin-left:60pt; text-indent:20pt; margin-top:8pt; width:396pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(A)&nbsp;&nbsp;&nbsp;If traded on a securities exchange, the value shall be deemed to be the average of the closing prices of the securities on such exchange over the thirty-day period ending three&#160;(3) days prior to the closing; </font>
        </div>
        <div style="margin-left:60pt; text-indent:20pt; margin-top:8pt; width:396pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(B) &nbsp;&nbsp;&nbsp;If actively traded over-the-counter, the value shall be deemed to be the average of the closing bid or sale prices (whichever is applicable) over the thirty-day period ending three&#160;(3) days prior to the closing; and </font>
        </div>
        <div style="margin-left:60pt; text-indent:20pt; margin-top:8pt; width:396pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(C)&nbsp;&nbsp;&nbsp;If there is no active public market, the value shall be the fair market value thereof, as determined in good faith by the Board of Directors. </font>
        </div>
        <div style="margin-left:40pt; text-indent:20pt; margin-top:8pt; width:416pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(ii)&nbsp;&nbsp;&nbsp;The method of valuation of securities subject to restrictions on free marketability (other than restrictions arising solely by virtue of a stockholder&#8217;s status as an affiliate or former affiliate) shall be to make an appropriate discount from the market value determined as above in (i)&#160;(A), (B)&#160;or (C)&#160;to reflect the approximate fair market value thereof, as mutually determined by the Corporation and the holders of at least a majority of the voting power of all then outstanding shares of Preferred Stock. </font>
        </div>
        <div style="margin-left:40pt; text-indent:20pt; margin-top:8pt; width:416pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(iii)&nbsp;&nbsp;&nbsp;In the event the requirements of Section&#160;2(c) are not complied with, the Corporation shall forthwith either: </font>
        </div>
        <div style="margin-left:60pt; text-indent:20pt; margin-top:8pt; width:396pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(A)&nbsp;&nbsp;&nbsp;cause such closing to be postponed until such time as the requirements of this Section&#160;5 have been complied with; or </font>
        </div>
        <div style="margin-left:60pt; text-indent:20pt; margin-top:8pt; width:396pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(B)&nbsp;&nbsp;&nbsp;cancel such transaction, in which event the rights, preferences and privileges of the holders of the Preferred Stock shall revert to and be the same as such rights, preferences and privileges existing immediately prior to the date of the first notice referred to in Section&#160;5(c)(iv) hereof. </font>
        </div>
        <div style="margin-left:40pt; text-indent:20pt; margin-top:8pt; width:416pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(iv) &nbsp;&nbsp;&nbsp;The Corporation shall give each holder of record of Preferred Stock written notice of such impending transaction not later than twenty (20) days prior to the stockholders&#8217; meeting called to approve such transaction, or twenty (20) days prior to the closing of such transaction, whichever is earlier, and shall also notify such holders in writing of the final approval of such transaction. The first of such notices shall describe the material terms and conditions of the impending transaction and the provisions of this Section&#160;5, and the Corporation shall thereafter give such holders prompt notice of any material changes. The transaction shall in no event take place sooner than twenty (20) days after the Corporation has given the first notice provided for herein or sooner than ten (10) days after the corporation has given notice of any material changes provided for herein; provided, however, that time periods set forth in this paragraph may be shortened upon the written consent of the holders of Preferred Stock that are entitled to such notice rights or similar notice rights and that represent at least a majority of the voting power of all then outstanding shares of such Preferred Stock. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Section&#160;6.&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Conversion</font><font style="letter-spacing:0.2pt;">. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">a) &nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Conversions at Option of Holder</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;Each one share of Preferred Stock shall be convertible, at any time and from time to time from and after the Original Issue Date at the option of the Holder thereof, into 2.65 shares of Common Stock (subject to the limitations set forth in </font><font style="font-weight:bold;letter-spacing:-0.2pt;">Section&#160;6(c))</font><font style="letter-spacing:0.2pt;"> (the &#8220;Conversion Ratio&#8221;). Holders shall effect conversions by providing the Corporation with the form of conversion notice attached hereto as </font><font style="font-weight:bold;letter-spacing:-0.2pt;">Annex A</font><font style="letter-spacing:0.2pt;"> ( a &#8220;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Notice of Conversion</font><font style="letter-spacing:0.2pt;">&#8221;). Each Notice of Conversion shall specify the number of shares of Preferred Stock to be converted, the number of shares of Preferred Stock owned prior to the conversion at issue, the number of shares of Preferred Stock owned subsequent to the conversion at issue and the date on which such conversion is to be effected, which date may not be prior to the date the applicable Holder delivers by facsimile or email such Notice of Conversion to the Corporation (such date, the &#8220;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Conversion Date</font><font style="letter-spacing:0.2pt;">&#8221;). If no Conversion Date is specified in a Notice of Conversion, the Conversion Date shall be the date that such Notice of Conversion to the Corporation is deemed delivered hereunder. No ink-original Notice of Conversion shall be required, nor shall any </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A-5</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:20pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">medallion guarantee (or other type of guarantee or notarization) of any Notice of Conversion form be required. The calculations and entries set forth in the Notice of Conversion shall control in the absence of manifest or mathematical error. To effect conversions of shares of Preferred Stock, a Holder shall not be required to surrender the certificate(s) representing the shares of Preferred Stock to the Corporation unless all of the shares of Preferred Stock represented thereby are so converted, in which case such Holder shall deliver the certificate representing such shares of Preferred Stock promptly following the Conversion Date at issue. Shares of Preferred Stock converted into Common Stock in accordance with the terms hereof shall be canceled and shall not be reissued. </font>
        </div>
        <div style="margin-left:40pt; margin-top:8pt; width:416pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">b)&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Mechanics of Conversion</font><font style="letter-spacing:0.2pt;">. </font>
        </div>
        <div style="margin-left:40pt; text-indent:20pt; margin-top:8pt; width:416pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">i.&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Delivery of Conversion Shares Upon Conversion</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;Not later than the earlier of (i)&#160;two&#160;(2) Trading Days and (ii)&#160;the number of Trading Days comprising the Standard Settlement Period (as defined below) after each Conversion Date (the &#8220;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Share Delivery Date</font><font style="letter-spacing:0.2pt;">&#8221;), the Corporation shall deliver, or cause to be delivered, to the converting Holder (A)&#160;the number of Conversion Shares being acquired upon the conversion of the Preferred Stock and (B)&#160;a bank check in the amount of accrued and unpaid dividends, if any. As used herein, &#8220;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Standard Settlement Period</font><font style="letter-spacing:0.2pt;">&#8221; means the standard settlement period, expressed in a number of Trading Days, on the Corporation&#8217;s primary Trading Market with respect to the Common Stock as in effect on the date of delivery of the Notice of Conversion. Notwithstanding the foregoing, with respect to any Notice(s) of Conversion delivered by 12:00&#160;pm (New York time) on the Original Issue Date, the Corporation agrees to deliver the Conversion Shares subject to such notice(s) by 4:00&#160;pm (New York time) on the Original Issue Date. </font>
        </div>
        <div style="margin-left:40pt; text-indent:20pt; margin-top:8pt; width:416pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">ii.&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Failure to Deliver Conversion Shares</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;If, in the case of any Notice of Conversion, such Conversion Shares are not delivered to or as directed by the applicable Holder by the Share Delivery Date, the Holder shall be entitled to elect by written notice to the Corporation at any time on or before its receipt of such Conversion Shares, to rescind such Conversion, in which event the Corporation shall promptly return to the Holder any original Preferred Stock certificate delivered to the Corporation and the Holder shall promptly return to the Corporation the Conversion Shares issued to such Holder pursuant to the rescinded Notice of Conversion. </font>
        </div>
        <div style="margin-left:40pt; text-indent:20pt; margin-top:8pt; width:416pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">iii.&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Obligation Absolute; Partial Liquidated Damages</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;The Corporation&#8217;s obligation to issue and deliver the Conversion Shares upon conversion of Preferred Stock in accordance with the terms hereof are absolute and unconditional, irrespective of any action or inaction by a Holder to enforce the same, any waiver or consent with respect to any provision hereof, the recovery of any judgment against any Person or any action to enforce the same, or any setoff, counterclaim, recoupment, limitation or termination, or any breach or alleged breach by such Holder or any other Person of any obligation to the Corporation or any violation or alleged violation of law by such Holder or any other person, and irrespective of any other circumstance which might otherwise limit such obligation of the Corporation to such Holder in connection with the issuance of such Conversion Shares; provided, however, that such delivery shall not operate as a waiver by the Corporation of any such action that the Corporation may have against such Holder. If the Corporation fails to deliver to a Holder such Conversion Shares pursuant to </font><font style="font-weight:bold;letter-spacing:-0.2pt;">Section&#160;6(b)(i)</font><font style="letter-spacing:0.2pt;"> by the Share Delivery Date applicable to such conversion, the Corporation shall pay to such Holder, in cash, as liquidated damages and not as a penalty, for each $1,000.00 of Stated Value of Preferred Stock being converted, per Trading Day for each Trading Day after the Share Delivery Date until such Conversion Shares are delivered or Holder rescinds such conversion. Nothing herein shall limit a Holder&#8217;s right to pursue actual damages for the Corporation&#8217;s failure to deliver Conversion Shares within the period specified herein, and such Holder shall have the right to pursue all remedies available to it hereunder, at law or in equity including, without limitation, a decree of specific performance and/or injunctive relief. The exercise of any such rights shall not prohibit a Holder from seeking to enforce damages pursuant to any other Section hereof or under applicable law. </font>
        </div>
        <div style="margin-left:40pt; text-indent:20pt; margin-top:8pt; width:416pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">iv.&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Compensation for Buy-In on Failure to Timely Deliver Conversion Shares Upon Conversion</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;In addition to any other rights available to the Holder, if the Corporation fails for any reason to deliver to a Holder the applicable Conversion Shares by the Share Delivery Date </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A-6</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:40pt; width:416pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">pursuant to </font><font style="font-weight:bold;letter-spacing:-0.2pt;">Section&#160;6(b</font><font style="letter-spacing:0.2pt;">)</font><font style="font-weight:bold;letter-spacing:-0.2pt;">(i)</font><font style="letter-spacing:0.2pt;">, and if after such Share Delivery Date such Holder is required by its brokerage firm to purchase (in an open market transaction or otherwise), or the Holder&#8217;s brokerage firm otherwise purchases, shares of Common Stock to deliver in satisfaction of a sale by such Holder of the Conversion Shares which such Holder was entitled to receive upon the conversion relating to such Share Delivery Date (a &#8220;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Buy-In</font><font style="letter-spacing:0.2pt;">&#8221;), then the Corporation shall (A)&#160;pay in cash to such Holder (in addition to any other remedies available to or elected by such Holder) the amount, if any, by which (x)&#160;such Holder&#8217;s total purchase price (including any brokerage commissions) for the Common Stock so purchased exceeds (y)&#160;the product of (1)&#160;the aggregate number of shares of Common Stock that such Holder was entitled to receive from the conversion at issue multiplied by (2)&#160;the actual sale price at which the sell order giving rise to such purchase obligation was executed (including any brokerage commissions) and (B)&#160;at the option of such Holder, either reissue (if surrendered) the shares of Preferred Stock equal to the number of shares of Preferred Stock submitted for conversion (in which case, such conversion shall be deemed rescinded) or deliver to such Holder the number of shares of Common Stock that would have been issued if the Corporation had timely complied with its delivery requirements under Section&#160;6(b)(i). For example, if a Holder purchases shares of Common Stock having a total purchase price of $11,000 to cover a Buy-In with respect to an attempted conversion of shares of Preferred Stock with respect to which the actual sale price of the Conversion Shares (including any brokerage commissions) giving rise to such purchase obligation was a total of $10,000 under clause (A)&#160;of the immediately preceding sentence, the Corporation shall be required to pay such Holder $1,000. The Holder shall provide the Corporation written notice indicating the amounts payable to such Holder in respect of the Buy-In and, upon request of the Corporation, evidence of the amount of such loss. Nothing herein shall limit a Holder&#8217;s right to pursue any other remedies available to it hereunder, at law or in equity including, without limitation, a decree of specific performance and/or injunctive relief with respect to the Corporation&#8217;s failure to timely deliver Conversion Shares upon conversion of the shares of Preferred Stock as required pursuant to the terms hereof. </font>
        </div>
        <div style="margin-left:40pt; text-indent:20pt; margin-top:8pt; width:416pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">v.&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Reservation of Shares Issuable Upon Conversion</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;Until no shares of Preferred Stock remain outstanding, the Corporation covenants that it will at all times reserve and keep available out of its authorized and unissued shares of Common Stock for the sole purpose of issuance upon conversion of the Preferred Stock as herein provided, free from preemptive rights or any other actual contingent purchase rights of Persons other than the Holder (and the other holders of the Preferred Stock), not less than such aggregate number of shares of the Common Stock as shall be issuable (taking into account the adjustments and restrictions of Section&#160;7) upon the conversion of the then outstanding shares of Preferred Stock. The Corporation covenants that all shares of Common Stock that shall be so issuable shall, upon issue, be duly authorized, validly issued, fully paid and nonassessable. </font>
        </div>
        <div style="margin-left:60pt; margin-top:8pt; width:396pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">vi. &nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">RESERVED</font><font style="letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-left:40pt; text-indent:20pt; margin-top:8pt; width:416pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">vii.&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Transfer Taxes and Expenses</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;The issuance of Conversion Shares on conversion of the Preferred Stock shall be made without charge to any Holder for any documentary stamp or similar taxes that may be payable in respect of the issue or delivery of such Conversion Shares, provided that the Corporation shall not be required to pay any tax that may be payable in respect of any transfer involved in the issuance and delivery of any such Conversion Shares upon conversion in a name other than that of the Holders of such shares of Preferred Stock and the Corporation shall not be required to issue or deliver such Conversion Shares unless or until the Person or Persons requesting the issuance thereof shall have paid to the Corporation the amount of such tax or shall have established to the satisfaction of the Corporation that such tax has been paid. The Corporation shall pay all Transfer Agent fees required for same-day processing of any Notice of Conversion and all fees to the DTC (or another established clearing corporation performing similar functions) required for same-day electronic delivery of the Conversion Shares. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">c)&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Beneficial Ownership Limitation</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;Notwithstanding anything to the contrary herein, the Corporation shall not effect any conversion of the Preferred Stock, and a Holder shall not have the right to convert any portion of the Preferred Stock, to the extent that, after giving effect to the conversion set forth on the applicable Notice of Conversion, such Holder (together with such Holder&#8217;s Affiliates, </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A-7</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:20pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">and any Persons acting as a group together with such Holder or any of such Holder&#8217;s Affiliates (such Persons, &#8220;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Attribution Parties</font><font style="letter-spacing:0.2pt;">&#8221;)) would beneficially own in excess of the Beneficial Ownership Limitation (as defined below); provided, however that following a vote of the stockholders of the Company in accordance with the rules and regulations of the Trading Market on which the Common Stock trades on such date and applicable securities laws to approve the removal of the Beneficial Ownership Limitation, the Corporation shall not effect any conversion of the Preferred Stock, and a Holder shall not have the right to convert any portion of the Preferred Stock, to the extent that, after giving effect to the conversion set forth on the applicable Notice of Conversion, such Holder (together with such Holder&#8217;s Affiliates and Attribution Parties) would beneficially own the number of shares of Common Stock which would be in excess of any statutory threshold pursuant to which the acquisition of such shares would trigger a compulsory offer requirement under applicable federal or state tender offer rules for the Holder and its Affiliates and Attribution Parties to make a tender offer for all the shares of the Company. For purposes of the foregoing sentence, the number of shares of Common Stock beneficially owned by such Holder and its Affiliates and Attribution Parties shall include the number of shares of Common Stock issuable upon conversion of the Preferred Stock with respect to which such determination is being made, but shall exclude the number of shares of Common Stock which are issuable upon (i)&#160;conversion of the remaining, unconverted Stated Value of Preferred Stock beneficially owned by such Holder or any of its Affiliates or Attribution Parties and (ii)&#160;exercise or conversion of the unexercised or unconverted portion of any other securities of the Corporation subject to a limitation on conversion or exercise analogous to the limitation contained herein (including, without limitation, the Preferred Stock) beneficially owned by such Holder or any of its Affiliates or Attribution Parties. Except as set forth in the preceding sentence, for purposes of this </font><font style="font-weight:bold;letter-spacing:-0.2pt;">Section&#160;6(c),</font><font style="letter-spacing:0.2pt;"> beneficial ownership shall be calculated in accordance with Section&#160;13(d) of the Exchange Act and the rules and regulations promulgated thereunder. To the extent that the limitation contained in this </font><font style="font-weight:bold;letter-spacing:-0.2pt;">Section&#160;6(c)</font><font style="letter-spacing:0.2pt;"> applies, the determination of whether the Preferred Stock is convertible (in relation to other securities owned by such Holder together with any Affiliates and Attribution Parties) and of how many shares of Preferred Stock are convertible shall be in the sole discretion of such Holder, and the submission of a Notice of Conversion shall be deemed to be such Holder&#8217;s determination of whether the shares of Preferred Stock may be converted (in relation to other securities owned by such Holder together with any Affiliates and Attribution Parties) and how many shares of the Preferred Stock are convertible, in each case subject to the Beneficial Ownership Limitation. To ensure compliance with this restriction, each Holder will be deemed to represent to the Corporation each time it delivers a Notice of Conversion that such conversion will not violate the restrictions set forth in this paragraph and the Corporation shall have no obligation to verify or confirm the accuracy of such representation. In addition, a determination as to any group status as contemplated above shall be determined in accordance with Section&#160;13(d) of the Exchange Act and the rules and regulations promulgated thereunder. For purposes of this </font><font style="font-weight:bold;letter-spacing:-0.2pt;">Section&#160;6(c),</font><font style="letter-spacing:0.2pt;"> in determining the number of outstanding shares of Common Stock, a Holder may rely solely on the number of outstanding shares of Common Stock as stated in a written notice by the Corporation or the Transfer Agent setting forth the number of shares of Common Stock outstanding. Upon the written or oral request (which may be via email) of a Holder, the Corporation shall within two Trading Days confirm orally and in writing to such Holder the number of shares of Common Stock then outstanding. In any case, the number of outstanding shares of Common Stock shall be determined after giving effect to the conversion or exercise of securities of the Corporation, including the Preferred Stock, by such Holder or its Affiliates or Attribution Parties since the date as of which such number of outstanding shares of Common Stock was reported. The &#8220;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Beneficial Ownership Limitation</font><font style="letter-spacing:0.2pt;">&#8221; shall mean, as of any date, the lower of(X) the maximum&#160;percentage of the number of shares of the Common Stock outstanding immediately after giving effect to the issuance of shares of Common Stock issuable upon conversion of the Preferred Stock that can be issued to the Holder without requiring a vote of the stockholders of the Company under the rules and regulations of the Trading Market on which the Common Stock trades on such date and applicable securities laws; and, (Y)&#160;</font><font style="font-style:italic;letter-spacing:0.2pt;">5%</font><font style="letter-spacing:0.2pt;"> of the number of shares of the Common Stock outstanding immediately before the Original Issue Date. The provisions of this paragraph shall be construed and implemented in a manner otherwise than in strict conformity with the terms of this </font><font style="font-weight:bold;letter-spacing:-0.2pt;">Section&#160;6(c)</font><font style="letter-spacing:0.2pt;"> to correct this paragraph (or any portion hereof) which may be defective or inconsistent with the intended Beneficial Ownership Limitation contained herein or to make changes or supplements necessary or desirable to properly give effect to such limitation. The limitations contained in this paragraph shall apply to a successor holder of Preferred Stock. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A-8</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:20pt; text-indent:20pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">d)&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Redemption</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;If, at any time after the Company holds four ( 4) meetings of the stockholders of the Company to approve the removal of the Beneficial Ownership Limitation, and such approval does not pass, the Holder may request that the Company pay an amount equal to the Fair Value (defined below) of such unconvertible shares, with such payment to be made within two Business Days from the date of request by the Holder, whereupon the unconvertible shares shall automatically be deemed cancelled and extinguished without further action on the part of the Holder or the Company and the Holder shall have no further rights relating thereto. Notwithstanding the foregoing, the Holder shall promptly return and deliver to the Company any certificate or certificates representing such unconvertible shares or deliver such other documentation reasonably requested by the Company evidencing such cancellation of the unconvertible shares. For purposes of this Section the &#8220;Fair Value&#8221; of shares shall be fixed with reference to the last reported closing stock price on the principal Trading Market on which the Common Stock is listed as of the day of the applicable fourth (4</font><font style=" position:relative; bottom:4.25pt;font-size:7.5pt;letter-spacing:0.15pt;">th</font><font style="letter-spacing:0.2pt;">) stockholders&#8217; meeting described in this section above. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Section&#160;7.&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Certain Adjustments</font><font style="letter-spacing:0.2pt;">. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">a)&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Stock Dividends and Stock Splits</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;If the Corporation, at any time while this Preferred Stock is outstanding: (i)&#160;pays a stock dividend or otherwise makes a distribution or distributions payable in shares of Common Stock on shares of Common Stock or any other Common Stock Equivalents (which, for avoidance of doubt, shall not include any shares of Common Stock issued by the Corporation upon conversion of, or payment of a dividend on, this Preferred Stock), (ii)&#160;subdivides outstanding shares of Common Stock into a larger number of shares, (iii)&#160;combines (including by way of a reverse stock split) outstanding shares of Common Stock into a smaller number of shares, or (iv)&#160;issues, in the event of a reclassification of shares of the Common Stock, any shares of capital stock of the Corporation, then the number of shares of Common Stock each share of Preferred Stock shall be convertible into shall be multiplied by a fraction of which the numerator shall be the number of shares of Common Stock (excluding any treasury shares of the Corporation) outstanding immediately before such event, and of which the denominator shall be the number of shares of Common Stock outstanding immediately after such event. Any adjustment made pursuant to this Section&#160;7(a) shall become effective immediately after the record date for the determination of stockholders entitled to receive such dividend or distribution and shall become effective immediately after the effective date in the case of a subdivision, combination or re-classification. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">b) &nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Subsequent Rights Offerings</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;In addition to any adjustments pursuant to Section&#160;7(a) above, if at any time the Corporation grants, issues or sells any Common Stock Equivalents or rights to purchase stock, warrants, securities or other property pro&#160;rata to the record holders of any class of shares of Common Stock (the &#8220;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Purchase Rights</font><font style="letter-spacing:0.2pt;">&#8221;), then the Holder will be entitled to acquire, upon the terms applicable to such Purchase Rights, the aggregate Purchase Rights which the Holder could have acquired if the Holder had held the number of shares of Common Stock acquirable upon complete conversion of such Holder&#8217;s Preferred Stock (without regard to any limitations on exercise hereof, including without limitation, the Beneficial Ownership Limitation) immediately before the date on which a record is taken for the grant, issuance or sale of such Purchase Rights, or, if no such record is taken, the date as of which the record holders of shares of Common Stock are to be determined for the grant, issue or sale of such Purchase Rights (provided, however, to the extent that the Holder&#8217;s right to participate in any such Purchase Right would result in the Holder exceeding the Beneficial Ownership Limitation, then the Holder shall not be entitled to participate in such Purchase Right to such extent (or beneficial ownership of such shares of Common Stock as a result of such Purchase Right to such extent) and such Purchase Right to such extent shall be held in abeyance for the Holder until such time, if ever, as its right thereto would not result in the Holder exceeding the Beneficial Ownership Limitation). </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">c)&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Pro Rata Distributions</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;During such time as this Preferred Stock is outstanding, if the Corporation declares or makes any dividend or other distribution of its assets (or rights to acquire its assets) to holders of shares of Common Stock, by way of return of capital or otherwise (including, without limitation, any distribution of cash, stock or other securities, property or options by way of a dividend, spin off, reclassification, corporate rearrangement, scheme of arrangement or other similar transaction) (a &#8220;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Distribution</font><font style="letter-spacing:0.2pt;">&#8221;), at any time after the issuance of this Preferred Stock, then, in each </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A-9</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:20pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">such case, the Holder shall be entitled to participate in such Distribution to the same extent that the Holder would have participated therein if the Holder had held the number of shares of Common Stock acquirable upon complete conversion of this Preferred Stock (without regard to any limitations on conversion hereof, including without limitation, the Beneficial Ownership Limitation) immediately before the date of which a record is taken for such Distribution, or, if no such record is taken, the date as of which the record holders of shares of Common Stock are to be determined for the participation in such Distribution (provided, however, to the extent that the Holder&#8217;s right to participate in any such Distribution would result in the Holder exceeding the Beneficial Ownership Limitation, then the Holder shall not be entitled to participate in such Distribution to such extent (or in the beneficial ownership of any shares of Common Stock as a result of such Distribution to such extent) and the portion of such Distribution shall be held in abeyance for the benefit of the Holder until such time, if ever, as its right thereto would not result in the Holder exceeding the Beneficial Ownership Limitation). </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">d)&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Fundamental Transaction</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;If, at any time while any shares of Preferred Stock are outstanding, (i)&#160;the Corporation, directly or indirectly, in one or more related transactions effects any merger or consolidation of the Corporation with or into another Person, (ii)&#160;the Corporation, directly or indirectly, effects any sale, lease, license, assignment, transfer, conveyance or other disposition of all or substantially all of its assets in one or a series of related transactions, (iii)&#160;any, direct or indirect, purchase offer, tender offer or exchange offer (whether by the Corporation or another Person) is completed pursuant to which holders of Common Stock are permitted to sell, tender or exchange their shares for other securities, cash or property and has been accepted by the holders of 50% or more of the outstanding Common Stock, (iv)&#160;the Corporation, directly or indirectly, in one or more related transactions effects any reclassification, reorganization or recapitalization of the Common Stock or any compulsory share exchange pursuant to which the Common Stock is effectively converted into or exchanged for other securities, cash or property, or (v)&#160;the Corporation, directly or indirectly, in one or more related transactions consummates a stock or share purchase agreement or other business combination (including, without limitation, a reorganization, recapitalization, spin-off or scheme of arrangement) with another Person whereby such other Person acquires more than 50% of the outstanding shares of Common Stock (not including any shares of Common Stock held by the other Person or other Persons making or party to, or associated or affiliated with the other Persons making or party to, such stock or share purchase agreement or other business combination) (each a &#8220;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Fundamental Transaction</font><font style="letter-spacing:0.2pt;">&#8221;), then, upon any subsequent conversion of the Preferred Stock by the Holder thereof, the Holder shall receive, for each Conversion Share that would have been issuable upon such conversion immediately prior to the occurrence of such Fundamental Transaction (without regard to any limitation in </font><font style="font-weight:bold;letter-spacing:-0.2pt;">Section&#160;6(c)</font><font style="letter-spacing:0.2pt;"> on the conversion of the Preferred Stock), the number of shares of common stock (as applicable) of the successor or acquiring corporation or the number of shares of Common Stock of the Corporation (as applicable), if it is the surviving corporation, and all additional securities (equity or debt), cash, property or other consideration (all such additional consideration, the &#8220;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Alternate Consideration</font><font style="letter-spacing:0.2pt;">&#8221;), receivable as a result of such Fundamental Transaction by a holder of the number of shares of Common Stock for which such Holder&#8217;s Preferred Stock is convertible immediately prior to such Fundamental Transaction (without regard to any limitation in </font><font style="font-weight:bold;letter-spacing:-0.2pt;">Section&#160;6(c)</font><font style="letter-spacing:0.2pt;"> on the conversion of the Preferred Stock). If holders of Common Stock are entitled to elect the proportion of securities, cash, property or other consideration to be received by holders of Common Stock in a Fundamental Transaction, then each Holder of Preferred Stock shall be given the same choice as to the proportion of securities, cash, property or other consideration such Holder is entitled to receive upon any conversion of such Holder&#8217;s shares of Preferred Stock following such Fundamental Transaction. To the extent necessary to effectuate the foregoing provisions, any successor to the Corporation or surviving entity in such Fundamental Transaction shall file a new Certificate of Designations in respect of a new series of preferred stock of the successor or acquiring corporation, or the Corporation, if it is the surviving corporation, setting forth the same rights, preferences, privileges and other terms contained in this Certificate of Designations in respect of the Preferred Stock, including, without limitation, the provisions contained in this </font><font style="font-weight:bold;letter-spacing:-0.2pt;">Section&#160;7(d)</font><font style="letter-spacing:0.2pt;"> and evidencing, among other things, the Holders&#8217; right to convert such new preferred stock into Alternate Consideration. The Corporation shall cause any successor entity in a Fundamental Transaction in which the Corporation is not the survivor (the &#8220;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Successor Entity</font><font style="letter-spacing:0.2pt;">&#8221;) to assume in writing all of the obligations of the Corporation under this Certificate of Designations in accordance with the provisions of this </font><font style="font-weight:bold;letter-spacing:-0.2pt;">Section&#160;7(d)</font><font style="letter-spacing:0.2pt;"> pursuant to written agreements in form and substance </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A-10</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:20pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">reasonably satisfactory to the Holder and approved by the Holder (without unreasonable delay) prior to such Fundamental Transaction and shall, at the option of a Holder of Preferred Stock, deliver to such Holder in exchange for such Holder&#8217;s Preferred Stock a security of the Successor Entity evidenced by a written instrument substantially similar in form and substance to the Preferred Stock which is convertible for a corresponding number of shares of capital stock of such Successor Entity (or its parent entity) equivalent to the shares of Common Stock acquirable and receivable upon conversion of the Preferred Stock (without regard to any limitations on the conversion of the Preferred Stock) prior to such Fundamental Transaction, and with a conversion price which applies the conversion price hereunder to such shares of capital stock (but taking into account the relative value of the shares of Common Stock pursuant to such Fundamental Transaction and the value of such shares of capital stock, such number of shares of capital stock and such conversion price being for the purpose of protecting the economic value of the Preferred Stock immediately prior to the consummation of such Fundamental Transaction), and which is reasonably satisfactory in form and substance to the Holder(s) thereof. Upon the occurrence of any such Fundamental Transaction, the Successor Entity shall succeed to, and be substituted for (so that from and after the date of such Fundamental Transaction, the provisions of this Certificate of Designations referring to the &#8220;Corporation&#8221; shall refer instead to the Successor Entity), and may exercise every right and power of the Corporation and shall assume all of the obligations of the Corporation under this Certificate of Designations with the same effect as if such Successor Entity had been named as the Corporation herein. For the avoidance of doubt, if, at any time while any shares of Preferred Stock are outstanding, a Fundamental Transaction occurs, pursuant to the terms of this </font><font style="font-weight:bold;letter-spacing:-0.2pt;">Section&#160;7(d),</font><font style="letter-spacing:0.2pt;"> a Holder of Preferred Stock shall not be entitled to receive any consideration in such Fundamental Transaction in respect of such Holder&#8217;s shares of Preferred Stock, except as provided for in this Certificate of Designations ( or any new Certificate of Designations in respect of a new series of preferred stock issued to the Holders of Preferred Stock as contemplated hereby). </font>
        </div>
        <div style="margin-left:40pt; margin-top:8pt; width:416pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">e)&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Intentionally Omitted</font><font style="letter-spacing:0.2pt;">. </font>
        </div>
        <div style="margin-left:40pt; margin-top:8pt; width:416pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">f)&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Notice to the Holders</font><font style="letter-spacing:0.2pt;">. </font>
        </div>
        <div style="margin-left:40pt; text-indent:20pt; margin-top:8pt; width:416pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">i.&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Adjustment to Conversion Amount</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;Whenever the number of shares of Common Stock that the shares of Preferred Stock are convertible into is adjusted pursuant to any provision of this </font><font style="font-weight:bold;letter-spacing:-0.2pt;">Section</font><font style="letter-spacing:0.2pt;"> 7, the Corporation shall promptly deliver to each Holder a notice setting forth the number of shares of Common Stock after such adjustment and setting forth a brief statement of the facts requiring such adjustment. </font>
        </div>
        <div style="margin-left:40pt; text-indent:20pt; margin-top:8pt; width:416pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">ii.&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Notice to Allow Conversion by Holder</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;If (A)&#160;the Corporation shall declare a dividend (or any other distribution in whatever form) on the Common Stock, (B)&#160;the Corporation shall declare a special nonrecurring cash dividend on or a redemption of the Common Stock, (C)&#160;the Corporation shall authorize the granting to all holders of the Common Stock of rights or warrants to subscribe for or purchase any shares of capital stock of any class or of any rights, (D)&#160;the approval of any stockholders of the Corporation shall be required in connection with any reclassification of the Common Stock, any consolidation or merger to which the Corporation is a party, any sale or transfer of all or substantially all of the assets of the Corporation, or any compulsory share exchange whereby the Common Stock is converted into other securities, cash or property or (E)&#160;the Corporation shall authorize the voluntary or involuntary dissolution, liquidation or winding up of the affairs of the Corporation, then, in each case, the Corporation shall cause to be filed at each office or agency maintained for the purpose of conversion of this Preferred Stock, and shall cause to be delivered to each Holder at its last address as it shall appear upon the stock books of the Corporation, at least fifteen (15) calendar days prior to the applicable record or effective date hereinafter specified, a notice stating (x)&#160;the date on which a record is to be taken for the purpose of such dividend, distribution, redemption, rights or warrants, or if a record is not to be taken, the date as of which the holders of the Common Stock of record to be entitled to such dividend, distributions, redemption, rights or warrants are to be determined or (y)&#160;the date on which such reclassification, consolidation, merger, sale, transfer or share exchange is expected to become effective or close, and the date as of which it is expected that holders of the Common Stock of record shall be entitled to exchange their shares of the Common Stock for securities, cash or other property deliverable upon such reclassification, consolidation, merger, sale, </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A-11</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:40pt; width:416pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">transfer or share exchange, provided that the failure to deliver such notice or any defect therein or in the delivery thereof shall not affect the validity of the corporate action required to be specified in such notice. To the extent that any notice provided hereunder constitutes, or contains, material, non-public information regarding the Corporation or any of the Subsidiaries, the Corporation shall simultaneously file such notice with the Commission pursuant to a Current Report on Form&#160;8-K. The Holder shall remain entitled to convert the Conversion Amount of this Preferred Stock (or any part hereof) during the 15-day period commencing on the date of such notice through the effective date of the event triggering such notice except as may otherwise be expressly set forth herein. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Section&#160;8.&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Miscellaneous</font><font style="letter-spacing:0.2pt;">. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">a)&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Notices</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;Any and all notices or other communications or deliveries to be provided by the Holders hereunder including, without limitation, any Notice of Conversion, shall be in writing and delivered personally, by facsimile, email address or sent by a nationally recognized overnight courier service, addressed to the Corporation at: </font>
        </div>
        <div style="margin-left:40pt; margin-top:8pt; width:416pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">Cyclacel Pharmaceuticals, Inc.</font> <br ><font style="letter-spacing:0.2pt;">200 Connell Drive, Suite 1500</font> <br ><font style="letter-spacing:0.2pt;">Berkeley Heights, New Jersey 07922</font> <br ><font style="letter-spacing:0.2pt;">Berkeley Heights, New Jersey 07922</font> <br ><font style="letter-spacing:0.2pt;">Attention: EVP, Finance and Chief Financial Officer</font><br ><font style="letter-spacing:0.2pt;">Email: pmcbarron@cyclacel.com </font></div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">or such other facsimile number or address (physical or email) as the Corporation may specify for such purposes by notice to the Holders delivered in accordance with this </font><font style="font-weight:bold;letter-spacing:-0.2pt;">Section&#160;8.</font><font style="letter-spacing:0.2pt;"> Any and all notices or other communications or deliveries to be provided by the Corporation hereunder shall be in writing and delivered personally, by facsimile, by email attachment or sent by a nationally recognized overnight courier service addressed to each Holder at the facsimile number, email address or address of such Holder appearing on the books of the Corporation, or if no such facsimile number, email address or address appears on the books of the Corporation, at the principal place of business of such Holder. Any notice or other communication or deliveries hereunder shall be deemed given and effective on the earliest of (i)&#160;the time of transmission, if such notice or communication is delivered via facsimile or email attachment at the facsimile number or email address set forth in this Section prior to 5:30&#160;p.m. (New York City time) on any date, (ii)&#160;the next Trading Day after the date of transmission, if such notice or communication is delivered via facsimile or email attachment at the facsimile number or email address set forth in this Section on a day that is not a Trading Day or later than 5:30&#160;p.m. (New York City time) on any Trading Day, (iii)&#160;the second Trading Day following the date of mailing, if sent by U.S. nationally recognized overnight courier service, or (iv)&#160;upon actual receipt by the Person to whom such notice is required to be given. Notwithstanding any other provision of this Certificate of Designations, where this Certificate of Designations provides for notice of any event to a Holder, if the Preferred Stock is held in global form by DTC ( or any successor depositary), such notice may be delivered via DTC ( or such successor depositary) pursuant to the procedures of DTC (or such successor depositary). </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">b) &nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Absolute Obligation</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;Except as expressly provided herein, no provision of this Certificate of Designations shall alter or impair the obligation of the Corporation, which is absolute and unconditional, to pay liquidated damages and accrued dividends, as applicable, on the shares of Preferred Stock at the time, place, and rate, and in the coin or currency, herein prescribed. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">c)&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Lost or Mutilated Preferred Stock Certificate</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;If a Holder&#8217;s Preferred Stock certificate shall be mutilated, lost, stolen or destroyed, the Corporation shall execute and deliver, in exchange and substitution for and upon cancellation of a mutilated certificate, or in lieu of or in substitution for a lost, stolen or destroyed certificate, a new certificate for the shares of Preferred Stock so mutilated, lost, </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A-12</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:20pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">stolen or destroyed, but only upon receipt of evidence of such loss, theft or destruction of such certificate, and of the ownership hereof reasonably satisfactory to the Corporation. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">d)&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Governing Law</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;All questions concerning the construction, validity, enforcement and interpretation of this Certificate of Designations shall be governed by and construed and enforced in accordance with the internal laws of the State of Delaware, without regard to the principles of conflict of laws thereof. Each of the Corporation and each Holder agrees that all legal proceedings concerning the interpretation, enforcement and defense of the transactions contemplated by this Certificate of Designations (whether brought against the Corporation, a Holder or any of their respective Affiliates, directors, officers, stockholders, employees or agents) shall be commenced in the state and federal courts sitting in the City of Wilmington, Delaware (the &#8220;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Delaware Courts</font><font style="letter-spacing:0.2pt;">&#8221;). Each of the Corporation and each Holder hereby irrevocably submits to the exclusive jurisdiction of the Delaware Courts for the adjudication of any dispute hereunder or in connection herewith or with any transaction contemplated hereby or discussed herein, and hereby irrevocably waives, and agrees not to assert in any suit, action or proceeding, any claim that it is not personally subject to the jurisdiction of such Delaware Courts, or such Delaware Courts are improper or inconvenient venue for such proceeding. Each of the Corporation and each Holder hereby irrevocably waives personal service of process and consents to process being served in any such suit, action or proceeding by mailing a copy thereof via registered or certified mail or overnight delivery (with evidence of delivery) to such Person at the address in effect for notices to it under this Certificate of Designation and agrees that such service shall constitute good and sufficient service of process and notice thereof. Nothing contained herein shall be deemed to limit in any way any right to serve process in any other manner permitted by applicable law. Each of the Corporation and each Holder hereby irrevocably waives, to the fullest extent permitted by applicable law, any and all right to trial by jury in any legal proceeding arising out of or relating to this Certificate of Designations or the transactions contemplated hereby. If the Corporation or any Holder shall commence an action or proceeding to enforce any provisions of this Certificate of Designations, then the prevailing party in such action or proceeding shall be reimbursed by the other party for its attorneys&#8217; fees and other costs and expenses incurred in the investigation, preparation and prosecution of such action or proceeding. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">e)&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Waiver</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;Any waiver by the Corporation or a Holder of a breach of any provision of this Certificate of Designations shall not operate as or be construed to be a waiver of any other breach of such provision or of any breach of any other provision of this Certificate of Designations or a waiver by any other Holders. The failure of the Corporation or a Holder to insist upon strict adherence to any term of this Certificate of Designations on one or more occasions shall not be considered a waiver or deprive that Person ( or any other Holder) of the right thereafter to insist upon strict adherence to that term or any other term of this Certificate of Designations on any other occasion. Any waiver by the Corporation or a Holder must be in writing. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">f)&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Severability</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;If any provision of this Certificate of Designations is invalid, illegal or unenforceable, the balance of this Certificate of Designations shall remain in effect, and if any provision is inapplicable to any Person or circumstance, it shall nevertheless remain applicable to all other Persons and circumstances. If it shall be found that any interest or other amount deemed interest due hereunder violates the applicable law governing usury, the applicable rate of interest due hereunder shall automatically be lowered to equal the maximum rate of interest permitted under applicable law. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">g)&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Next Business Day</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;Whenever any payment or other obligation hereunder shall be due on a day other than a Business Day, such payment shall be made on the next succeeding Business Day. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">h)&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Headings</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;The headings contained herein are for convenience only, do not constitute a part of this Certificate of Designations and shall not be deemed to limit or affect any of the provisions hereof. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">i)&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Status of Converted Preferred Stock</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;If any shares of Preferred Stock shall be converted or reacquired by the Corporation, such shares shall resume the status of authorized but unissued shares of preferred stock and shall no longer be designated as Series&#160;C Convertible Preferred Stock. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="font-weight:bold;letter-spacing:-0.2pt;">RESOLVED, FURTHER</font><font style="letter-spacing:0.2pt;">, that the chief executive officer, the president or any vice-president, and the secretary or any assistant secretary, of the Corporation be and they hereby are authorized and directed to </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A-13</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Helvetica, Arial, sans-serif;font-size:9pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:502pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">prepare and file this Certificate of Designations, Preferences, Rights and Limitations in accordance with the foregoing resolution and the provisions of Delaware law. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="font-weight:bold;letter-spacing:-0.2pt;">IN WITNESS WHEREOF</font><font style="letter-spacing:0.2pt;">, the undersigned have executed this Certificate this second day of January, 2025. </font>
        </div>
        <div style="margin-left:220pt; margin-top:8pt; width:236pt; line-height:12pt;font-weight:bold;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:-0.2pt;">CYCLACEL PHARMACEUTICALS, INC.</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style=" float:left; margin-left:220pt; line-height:12pt; margin-top:12pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">By:</font>
          <br >
        </div>
        <div style=" margin-top:12pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:240pt;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">/s/ Paul McBarron</font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-left:240pt; margin-top:2.5pt; width:216pt;">
          <div style="margin-left: 0pt; width: 216pt; margin-top: 0pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
        </div>
        <div style="margin-left:240pt; margin-top:2pt; width:216pt; line-height:12pt;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">Name: Paul McBarron </font>
        </div>
        <div style="text-indent:240pt; margin-top:2pt; width:456pt; line-height:12pt;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">Title: EVP, Finance and Chief Operating Officer</font>
        </div>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">A-14</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:382pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:right; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">ANNEX A</font>&#8203;</div>
        <div style="margin-top:12pt; text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">NOTICE OF CONVERSION</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The undersigned hereby elects to convert shares of Series&#160;C Convertible Preferred Stock (the &#8220;Preferred Stock&#8221;), into shares of common stock (&#8220;Common Stock&#8221;) of Cyclacel Pharmaceuticals, Inc. according to the terms and conditions of the Certificate of Designation of Preferences, Rights and Limitations of Series&#160;C Convertible Preferred Stock (the &#8220;Certificate of Designation&#8221;), as of the date written below. Capitalized terms used herein and not otherwise defined shall have the respective meanings set forth in the Certificate of Designation. </font>
        </div>
        <div style="margin-left:100pt; margin-top:8pt; width:356pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Date of Conversion: </font>
        </div>
        <div style="margin-left:100pt; margin-top:8pt; width:356pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Number of Shares of Preferred Stock to be Converted: </font>
        </div>
        <div style="margin-left:100pt; margin-top:8pt; width:356pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Number of Shares of Preferred Stock Owned Prior to Conversion: </font>
        </div>
        <div style="margin-left:100pt; margin-top:8pt; width:356pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Number of Shares of Preferred Stock Owned After Conversion: </font>
        </div>
        <div style=" float:left; margin-left:220pt; line-height:12pt; margin-top:12pt; margin-bottom:0pt; text-align:left; width:48pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">Signature:</font>
          <br >
        </div>
        <div style=" margin-top:12pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:268pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">&#8199;</font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="white-space:nowrap; margin-left:268pt; margin-top:2.5pt; width:188pt;">
          <div style="margin-left: 0pt; width: 188pt; margin-top: 0pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
        </div>
        <div style="margin-left:220pt; margin-top:2pt; width:236pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Name: </font>
        </div>
        <div style="margin-left:220pt; margin-top:2pt; width:236pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Title:</font>
        </div>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A-15</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a><a name="tCPI">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Appendix B</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">CYCLACEL PHARMACEUTICALS, INC. </font>
          <br >
          <font style="letter-spacing:-0.2pt;">AMENDED AND RESTATED CERTIFICATE OF DESIGNATIONS, PREFERENCES,</font>
          <br >
          <font style="letter-spacing:-0.2pt;">RIGHTS AND LIMITATIONS </font>
          <br >
          <font style="letter-spacing:-0.2pt;">OF </font>
          <br >
          <font style="letter-spacing:-0.2pt;">SERIES C CONVERTIBLE PREFERRED STOCK</font>
          <br >
          <font style="letter-spacing:-0.2pt;">PURSUANT TO SECTION 151 OF THE </font>
          <br >
          <font style="letter-spacing:-0.2pt;">DELAWARE GENERAL CORPORATION LAW</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The undersigned, David Lazar, does hereby certify that: </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">1.&nbsp;&nbsp;&nbsp;He is the interim Chief Executive Officer of Cyclacel Pharmaceuticals, Inc., a Delaware corporation (the &#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">Corporation</font><font style="letter-spacing:0.2pt;">&#8221;). </font>
        </div>
        <div style="margin-left:40pt; margin-top:8pt; width:416pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">2.&nbsp;&nbsp;&nbsp;The Corporation is authorized to issue 5,000,000 shares of preferred stock. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">3.&nbsp;&nbsp;&nbsp;The board of directors of the Corporation (the &#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">Board of Directors</font><font style="letter-spacing:0.2pt;">&#8221;) previously adopted a resolution authorizing the creation and issuance of shares of preferred stock designated Series&#160;C Convertible Preferred Stock and the Certificate of Designations, Preferences, Rights and Limitations for the Series&#160;C Convertible Preferred Stock was filed with the Secretary of State of the State of Delaware on January&#160;3, 2025. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="font-weight:bold;letter-spacing:-0.2pt;">NOW, THEREFORE, BE IT RESOLVED</font><font style="letter-spacing:0.2pt;">, that the Board of Directors, pursuant to authority expressly granted to and vested in the Board of Directors by the Amended and Restated Certificate of Incorporation of the Corporation, as amended, approves and declares it advisable and in the best interest of the Corporation to amend and restate the terms of the Series&#160;C Convertible Preferred Stock of the Corporation, and hereby fixes the designation thereof, and the voting powers, preferences and relative, participating, optional and other special rights, and the qualifications, limitations or restrictions thereon (in addition to the designation, preferences and relative, participating and other special rights, and the qualifications, limitations or restrictions thereof, set forth in the Amended and Restated Certificate of Incorporation of the Corporation, as amended, which are applicable to the preferred stock, if any) as follows: </font>
        </div>
        <div style="margin-top:12pt; text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">TERMS OF PREFERRED STOCK</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Section&#160;1.&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Definitions</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;For the purposes hereof, the following terms shall have the following meanings: </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">Affiliate</font><font style="letter-spacing:0.2pt;">&#8221; means any Person that, directly or indirectly through one or more intermediaries, controls or is controlled by or is under common control with a Person, as such terms are used in and construed under Rule&#160;405 of the Securities Act. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">Business Day</font><font style="letter-spacing:0.2pt;">&#8221; means any day except any Saturday, any Sunday, any day which is a federal legal holiday in the United States or any day on which banking institutions in the State of New York are authorized or required by law or other governmental action to close. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">Commission</font><font style="letter-spacing:0.2pt;">&#8221; means the United States Securities and Exchange Commission. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">Common Stock</font><font style="letter-spacing:0.2pt;">&#8221; means the Corporation&#8217;s common stock, par value $0.001 per share, and stock of any other class of securities into which such securities may hereafter be reclassified or changed. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">Common Stock Equivalents</font><font style="letter-spacing:0.2pt;">&#8221; means any securities of the Corporation or its subsidiaries which would entitle the holder thereof to acquire at any time Common Stock, including, without limitation, any debt, preferred stock, rights, options, warrants or other instrument that is at any time convertible into or exercisable or exchangeable for, or otherwise entitles the holder thereof to receive, Common Stock. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">Conversion Amount</font><font style="letter-spacing:0.2pt;">&#8221; means the sum of the Stated Value at issue.</font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">Conversion Date</font><font style="letter-spacing:0.2pt;">&#8221; shall have the meaning set forth in </font><font style="font-weight:bold;letter-spacing:-0.2pt;">Section&#160;6(a)</font><font style="letter-spacing:0.2pt;">. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">B-1</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-indent:20pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">Conversion Shares</font><font style="letter-spacing:0.2pt;">&#8221; means, collectively, the shares of Common Stock issuable upon conversion of the shares of Preferred Stock in accordance with the terms hereof. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">Exchange Act</font><font style="letter-spacing:0.2pt;">&#8221; means the Securities Exchange Act of 1934, as amended, and the rules and regulations promulgated thereunder. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">Fundamental Transaction</font><font style="letter-spacing:0.2pt;">&#8221; shall have the meaning set forth in </font><font style="font-weight:bold;letter-spacing:-0.2pt;">Section&#160;7(d)</font><font style="letter-spacing:0.2pt;">.</font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">GAAP</font><font style="letter-spacing:0.2pt;">&#8221; means United States generally accepted accounting principles.</font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">Holder</font><font style="letter-spacing:0.2pt;">&#8221; shall have the meaning set forth in </font><font style="font-weight:bold;letter-spacing:-0.2pt;">Section&#160;2</font><font style="letter-spacing:0.2pt;">. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">Liquidation</font><font style="letter-spacing:0.2pt;">&#8221; shall have the meaning set forth in </font><font style="font-weight:bold;letter-spacing:-0.2pt;">Section&#160;5</font><font style="letter-spacing:0.2pt;">. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">New York Courts</font><font style="letter-spacing:0.2pt;">&#8221; shall have the meaning set forth in </font><font style="font-weight:bold;letter-spacing:-0.2pt;">Section&#160;8(d)</font><font style="letter-spacing:0.2pt;">.</font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">Notice of Conversion</font><font style="letter-spacing:0.2pt;">&#8221; shall have the meaning set forth in </font><font style="font-weight:bold;letter-spacing:-0.2pt;">Section&#160;6(a)</font><font style="letter-spacing:0.2pt;">. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">Original Issue Date</font><font style="letter-spacing:0.2pt;">&#8221; means the date of the first issuance of any shares of the Preferred Stock regardless of the number of transfers of any particular shares of Preferred Stock and regardless of the number of certificates which may be issued to evidence such Preferred Stock. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">Person</font><font style="letter-spacing:0.2pt;">&#8221; means an individual or corporation, partnership, trust, incorporated or unincorporated association, joint venture, limited liability company, joint stock company, government (or an agency or subdivision thereof) or other entity of any kind. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">Preferred Stock</font><font style="letter-spacing:0.2pt;">&#8221; shall have the meaning set forth in </font><font style="font-weight:bold;letter-spacing:-0.2pt;">Section&#160;2</font><font style="letter-spacing:0.2pt;">. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">Securities Act</font><font style="letter-spacing:0.2pt;">&#8221; means the Securities Act of 1933, as amended, and the rules and regulations promulgated thereunder. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">Share Delivery Date</font><font style="letter-spacing:0.2pt;">&#8221; shall have the meaning set forth in </font><font style="font-weight:bold;letter-spacing:-0.2pt;">Section&#160;6(b)</font><font style="letter-spacing:0.2pt;">. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">Stated Value</font><font style="letter-spacing:0.2pt;">&#8221; shall have the meaning set forth in </font><font style="font-weight:bold;letter-spacing:-0.2pt;">Section&#160;2</font><font style="letter-spacing:0.2pt;">, as the same may be increased pursuant to Section&#160;3. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">Successor Entity</font><font style="letter-spacing:0.2pt;">&#8221; shall have the meaning set forth in </font><font style="font-weight:bold;letter-spacing:-0.2pt;">Section&#160;7(d)</font><font style="letter-spacing:0.2pt;">. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">Trading Day</font><font style="letter-spacing:0.2pt;">&#8221; means a day on which the principal Trading Market is open for business. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">Trading Market</font><font style="letter-spacing:0.2pt;">&#8221; means any of the following markets or exchanges on which the Common Stock is listed or quoted for trading on the date in question: the Nasdaq Capital Market, the Nasdaq Global Market, the Nasdaq Global Select Market, the NYSE MKT or the New York Stock Exchange (or any successors to any of the foregoing). </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#8220;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">Transfer Agent</font><font style="letter-spacing:0.2pt;">&#8221; means Equiniti Trust Company, LLC, and any successor transfer agent of the Corporation. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Section&#160;2.&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Designation, Amount and Par Value</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;The series of preferred stock shall be designated as the Series&#160;C Convertible Preferred Stock (the &#8220;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Preferred Stock</font><font style="letter-spacing:0.2pt;">&#8221;) and the number of shares so designated shall be 1,000,000 (which shall not be subject to change without the written consent of a majority of the holders of the Preferred Stock (each, a &#8220;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Holder</font><font style="letter-spacing:0.2pt;">&#8221; and collectively, the &#8220;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Holders</font><font style="letter-spacing:0.2pt;">&#8221;)). Each share of Preferred Stock shall have a par value of $0.001 per share and a stated value equal to $1.00 (the &#8220;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Stated Value</font><font style="letter-spacing:0.2pt;">&#8221;). </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Section&#160;3.&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Dividends</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;Except for stock dividends or distributions for which adjustments are to be made pursuant to </font><font style="font-weight:bold;letter-spacing:-0.2pt;">Section&#160;7</font><font style="letter-spacing:0.2pt;">, Holders shall be entitled to receive, and the Corporation shall pay, dividends on shares of Preferred Stock equal (on an as-if-converted-to-Common-Stock basis, without regard to conversion limitations herein) to and in the same form as dividends actually paid on shares of the Common Stock when, as and if such dividends are paid on shares of the Common Stock. No other dividends shall be paid on shares of Preferred Stock. The Corporation shall not pay any dividends on the Common Stock unless the Corporation simultaneously complies with this provision. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">B-2</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-indent:20pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Section&#160;4.&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Voting Rights</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;The Preferred Stock shall be counted for purposes of determining a quorum at a meeting of stockholders and shall vote on matters of the Corporation on an as-if-converted-to-Common-Stock basis, subject to the provisions of the Delaware General Corporation Law. Subject to the provisions of Section&#160;6(c) hereof, each share of Preferred Stock shall entitle the holder thereof to cast that number of votes per share of Preferred Stock as is equal to the Stated Value of such share of Preferred Stock divided by the Nasdaq Minimum Price (as defined in Nasdaq Listing Rule&#160;5635(d)) immediately preceding the Original Issue Date, and subject to adjustments for any stock splits, stock dividends, stock combinations, recapitalizations or other similar transactions following the date hereof). </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Section&#160;5.&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Liquidation Preference.</font><font style="letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(a)&nbsp;&nbsp;&nbsp;In the event of any liquidation, dissolution or winding up of the Corporation, either voluntary or involuntary, subject to the rights of any existing series of preferred stock or to the rights of any series of preferred stock which may from time to time hereafter come into existence, the holders of the Preferred Stock shall be entitled to receive, prior and in preference to any distribution of any of the assets of the Corporation to the holders of Common Stock by reason of their ownership thereof, the Stated Value per share of Preferred Stock then held by them, plus declared but unpaid dividends. If, upon the occurrence of any liquidation, dissolution or winding up of the Corporation, the assets and funds thus distributed among the holders of the Preferred Stock shall be insufficient to permit the payment to such holders of the full aforesaid preferential amounts, then, subject to the rights of any existing series of preferred stock or to the rights of any series of preferred stock which may from time to time hereafter come into existence, the entire assets and funds of the Corporation legally available for distribution shall be distributed ratably among the holders of each series of preferred stock in proportion to the preferential amount each such holder is otherwise entitled to receive. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(b)&nbsp;&nbsp;&nbsp;Upon the completion of the distribution required by Section&#160;5(a) above and any other distribution that may be required with respect to the rights of any existing series of preferred stock or to the rights of any series of preferred stock which may from time to time hereafter come into existence, if assets remain in the Corporation, the remaining assets shall be distributed to the holders of the Common Stock until such time as the holders of the Common stock shall have received a return of the capital originally contributed thereby. Thereafter, if assets remain in the Corporation, all remaining assets shall be distributed to all holders of Common Stock and to each series of Preferred Stock, pro&#160;rata based on the number of shares of Common Stock held by each (assuming conversion of all such Preferred Stock into Common Stock). </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(c)&nbsp;&nbsp;&nbsp;For purposes of this Section&#160;5, a liquidation, dissolution or winding up of the Corporation shall be deemed to be occasioned by, or to include, (i)&#160;the acquisition of the Corporation by another entity by means of any transaction or series of related transactions (including, without limitation, any reorganization, merger or consolidation, but excluding any merger effected exclusively for the purpose of changing the domicile of the Corporation); or (ii)&#160;a sale of all or substantially all of the assets of the Corporation, unless the Corporation&#8217;s stockholders of record as constituted immediately prior to such acquisition or sale will, immediately after such acquisition or sale (by virtue of securities issued as consideration for the Corporation&#8217;s acquisition or sale or otherwise) hold at least fifty&#160;percent (50%) of the voting power of the surviving or acquiring entity in approximately the same relative&#160;percentages after such acquisition or sale as before such acquisition or sale. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(d)&nbsp;&nbsp;&nbsp;In any of the events specified in subsection (c)&#160;above, if the consideration received by the corporation is other than cash, its value will be deemed its fair market value. Any securities shall be valued as follows: </font>
        </div>
        <div style="margin-left:40pt; margin-top:8pt; width:416pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(i)&nbsp;&nbsp;&nbsp;Securities not subject to restrictions on free marketability: </font>
        </div>
        <div style="margin-left:40pt; text-indent:20pt; margin-top:8pt; width:416pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(A)&nbsp;&nbsp;&nbsp;If traded on a securities exchange, the value shall be deemed to be the average of the closing prices of the securities on such exchange over the thirty-day period ending three (3)&#160;days prior to the closing; </font>
        </div>
        <div style="margin-left:40pt; text-indent:20pt; margin-top:8pt; width:416pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(B)&nbsp;&nbsp;&nbsp;If actively traded over-the-counter, the value shall be deemed to be the average of the closing bid or sale prices (whichever is applicable) over the thirty-day period ending three (3)&#160;days prior to the closing; and </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">B-3</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:40pt; text-indent:20pt; width:416pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(C)&nbsp;&nbsp;&nbsp;If there is no active public market, the value shall be the fair market value thereof, as determined in good faith by the Board of Directors. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(ii)&nbsp;&nbsp;&nbsp;The method of valuation of securities subject to restrictions on free marketability (other than restrictions arising solely by virtue of a stockholder&#8217;s status as an affiliate or former affiliate) shall be to make an appropriate discount from the market value determined as above in (i)&#160;(A), (B)&#160;or (C)&#160;to reflect the approximate fair market value thereof, as mutually determined by the Corporation and the holders of at least a majority of the voting power of all then outstanding shares of Preferred Stock. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(iii)&nbsp;&nbsp;&nbsp;In the event the requirements of Section&#160;2(c) are not complied with, the Corporation shall forthwith either: </font>
        </div>
        <div style="margin-left:40pt; text-indent:20pt; margin-top:8pt; width:416pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(A)&nbsp;&nbsp;&nbsp;cause such closing to be postponed until such time as the requirements of this Section&#160;5 have been complied with; or </font>
        </div>
        <div style="margin-left:40pt; text-indent:20pt; margin-top:8pt; width:416pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(B)&nbsp;&nbsp;&nbsp;cancel such transaction, in which event the rights, preferences and privileges of the holders of the Preferred Stock shall revert to and be the same as such rights, preferences and privileges existing immediately prior to the date of the first notice referred to in Section&#160;5(c)(iv) hereof. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(iv)&nbsp;&nbsp;&nbsp;The Corporation shall give each holder of record of Preferred Stock written notice of such impending transaction not later than twenty (20) days prior to the stockholders&#8217; meeting called to approve such transaction, or twenty (20) days prior to the closing of such transaction, whichever is earlier, and shall also notify such holders in writing of the final approval of such transaction. The first of such notices shall describe the material terms and conditions of the impending transaction and the provisions of this Section&#160;5, and the Corporation shall thereafter give such holders prompt notice of any material changes. The transaction shall in no event take place sooner than twenty (20) days after the Corporation has given the first notice provided for herein or sooner than ten (10) days after the corporation has given notice of any material changes provided for herein; provided, however, that time periods set forth in this paragraph may be shortened upon the written consent of the holders of Preferred Stock that are entitled to such notice rights or similar notice rights and that represent at least a majority of the voting power of all then outstanding shares of such Preferred Stock. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Section&#160;6.&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Conversion</font><font style="letter-spacing:0.2pt;">. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">a)&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Conversions at Option of Holder</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;Each one share of Preferred Stock shall be convertible, at any time and from time to time from and after the Original Issue Date at the option of the Holder thereof, into 2.65 shares of Common Stock (subject to the limitations set forth in </font><font style="font-weight:bold;letter-spacing:-0.2pt;">Section&#160;6(c)</font><font style="letter-spacing:0.2pt;">) (the &#8220;Conversion Ratio&#8221;). Holders shall effect conversions by providing the Corporation with the form of conversion notice attached hereto as </font><font style="font-weight:bold;letter-spacing:-0.2pt;">Annex A</font><font style="letter-spacing:0.2pt;"> (a &#8220;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Notice of Conversion</font><font style="letter-spacing:0.2pt;">&#8221;). Each Notice of Conversion shall specify the number of shares of Preferred Stock to be converted, the number of shares of Preferred Stock owned prior to the conversion at issue, the number of shares of Preferred Stock owned subsequent to the conversion at issue and the date on which such conversion is to be effected, which date may not be prior to the date the applicable Holder delivers by facsimile or email such Notice of Conversion to the Corporation (such date, the &#8220;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Conversion Date</font><font style="letter-spacing:0.2pt;">&#8221;). If no Conversion Date is specified in a Notice of Conversion, the Conversion Date shall be the date that such Notice of Conversion to the Corporation is deemed delivered hereunder. No ink-original Notice of Conversion shall be required, nor shall any medallion guarantee (or other type of guarantee or notarization) of any Notice of Conversion form be required. The calculations and entries set forth in the Notice of Conversion shall control in the absence of manifest or mathematical error. To effect conversions of shares of Preferred Stock, a Holder shall not be required to surrender the certificate(s) representing the shares of Preferred Stock to the Corporation unless all of the shares of Preferred Stock represented thereby are so converted, in which case such Holder shall deliver the certificate representing such shares of Preferred Stock promptly following the Conversion Date at issue. Shares of Preferred Stock converted into Common Stock in accordance with the terms hereof shall be canceled and shall not be reissued. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">b)&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Mechanics of Conversion</font><font style="letter-spacing:0.2pt;">. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">i.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Delivery of Conversion Shares Upon Conversion</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;Not later than the earlier of (i)&#160;two&#160;(2) Trading Days and (ii)&#160;the number of Trading Days comprising the Standard Settlement Period (as </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">B-4</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:20pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">defined below) after each Conversion Date (the &#8220;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Share Delivery Date</font><font style="letter-spacing:0.2pt;">&#8221;), the Corporation shall deliver, or cause to be delivered, to the converting Holder (A)&#160;the number of Conversion Shares being acquired upon the conversion of the Preferred Stock and (B)&#160;a bank check in the amount of accrued and unpaid dividends, if any. As used herein, &#8220;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Standard Settlement Period</font><font style="letter-spacing:0.2pt;">&#8221; means the standard settlement period, expressed in a number of Trading Days, on the Corporation&#8217;s primary Trading Market with respect to the Common Stock as in effect on the date of delivery of the Notice of Conversion. Notwithstanding the foregoing, with respect to any Notice(s) of Conversion delivered by 12:00&#160;pm (New York time) on the Original Issue Date, the Corporation agrees to deliver the Conversion Shares subject to such notice(s) by 4:00&#160;pm (New York time) on the Original Issue Date. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">ii.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Failure to Deliver Conversion Shares</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;If, in the case of any Notice of Conversion, such Conversion Shares are not delivered to or as directed by the applicable Holder by the Share Delivery Date, the Holder shall be entitled to elect by written notice to the Corporation at any time on or before its receipt of such Conversion Shares, to rescind such Conversion, in which event the Corporation shall promptly return to the Holder any original Preferred Stock certificate delivered to the Corporation and the Holder shall promptly return to the Corporation the Conversion Shares issued to such Holder pursuant to the rescinded Notice of Conversion. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">iii.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Obligation Absolute; Partial Liquidated Damages</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;The Corporation&#8217;s obligation to issue and deliver the Conversion Shares upon conversion of Preferred Stock in accordance with the terms hereof are absolute and unconditional, irrespective of any action or inaction by a Holder to enforce the same, any waiver or consent with respect to any provision hereof, the recovery of any judgment against any Person or any action to enforce the same, or any setoff, counterclaim, recoupment, limitation or termination, or any breach or alleged breach by such Holder or any other Person of any obligation to the Corporation or any violation or alleged violation of law by such Holder or any other person, and irrespective of any other circumstance which might otherwise limit such obligation of the Corporation to such Holder in connection with the issuance of such Conversion Shares; provided, however, that such delivery shall not operate as a waiver by the Corporation of any such action that the Corporation may have against such Holder. If the Corporation fails to deliver to a Holder such Conversion Shares pursuant to </font><font style="font-weight:bold;letter-spacing:-0.2pt;">Section&#160;6(b)(i)</font><font style="letter-spacing:0.2pt;"> by the Share Delivery Date applicable to such conversion, the Corporation shall pay to such Holder, in cash, as liquidated damages and not as a penalty, for each $1,000.00 of Stated Value of Preferred Stock being converted, per Trading Day for each Trading Day after the Share Delivery Date until such Conversion Shares are delivered or Holder rescinds such conversion. Nothing herein shall limit a Holder&#8217;s right to pursue actual damages for the Corporation&#8217;s failure to deliver Conversion Shares within the period specified herein, and such Holder shall have the right to pursue all remedies available to it hereunder, at law or in equity including, without limitation, a decree of specific performance and/or injunctive relief. The exercise of any such rights shall not prohibit a Holder from seeking to enforce damages pursuant to any other Section hereof or under applicable law. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">i.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Compensation for Buy-In on Failure to Timely Deliver Conversion Shares Upon Conversion</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;In addition to any other rights available to the Holder, if the Corporation fails for any reason to deliver to a Holder the applicable Conversion Shares by the Share Delivery Date pursuant to </font><font style="font-weight:bold;letter-spacing:-0.2pt;">Section&#160;6(b)(i)</font><font style="letter-spacing:0.2pt;">, and if after such Share Delivery Date such Holder is required by its brokerage firm to purchase (in an open market transaction or otherwise), or the Holder&#8217;s brokerage firm otherwise purchases, shares of Common Stock to deliver in satisfaction of a sale by such Holder of the Conversion Shares which such Holder was entitled to receive upon the conversion relating to such Share Delivery Date (a &#8220;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Buy-In</font><font style="letter-spacing:0.2pt;">&#8221;), then the Corporation shall (A)&#160;pay in cash to such Holder (in addition to any other remedies available to or elected by such Holder) the amount, if any, by which (x)&#160;such Holder&#8217;s total purchase price (including any brokerage commissions) for the Common Stock so purchased exceeds (y)&#160;the product of (1)&#160;the aggregate number of shares of Common Stock that such Holder was entitled to receive from the conversion at issue multiplied by (2)&#160;the actual sale price at which the sell order giving rise to such purchase obligation was executed (including any brokerage commissions) and (B)&#160;at the option of such Holder, either reissue (if surrendered) the shares of Preferred Stock equal to the number of shares of Preferred Stock submitted for conversion (in which case, such conversion shall be deemed rescinded) or deliver to such Holder the number of shares of Common Stock that would have been issued if the Corporation had timely complied with its delivery requirements under Section&#160;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">6(b)(i)</font><font style="letter-spacing:0.2pt;">. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">B-5</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:20pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">For example, if a Holder purchases shares of Common Stock having a total purchase price of $11,000 to cover a Buy-In with respect to an attempted conversion of shares of Preferred Stock with respect to which the actual sale price of the Conversion Shares (including any brokerage commissions) giving rise to such purchase obligation was a total of $10,000 under clause (A)&#160;of the immediately preceding sentence, the Corporation shall be required to pay such Holder $1,000. The Holder shall provide the Corporation written notice indicating the amounts payable to such Holder in respect of the Buy-In and, upon request of the Corporation, evidence of the amount of such loss. Nothing herein shall limit a Holder&#8217;s right to pursue any other remedies available to it hereunder, at law or in equity including, without limitation, a decree of specific performance and/or injunctive relief with respect to the Corporation&#8217;s failure to timely deliver Conversion Shares upon conversion of the shares of Preferred Stock as required pursuant to the terms hereof. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">ii.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Reservation of Shares Issuable Upon Conversion</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;Until no shares of Preferred Stock remain outstanding, the Corporation covenants that it will at all times reserve and keep available out of its authorized and unissued shares of Common Stock for the sole purpose of issuance upon conversion of the Preferred Stock as herein provided, free from preemptive rights or any other actual contingent purchase rights of Persons other than the Holder (and the other holders of the Preferred Stock), not less than such aggregate number of shares of the Common Stock as shall be issuable (taking into account the adjustments and restrictions of Section&#160;7) upon the conversion of the then outstanding shares of Preferred Stock. The Corporation covenants that all shares of Common Stock that shall be so issuable shall, upon issue, be duly authorized, validly issued, fully paid and nonassessable. </font>
        </div>
        <div style="margin-left:40pt; margin-top:8pt; width:416pt; line-height:12pt;">
          <font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">iii.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">RESERVED</font><font style="letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">iv.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Transfer Taxes and Expenses</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;The issuance of Conversion Shares on conversion of the Preferred Stock shall be made without charge to any Holder for any documentary stamp or similar taxes that may be payable in respect of the issue or delivery of such Conversion Shares, provided that the Corporation shall not be required to pay any tax that may be payable in respect of any transfer involved in the issuance and delivery of any such Conversion Shares upon conversion in a name other than that of the Holders of such shares of Preferred Stock and the Corporation shall not be required to issue or deliver such Conversion Shares unless or until the Person or Persons requesting the issuance thereof shall have paid to the Corporation the amount of such tax or shall have established to the satisfaction of the Corporation that such tax has been paid. The Corporation shall pay all Transfer Agent fees required for same-day processing of any Notice of Conversion and all fees to the DTC (or another established clearing corporation performing similar functions) required for same-day electronic delivery of the Conversion Shares. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">c)</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Conversion Limitation</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;Notwithstanding anything to the contrary herein, the Corporation shall not effect any conversion of the Preferred Stock, and a Holder shall not have the right to convert any portion of the Preferred Stock, to the extent that, after giving effect to the conversion set forth on the applicable Notice of Conversion, such Holder (together with such Holder&#8217;s Affiliates, and any Persons acting as a group together with such Holder or any of such Holder&#8217;s Affiliates (such Persons, &#8220;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Attribution Parties</font><font style="letter-spacing:0.2pt;">&#8221;)) would beneficially own the number of shares of Common Stock which would be in excess of any statutory threshold pursuant to which the acquisition of such shares would trigger a compulsory offer requirement under applicable federal or state tender offer rules for the Holder and its Affiliates and Attribution Parties to make a tender offer for all the shares of the Company. For purposes of the foregoing sentence, the number of shares of Common Stock beneficially owned by such Holder and its Affiliates and Attribution Parties shall include the number of shares of Common Stock issuable upon conversion of the Preferred Stock with respect to which such determination is being made, but shall exclude the number of shares of Common Stock which are issuable upon (i)&#160;conversion of the remaining, unconverted Stated Value of Preferred Stock beneficially owned by such Holder or any of its Affiliates or Attribution Parties and (ii)&#160;exercise or conversion of the unexercised or unconverted portion of any other securities of the Corporation subject to a limitation on conversion or exercise analogous to the limitation contained herein (including, without limitation, the Preferred Stock) beneficially owned by such Holder or any of its Affiliates or Attribution Parties. Except as set forth in the preceding sentence, for purposes of this </font><font style="font-weight:bold;letter-spacing:-0.2pt;">Section&#160;6(c)</font><font style="letter-spacing:0.2pt;">, beneficial ownership shall be calculated in accordance with Section&#160;13(d) of the Exchange Act and the rules and regulations promulgated thereunder. To the extent that the limitation contained in this </font><font style="font-weight:bold;letter-spacing:-0.2pt;">Section&#160;6(c)</font><font style="letter-spacing:0.2pt;"> applies, the determination of whether the </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">B-6</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Preferred Stock is convertible (in relation to other securities owned by such Holder together with any Affiliates and Attribution Parties) and of how many shares of Preferred Stock are convertible shall be in the sole discretion of such Holder, and the submission of a Notice of Conversion shall be deemed to be such Holder&#8217;s determination of whether the shares of Preferred Stock may be converted (in relation to other securities owned by such Holder together with any Affiliates and Attribution Parties) and how many shares of the Preferred Stock are convertible. To ensure compliance with this restriction, each Holder will be deemed to represent to the Corporation each time it delivers a Notice of Conversion that such conversion will not violate the restriction set forth in this paragraph and the Corporation shall have no obligation to verify or confirm the accuracy of such representation. In addition, a determination as to any group status as contemplated above shall be determined in accordance with Section&#160;13(d) of the Exchange Act and the rules and regulations promulgated thereunder. For purposes of this </font><font style="font-weight:bold;letter-spacing:-0.2pt;">Section&#160;6(c)</font><font style="letter-spacing:0.2pt;">, in determining the number of outstanding shares of Common Stock, a Holder may rely solely on the number of outstanding shares of Common Stock as stated in a written notice by the Corporation or the Transfer Agent setting forth the number of shares of Common Stock outstanding. Upon the written or oral request (which may be via email) of a Holder, the Corporation shall within two Trading Days confirm orally and in writing to such Holder the number of shares of Common Stock then outstanding. In any case, the number of outstanding shares of Common Stock shall be determined after giving effect to the conversion or exercise of securities of the Corporation, including the Preferred Stock, by such Holder or its Affiliates or Attribution Parties since the date as of which such number of outstanding shares of Common Stock was reported. The provisions of this paragraph shall be construed and implemented in a manner otherwise than in strict conformity with the terms of this </font><font style="font-weight:bold;letter-spacing:-0.2pt;">Section&#160;6(c)</font><font style="letter-spacing:0.2pt;"> to correct this paragraph (or any portion hereof) which may be defective or inconsistent with the intended limitation contained herein or to make changes or supplements necessary or desirable to properly give effect to such limitation. The limitations contained in this paragraph shall apply to a successor holder of Preferred Stock. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Section&#160;7.&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Certain Adjustments</font><font style="letter-spacing:0.2pt;">. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">a)</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Stock Dividends and Stock Splits</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;If the Corporation, at any time while this Preferred Stock is outstanding: (i)&#160;pays a stock dividend or otherwise makes a distribution or distributions payable in shares of Common Stock on shares of Common Stock or any other Common Stock Equivalents (which, for avoidance of doubt, shall not include any shares of Common Stock issued by the Corporation upon conversion of, or payment of a dividend on, this Preferred Stock), (ii)&#160;subdivides outstanding shares of Common Stock into a larger number of shares, (iii)&#160;combines (including by way of a reverse stock split) outstanding shares of Common Stock into a smaller number of shares, or (iv)&#160;issues, in the event of a reclassification of shares of the Common Stock, any shares of capital stock of the Corporation, then the number of shares of Common Stock each share of Preferred Stock shall be convertible into shall be multiplied by a fraction of which the numerator shall be the number of shares of Common Stock (excluding any treasury shares of the Corporation) outstanding immediately before such event, and of which the denominator shall be the number of shares of Common Stock outstanding immediately after such event. Any adjustment made pursuant to this Section&#160;7(a) shall become effective immediately after the record date for the determination of stockholders entitled to receive such dividend or distribution and shall become effective immediately after the effective date in the case of a subdivision, combination or re-classification. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">b)</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Subsequent Rights Offerings</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;In addition to any adjustments pursuant to Section&#160;7(a) above, if at any time the Corporation grants, issues or sells any Common Stock Equivalents or rights to purchase stock, warrants, securities or other property pro&#160;rata to the record holders of any class of shares of Common Stock (the &#8220;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Purchase Rights</font><font style="letter-spacing:0.2pt;">&#8221;), then the Holder will be entitled to acquire, upon the terms applicable to such Purchase Rights, the aggregate Purchase Rights which the Holder could have acquired if the Holder had held the number of shares of Common Stock acquirable upon complete conversion of such Holder&#8217;s Preferred Stock (without regard to any limitations on exercise hereof) immediately before the date on which a record is taken for the grant, issuance or sale of such Purchase Rights, or, if no such record is taken, the date as of which the record holders of shares of Common Stock are to be determined for the grant, issue or sale of such Purchase Rights. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">c)</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Pro Rata Distributions</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;During such time as this Preferred Stock is outstanding, if the Corporation declares or makes any dividend or other distribution of its assets (or rights to acquire its assets) to holders of shares of Common Stock, by way of return of capital or otherwise (including, without limitation, any </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">B-7</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">distribution of cash, stock or other securities, property or options by way of a dividend, spin off, reclassification, corporate rearrangement, scheme of arrangement or other similar transaction) (a &#8220;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Distribution</font><font style="letter-spacing:0.2pt;">&#8221;), at any time after the issuance of this Preferred Stock, then, in each such case, the Holder shall be entitled to participate in such Distribution to the same extent that the Holder would have participated therein if the Holder had held the number of shares of Common Stock acquirable upon complete conversion of this Preferred Stock (without regard to any limitations on conversion hereof) immediately before the date of which a record is taken for such Distribution, or, if no such record is taken, the date as of which the record holders of shares of Common Stock are to be determined for the participation in such Distribution. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">d)&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Fundamental Transaction</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;If, at any time while any shares of Preferred Stock are outstanding, (i)&#160;the Corporation, directly or indirectly, in one or more related transactions effects any merger or consolidation of the Corporation with or into another Person, (ii)&#160;the Corporation, directly or indirectly, effects any sale, lease, license, assignment, transfer, conveyance or other disposition of all or substantially all of its assets in one or a series of related transactions, (iii)&#160;any, direct or indirect, purchase offer, tender offer or exchange offer (whether by the Corporation or another Person) is completed pursuant to which holders of Common Stock are permitted to sell, tender or exchange their shares for other securities, cash or property and has been accepted by the holders of 50% or more of the outstanding Common Stock, (iv)&#160;the Corporation, directly or indirectly, in one or more related transactions effects any reclassification, reorganization or recapitalization of the Common Stock or any compulsory share exchange pursuant to which the Common Stock is effectively converted into or exchanged for other securities, cash or property, or (v)&#160;the Corporation, directly or indirectly, in one or more related transactions consummates a stock or share purchase agreement or other business combination (including, without limitation, a reorganization, recapitalization, spin-off or scheme of arrangement) with another Person whereby such other Person acquires more than 50% of the outstanding shares of Common Stock (not including any shares of Common Stock held by the other Person or other Persons making or party to, or associated or affiliated with the other Persons making or party to, such stock or share purchase agreement or other business combination) (each a &#8220;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Fundamental Transaction</font><font style="letter-spacing:0.2pt;">&#8221;), then, upon any subsequent conversion of the Preferred Stock by the Holder thereof, the Holder shall receive, for each Conversion Share that would have been issuable upon such conversion immediately prior to the occurrence of such Fundamental Transaction (without regard to any limitation in </font><font style="font-weight:bold;letter-spacing:-0.2pt;">Section&#160;6(c)</font><font style="letter-spacing:0.2pt;"> on the conversion of the Preferred Stock), the number of shares of common stock (as applicable) of the successor or acquiring corporation or the number of shares of Common Stock of the Corporation (as applicable), if it is the surviving corporation, and all additional securities (equity or debt), cash, property or other consideration (all such additional consideration, the &#8220;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Alternate Consideration</font><font style="letter-spacing:0.2pt;">&#8221;), receivable as a result of such Fundamental Transaction by a holder of the number of shares of Common Stock for which such Holder&#8217;s Preferred Stock is convertible immediately prior to such Fundamental Transaction (without regard to any limitation in </font><font style="font-weight:bold;letter-spacing:-0.2pt;">Section&#160;6(c)</font><font style="letter-spacing:0.2pt;"> on the conversion of the Preferred Stock). If holders of Common Stock are entitled to elect the proportion of securities, cash, property or other consideration to be received by holders of Common Stock in a Fundamental Transaction, then each Holder of Preferred Stock shall be given the same choice as to the proportion of securities, cash, property or other consideration such Holder is entitled to receive upon any conversion of such Holder&#8217;s shares of Preferred Stock following such Fundamental Transaction. To the extent necessary to effectuate the foregoing provisions, any successor to the Corporation or surviving entity in such Fundamental Transaction shall file a new Certificate of Designations in respect of a new series of preferred stock of the successor or acquiring corporation, or the Corporation, if it is the surviving corporation, setting forth the same rights, preferences, privileges and other terms contained in this Amended and Restated Certificate of Designations in respect of the Preferred Stock, including, without limitation, the provisions contained in this </font><font style="font-weight:bold;letter-spacing:-0.2pt;">Section&#160;7(d)</font><font style="letter-spacing:0.2pt;"> and evidencing, among other things, the Holders&#8217; right to convert such new preferred stock into Alternate Consideration. The Corporation shall cause any successor entity in a Fundamental Transaction in which the Corporation is not the survivor (the &#8220;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Successor Entity</font><font style="letter-spacing:0.2pt;">&#8221;) to assume in writing all of the obligations of the Corporation under this Amended and Restated Certificate of Designations in accordance with the provisions of this </font><font style="font-weight:bold;letter-spacing:-0.2pt;">Section&#160;7(d)</font><font style="letter-spacing:0.2pt;"> pursuant to written agreements in form and substance reasonably satisfactory to the Holder and approved by the Holder (without unreasonable delay) prior to such Fundamental Transaction and shall, at the option of a Holder of Preferred Stock, deliver to such Holder in exchange for such Holder&#8217;s Preferred Stock a security of the Successor Entity evidenced by a written instrument substantially similar in form and substance to the Preferred Stock which is convertible for a corresponding number of shares of capital stock of such Successor Entity (or its parent entity) equivalent to the shares of </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">B-8</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Common Stock acquirable and receivable upon conversion of the Preferred Stock (without regard to any limitations on the conversion of the Preferred Stock) prior to such Fundamental Transaction, and with a conversion price which applies the conversion price hereunder to such shares of capital stock (but taking into account the relative value of the shares of Common Stock pursuant to such Fundamental Transaction and the value of such shares of capital stock, such number of shares of capital stock and such conversion price being for the purpose of protecting the economic value of the Preferred Stock immediately prior to the consummation of such Fundamental Transaction), and which is reasonably satisfactory in form and substance to the Holder(s) thereof. Upon the occurrence of any such Fundamental Transaction, the Successor Entity shall succeed to, and be substituted for (so that from and after the date of such Fundamental Transaction, the provisions of this Amended and Restated Certificate of Designations referring to the &#8220;Corporation&#8221; shall refer instead to the Successor Entity), and may exercise every right and power of the Corporation and shall assume all of the obligations of the Corporation under this Amended and Restated Certificate of Designations with the same effect as if such Successor Entity had been named as the Corporation herein. For the avoidance of doubt, if, at any time while any shares of Preferred Stock are outstanding, a Fundamental Transaction occurs, pursuant to the terms of this </font><font style="font-weight:bold;letter-spacing:-0.2pt;">Section&#160;7(d)</font><font style="letter-spacing:0.2pt;">, a Holder of Preferred Stock shall not be entitled to receive any consideration in such Fundamental Transaction in respect of such Holder&#8217;s shares of Preferred Stock, except as provided for in this Amended and Restated Certificate of Designations (or any new Certificate of Designations in respect of a new series of preferred stock issued to the Holders of Preferred Stock as contemplated hereby). </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">e)</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Intentionally Omitted.</font><font style="letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">f)</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Notice to the Holders</font><font style="letter-spacing:0.2pt;">. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">i.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Adjustment to Conversion Amount</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;Whenever the number of shares of Common Stock that the shares of Preferred Stock are convertible into is adjusted pursuant to any provision of this </font><font style="font-weight:bold;letter-spacing:-0.2pt;">Section&#160;7</font><font style="letter-spacing:0.2pt;">, the Corporation shall promptly deliver to each Holder a notice setting forth the number of shares of Common Stock after such adjustment and setting forth a brief statement of the facts requiring such adjustment. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">ii.</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Notice to Allow Conversion by Holder</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;If (A)&#160;the Corporation shall declare a dividend (or any other distribution in whatever form) on the Common Stock, (B)&#160;the Corporation shall declare a special nonrecurring cash dividend on or a redemption of the Common Stock, (C)&#160;the Corporation shall authorize the granting to all holders of the Common Stock of rights or warrants to subscribe for or purchase any shares of capital stock of any class or of any rights, (D)&#160;the approval of any stockholders of the Corporation shall be required in connection with any reclassification of the Common Stock, any consolidation or merger to which the Corporation is a party, any sale or transfer of all or substantially all of the assets of the Corporation, or any compulsory share exchange whereby the Common Stock is converted into other securities, cash or property or (E)&#160;the Corporation shall authorize the voluntary or involuntary dissolution, liquidation or winding up of the affairs of the Corporation, then, in each case, the Corporation shall cause to be filed at each office or agency maintained for the purpose of conversion of this Preferred Stock, and shall cause to be delivered to each Holder at its last address as it shall appear upon the stock books of the Corporation, at least fifteen (15) calendar days prior to the applicable record or effective date hereinafter specified, a notice stating (x)&#160;the date on which a record is to be taken for the purpose of such dividend, distribution, redemption, rights or warrants, or if a record is not to be taken, the date as of which the holders of the Common Stock of record to be entitled to such dividend, distributions, redemption, rights or warrants are to be determined or (y)&#160;the date on which such reclassification, consolidation, merger, sale, transfer or share exchange is expected to become effective or close, and the date as of which it is expected that holders of the Common Stock of record shall be entitled to exchange their shares of the Common Stock for securities, cash or other property deliverable upon such reclassification, consolidation, merger, sale, transfer or share exchange, provided that the failure to deliver such notice or any defect therein or in the delivery thereof shall not affect the validity of the corporate action required to be specified in such notice. To the extent that any notice provided hereunder constitutes, or contains, material, non-public information regarding the Corporation or any of the Subsidiaries, the Corporation shall simultaneously file such notice with the Commission pursuant to a Current Report on Form 8-K. The Holder shall remain entitled to convert the Conversion </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">B-9</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:20pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Amount of this Preferred Stock (or any part hereof) during the 15-day period commencing on the date of such notice through the effective date of the event triggering such notice except as may otherwise be expressly set forth herein. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Section&#160;8.&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Miscellaneous</font><font style="letter-spacing:0.2pt;">. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">a)&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Notices</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;Any and all notices or other communications or deliveries to be provided by the Holders hereunder including, without limitation, any Notice of Conversion, shall be in writing and delivered personally, by facsimile, email address or sent by a nationally recognized overnight courier service, addressed to the Corporation at: </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Cyclacel Pharmaceuticals, Inc. </font> <br ><font style="letter-spacing:0.2pt;">200 Connell Drive, Suite 1500 </font> <br ><font style="letter-spacing:0.2pt;">Berkeley Heights, New Jersey 07922 </font> <br ><font style="letter-spacing:0.2pt;">Berkeley Heights, New Jersey 07922 </font> <br ><font style="letter-spacing:0.2pt;">Attention: Interim Chief Executive Officer </font> <br ><font style="letter-spacing:0.2pt;">Email: david@activistinvestingllc.com </font></div>
        <div style="margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">or such other facsimile number or address (physical or email) as the Corporation may specify for such purposes by notice to the Holders delivered in accordance with this </font><font style="font-weight:bold;letter-spacing:-0.2pt;">Section&#160;8</font><font style="letter-spacing:0.2pt;">. Any and all notices or other communications or deliveries to be provided by the Corporation hereunder shall be in writing and delivered personally, by facsimile, by email attachment or sent by a nationally recognized overnight courier service addressed to each Holder at the facsimile number, email address or address of such Holder appearing on the books of the Corporation, or if no such facsimile number, email address or address appears on the books of the Corporation, at the principal place of business of such Holder. Any notice or other communication or deliveries hereunder shall be deemed given and effective on the earliest of (i)&#160;the time of transmission, if such notice or communication is delivered via facsimile or email attachment at the facsimile number or email address set forth in this Section prior to 5:30&#160;p.m. (New York City time) on any date, (ii)&#160;the next Trading Day after the date of transmission, if such notice or communication is delivered via facsimile or email attachment at the facsimile number or email address set forth in this Section on a day that is not a Trading Day or later than 5:30&#160;p.m. (New York City time) on any Trading Day, (iii)&#160;the second Trading Day following the date of mailing, if sent by U.S. nationally recognized overnight courier service, or (iv)&#160;upon actual receipt by the Person to whom such notice is required to be given. Notwithstanding any other provision of this Amended and Restated Certificate of Designations, where this Amended and Restated Certificate of Designations provides for notice of any event to a Holder, if the Preferred Stock is held in global form by DTC (or any successor depositary), such notice may be delivered via DTC (or such successor depositary) pursuant to the procedures of DTC (or such successor depositary). </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">b)</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Absolute Obligation</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;Except as expressly provided herein, no provision of this Amended and Restated Certificate of Designations shall alter or impair the obligation of the Corporation, which is absolute and unconditional, to pay liquidated damages and accrued dividends, as applicable, on the shares of Preferred Stock at the time, place, and rate, and in the coin or currency, herein prescribed. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">c)</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Lost or Mutilated Preferred Stock Certificate</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;If a Holder&#8217;s Preferred Stock certificate shall be mutilated, lost, stolen or destroyed, the Corporation shall execute and deliver, in exchange and substitution for and upon cancellation of a mutilated certificate, or in lieu of or in substitution for a lost, stolen or destroyed certificate, a new certificate for the shares of Preferred Stock so mutilated, lost, stolen or destroyed, but only upon receipt of evidence of such loss, theft or destruction of such certificate, and of the ownership hereof reasonably satisfactory to the Corporation. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">d)</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Governing Law</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;All questions concerning the construction, validity, enforcement and interpretation of this Amended and Restated Certificate of Designations shall be governed by and construed and enforced in accordance with the internal laws of the State of Delaware, without regard to the principles of conflict of laws thereof. Each of the Corporation and each Holder agrees that all legal proceedings concerning the interpretation, enforcement and defense of the transactions contemplated by this Amended and Restated Certificate of Designations (whether brought against the Corporation, a Holder or any of their respective Affiliates, directors, officers, stockholders, employees or agents) shall be commenced in the state and federal courts sitting in the City of Wilmington, Delaware (the &#8220;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Delaware Courts</font><font style="letter-spacing:0.2pt;">&#8221;). Each of the Corporation and </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">B-10</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:40pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">each Holder hereby irrevocably submits to the exclusive jurisdiction of the Delaware Courts for the adjudication of any dispute hereunder or in connection herewith or with any transaction contemplated hereby or discussed herein, and hereby irrevocably waives, and agrees not to assert in any suit, action or proceeding, any claim that it is not personally subject to the jurisdiction of such Delaware Courts, or such Delaware Courts are improper or inconvenient venue for such proceeding. Each of the Corporation and each Holder hereby irrevocably waives personal service of process and consents to process being served in any such suit, action or proceeding by mailing a copy thereof via registered or certified mail or overnight delivery (with evidence of delivery) to such Person at the address in effect for notices to it under this Certificate of Designation and agrees that such service shall constitute good and sufficient service of process and notice thereof. Nothing contained herein shall be deemed to limit in any way any right to serve process in any other manner permitted by applicable law. Each of the Corporation and each Holder hereby irrevocably waives, to the fullest extent permitted by applicable law, any and all right to trial by jury in any legal proceeding arising out of or relating to this Amended and Restated Certificate of Designations or the transactions contemplated hereby. If the Corporation or any Holder shall commence an action or proceeding to enforce any provisions of this Amended and Restated Certificate of Designations, then the prevailing party in such action or proceeding shall be reimbursed by the other party for its attorneys&#8217; fees and other costs and expenses incurred in the investigation, preparation and prosecution of such action or proceeding. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">e)</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Waiver</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;Any waiver by the Corporation or a Holder of a breach of any provision of this Amended and Restated Certificate of Designations shall not operate as or be construed to be a waiver of any other breach of such provision or of any breach of any other provision of this Amended and Restated Certificate of Designations or a waiver by any other Holders. The failure of the Corporation or a Holder to insist upon strict adherence to any term of this Amended and Restated Certificate of Designations on one or more occasions shall not be considered a waiver or deprive that Person (or any other Holder) of the right thereafter to insist upon strict adherence to that term or any other term of this Amended and Restated Certificate of Designations on any other occasion. Any waiver by the Corporation or a Holder must be in writing. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">f)</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Severability</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;If any provision of this Amended and Restated Certificate of Designations is invalid, illegal or unenforceable, the balance of this Amended and Restated Certificate of Designations shall remain in effect, and if any provision is inapplicable to any Person or circumstance, it shall nevertheless remain applicable to all other Persons and circumstances. If it shall be found that any interest or other amount deemed interest due hereunder violates the applicable law governing usury, the applicable rate of interest due hereunder shall automatically be lowered to equal the maximum rate of interest permitted under applicable law. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">g)</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Next Business Day</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;Whenever any payment or other obligation hereunder shall be due on a day other than a Business Day, such payment shall be made on the next succeeding Business Day. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">h)</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Headings</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;The headings contained herein are for convenience only, do not constitute a part of this Amended and Restated Certificate of Designations and shall not be deemed to limit or affect any of the provisions hereof. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">i)</font><font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Status of Converted Preferred Stock</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;If any shares of Preferred Stock shall be converted or reacquired by the Corporation, such shares shall resume the status of authorized but unissued shares of preferred stock and shall no longer be designated as Series&#160;C Convertible Preferred Stock. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="font-weight:bold;letter-spacing:-0.2pt;">RESOLVED, FURTHER</font><font style="letter-spacing:0.2pt;">, that the chief executive officer, the president or any vice-president, and the secretary or any assistant secretary, of the Corporation be and they hereby are authorized and directed to prepare and file this Amended and Restated Certificate of Designations, Preferences, Rights and Limitations in accordance with the foregoing resolution and the provisions of Delaware law. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">B-11</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Helvetica, Arial, sans-serif;font-size:9pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:520pt;margin-left:69.66pt;width:456pt;">
        <div style="text-indent:20pt; width:456pt; line-height:12pt;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="font-weight:bold;letter-spacing:-0.2pt;">IN WITNESS WHEREOF</font><font style="letter-spacing:0.2pt;">, the undersigned have executed this Amended and Restated Certificate this &#8199;&#8199;&#8199;&#8199;&#8199;&#8199;&#8199;&#8199;&#8199; day of&#8199;&#8199;&#8199;&#8199;&#8199;&#8199;&#8199;&#8199;&#8199;&#8199;, 2025. </font>
        </div>
        <div style="margin-left:216pt; margin-top:8pt; width:240pt; line-height:12pt;font-weight:bold;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:-0.2pt;">CYCLACEL PHARMACEUTICALS, INC.</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style=" float:left; margin-left:216pt; line-height:12pt; margin-top:24pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">By:</font>
          <br >
        </div>
        <div style=" margin-top:24pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:236pt;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;</font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-left:236pt; margin-top:2.5pt; width:220pt;">
          <div style="margin-left: 0pt; width: 220pt; margin-top: 0pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
        </div>
        <div style=" float:left; margin-left:236pt; margin-top:3pt; margin-bottom:0pt; text-align:left; width:36pt;white-space:nowrap;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">Name:</font>
          <br >
        </div>
        <div style=" margin-top:3pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:272pt;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">David Lazar </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; margin-left:236pt; line-height:12pt; margin-top:1pt; margin-bottom:0pt; text-align:left; width:36pt;white-space:nowrap;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">Title:</font>
          <br >
        </div>
        <div style=" margin-top:1pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:272pt;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Interim Chief Executive Officer </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">B-12</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:368pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:right; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">ANNEX A</font>&#8203;</div>
        <div style="margin-top:12pt; text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">NOTICE OF CONVERSION</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The undersigned hereby elects to convert shares of Series&#160;C Convertible Preferred Stock (the &#8220;Preferred Stock&#8221;), into shares of common stock (&#8220;Common Stock&#8221;) of Cyclacel Pharmaceuticals, Inc. according to the terms and conditions of the Amended and Restated Certificate of Designation of Preferences, Rights and Limitations of Series&#160;C Convertible Preferred Stock (the &#8220;Certificate of Designation&#8221;), as of the date written below. Capitalized terms used herein and not otherwise defined shall have the respective meanings set forth in the Certificate of Designation. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Date of Conversion: </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Number of Shares of Preferred Stock to be Converted: </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Number of Shares of Preferred Stock Owned Prior to Conversion: </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Number of Shares of Preferred Stock Owned After Conversion: </font>
        </div>
        <div style=" float:left; margin-left:216pt; line-height:12pt; margin-top:24pt; margin-bottom:0pt; text-align:left; width:48pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">Signature:</font>
          <br >
        </div>
        <div style=" margin-top:24pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:264pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;</font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="white-space:nowrap; margin-left:264pt; margin-top:2.5pt; width:192pt;">
          <div style="margin-left: 0pt; width: 192pt; margin-top: 0pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
        </div>
        <div style="margin-left:264pt; margin-top:4pt; width:192pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Name:</font>
          <br >
          <font style="letter-spacing:0.2pt;">Title:</font>
        </div>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">B-13</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a><a name="tAPC">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:312pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Appendix&#160;C</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:8pt; text-align:center; width:456pt; line-height:12pt;">
          <font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Delaware</font><font style="letter-spacing:0.2pt;"> </font>
          <br >
          <font style="letter-spacing:0.2pt;">The First State </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;font-style:italic;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">I, JEFFREY W. BULLOCK, SECRETARY OF STATE OF THE STATE OF DELAWARE, DO HEREBY CERTIFY THE ATTACHED IS A TRUE AND CORRECT COPY OF THE CERTIFICATE OF DESIGNATION OF &#8220;CYCLACEL PHARMACEUTICALS, INC.&#8221;, FILED IN THIS OFFICE ON THE THIRD DAY OF JANUARY, A.D. 2025, AT 9:31 O`CLOCK A.M.</font><font style="font-style:normal;font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="position:relative;margin-left:220pt; margin-top:10pt; text-align:center; width:236pt;">
          <img src="sg_jeffreywbullock-bw.jpg" alt="[MISSING IMAGE: sg_jeffreywbullock-bw.jpg]" height="92" width="184" >
        </div>
        <div style="margin-left:260pt; margin-top:5pt; width:196pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Jeffrey W. Bullock, Secretary of State </font>
        </div>
        <table style="width:456pt;margin-top:10pt;border-collapse: collapse;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <tr style="height:94pt;white-space:nowrap;text-align:left;vertical-align:bottom;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
            <td style="padding:0pt; width:0pt;">&#8203;</td>
            <td style="padding:0pt 0pt 1pt 0pt; width:144pt;">
              <div style="line-height:12pt;">
                <font style="letter-spacing:0.2pt;">2579644 8100</font>
                <br >
                <font style="letter-spacing:0.2pt;">SR# 20250015081 </font>
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0pt 8pt 0pt; width:144pt;white-space:normal;text-align:center;">
              <div style="position:relative;text-align:center;">
                <img src="lg_secretarysoffistamp-bwlr.jpg" alt="[MISSING IMAGE: lg_secretarysoffistamp-bwlr.jpg]" height="115" width="115" >
              </div>
            </td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt; width:6pt;">&#8203;</td>
            <td style="padding:0pt 0.5pt 1pt 0pt; width:144pt;text-align:right;">
              <div style="text-align:right; line-height:12pt;">
                <font style="letter-spacing:0.2pt;">Authentication: 202612105</font>
                <br >
                <font style="letter-spacing:0.2pt;">Date: 01-03-25</font>
              </div>
            </td>
            <td style="padding:0pt; width:0pt;">&#8203;</td>
          </tr>
        </table>
        <div style="margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">You may verify this certificate online at corp.delaware.gov/authver.shtml </font>
        </div>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">C-1</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">CYCLACEL PHARMACEUTICALS, INC.</font>
        </div>
        <div style="margin-top:6pt; text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">CERTIFICATE OF DESIGNATIONS, PREFERENCES,</font>
        </div>
        <div style="margin-top:6pt; text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">RIGHTS AND LIMITATIONS</font>
        </div>
        <div style="margin-top:6pt; text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">OF</font>
        </div>
        <div style="margin-top:6pt; text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">SERIES D CONVERTIBLE PREFERRED STOCK</font>
        </div>
        <div style="margin-top:6pt; text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">PURSUANT TO SECTION 151 OF THE</font>
        </div>
        <div style="margin-top:6pt; text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">DELAWARE GENERAL CORPORATION LAW</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The undersigned, Paul McBarron, does hereby certify that: </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">1.&nbsp;&nbsp;&nbsp;He is the EVP, Finance and Chief Financial Officer of Cyclacel Pharmaceuticals, Inc., a Delaware corporation (the </font><font style="font-weight:bold;letter-spacing:-0.2pt;">&#8220;Corporation&#8221;)</font><font style="letter-spacing:0.2pt;">. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">2.&nbsp;&nbsp;&nbsp;The Corporation is authorized to issue 5,000,000 shares of preferred stock. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">3.&nbsp;&nbsp;&nbsp;The following resolutions were duly adopted by the board of directors of the Corporation (the </font><font style="font-weight:bold;letter-spacing:-0.2pt;">&#8220;Board of Directors&#8221;)</font><font style="letter-spacing:0.2pt;">: </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="font-weight:bold;letter-spacing:-0.2pt;">WHEREAS</font><font style="letter-spacing:0.2pt;">, the Amended and Restated Certificate of Incorporation of the Corporation, as amended, provides for a class of its authorized capital stock known as preferred stock, consisting of 5,000,000 shares, $0.001 par value per share, issuable from time to time in one or more series; </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="font-weight:bold;letter-spacing:-0.2pt;">WHEREAS</font><font style="letter-spacing:0.2pt;">, the Board of Directors is authorized to provide for the issuance of the shares of preferred stock in series and to establish, from time to time, the number of shares to be included in each such series, and to fix the number, designation, powers, preferences and rights of the shares of each such series and any qualifications, limitations or restrictions thereon; and </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="font-weight:bold;letter-spacing:-0.2pt;">WHEREAS</font><font style="letter-spacing:0.2pt;">, it is the desire of the Board of Directors, pursuant to its authority as aforesaid, to fix the rights, preferences, restrictions and other matters relating to a series of the preferred stock; </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="font-weight:bold;letter-spacing:-0.2pt;">NOW</font><font style="letter-spacing:0.2pt;">, </font><font style="font-weight:bold;letter-spacing:-0.2pt;">THEREFORE, BE IT RESOLVED</font><font style="letter-spacing:0.2pt;">, that the Board of Directors does hereby provide for the issuance of a series of preferred stock to be designated the &#8220;Series&#160;D Convertible Preferred Stock&#8221; and does hereby fix and determine the rights, preferences, restrictions and other matters relating to such series of preferred stock as follows: </font>
        </div>
        <div style="margin-top:12pt; text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">TERMS OF PREFERRED STOCK</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Section&#160;1.&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Definitions</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;For the purposes hereof, the following terms shall have the following meanings: </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="font-weight:bold;letter-spacing:-0.2pt;">&#8220;Affiliate&#8221;</font><font style="letter-spacing:0.2pt;"> means any Person that, directly or indirectly through one or more intermediaries, controls or is controlled by or is under common control with a Person, as such terms are used in and construed under Rule&#160;405 of the Securities Act. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">&#8220;Beneficial Ownership Limitation&#8221;</font><font style="font-weight:normal;letter-spacing:0.2pt;"> shall have the meaning set forth in </font><font style="letter-spacing:-0.2pt;">Section&#160;6(c).</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="font-weight:bold;letter-spacing:-0.2pt;">&#8220;Business Day&#8221;</font><font style="letter-spacing:0.2pt;"> means any day except any Saturday, any Sunday, any day which is a federal legal holiday in the United States or any day on which banking institutions in the State of New York are authorized or required by law or other governmental action to close. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="font-weight:bold;letter-spacing:-0.2pt;">&#8220;Commission&#8221;</font><font style="letter-spacing:0.2pt;"> means the United States Securities and Exchange Commission. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="font-weight:bold;letter-spacing:-0.2pt;">&#8220;Common Stock&#8221;</font><font style="letter-spacing:0.2pt;"> means the Corporation&#8217;s common stock, par value $0.001 per share, and stock of any other class of securities into which such securities may hereafter be reclassified or changed. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="font-weight:bold;letter-spacing:-0.2pt;">&#8220;Common Stock Equivalents&#8221;</font><font style="letter-spacing:0.2pt;"> means any securities of the Corporation or its subsidiaries which would entitle the holder thereof to acquire at any time Common Stock, including, without limitation, any debt, </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">C-2</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">preferred stock, rights, options, warrants or other instrument that is at any time convertible into or exercisable or exchangeable for, or otherwise entitles the holder thereof to receive, Common Stock. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="font-weight:bold;letter-spacing:-0.2pt;">&#8220;Conversion Amount&#8221;</font><font style="letter-spacing:0.2pt;"> means the sum of the Stated Value at issue. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="font-weight:bold;letter-spacing:-0.2pt;">&#8220;Conversion Date&#8221;</font><font style="letter-spacing:0.2pt;"> shall have the meaning set forth in </font><font style="font-weight:bold;letter-spacing:-0.2pt;">Section&#160;6(a)</font><font style="letter-spacing:0.2pt;">. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="font-weight:bold;letter-spacing:-0.2pt;">&#8220;Conversion Shares&#8221;</font><font style="letter-spacing:0.2pt;"> means, collectively, the shares of Common Stock issuable upon conversion of the shares of Preferred Stock in accordance with the terms hereof. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="font-weight:bold;letter-spacing:-0.2pt;">&#8220;Exchange Act&#8221;</font><font style="letter-spacing:0.2pt;"> means the Securities Exchange Act of 1934, as amended, and the rules and regulations promulgated thereunder. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="font-weight:bold;letter-spacing:-0.2pt;">&#8220;Fundamental Transaction&#8221;</font><font style="letter-spacing:0.2pt;"> shall have the meaning set forth in </font><font style="font-weight:bold;letter-spacing:-0.2pt;">Section&#160;7(d)</font><font style="letter-spacing:0.2pt;">. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="font-weight:bold;letter-spacing:-0.2pt;">&#8220;GAAP&#8221;</font><font style="letter-spacing:0.2pt;"> means United States generally accepted accounting principles. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="font-weight:bold;letter-spacing:-0.2pt;">&#8220;Holder&#8221;</font><font style="letter-spacing:0.2pt;"> shall have the meaning set forth in </font><font style="font-weight:bold;letter-spacing:-0.2pt;">Section&#160;2</font><font style="letter-spacing:0.2pt;">. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="font-weight:bold;letter-spacing:-0.2pt;">&#8220;Liquidation&#8221;</font><font style="letter-spacing:0.2pt;"> shall have the meaning set forth in </font><font style="font-weight:bold;letter-spacing:-0.2pt;">Section&#160;5</font><font style="letter-spacing:0.2pt;">. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="font-weight:bold;letter-spacing:-0.2pt;">&#8220;New York Courts&#8221;</font><font style="letter-spacing:0.2pt;"> shall have the meaning set forth in </font><font style="font-weight:bold;letter-spacing:-0.2pt;">Section&#160;8(d)</font><font style="letter-spacing:0.2pt;">. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="font-weight:bold;letter-spacing:-0.2pt;">&#8220;Notice of Conversion&#8221;</font><font style="letter-spacing:0.2pt;"> shall have the meaning set forth in </font><font style="font-weight:bold;letter-spacing:-0.2pt;">Section&#160;6(a)</font><font style="letter-spacing:0.2pt;">. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="font-weight:bold;letter-spacing:-0.2pt;">&#8220;Original Issue Date&#8221;</font><font style="letter-spacing:0.2pt;"> means the date of the first issuance of any shares of the Preferred Stock regardless of the number of transfers of any particular shares of Preferred Stock and regardless of the number of certificates which may be issued to evidence such Preferred Stock. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="font-weight:bold;letter-spacing:-0.2pt;">&#8220;Person&#8221;</font><font style="letter-spacing:0.2pt;"> means an individual or corporation, partnership, trust, incorporated or unincorporated association, joint venture, limited liability company, joint stock company, government (or an agency or subdivision thereof) or other entity of any kind. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="font-weight:bold;letter-spacing:-0.2pt;">&#8220;Preferred Stock&#8221;</font><font style="letter-spacing:0.2pt;"> shall have the meaning set forth in </font><font style="font-weight:bold;letter-spacing:-0.2pt;">Section&#160;2</font><font style="letter-spacing:0.2pt;">. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="font-weight:bold;letter-spacing:-0.2pt;">&#8220;Securities Act&#8221;</font><font style="letter-spacing:0.2pt;"> means the Securities Act of 1933, as amended, and the rules and regulations promulgated thereunder. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="font-weight:bold;letter-spacing:-0.2pt;">&#8220;Share Delivery Date&#8221;</font><font style="letter-spacing:0.2pt;"> shall have the meaning set forth in </font><font style="font-weight:bold;letter-spacing:-0.2pt;">Section&#160;6(b)</font><font style="letter-spacing:0.2pt;">. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="font-weight:bold;letter-spacing:-0.2pt;">&#8220;Stated Value&#8221;</font><font style="letter-spacing:0.2pt;"> shall have the meaning set forth in </font><font style="font-weight:bold;letter-spacing:-0.2pt;">Section&#160;2</font><font style="letter-spacing:0.2pt;">, as the same may be increased pursuant to Section&#160;3. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="font-weight:bold;letter-spacing:-0.2pt;">&#8220;Successor Entity&#8221;</font><font style="letter-spacing:0.2pt;"> shall have the meaning set forth in </font><font style="font-weight:bold;letter-spacing:-0.2pt;">Section&#160;7(d)</font><font style="letter-spacing:0.2pt;">. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="font-weight:bold;letter-spacing:-0.2pt;">&#8220;Trading Day&#8221;</font><font style="letter-spacing:0.2pt;"> means a day on which the principal Trading Market is open for business. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="font-weight:bold;letter-spacing:-0.2pt;">&#8220;Trading Market&#8221;</font><font style="letter-spacing:0.2pt;"> means any of the following markets or exchanges on which the Common Stock is listed or quoted for trading on the date in question: the Nasdaq Capital Market, the Nasdaq Global Market, the Nasdaq Global Select Market, the NYSE MKT or the New York Stock Exchange (or any successors to any of the foregoing). </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="font-weight:bold;letter-spacing:-0.2pt;">&#8220;Transfer Agent&#8221;</font><font style="letter-spacing:0.2pt;"> means Equiniti Trust Company, LLC, and any successor transfer agent of the Corporation. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Section&#160;2.&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Designation, Amount and Par Value</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;The series of preferred stock shall be designated as the Series&#160;D Convertible Preferred Stock (the &#8220;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Preferred Stock</font><font style="letter-spacing:0.2pt;">&#8221;) and the number of shares so designated shall be 2,100,000 (which shall not be subject to change without the written consent of a majority of the holders of the Preferred Stock (each, a &#8220;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Holder</font><font style="letter-spacing:0.2pt;">&#8221; and collectively, the &#8220;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Holders</font><font style="letter-spacing:0.2pt;">&#8221;)). Each share of Preferred Stock shall have a par value of$0.001 per share and a stated value equal to $1.00 (the &#8220;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Stated Value</font><font style="letter-spacing:0.2pt;">&#8221;). </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Section&#160;3.&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Dividends</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;Except for stock dividends or distributions for which adjustments are to be made pursuant to </font><font style="font-weight:bold;letter-spacing:-0.2pt;">Section&#160;7,</font><font style="letter-spacing:0.2pt;"> Holders shall be entitled to receive, and the Corporation shall pay, dividends </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">C-3</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">on shares of Preferred Stock equal (on an as-if-converted-to-Common-Stock basis, without regard to conversion limitations herein) to and in the same form as dividends actually paid on shares of the Common Stock when, as and if such dividends are paid on shares of the Common Stock. No other dividends shall be paid on shares of Preferred Stock. The Corporation shall not pay any dividends on the Common Stock unless the Corporation simultaneously complies with this provision. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">Section&#160;4.&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Voting Rights</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;The Preferred Stock shall be counted for purposes of determining a quorum at a meeting of stockholders and shall vote on matters of the Corporation on an as-if-converted-to-Common-Stock basis, subject to the provisions of the Delaware General Corporation Law and subject to the Beneficial Ownership Limitation. Subject to the provisions of Section&#160;6(c) hereof, each share of Preferred Stock shall entitle the holder thereof to cast that number of votes per share of Preferred Stock as is equal to the Stated Value of such share of Preferred Stock divided by the Nasdaq Minimum Price (as defined in Nasdaq Listing Rule&#160;5635(d)) immediately preceding the Original Issue Date, and subject to adjustments for any stock splits, stock dividends, stock combinations, recapitalizations or other similar transactions following the date hereof). </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Section&#160;5.&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Liquidation Preference</font><font style="letter-spacing:0.2pt;">. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">(a)&nbsp;&nbsp;&nbsp; In the event of any liquidation, dissolution or winding up of the Corporation, either voluntary or involuntary, subject to the rights of any existing series of preferred stock or to the rights of any series of preferred stock which may from time to time hereafter come into existence, the holders of the Preferred Stock shall be entitled to receive, prior and in preference to any distribution of any of the assets of the Corporation to the holders of Common Stock by reason of their ownership thereof, the Stated Value per share of Preferred Stock then held by them, plus declared but unpaid dividends. If, upon the occurrence of any liquidation, dissolution or winding up of the Corporation, the assets and funds thus distributed among the holders of the Preferred Stock shall be insufficient to permit the payment to such holders of the full aforesaid preferential amounts, then, subject to the rights of any existing series of preferred stock or to the rights of any series of preferred stock which may from time to time hereafter come into existence, the entire assets and funds of the Corporation legally available for distribution shall be distributed ratably among the holders of each series of preferred stock in proportion to the preferential amount each such holder is otherwise entitled to receive. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">(b)&nbsp;&nbsp;&nbsp;Upon the completion of the distribution required by Section&#160;5(a) above and any other distribution that may be required with respect to the rights of any existing series of preferred stock or to the rights of any series of preferred stock which may from time to time hereafter come into existence, if assets remain in the Corporation, the remaining assets shall be distributed to the holders of the Common Stock until such time as the holders of the Common stock shall have received a return of the capital originally contributed thereby. Thereafter, if assets remain in the Corporation, all remaining assets shall be distributed to all holders of Common Stock and to each series of Preferred Stock, pro&#160;rata based on the number of shares of Common Stock held by each (assuming conversion of all such Preferred Stock into Common Stock). </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">(c)&nbsp;&nbsp;&nbsp;For purposes of this Section&#160;5, a liquidation, dissolution or winding up of the Corporation shall be deemed to be occasioned by, or to include, (i)&#160;the acquisition of the Corporation by another entity by means of any transaction or series of related transactions (including, without limitation, any reorganization, merger or consolidation, but excluding any merger effected exclusively for the purpose of changing the domicile of the Corporation); or (ii)&#160;a sale of all or substantially all of the assets of the Corporation, unless the Corporation&#8217;s stockholders of record as constituted immediately prior to such acquisition or sale will, immediately after such acquisition or sale (by virtue of securities issued as consideration for the Corporation&#8217;s acquisition or sale or otherwise) hold at least fifty&#160;percent (50%) of the voting power of the surviving or acquiring entity in approximately the same relative&#160;percentages after such acquisition or sale as before such acquisition or sale. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12.5pt;">
          <font style="letter-spacing:0.2pt;">(d)&nbsp;&nbsp;&nbsp;In any of the events specified in subsection (c)&#160;above, if the consideration received by the corporation is other than cash, its value will be deemed its fair market value. Any securities shall be valued as follows: </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">C-4</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:40pt; width:416pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(i)&nbsp;&nbsp;&nbsp;Securities not subject to restrictions on free marketability: </font>
        </div>
        <div style="margin-left:40pt; text-indent:20pt; margin-top:8pt; width:416pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(A)&nbsp;&nbsp;&nbsp;If traded on a securities exchange, the value shall be deemed to be the average of the closing prices of the securities on such exchange over the thirty-day period ending three (3)&#160;days prior to the closing; </font>
        </div>
        <div style="margin-left:40pt; text-indent:20pt; margin-top:8pt; width:416pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(B)&nbsp;&nbsp;&nbsp; If actively traded over-the-counter, the value shall be deemed to be the average of the closing bid or sale prices (whichever is applicable) over the thirty-day period ending three (3)&#160;days prior to the closing; and </font>
        </div>
        <div style="margin-left:40pt; text-indent:20pt; margin-top:8pt; width:416pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(C)&nbsp;&nbsp;&nbsp;If there is no active public market, the value shall be the fair market value thereof, as determined in good faith by the Board of Directors. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(ii)&nbsp;&nbsp;&nbsp; The method of valuation of securities subject to restrictions on free marketability (other than restrictions arising solely by virtue of a stockholder&#8217;s status as an affiliate or former affiliate) shall be to make an appropriate discount from the market value determined as above in (i)&#160;(A), (B)&#160;or (C)&#160;to reflect the approximate fair market value thereof, as mutually determined by the Corporation and the holders of at least a majority of the voting power of all then outstanding shares of Preferred Stock. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(iii)&nbsp;&nbsp;&nbsp;In the event the requirements of Section&#160;2(c) are not complied with, the Corporation shall forthwith either: </font>
        </div>
        <div style="margin-left:40pt; text-indent:20pt; margin-top:8pt; width:416pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(A)&nbsp;&nbsp;&nbsp;cause such closing to be postponed until such time as the requirements of this Section&#160;5 have been complied with; or </font>
        </div>
        <div style="margin-left:40pt; text-indent:20pt; margin-top:8pt; width:416pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(B)&nbsp;&nbsp;&nbsp; cancel such transaction, in which event the rights, preferences and privileges of the holders of the Preferred Stock shall revert to and be the same as such rights, preferences and privileges existing immediately prior to the date of the first notice referred to in Section&#160;5(c)(iv) hereof. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(iv)&nbsp;&nbsp;&nbsp;The Corporation shall give each holder of record of Preferred Stock written notice of such impending transaction not later than twenty (20) days prior to the stockholders&#8217; meeting called to approve such transaction, or twenty (20) days prior to the closing of such transaction, whichever is earlier, and shall also notify such holders in writing of the final approval of such transaction. The first of such notices shall describe the material terms and conditions of the impending transaction and the provisions of this Section&#160;5, and the Corporation shall thereafter give such holders prompt notice of any material changes. The transaction shall in no event take place sooner than twenty (20) days after the Corporation has given the first notice provided for herein or sooner than ten (10) days after the corporation has given notice of any material changes provided for herein; provided, however, that time periods set forth in this paragraph may be shortened upon the written consent of the holders of Preferred Stock that are entitled to such notice rights or similar notice rights and that represent at least a majority of the voting power of all then outstanding shares of such Preferred Stock. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Section&#160;6.&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Conversion</font><font style="letter-spacing:0.2pt;">. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">a)&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Conversions at Option of Holder</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;Each one share of Preferred Stock shall be convertible, at any time and from time to time from and after the Original Issue Date at the option of the Holder thereof, into one hundred ten (110) shares of Common Stock (subject to the limitations set forth in </font><font style="font-weight:bold;letter-spacing:-0.2pt;">Section&#160;6(c)</font><font style="letter-spacing:0.2pt;">) (the &#8220;Conversion Ratio&#8221;). Holders shall effect conversions by providing the Corporation with the form of conversion notice attached hereto as </font><font style="font-weight:bold;letter-spacing:-0.2pt;">Annex A</font><font style="letter-spacing:0.2pt;"> (a &#8220;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Notice of Conversion</font><font style="letter-spacing:0.2pt;">&#8221;). Each Notice of Conversion shall specify the number of shares of Preferred Stock to be converted, the number of shares of Preferred Stock owned prior to the conversion at issue, the number of shares of Preferred Stock owned subsequent to the conversion at issue and the date on which such conversion is to be effected, which date may not be prior to the date the applicable Holder delivers by facsimile or email such Notice of Conversion to the Corporation (such date, the &#8220;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Conversion Date</font><font style="letter-spacing:0.2pt;">&#8221;). If no Conversion Date is specified in a Notice of Conversion, the Conversion Date shall be the date that such Notice of Conversion to the Corporation is deemed delivered hereunder. No ink-original Notice of Conversion shall be required, nor shall any medallion guarantee (or other type of guarantee or notarization) of any Notice of Conversion form be required. The calculations and </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">C-5</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">entries set forth in the Notice of Conversion shall control in the absence of manifest or mathematical error. To effect conversions of shares of Preferred Stock, a Holder shall not be required to surrender the certificate(s) representing the shares of Preferred Stock to the Corporation unless all of the shares of Preferred Stock represented thereby are so converted, in which case such Holder shall deliver the certificate representing such shares of Preferred Stock promptly following the Conversion Date at issue. Shares of Preferred Stock converted into Common Stock in accordance with the terms hereof shall be canceled and shall not be reissued. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">b)&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Mechanics of Conversion</font><font style="letter-spacing:0.2pt;">. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">i.&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Delivery of Conversion Shares Upon Conversion</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;Not later than the earlier of (i)&#160;two&#160;(2) Trading Days and (ii)&#160;the number of Trading Days comprising the Standard Settlement Period (as defined below) after each Conversion Date (the &#8220;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Share Delivery Date</font><font style="letter-spacing:0.2pt;">&#8221;), the Corporation shall deliver, or cause to be delivered, to the converting Holder (A)&#160;the number of Conversion Shares being acquired upon the conversion of the Preferred Stock and (B)&#160;a bank check in the amount of accrued and unpaid dividends, if any. As used herein, &#8220;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Standard Settlement Period</font><font style="letter-spacing:0.2pt;">&#8221; means the standard settlement period, expressed in a number of Trading Days, on the Corporation&#8217;s primary Trading Market with respect to the Common Stock as in effect on the date of delivery of the Notice of Conversion. Notwithstanding the foregoing, with respect to any Notice(s) of Conversion delivered by 12:00&#160;pm (New York time) on the Original Issue Date, the Corporation agrees to deliver the Conversion Shares subject to such notice(s) by 4:00&#160;pm (New York time) on the Original Issue Date. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">ii.&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Failure to Deliver Conversion Shares</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;If, in the case of any Notice of Conversion, such Conversion Shares are not delivered to or as directed by the applicable Holder by the Share Delivery Date, the Holder shall be entitled to elect by written notice to the Corporation at any time on or before its receipt of such Conversion Shares, to rescind such Conversion, in which event the Corporation shall promptly return to the Holder any original Preferred Stock certificate delivered to the Corporation and the Holder shall promptly return to the Corporation the Conversion Shares issued to such Holder pursuant to the rescinded Notice of Conversion. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">iii.&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Obligation Absolute; Partial Liquidated Damages</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;The Corporation&#8217;s obligation to issue and deliver the Conversion Shares upon conversion of Preferred Stock in accordance with the terms hereof are absolute and unconditional, irrespective of any action or inaction by a Holder to enforce the same, any waiver or consent with respect to any provision hereof, the recovery of any judgment against any Person or any action to enforce the same, or any setoff, counterclaim, recoupment, limitation or termination, or any breach or alleged breach by such Holder or any other Person of any obligation to the Corporation or any violation or alleged violation of law by such Holder or any other person, and irrespective of any other circumstance which might otherwise limit such obligation of the Corporation to such Holder in connection with the issuance of such Conversion Shares; provided, however, that such delivery shall not operate as a waiver by the Corporation of any such action that the Corporation may have against such Holder. If the Corporation fails to deliver to a Holder such Conversion Shares pursuant to </font><font style="font-weight:bold;letter-spacing:-0.2pt;">Section&#160;6(b)(i)</font><font style="letter-spacing:0.2pt;"> by the Share Delivery Date applicable to such conversion, the Corporation shall pay to such Holder, in cash, as liquidated damages and not as a penalty, for each $1,000.00 of Stated Value of Preferred Stock being converted, per Trading Day for each Trading Day after the Share Delivery Date until such Conversion Shares are delivered or Holder rescinds such conversion. Nothing herein shall limit a Holder&#8217;s right to pursue actual damages for the Corporation&#8217;s failure to deliver Conversion Shares within the period specified herein, and such Holder shall have the right to pursue all remedies available to it hereunder, at law or in equity including, without limitation, a decree of specific performance and/or injunctive relief. The exercise of any such rights shall not prohibit a Holder from seeking to enforce damages pursuant to any other Section hereof or under applicable law. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">iv.&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Compensation for Buy-In on Failure to Timely Deliver Conversion Shares Upon Conversion</font><font style="letter-spacing:0.2pt;">. In addition to any other rights available to the Holder, if the Corporation fails for any reason to deliver to a Holder the applicable Conversion Shares by the Share Delivery Date pursuant to </font><font style="font-weight:bold;letter-spacing:-0.2pt;">Section&#160;6(b)(i)</font><font style="letter-spacing:0.2pt;">, and if after such Share Delivery Date such Holder is required by its brokerage firm to purchase (in an open market transaction or otherwise), or the Holder&#8217;s brokerage firm otherwise purchases, shares of Common Stock to deliver in satisfaction of a sale by such Holder of the Conversion Shares which </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">C-6</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:20pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">such Holder was entitled to receive upon the conversion relating to such Share Delivery Date (a &#8220;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Buy-In</font><font style="letter-spacing:0.2pt;">&#8221;), then the Corporation shall (A)&#160;pay in cash to such Holder (in addition to any other remedies available to or elected by such Holder) the amount, if any, by which (x)&#160;such Holder&#8217;s total purchase price (including any brokerage commissions) for the Common Stock so purchased exceeds (y)&#160;the product of (1)&#160;the aggregate number of shares of Common Stock that such Holder was entitled to receive from the conversion at issue multiplied by (2)&#160;the actual sale price at which the sell order giving rise to such purchase obligation was executed (including any brokerage commissions) and (B)&#160;at the option of such Holder, either reissue (if surrendered) the shares of Preferred Stock equal to the number of shares of Preferred Stock submitted for conversion (in which case, such conversion shall be deemed rescinded) or deliver to such Holder the number of shares of Common Stock that would have been issued if the Corporation had timely complied with its delivery requirements under </font><font style="font-weight:bold;letter-spacing:-0.2pt;">Section&#160;6(b)(i)</font><font style="letter-spacing:0.2pt;">. For example, if a Holder purchases shares of Common Stock having a total purchase price of $11,000 to cover a Buy-In with respect to an attempted conversion of shares of Preferred Stock with respect to which the actual sale price of the Conversion Shares (including any brokerage commissions) giving rise to such purchase obligation was a total of $10,000 under clause (A)&#160;of the immediately preceding sentence, the Corporation shall be required to pay such Holder $1,000. The Holder shall provide the Corporation written notice indicating the amounts payable to such Holder in respect of the Buy-In and, upon request of the Corporation, evidence of the amount of such loss. Nothing herein shall limit a Holder&#8217;s right to pursue any other remedies available to it hereunder, at law or in equity including, without limitation, a decree of specific performance and/or injunctive relief with respect to the Corporation&#8217;s failure to timely deliver Conversion Shares upon conversion of the shares of Preferred Stock as required pursuant to the terms hereof. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">v.&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Reservation of Shares Issuable Upon Conversion</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;Until no shares of Preferred Stock remain outstanding, the Corporation covenants that it will at all times reserve and keep available out of its authorized and unissued shares of Common Stock for the sole purpose of issuance upon conversion of the Preferred Stock as herein provided, free from preemptive rights or any other actual contingent purchase rights of Persons other than the Holder (and the other holders of the Preferred Stock), not less than such aggregate number of shares of the Common Stock as shall be issuable (taking into account the adjustments and restrictions of Section&#160;7) upon the conversion of the then outstanding shares of Preferred Stock. The Corporation covenants that all shares of Common Stock that shall be so issuable shall, upon issue, be duly authorized, validly issued, fully paid and nonassessable. </font>
        </div>
        <div style="margin-left:40pt; margin-top:8pt; width:416pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">vi.&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">RESERVED</font><font style="letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">vii.&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Transfer Taxes and Expenses</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;The issuance of Conversion Shares on conversion of the Preferred Stock shall be made without charge to any Holder for any documentary stamp or similar taxes that may be payable in respect of the issue or delivery of such Conversion Shares, provided that the Corporation shall not be required to pay any tax that may be payable in respect of any transfer involved in the issuance and delivery of any such Conversion Shares upon conversion in a name other than that of the Holders of such shares of Preferred Stock and the Corporation shall not be required to issue or deliver such Conversion Shares unless or until the Person or Persons requesting the issuance thereof shall have paid to the Corporation the amount of such tax or shall have established to the satisfaction of the Corporation that such tax has been paid. The Corporation shall pay all Transfer Agent fees required for same-day processing of any Notice of Conversion and all fees to the DTC (or another established clearing corporation performing similar functions) required for same-day electronic delivery of the Conversion Shares. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">c)&nbsp;&nbsp;&nbsp; </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Beneficial Ownership Limitation</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;Notwithstanding anything to the contrary herein, the Corporation shall not effect any conversion of the Preferred Stock, and a Holder shall not have the right to convert any portion of the Preferred Stock, to the extent that, after giving effect to the conversion set forth on the applicable Notice of Conversion, such Holder (together with such Holder&#8217;s Affiliates, and any Persons acting as a group together with such Holder or any of such Holder&#8217;s Affiliates (such Persons, &#8220;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Attribution Parties</font><font style="letter-spacing:0.2pt;">&#8221;)) would beneficially own in excess of the Beneficial Ownership Limitation (as defined below); provided, however that following a vote of the stockholders of the Company in accordance with the rules and regulations of the Trading Market on which the Common Stock trades on such date and applicable securities laws to approve the removal of the Beneficial Ownership Limitation, the Corporation </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">C-7</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">shall not effect any conversion of the Preferred Stock, and a Holder shall not have the right to convert any portion of the Preferred Stock, to the extent that, after giving effect to the conversion set forth on the applicable Notice of Conversion, such Holder (together with such Holder&#8217;s Affiliates and Attribution Parties) would beneficially own the number of shares of Common Stock which would be in excess of any statutory threshold pursuant to which the acquisition of such shares would trigger a compulsory offer requirement under applicable federal or state tender offer rules for the Holder and its Affiliates and Attribution Parties to make a tender offer for all the shares of the Company. For purposes of the foregoing sentence, the number of shares of Common Stock beneficially owned by such Holder and its Affiliates and Attribution Parties shall include the number of shares of Common Stock issuable upon conversion of the Preferred Stock with respect to which such determination is being made, but shall exclude the number of shares of Common Stock which are issuable upon (i)&#160;conversion of the remaining, unconverted Stated Value of Preferred Stock beneficially owned by such Holder or any of its Affiliates or Attribution Parties and (ii)&#160;exercise or conversion of the unexercised or unconverted portion of any other securities of the Corporation subject to a limitation on conversion or exercise analogous to the limitation contained herein (including, without limitation, the Preferred Stock) beneficially owned by such Holder or any of its Affiliates or Attribution Parties. Except as set forth in the preceding sentence, for purposes of this </font><font style="font-weight:bold;letter-spacing:-0.2pt;">Section&#160;6(c),</font><font style="letter-spacing:0.2pt;"> beneficial ownership shall be calculated in accordance with Section&#160;13(d) of the Exchange Act and the rules and regulations promulgated thereunder. To the extent that the limitation contained in this </font><font style="font-weight:bold;letter-spacing:-0.2pt;">Section&#160;6(c)</font><font style="letter-spacing:0.2pt;"> applies, the determination of whether the Preferred Stock is convertible (in relation to other securities owned by such Holder together with any Affiliates and Attribution Parties) and of how many shares of Preferred Stock are convertible shall be in the sole discretion of such Holder, and the submission of a Notice of Conversion shall be deemed to be such Holder&#8217;s determination of whether the shares of Preferred Stock may be converted (in relation to other securities owned by such Holder together with any Affiliates and Attribution Parties) and how many shares of the Preferred Stock are convertible, in each case subject to the Beneficial Ownership Limitation. To ensure compliance with this restriction, each Holder will be deemed to represent to the Corporation each time it delivers a Notice of Conversion that such conversion will not violate the restrictions set forth in this paragraph and the Corporation shall have no obligation to verify or confirm the accuracy of such representation. In addition, a determination as to any group status as contemplated above shall be determined in accordance with Section&#160;13(d) of the Exchange Act and the rules and regulations promulgated thereunder. For purposes of this </font><font style="font-weight:bold;letter-spacing:-0.2pt;">Section&#160;6(c),</font><font style="letter-spacing:0.2pt;"> in determining the number of outstanding shares of Common Stock, a Holder may rely solely on the number of outstanding shares of Common Stock as stated in a written notice by the Corporation or the Transfer Agent setting forth the number of shares of Common Stock outstanding. Upon the written or oral request (which may be via email) of a Holder, the Corporation shall within two Trading Days confirm orally and in writing to such Holder the number of shares of Common Stock then outstanding. In any case, the number of outstanding shares of Common Stock shall be determined after giving effect to the conversion or exercise of securities of the Corporation, including the Preferred Stock, by such Holder or its Affiliates or Attribution Parties since the date as of which such number of outstanding shares of Common Stock was reported. The &#8220;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Beneficial Ownership Limitation</font><font style="letter-spacing:0.2pt;">&#8221; shall mean, as of any date </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">prior to</font><font style="letter-spacing:0.2pt;"> the completion of a Fundamental Transaction (the &#8220;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Fundamental Transaction Date</font><font style="letter-spacing:0.2pt;">&#8221;), the lower of (X)&#160;the maximum&#160;percentage of the number of shares of the Common Stock outstanding immediately after giving effect to the issuance of shares of Common Stock issuable upon conversion of the Preferred Stock that can be issued to the Holder without requiring a vote of the stockholders of the Company under the rules and regulations of the Trading Market on which the Common Stock trades on such date and applicable securities laws; and, (Y)&#160;49.99% of the number of shares of the Common Stock outstanding immediately before the Original Issue Date. The term &#8220;Fundamental Transaction,&#8221; as used herein means when (i)&#160;the Corporation effects any merger of the Corporation with or into another entity and the Corporation is not the surviving entity, (ii)&#160;any tender offer or exchange offer (whether by the Corporation or by another individual or entity, and approved by the Corporation) is completed pursuant to which holders of Common Stock are permitted to tender or exchange their shares of Common Stock for other securities, cash or property and the holders of at least 50% of the Common Stock accept such offer, or (iii)&#160;the Corporation effects any reclassification of the Common Stock or any compulsory share exchange pursuant to which the Common Stock is effectively converted into or exchanged for other securities, cash or property ( other than as a result of a subdivision or combination of shares of Common Stock). The provisions of this paragraph shall be construed and implemented in a manner otherwise than in strict conformity with the terms of this Section&#160;6(c) to correct this paragraph (or any portion hereof) which may be defective or inconsistent with the intended Beneficial Ownership Limitation contained </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">C-8</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">herein or to make changes or supplements necessary or desirable to properly give effect to such limitation. The limitations contained in this paragraph shall apply to a successor holder of Preferred Stock. The Beneficial Ownership Limitation shall cease on the Fundamental Transaction Date. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Section&#160;7.&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Certain Adjustments</font><font style="letter-spacing:0.2pt;">. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">a)&nbsp;&nbsp;&nbsp; </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Stock Dividends and Stock Splits</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;If the Corporation, at any time while this Preferred Stock is outstanding: (i)&#160;pays a stock dividend or otherwise makes a distribution or distributions payable in shares of Common Stock on shares of Common Stock or any other Common Stock Equivalents (which, for avoidance of doubt, shall not include any shares of Common Stock issued by the Corporation upon conversion of, or payment of a dividend on, this Preferred Stock), (ii)&#160;subdivides outstanding shares of Common Stock into a larger number of shares, (iii)&#160;combines (including by way of a reverse stock split) outstanding shares of Common Stock into a smaller number of shares, or (iv)&#160;issues, in the event of a reclassification of shares of the Common Stock, any shares of capital stock of the Corporation, then the number of shares of Common Stock each share of Preferred Stock shall be convertible into shall be multiplied by a fraction of which the numerator shall be the number of shares of Common Stock (excluding any treasury shares of the Corporation) outstanding immediately before such event, and of which the denominator shall be the number of shares of Common Stock outstanding immediately after such event. Any adjustment made pursuant to this Section&#160;7(a) shall become effective immediately after the record date for the determination of stockholders entitled to receive such dividend or distribution and shall become effective immediately after the effective date in the case of a subdivision, combination or re-classification. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">b)&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Subsequent Rights Offerings</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;In addition to any adjustments pursuant to Section&#160;7(a) above, if at any time the Corporation grants, issues or sells any Common Stock Equivalents or rights to purchase stock, warrants, securities or other property pro&#160;rata to the record holders of any class of shares of Common Stock (the &#8220;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Purchase Rights</font><font style="letter-spacing:0.2pt;">&#8221;), then the Holder will be entitled to acquire, upon the terms applicable to such Purchase Rights, the aggregate Purchase Rights which the Holder could have acquired if the Holder had held the number of shares of Common Stock acquirable upon complete conversion of such Holder&#8217;s Preferred Stock (without regard to any limitations on exercise hereof, including without limitation, the Beneficial Ownership Limitation) immediately before the date on which a record is taken for the grant, issuance or sale of such Purchase Rights, or, if no such record is taken, the date as of which the record holders of shares of Common Stock are to be determined for the grant, issue or sale of such Purchase Rights (provided, however, to the extent that the Holder&#8217;s right to participate in any such Purchase Right would result in the Holder exceeding the Beneficial Ownership Limitation, then the Holder shall not be entitled to participate in such Purchase Right to such extent (or beneficial ownership of such shares of Common Stock as a result of such Purchase Right to such extent) and such Purchase Right to such extent shall be held in abeyance for the Holder until such time, if ever, as its right thereto would not result in the Holder exceeding the Beneficial Ownership Limitation). </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">c)&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Pro Rata Distributions</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;During such time as this Preferred Stock is outstanding, if the Corporation declares or makes any dividend or other distribution of its assets ( or rights to acquire its assets) to holders of shares of Common Stock, by way of return of capital or otherwise (including, without limitation, any distribution of cash, stock or other securities, property or options by way of a dividend, spin off, reclassification, corporate rearrangement, scheme of arrangement or other similar transaction) (a &#8220;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Distribution</font><font style="letter-spacing:0.2pt;">&#8221;), at any time after the issuance of this Preferred Stock, then, in each such case, the Holder shall be entitled to participate in such Distribution to the same extent that the Holder would have participated therein if the Holder had held the number of shares of Common Stock acquirable upon complete conversion of this Preferred Stock (without regard to any limitations on conversion hereof, including without limitation, the Beneficial Ownership Limitation) immediately before the date of which a record is taken for such Distribution, or, if no such record is taken, the date as of which the record holders of shares of Common Stock are to be determined for the participation in such Distribution (provided, however, to the extent that the Holder&#8217;s right to participate in any such Distribution would result in the Holder exceeding the Beneficial Ownership Limitation, then the Holder shall not be entitled to participate in such Distribution to such extent (or in the beneficial ownership of any shares of Common Stock as a result of such Distribution to such extent) and the portion of such Distribution shall be held in abeyance for the benefit of the Holder until such time, if ever, as its right thereto would not result in the Holder exceeding the Beneficial Ownership Limitation). </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">C-9</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-indent:20pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">d)&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Fundamental Transaction</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;If, at any time while any shares of Preferred Stock are outstanding, (i)&#160;the Corporation, directly or indirectly, in one or more related transactions effects any merger or consolidation of the Corporation with or into another Person, (ii)&#160;the Corporation, directly or indirectly, effects any sale, lease, license, assignment, transfer, conveyance or other disposition of all or substantially all of its assets in one or a series of related transactions, (iii)&#160;any, direct or indirect, purchase offer, tender offer or exchange offer (whether by the Corporation or another Person) is completed pursuant to which holders of Common Stock are permitted to sell, tender or exchange their shares for other securities, cash or property and has been accepted by the holders of 50% or more of the outstanding Common Stock, (iv)&#160;the Corporation, directly or indirectly, in one or more related transactions effects any reclassification, reorganization or recapitalization of the Common Stock or any compulsory share exchange pursuant to which the Common Stock is effectively converted into or exchanged for other securities, cash or property, or (v)&#160;the Corporation, directly or indirectly, in one or more related transactions consummates a stock or share purchase agreement or other business combination (including, without limitation, a reorganization, recapitalization, spin-off or scheme of arrangement) with another Person whereby such other Person acquires more than 50% of the outstanding shares of Common Stock (not including any shares of Common Stock held by the other Person or other Persons making or party to, or associated or affiliated with the other Persons making or party to, such stock or share purchase agreement or other business combination) (each a &#8220;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Fundamental Transaction</font><font style="letter-spacing:0.2pt;">&#8221;), then, upon any subsequent conversion of the Preferred Stock by the Holder thereof, the Holder shall receive, for each Conversion Share that would have been issuable upon such conversion immediately prior to the occurrence of such Fundamental Transaction (without regard to any limitation in </font><font style="font-weight:bold;letter-spacing:-0.2pt;">Section&#160;6(c)</font><font style="letter-spacing:0.2pt;"> on the conversion of the Preferred Stock), the number of shares of common stock (as applicable) of the successor or acquiring corporation or the number of shares of Common Stock of the Corporation (as applicable), if it is the surviving corporation, and all additional securities (equity or debt), cash, property or other consideration (all such additional consideration, the &#8220;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Alternate Consideration</font><font style="letter-spacing:0.2pt;">&#8221;), receivable as a result of such Fundamental Transaction by a holder of the number of shares of Common Stock for which such Holder&#8217;s Preferred Stock is convertible immediately prior to such Fundamental Transaction (without regard to any limitation in </font><font style="font-weight:bold;letter-spacing:-0.2pt;">Section&#160;6(c)</font><font style="letter-spacing:0.2pt;"> on the conversion of the Preferred Stock). If holders of Common Stock are entitled to elect the proportion of securities, cash, property or other consideration to be received by holders of Common Stock in a Fundamental Transaction, then each Holder of Preferred Stock shall be given the same choice as to the proportion of securities, cash, property or other consideration such Holder is entitled to receive upon any conversion of such Holder&#8217;s shares of Preferred Stock following such Fundamental Transaction. To the extent necessary to effectuate the foregoing provisions, any successor to the Corporation or surviving entity in such Fundamental Transaction shall file a new Certificate of Designations in respect of a new series of preferred stock of the successor or acquiring corporation, or the Corporation, if it is the surviving corporation, setting forth the same rights, preferences, privileges and other terms contained in this Certificate of Designations in respect of the Preferred Stock, including, without limitation, the provisions contained in this </font><font style="font-weight:bold;letter-spacing:-0.2pt;">Section&#160;7(d)</font><font style="letter-spacing:0.2pt;"> and evidencing, among other things, the Holders&#8217; right to convert such new preferred stock into Alternate Consideration. The Corporation shall cause any successor entity in a Fundamental Transaction in which the Corporation is not the survivor (the &#8220;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Successor Entity</font><font style="letter-spacing:0.2pt;">&#8221;) to assume in writing all of the obligations of the Corporation under this Certificate of Designations in accordance with the provisions of this </font><font style="font-weight:bold;letter-spacing:-0.2pt;">Section&#160;7(d)</font><font style="letter-spacing:0.2pt;"> pursuant to written agreements in form and substance reasonably satisfactory to the Holder and approved by the Holder (without unreasonable delay) prior to such Fundamental Transaction and shall, at the option of a Holder of Preferred Stock, deliver to such Holder in exchange for such Holder&#8217;s Preferred Stock a security of the Successor Entity evidenced by a written instrument substantially similar in form and substance to the Preferred Stock which is convertible for a corresponding number of shares of capital stock of such Successor Entity (or its parent entity) equivalent to the shares of Common Stock acquirable and receivable upon conversion of the Preferred Stock (without regard to any limitations on the conversion of the Preferred Stock) prior to such Fundamental Transaction, and with a conversion price which applies the conversion price hereunder to such shares of capital stock (but taking into account the relative value of the shares of Common Stock pursuant to such Fundamental Transaction and the value of such shares of capital stock, such number of shares of capital stock and such conversion price being for the purpose of protecting the economic value of the Preferred Stock immediately prior to the consummation of such Fundamental Transaction), and which is reasonably satisfactory in form and substance to the Holder(s) thereof. Upon the occurrence of any such Fundamental Transaction, the Successor Entity shall succeed to, and be substituted for (so that from and after the date of such Fundamental Transaction, the provisions of this Certificate of Designations referring to the </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">C-10</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#8220;Corporation&#8221; shall refer instead to the Successor Entity), and may exercise every right and power of the Corporation and shall assume all of the obligations of the Corporation under this Certificate of Designations with the same effect as if such Successor Entity had been named as the Corporation herein. For the avoidance of doubt, if, at any time while any shares of Preferred Stock are outstanding, a Fundamental Transaction occurs, pursuant to the terms of this </font><font style="font-weight:bold;letter-spacing:-0.2pt;">Section&#160;7(d),</font><font style="letter-spacing:0.2pt;"> a Holder of Preferred Stock shall not be entitled to receive any consideration in such Fundamental Transaction in respect of such Holder&#8217;s shares of Preferred Stock, except as provided for in this Certificate of Designations (or any new Certificate of Designations in respect of a new series of preferred stock issued to the Holders of Preferred Stock as contemplated hereby). </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">e)&nbsp;&nbsp;&nbsp; </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Intentionally Omitted</font><font style="letter-spacing:0.2pt;">. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">f)&nbsp;&nbsp;&nbsp; </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Notice to the Holders</font><font style="letter-spacing:0.2pt;">. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">i.&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Adjustment to Conversion Amount</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;Whenever the number of shares of Common Stock that the shares of Preferred Stock are convertible into is adjusted pursuant to any provision of this </font><font style="font-weight:bold;letter-spacing:-0.2pt;">Section&#160;7</font><font style="letter-spacing:0.2pt;">, the Corporation shall promptly deliver to each Holder a notice setting forth the number of shares of Common Stock after such adjustment and setting forth a brief statement of the facts requiring such adjustment. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">ii.&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Notice to Allow Conversion by Holder</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;If (A)&#160;the Corporation shall declare a dividend (or any other distribution in whatever form) on the Common Stock, (B)&#160;the Corporation shall declare a special nonrecurring cash dividend on or a redemption of the Common Stock, (C)&#160;the Corporation shall authorize the granting to all holders of the Common Stock of rights or warrants to subscribe for or purchase any shares of capital stock of any class or of any rights, (D)&#160;the approval of any stockholders of the Corporation shall be required in connection with any reclassification of the Common Stock, any consolidation or merger to which the Corporation is a party, any sale or transfer of all or substantially all of the assets of the Corporation, or any compulsory share exchange whereby the Common Stock is converted into other securities, cash or property or (E)&#160;the Corporation shall authorize the voluntary or involuntary dissolution, liquidation or winding up of the affairs of the Corporation, then, in each case, the Corporation shall cause to be filed at each office or agency maintained for the purpose of conversion of this Preferred Stock, and shall cause to be delivered to each Holder at its last address as it shall appear upon the stock books of the Corporation, at least fifteen (15) calendar days prior to the applicable record or effective date hereinafter specified, a notice stating (x)&#160;the date on which a record is to be taken for the purpose of such dividend, distribution, redemption, rights or warrants, or if a record is not to be taken, the date as of which the holders of the Common Stock of record to be entitled to such dividend, distributions, redemption, rights or warrants are to be determined or (y)&#160;the date on which such reclassification, consolidation, merger, sale, transfer or share exchange is expected to become effective or close, and the date as of which it is expected that holders of the Common Stock of record shall be entitled to exchange their shares of the Common Stock for securities, cash or other property deliverable upon such reclassification, consolidation, merger, sale, transfer or share exchange, provided that the failure to deliver such notice or any defect therein or in the delivery thereof shall not affect the validity of the corporate action required to be specified in such notice. To the extent that any notice provided hereunder constitutes, or contains, material, non-public information regarding the Corporation or any of the Subsidiaries, the Corporation shall simultaneously file such notice with the Commission pursuant to a Current Report on Form 8-K. The Holder shall remain entitled to convert the Conversion Amount of this Preferred Stock (or any part hereof) during the 15-day period commencing on the date of such notice through the effective date of the event triggering such notice except as may otherwise be expressly set forth herein. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Section&#160;8.&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Miscellaneous</font><font style="letter-spacing:0.2pt;">. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">a)&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Notices</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;Any and all notices or other communications or deliveries to be provided by the Holders hereunder including, without limitation, any Notice of Conversion, shall be in writing and delivered personally, by facsimile, email address or sent by a nationally recognized overnight courier service, addressed to the Corporation at: </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">C-11</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:20pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Cyclacel Pharmaceuticals, Inc.</font> <br ><font style="letter-spacing:0.2pt;">200 Connell Drive, Suite 1500</font> <br ><font style="letter-spacing:0.2pt;">Berkeley Heights, New Jersey 07922</font> <br ><font style="letter-spacing:0.2pt;">Berkeley Heights, New Jersey 07922</font> <br ><font style="letter-spacing:0.2pt;">Attention: EVP, Finance and Chief Financial Officer</font><br ><font style="letter-spacing:0.2pt;">Email: pmcbarron@cyclacel.com </font></div>
        <div style="margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">or such other facsimile number or address (physical or email) as the Corporation may specify for such purposes by notice to the Holders delivered in accordance with this </font><font style="font-weight:bold;letter-spacing:-0.2pt;">Section&#160;8.</font><font style="letter-spacing:0.2pt;"> Any and all notices or other communications or deliveries to be provided by the Corporation hereunder shall be in writing and delivered personally, by facsimile, by email attachment or sent by a nationally recognized overnight courier service addressed to each Holder at the facsimile number, email address or address of such Holder appearing on the books of the Corporation, or if no such facsimile number, email address or address appears on the books of the Corporation, at the principal place of business of such Holder. Any notice or other communication or deliveries hereunder shall be deemed given and effective on the earliest of (i)&#160;the time of transmission, if such notice or communication is delivered via facsimile or email attachment at the facsimile number or email address set forth in this Section prior to 5:30&#160;p.m. (New York City time) on any date, (ii)&#160;the next Trading Day after the date of transmission, if such notice or communication is delivered via facsimile or email attachment at the facsimile number or email address set forth in this Section on a day that is not a Trading Day or later than 5:30&#160;p.m. (New York City time) on any Trading Day, (iii)&#160;the second Trading Day following the date of mailing, if sent by U.S. nationally recognized overnight courier service, or (iv)&#160;upon actual receipt by the Person to whom such notice is required to be given. Notwithstanding any other provision of this Certificate of Designations, where this Certificate of Designations provides for notice of any event to a Holder, if the Preferred Stock is held in global form by DTC ( or any successor depositary), such notice may be delivered via DTC ( or such successor depositary) pursuant to the procedures of DTC (or such successor depositary). </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">b)&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Absolute Obligation</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;Except as expressly provided herein, no provision of this Certificate of Designations shall alter or impair the obligation of the Corporation, which is absolute and unconditional, to pay liquidated damages and accrued dividends, as applicable, on the shares of Preferred Stock at the time, place, and rate, and in the coin or currency, herein prescribed. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">c)&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Lost or Mutilated Preferred Stock Certificate</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;If a Holder&#8217;s Preferred Stock certificate shall be mutilated, lost, stolen or destroyed, the Corporation shall execute and deliver, in exchange and substitution for and upon cancellation of a mutilated certificate, or in lieu of or in substitution for a lost, stolen or destroyed certificate, a new certificate for the shares of Preferred Stock so mutilated, lost, stolen or destroyed, but only upon receipt of evidence of such loss, theft or destruction of such certificate, and of the ownership hereof reasonably satisfactory to the Corporation. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">d)&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Governing Law</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;All questions concerning the construction, validity, enforcement and interpretation of this Certificate of Designations shall be governed by and construed and enforced in accordance with the internal laws of the State of Delaware, without regard to the principles of conflict of laws thereof. Each of the Corporation and each Holder agrees that all legal proceedings concerning the interpretation, enforcement and defense of the transactions contemplated by this Certificate of Designations (whether brought against the Corporation, a Holder or any of their respective Affiliates, directors, officers, stockholders, employees or agents) shall be commenced in the state and federal courts sitting in the City of Wilmington, Delaware (the &#8220;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Delaware Courts</font><font style="letter-spacing:0.2pt;">&#8221;). Each of the Corporation and each Holder hereby irrevocably submits to the exclusive jurisdiction of the Delaware Courts for the adjudication of any dispute hereunder or in connection herewith or with any transaction contemplated hereby or discussed herein, and hereby irrevocably waives, and agrees not to assert in any suit, action or proceeding, any claim that it is not personally subject to the jurisdiction of such Delaware Courts, or such Delaware Courts are improper or inconvenient venue for such proceeding. Each of the Corporation and each Holder hereby irrevocably waives personal service of process and consents to process being served in any such suit, action or proceeding by mailing a copy thereof via registered or certified mail or overnight delivery (with evidence of delivery) to such Person at the address in effect for notices to it under this Certificate of Designation and agrees that such service shall constitute good and sufficient service of process and notice thereof. Nothing contained herein shall be deemed to limit in any way any right to serve process in any other manner permitted by applicable law. Each of the </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">C-12</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:94pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Corporation and each Holder hereby irrevocably waives, to the fullest extent permitted by applicable law, any and all right to trial by jury in any legal proceeding arising out of or relating to this Certificate of Designations or the transactions contemplated hereby. If the Corporation or any Holder shall commence an action or proceeding to enforce any provisions of this Certificate of Designations, then the prevailing party in such action or proceeding shall be reimbursed by the other party for its attorneys&#8217; fees and other costs and expenses incurred in the investigation, preparation and prosecution of such action or proceeding. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">e)&nbsp;&nbsp;&nbsp; </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Waiver</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;Any waiver by the Corporation or a Holder of a breach of any provision of this Certificate of Designations shall not operate as or be construed to be a waiver of any other breach of such provision or of any breach of any other provision of this Certificate of Designations or a waiver by any other Holders. The failure of the Corporation or a Holder to insist upon strict adherence to any term of this Certificate of Designations on one or more occasions shall not be considered a waiver or deprive that Person ( or any other Holder) of the right thereafter to insist upon strict adherence to that term or any other term of this Certificate of Designations on any other occasion. Any waiver by the Corporation or a Holder must be in writing. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">f)&nbsp;&nbsp;&nbsp; </font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Severability</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;If any provision of this Certificate of Designations is invalid, illegal or unenforceable, the balance of this Certificate of Designations shall remain in effect, and if any provision is inapplicable to any Person or circumstance, it shall nevertheless remain applicable to all other Persons and circumstances. If it shall be found that any interest or other amount deemed interest due hereunder violates the applicable law governing usury, the applicable rate of interest due hereunder shall automatically be lowered to equal the maximum rate of interest permitted under applicable law. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">g)&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Next Business Day</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;Whenever any payment or other obligation hereunder shall be due on a day other than a Business Day, such payment shall be made on the next succeeding Business Day. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">h)&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Headings</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;The headings contained herein are for convenience only, do not constitute a part of this Certificate of Designations and shall not be deemed to limit or affect any of the provisions hereof. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">i)&nbsp;&nbsp;&nbsp;</font><font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">Status of Converted Preferred Stock</font><font style="letter-spacing:0.2pt;">.&nbsp;&nbsp;&nbsp;If any shares of Preferred Stock shall be converted or reacquired by the Corporation, such shares shall resume the status of authorized but unissued shares of preferred stock and shall no longer be designated as Series&#160;D Convertible Preferred Stock. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="font-weight:bold;letter-spacing:-0.2pt;">RESOLVED</font><font style="letter-spacing:0.2pt;">, </font><font style="font-weight:bold;letter-spacing:-0.2pt;">FURTHER</font><font style="letter-spacing:0.2pt;">, that the chief executive officer, the president or any vice-president, and the secretary or any assistant secretary, of the Corporation be and they hereby are authorized and directed to prepare and file this Certificate of Designations, Preferences, Rights and Limitations in accordance with the foregoing resolution and the provisions of Delaware law. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="font-weight:bold;letter-spacing:-0.2pt;">IN WITNESS WHEREOF</font><font style="letter-spacing:0.2pt;">, the undersigned have executed this Certificate this second day of January, 2025. </font>
        </div>
        <div style="margin-left:220pt; margin-top:8pt; width:236pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">CYCLACEL PHARMACEUTICALS, INC.</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style=" float:left; margin-left:220pt; line-height:12pt; margin-top:24pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">By:</font>
          <br >
        </div>
        <div style=" margin-top:24pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:240pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">/s/ Paul McBarron</font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-left:240pt; margin-top:2.5pt; width:216pt;">
          <div style="margin-left: 0pt; width: 216pt; margin-top: 0pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
        </div>
        <div style="margin-left:240pt; margin-top:2pt; width:216pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Name: Paul McBarron </font>
          <br >
          <font style="letter-spacing:0.2pt;">Title: EVP, Finance and Chief Operating Officer</font>
        </div>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">C-13</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:368pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:20pt; text-align:right; width:436pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">ANNEX A</font>&#8203;</div>
        <div style="margin-top:12pt; text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">NOTICE OF CONVERSION</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The undersigned hereby elects to convert shares of Series&#160;D Convertible Preferred Stock (the &#8220;Preferred Stock&#8221;), into shares of common stock (&#8220;Common Stock&#8221;) of Cyclacel Pharmaceuticals, Inc. according to the terms and conditions of the Certificate of Designation of Preferences, Rights and Limitations of Series&#160;D Convertible Preferred Stock (the &#8220;Certificate of Designation&#8221;), as of the date written below. Capitalized terms used herein and not otherwise defined shall have the respective meanings set forth in the Certificate of Designation. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Date of Conversion: </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Number of Shares of Preferred Stock to be Converted: </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Number of Shares of Preferred Stock Owned Prior to Conversion: </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Number of Shares of Preferred Stock Owned After Conversion: </font>
        </div>
        <div style=" float:left; margin-left:216pt; line-height:12pt; margin-top:24pt; margin-bottom:0pt; text-align:left; width:48pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">Signature:</font>
          <br >
        </div>
        <div style=" margin-top:24pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:264pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;</font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="white-space:nowrap; margin-left:264pt; margin-top:2.5pt; width:192pt;">
          <div style="margin-left: 0pt; width: 192pt; margin-top: 0pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
        </div>
        <div style="margin-left:264pt; margin-top:4pt; width:192pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Name:</font>
          <br >
          <font style="letter-spacing:0.2pt;">Title: </font>
        </div>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">C-14</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a><a name="tAPD">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Appendix D</font>
        </div>
        <div style="margin-top:12pt; text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">CERTIFICATE OF AMENDMENT</font>
          <br >
          <font style="letter-spacing:-0.2pt;">TO THE</font>
          <br >
          <font style="letter-spacing:-0.2pt;">AMENDED AND RESTATED CERTIFICATE OF INCORPORATION</font>
          <br >
          <font style="letter-spacing:-0.2pt;">OF</font>
          <br >
          <font style="letter-spacing:-0.2pt;">CYCLACEL PHARMACEUTICALS, INC.</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:8pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Pursuant to Section&#160;242 of</font>
          <br >
          <font style="letter-spacing:0.2pt;">the General Corporation Law of the</font>
          <br >
          <font style="letter-spacing:0.2pt;">State of Delaware </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Cyclacel Pharmaceuticals, Inc., a corporation organized and existing under and by virtue of the General Corporation Law of the State of Delaware (the &#8220;Corporation&#8221;), does hereby certify: </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="font-weight:bold;letter-spacing:-0.2pt;">FIRST:</font><font style="letter-spacing:0.2pt;"> The Board of Directors of the Corporation duly adopted resolutions approving the following amendment to the Corporation&#8217;s Amended and Restated Certificate of Incorporation (the &#8220;Certificate of Incorporation&#8221;), declaring said amendment to be advisable and providing for the consideration of such amendment at a special meeting of stockholders of the Corporation. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="font-weight:bold;letter-spacing:-0.2pt;">SECOND:</font><font style="letter-spacing:0.2pt;"> On [&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;], 2025, the special meeting of stockholders of the Corporation was duly called and held, upon notice in accordance with Section&#160;222 of the General Corporation Law of the State of Delaware, at which meeting the necessary number of shares required by statute were voted in favor of the amendment. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="font-weight:bold;letter-spacing:-0.2pt;">THIRD:</font><font style="letter-spacing:0.2pt;"> Said amendment was duly adopted in accordance with the provisions of Section&#160;242 of the General Corporation Law of the State of Delaware. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="font-weight:bold;letter-spacing:-0.2pt;">FOURTH:</font><font style="letter-spacing:0.2pt;"> Section (C)&#160;of Article&#160;FOURTH of the Certificate of Incorporation is hereby amended in its entirety to state the following: </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#8220;Effective as of 5:00&#160;p.m., New York City time, on [&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;], 2025 (the &#8220;Effective Time&#8221;), each [&#8199;&#8199;&#8199;&#8199;&#8199;&#8199; &#8199;&#8199;] ([&#8199;&#8199;&#8199;&#8199;&#8199;]) shares of Common Stock issued and outstanding or held as treasury shares immediately prior to the Effective Time (the &#8220;Old Common Stock&#8221;) shall automatically and without any action on the part of the holder thereof be reclassified, combined and converted into one (1)&#160;share of Common Stock (the &#8220;New Common Stock&#8221;) (such reclassification, combination and conversion, the &#8220;Reverse Stock Split&#8221;). Notwithstanding the immediately preceding sentence, no fractional shares of New Common Stock shall be issued to holders of record of Old Common Stock as of the Effective Time. In lieu thereof, each holder of record of Old Common Stock as of the Effective Time that would otherwise be entitled to receive a fractional share of New Common Stock as a result of the Reverse Stock Split shall be entitled to receive, upon surrender of certificates representing such Old Common Stock, a cash payment in an amount equal to the fraction to which the stockholder would otherwise be entitled multiplied by the then-prevailing price as reported by The Nasdaq Stock Market (or if such price is not available, then such other price as determined by the Board of Directors). The ownership of a fractional share of New Common Stock shall not give the holder any voting, dividend or other rights, except the right to receive the cash payment described in the immediately preceding sentence. Whether or not the Reverse Stock Split would result in fractional shares for a holder of record of Old Common Stock as of the Effective Time shall be determined on the basis of the total number of shares of Old Common Stock held by such holder of record as of the Effective Time. Each stock certificate that, immediately prior to the Effective Time, represented shares of Old Common Stock shall, from and after the Effective Time, automatically and without the necessity of presenting the same for exchange, represent the number of whole shares of New Common Stock into which the shares of Old Common Stock represented by such certificate shall have been reclassified, combined and converted in the Reverse Stock Split (as well as the right to receive cash in lieu of fractional shares as described above). The New Common Stock issued in the Reverse Stock Split shall have the rights, preferences and privileges as the Common Stock.&#8221; </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="font-weight:bold;letter-spacing:-0.2pt;">FIFTH:</font><font style="letter-spacing:0.2pt;"> The foregoing amendment to the Certificate of Incorporation shall be effective as of 5:00&#160;pm Eastern Daylight Time on [&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;], 2025. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">D-1</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Helvetica, Arial, sans-serif;font-size:9pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:546pt;margin-left:69.66pt;width:456pt;">
        <div style="text-indent:20pt; width:456pt; line-height:12pt;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">IN WITNESS WHEREOF, Cyclacel Pharmaceuticals, Inc. has caused this Certificate of Amendment to the Certificate of Incorporation to be signed by the undersigned, thereunto duly appointed, this &#8199;&#8199;&#8199;&#8199;&#8199;&#8199;&#8199;&#8199; &#8199;&#8199;, 2025. </font>
        </div>
        <div style=" float:left; margin-left:220pt; line-height:12pt; margin-top:8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">By: &#8194;</font>
          <br >
        </div>
        <div style=" margin-top:8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:240pt;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">&#8194;</font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-left:240pt; margin-top:2.5pt; width:216pt;">
          <div style="margin-left: 0pt; width: 216pt; margin-top: 0pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
        </div>
        <div style="margin-left:240pt; margin-top:2pt; width:216pt; line-height:12pt;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">David Lazar</font>
          <br >
          <font style="letter-spacing:0.2pt;">Interim Chief Executive Officer</font>
        </div>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;font-family:Times New Roman, Times, serif ;font-size:10pt;">
          <font style="letter-spacing:0.2pt;">D-2</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a><a name="tAPE">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:231pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Appendix E</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">CERTIFICATE OF AMENDMENT </font>
          <br >
          <font style="letter-spacing:-0.2pt;">TO THE </font>
          <br >
          <font style="letter-spacing:-0.2pt;">AMENDED AND RESTATED </font>
          <br >
          <font style="letter-spacing:-0.2pt;">CERTIFICATE OF INCORPORATION </font>
          <br >
          <font style="letter-spacing:-0.2pt;">OF </font>
          <br >
          <font style="letter-spacing:-0.2pt;">CYCLACEL PHARMACEUTICALS, INC.</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">It is hereby certified that: </font>
        </div>
        <div style=" float:left; line-height:12pt; margin-top:8pt; margin-bottom:0pt; text-align:left; width:53pt;white-space:nowrap;">
          <font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">FIRST</font><font style="letter-spacing:0.2pt;">:</font>
          <br >
        </div>
        <div style=" margin-top:8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:53pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">The name of the corporation is Cyclacel Pharmaceuticals, Inc. (the &#8220;Corporation&#8221;). </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:8pt; margin-bottom:0pt; text-align:left; width:53pt;white-space:nowrap;">
          <font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">SECOND</font><font style="letter-spacing:0.2pt;">:</font>
          <br >
        </div>
        <div style=" margin-top:8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:53pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">Section&#160;A of Article&#160;IV of the Amended and Restated Certificate of Incorporation of the Corporation is hereby amended and restated in its entirety to read as follows: </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:8pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="font-weight:bold;letter-spacing:-0.2pt;">A.</font>
          <br >
        </div>
        <div style=" margin-top:8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">The Corporation is authorized to issue two classes of stock to be designated, respectively, &#8220;Common Stock&#8221; and &#8220;Preferred Stock.&#8221; The total number of shares which the Corporation is authorized to issue is two hundred fifty-five million (255,000,000) shares, each with a par value of $0.001 per share. Two hundred fifty million (250,000,000) shares shall be Common Stock and five million (5,000,000) shares shall be Preferred Stock. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style=" float:left; line-height:12pt; margin-top:8pt; margin-bottom:0pt; text-align:left; width:53pt;white-space:nowrap;">
          <font style=" text-decoration:underline #000000 solid;letter-spacing:0.2pt;">THIRD</font><font style="letter-spacing:0.2pt;">:</font>
          <br >
        </div>
        <div style=" margin-top:8pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:53pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">The amendment of the Certificate of Incorporation herein certified has been duly adopted in accordance with the provisions of Section&#160;242 of the General Corporation Law of the State of Delaware. </font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">IN WITNESS WHEREOF, the Corporation has caused this Certificate of Amendment to be signed by to be signed by its duly authorized officer this [&#8226;] day of [&#8226;], 2025. </font>
        </div>
        <div style="margin-top:8pt; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">CYCLACEL PHARMACEUTICALS, INC.</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style=" float:left; line-height:12pt; margin-top:17pt; margin-bottom:0pt; text-align:left; width:20pt;white-space:nowrap;">
          <font style="letter-spacing:0.2pt;">By:</font>
          <br >
        </div>
        <div style=" margin-top:17pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt;">
          <!--blacklining:none;-->
          <font style="letter-spacing:0.2pt;">&nbsp;&nbsp;&nbsp;</font>
        </div>
        <div style="clear:both; padding:0pt; margin:0pt;font-size:0pt;line-height:0pt;">&#8203;</div>
        <div style="margin-left:20pt; margin-top:10.5pt; width:436pt;">
          <div style="margin-left: 0pt; width: 216pt; margin-top: 0pt; font-size: 1pt; line-height: 0pt; border-bottom: 1pt solid #000000; ">&#8203;</div>
        </div>
        <div style="margin-left:20pt; margin-top:4pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Name:&#8199;David Lazar </font> <br ><font style="letter-spacing:0.2pt;">Title:&nbsp;&nbsp;&nbsp;Interim CEO</font></div>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">E-1</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a><a name="tAPF">&#8203;</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">Appendix F</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:12pt; text-align:center; width:456pt; line-height:12pt;font-weight:bold;">
          <font style="letter-spacing:-0.2pt;">2018 EQUITY INCENTIVE PLAN, AS AMENDED </font>
          <br >
          <font style="letter-spacing:-0.2pt;">Effective [&#8226;]</font><font style="font-weight:normal;letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">1.&nbsp;&nbsp;&nbsp;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">DEFINITIONS.</font><font style="letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Unless otherwise specified or unless the context otherwise requires, the following terms, as used in this Cyclacel Pharmaceuticals, Inc. 2018 Equity Incentive Plan, have the following meanings: </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Administrator means the Board of Directors, unless it has delegated power to act on its behalf to the Committee, in which case the Administrator means the Committee. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Affiliate means a corporation, which, for purposes of Section&#160;424 of the Code, is a parent or subsidiary of the Company, direct or indirect. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Agreement means a written or electronic document setting forth the terms of a Stock Right delivered pursuant to the Plan in such form as the Administrator shall approve. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Board of Directors means the Board of Directors of the Company. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Cause means, with respect to a Participant (a)&#160;dishonesty with respect to the Company or any Affiliate, (b)&#160;insubordination, substantial malfeasance or non-feasance of duty, (c)&#160;unauthorized disclosure of confidential information, (d)&#160;breach by a Participant of any provision of any employment, consulting, advisory, nondisclosure, non-competition or similar agreement between the Participant and the Company or any Affiliate, and (e)&#160;conduct substantially prejudicial to the business of the Company or any Affiliate; provided, however, that any provision in an agreement between a Participant and the Company or an Affiliate, which contains a conflicting definition of Cause for termination and which is in effect at the time of such termination, shall supersede this definition with respect to that Participant. The determination of the Administrator as to the existence of Cause will be conclusive on the Participant and the Company. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Change of Control means the occurrence of any of the following events: (a)&#160;any person, partnership, joint venture, corporation or other entity, or two or more of any of the foregoing acting as a group (or any &#8220;person&#8221; within the meaning of Sections&#160;13(d) and 14(d) of the Exchange Act), other than the Company, an Affiliate, or an employee benefit plan (or related trust) of the Company or an Affiliate, become(s) the &#8220;beneficial owner&#8221; &#8203;(as defined in Rule&#160;13d-3 under the Exchange Act) of 30% or more of the then-outstanding voting stock of the Company; (b)&#160;during any period of two consecutive&#160;years, individuals who at the beginning of such period constitute the Board of Directors (together with any new director whose election by the Board of Directors or whose nomination for election by the Company&#8217;s stockholders, was approved by a vote of at least two-thirds of the directors then still in office who either were directors at the beginning of such period or whose election or nomination for election was previously so approved) cease for any reason to constitute a majority of the directors then in office; (c)&#160;all or substantially all of the business of the Company is disposed of pursuant to a merger, consolidation or other transaction in which the Company is not the surviving corporation or the Company combines with another company and is the surviving corporation (unless the stockholders of the Company immediately following such merger, consolidation, combination, or other transaction beneficially own, directly or indirectly, more than 50% of the aggregate voting stock or other ownership interests of (x)&#160;the entity or entities, if any, that succeed to the business of the Company or (y)&#160;the combined company); (d)&#160;the Company is a party to a merger, consolidation, sale of assets or other reorganization, or a proxy contest, as a consequence of which the Board of Directors in office immediately prior to such transaction or event constitutes less than a majority of the Board of Directors thereafter; or (e)&#160;the stockholders of the Company approve a sale of all or substantially all of the assets of the Company or a liquidation or dissolution of the Company; provided, that if any payment or benefit payable hereunder upon or following a Change of Control would be required to comply with the limitations of Section&#160;409A(a)(2)(A)(v) of the Code in order to avoid an additional tax under Section&#160;409A of the Code, such payment or benefit shall be made only if such Change of Control constitutes a change in ownership or control of the Company, or a change in ownership of the Company&#8217;s assets in accordance with Section&#160;409A of the Code. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-1</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="text-indent:20pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Code means the United States Internal Revenue Code of 1986, as amended including any successor statute, regulation and guidance thereto. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Committee means the committee of the Board of Directors to which the Board of Directors has delegated power to act under or pursuant to the provisions of the Plan. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Common Stock means shares of the Company&#8217;s common stock, $0.001 par value per share. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Company means Cyclacel Pharmaceuticals, Inc., a Delaware corporation. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Consultant means any natural person who is an advisor or consultant who provides bona fide services to the Company or its Affiliates, provided that such services are not in connection with the offer or sale of securities in a capital raising transaction, and do not directly or indirectly promote or maintain a market for the Company&#8217;s or its Affiliates&#8217; securities. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Corporate Transaction means a merger, consolidation, or sale of all or substantially all of the Company&#8217;s assets or the acquisition of all of the outstanding voting stock of the Company in a single transaction or a series of related transactions by a single entity other than a transaction to merely change the state of incorporation. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Disability or Disabled means permanent and total disability as defined in Section&#160;22(e)(3) of the Code. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Employee means any employee of the Company or of an Affiliate (including, without limitation, an employee who is also serving as an officer or director of the Company or of an Affiliate), designated by the Administrator to be eligible to be granted one or more Stock Rights under the Plan. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Exchange Act means the United States Securities Exchange Act of 1934, as amended. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Fair Market Value of a Share of Common Stock means: </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">If the Common Stock is listed on a national securities exchange or traded in the over-the-counter market and sales prices are regularly reported for the Common Stock, the closing or, if not applicable, the last price of the Common Stock on the composite tape or other comparable reporting system for the trading day on the applicable date and if such applicable date is not a trading day, the last market trading day prior to such date; </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">If the Common Stock is not traded on a national securities exchange but is traded on the over-the-counter market, if sales prices are not regularly reported for the Common Stock for the trading day referred to in clause (1), and if bid and asked prices for the Common Stock are regularly reported, the mean between the bid and the asked price for the Common Stock at the close of trading in the over-the-counter market for the trading day on which Common Stock was traded on the applicable date and if such applicable date is not a trading day, the last market trading day prior to such date; and </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">If the Common Stock is neither listed on a national securities exchange nor traded in the over-the-counter market, such value as the Administrator, in good faith, shall determine in compliance with applicable laws. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">ISO means an option intended to qualify as an incentive stock option under Section&#160;422 of the Code. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Non-Qualified Option means an option which is not intended to qualify as an ISO. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Option means an ISO or Non-Qualified Option granted under the Plan. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Participant means an Employee, director or Consultant of the Company or an Affiliate to whom one or more Stock Rights are granted under the Plan. As used herein, &#8220;Participant&#8221; shall include &#8220;Participant&#8217;s Survivors&#8221; where the context requires. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Performance-Based Award means a Stock Grant or Stock-Based Award which vests based on the attainment of written Performance Goals as set forth in Paragraph 9 hereof. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Performance Goals means performance goals determined by the Committee in its sole discretion and set forth in an Agreement. The satisfaction of Performance Goals shall be subject to certification by the </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-2</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Committee. The Committee has the authority to take appropriate action with respect to the Performance Goals (including, without limitation, making adjustments to the Performance Goals or determining the satisfaction of the Performance Goals in connection with a Corporate Transaction) provided that any such action does not otherwise violate the terms of the Plan. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Plan means this Cyclacel Pharmaceuticals, Inc. 2018 Equity Incentive Plan. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Securities Act means the United States Securities Act of 1933, as amended. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Shares means shares of the Common Stock as to which Stock Rights have been or may be granted under the Plan or any shares of capital stock into which the Shares are changed or for which they are exchanged within the provisions of Paragraph 3 of the Plan. The Shares issued under the Plan may be authorized and unissued shares or shares held by the Company in its treasury, or both. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Stock-Based Award means a grant by the Company under the Plan of an equity award or an equity based award, which is not an Option or a Stock Grant. </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Stock Grant means a grant by the Company of Shares under the Plan. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Stock Right means a right to Shares or the value of Shares of the Company granted pursuant to the Plan&#8201;&#8212;&#8201;an ISO, a Non-Qualified Option, a Stock Grant or a Stock-Based Award. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Survivor means a deceased Participant&#8217;s legal representatives and/or any person or persons who acquired the Participant&#8217;s rights to a Stock Right by will or by the laws of descent and distribution. </font>
        </div>
        <div style="margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">2.&nbsp;&nbsp;&nbsp;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">PURPOSES OF THE PLAN.</font><font style="letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The Plan is intended to encourage ownership of Shares by Employees and directors of and certain Consultants to the Company and its Affiliates in order to attract and retain such people, to induce them to work for the benefit of the Company or of an Affiliate and to provide additional incentive for them to promote the success of the Company or of an Affiliate. The Plan provides for the granting of ISOs, Non-Qualified Options, Stock Grants and Stock-Based Awards. </font>
        </div>
        <div style="margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">3.&nbsp;&nbsp;&nbsp;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">SHARES SUBJECT TO THE PLAN.</font><font style="letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(a)&nbsp;&nbsp;&nbsp;The number of Shares which may be issued from time to time pursuant to this Plan shall be the sum of: (i)&#160;3,375,000 shares of Common Stock and (ii)&#160;any shares of Common Stock that are represented by awards granted under the Company&#8217;s 2015 Equity Incentive Plan and the Company&#8217;s Amended and Restated 2006 Equity Incentive Plan that are forfeited, expire or are cancelled without delivery of shares of Common Stock or which result in the forfeiture of shares of Common Stock back to the Company on or after May&#160;31, 2018, or the equivalent of such number of Shares after the Administrator, in its sole discretion, has interpreted the effect of any stock split, stock dividend, combination, recapitalization or similar transaction in accordance with Paragraph 25 of this Plan; provided, however, that no more than 35,494 Shares shall be added to the Plan pursuant to subsection (ii). </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(b)&nbsp;&nbsp;&nbsp;If an Option ceases to be &#8220;outstanding&#8221;, in whole or in part (other than by exercise), or if the Company shall reacquire (at not more than its original issuance price) any Shares issued pursuant to a Stock Grant or Stock-Based Award, or if any Stock Right expires or is forfeited, cancelled, or otherwise terminated or results in any Shares not being issued, the unissued or reacquired Shares which were subject to such Stock Right shall again be available for issuance from time to time pursuant to this Plan. Notwithstanding the foregoing, if a Stock Right is exercised, in whole or in part, by tender or withholding of Shares or if the Company or an Affiliate&#8217;s tax withholding obligation is satisfied by the tender or withholding of Shares, the number of Shares deemed to have been issued under the Plan for purposes of the limitation set forth in Paragraph 3(a) above shall be the number of Shares that were subject to the Stock Right or portion thereof, and not the net number of Shares actually issued. In addition, Shares repurchased by the Company with the proceeds of the option exercise price may not be reissued under the Plan. However, in the case of ISOs, the foregoing provisions shall be subject to any limitations under the Code. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-3</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">4.&nbsp;&nbsp;&nbsp;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">ADMINISTRATION OF THE PLAN.</font><font style="letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The Administrator of the Plan will be the Board of Directors, except to the extent the Board of Directors delegates its authority to the Committee, in which case the Committee shall be the Administrator. Subject to the provisions of the Plan, the Administrator is authorized to: </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(a)&nbsp;&nbsp;&nbsp;Interpret the provisions of the Plan and all Stock Rights and to make all rules and determinations which it deems necessary or advisable for the administration of the Plan; </font>
        </div>
        <div style="margin-left:40pt; margin-top:8pt; width:416pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(b)&nbsp;&nbsp;&nbsp;Determine which Employees, directors and Consultants shall be granted Stock Rights; </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(c)&nbsp;&nbsp;&nbsp;Determine the number of Shares for which a Stock Right or Stock Rights shall be granted, provided however that in no event shall Stock Rights to be granted to any non-employee director under the Plan in any calendar year exceed an aggregate grant date fair value of $100,000 except that the foregoing limitation shall not apply to (i)&#160;awards made pursuant to an election by a non-employee director to receive an award in lieu of cash for all or a portion of cash fees to be received for service on the Board or any Committee thereof and (ii)&#160;in connection with a non-employee director initially joining the Board of Directors; </font>
        </div>
        <div style="text-indent:40pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(d)&nbsp;&nbsp;&nbsp;Specify the terms and conditions upon which a Stock Right or Stock Rights may be granted; </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(e)&nbsp;&nbsp;&nbsp;Amend any term or condition of any outstanding Stock Right, other than reducing the exercise price or purchase price or extending the expiration date of an Option, provided that (i)&#160;such term or condition as amended is not prohibited by the Plan; (ii)&#160;any such amendment shall not impair the rights of a Participant under any Stock Right previously granted without such Participant&#8217;s consent or in the event of death of the Participant the Participant&#8217;s Survivors; and (iii)&#160;any such amendment shall be made only after the Administrator determines whether such amendment would cause any adverse tax consequences to the Participant, including, but not limited to, the annual vesting limitation contained in Section&#160;422(d) of the Code and described in Paragraph 6(b)(iv) below with respect to ISOs and pursuant to Section&#160;409A of the Code; </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(f)&nbsp;&nbsp;&nbsp;Determine and make any adjustments in the Performance Goals included in any Performance-Based Awards; and </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(g)&nbsp;&nbsp;&nbsp;Adopt any sub-plans applicable to residents of any specified jurisdiction as it deems necessary or appropriate in order to comply with or take advantage of any tax or other laws applicable to the Company, any Affiliate or to Participants or to otherwise facilitate the administration of the Plan, which sub-plans may include additional restrictions or conditions applicable to Stock Rights or Shares issuable pursuant to a Stock Right; </font>
        </div>
        <div style="margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">provided, however, that all such interpretations, rules, determinations, terms and conditions shall be made and prescribed in the context of potential tax consequences under Section&#160;409A of the Code and preserving the tax status under Section&#160;422 of the Code of those Options which are designated as ISOs. Subject to the foregoing, the interpretation and construction by the Administrator of any provisions of the Plan or of any Stock Right granted under it shall be final, unless otherwise determined by the Board of Directors, if the Administrator is the Committee. In addition, if the Administrator is the Committee, the Board of Directors may take any action under the Plan that would otherwise be the responsibility of the Committee. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">To the extent permitted under applicable law, the Board of Directors or the Committee may allocate all or any portion of its responsibilities and powers to any one or more of its members and may delegate all or any portion of its responsibilities and powers to any other person selected by it. The Board of Directors or the Committee may revoke any such allocation or delegation at any time. Notwithstanding the foregoing, only the Board of Directors or the Committee shall be authorized to grant a Stock Right to any director of the Company or to any &#8220;officer&#8221; of the Company as defined by Rule&#160;16a-1 under the Exchange Act. </font>
        </div>
        <div style="margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">5.&nbsp;&nbsp;&nbsp;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">ELIGIBILITY FOR PARTICIPATION.</font><font style="letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The Administrator will, in its sole discretion, name the Participants in the Plan; provided, however, that each Participant must be an Employee, director or Consultant of the Company or of an Affiliate at the time a Stock Right is granted. Notwithstanding the foregoing, the Administrator may authorize the grant </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-4</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">of a Stock Right to a person not then an Employee, director or Consultant of the Company or of an Affiliate; provided, however, that the actual grant of such Stock Right shall be conditioned upon such person becoming eligible to become a Participant at or prior to the time of the execution of the Agreement evidencing such Stock Right. ISOs may be granted only to Employees who are deemed to be residents of the United States for tax purposes. Non-Qualified Options, Stock Grants and Stock-Based Awards may be granted to any Employee, director or Consultant of the Company or an Affiliate. The granting of any Stock Right to any individual shall neither entitle that individual to, nor disqualify him or her from, participation in any other grant of Stock Rights or any grant under any other benefit plan established by the Company or any Affiliate for Employees, directors or Consultants. </font>
        </div>
        <div style="margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">6.&nbsp;&nbsp;&nbsp;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">TERMS AND CONDITIONS OF OPTIONS.</font><font style="letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Each Option shall be set forth in an Option Agreement, duly executed by the Company and, to the extent required by law or requested by the Company, by the Participant. The Administrator may provide that Options be granted subject to such terms and conditions, consistent with the terms and conditions specifically required under this Plan, as the Administrator may deem appropriate including, without limitation, subsequent approval by the shareholders of the Company of this Plan or any amendments thereto. The Option Agreements shall be subject to at least the following terms and conditions: </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(a)&nbsp;&nbsp;&nbsp;Non-Qualified Options: Each Option intended to be a Non-Qualified Option shall be subject to the terms and conditions which the Administrator determines to be appropriate and in the best interest of the Company, subject to the following minimum standards for any such Non-Qualified Option: </font>
        </div>
        <div style="margin-left:40pt; text-indent:20pt; margin-top:8pt; width:416pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(i)&nbsp;&nbsp;&nbsp;Exercise Price: Each Option Agreement shall state the exercise price (per share) of the Shares covered by each Option, which exercise price shall be determined by the Administrator and shall be at least equal to the Fair Market Value per share of the Common Stock on the date of grant of the Option. </font>
        </div>
        <div style="margin-left:40pt; text-indent:20pt; margin-top:8pt; width:416pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(ii)&nbsp;&nbsp;&nbsp;Number of Shares: Each Option Agreement shall state the number of Shares to which it pertains. </font>
        </div>
        <div style="margin-left:40pt; text-indent:20pt; margin-top:8pt; width:416pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(iii)&nbsp;&nbsp;&nbsp;Vesting: Each Option Agreement shall state the date or dates on which it first is exercisable and the date after which it may no longer be exercised, and may provide that the Option rights accrue or become exercisable in installments over a period of&#160;months or&#160;years, or upon the occurrence of certain performance conditions or the attainment of stated goals or events. </font>
        </div>
        <div style="margin-left:40pt; text-indent:20pt; margin-top:8pt; width:416pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(iv)&nbsp;&nbsp;&nbsp;Additional Conditions: Exercise of any Option may be conditioned upon the Participant&#8217;s execution of a shareholders agreement in a form satisfactory to the Administrator providing for certain protections for the Company and its other shareholders, including requirements that: </font>
        </div>
        <div style="margin-left:60pt; text-indent:20pt; margin-top:8pt; width:396pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">A.&nbsp;&nbsp;&nbsp;The Participant&#8217;s or the Participant&#8217;s Survivors&#8217; right to sell or transfer the Shares may be restricted; and </font>
        </div>
        <div style="margin-left:60pt; text-indent:20pt; margin-top:8pt; width:396pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">B.&nbsp;&nbsp;&nbsp;The Participant or the Participant&#8217;s Survivors may be required to execute letters of investment intent and must also acknowledge that the Shares will bear legends noting any applicable restrictions. </font>
        </div>
        <div style="margin-left:40pt; text-indent:20pt; margin-top:8pt; width:416pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(v)&nbsp;&nbsp;&nbsp;Term of Option: Each Option shall terminate not more than ten&#160;years from the date of the grant or at such earlier time as the Option Agreement may provide. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(b)&nbsp;&nbsp;&nbsp;ISOs: Each Option intended to be an ISO shall be issued only to an Employee who is deemed to be a resident of the United States for tax purposes, and shall be subject to the following terms and conditions, with such additional restrictions or changes as the Administrator determines are appropriate but not in conflict with Section&#160;422 of the Code and relevant regulations and rulings of the Internal Revenue Service: </font>
        </div>
        <div style="margin-left:40pt; text-indent:20pt; margin-top:8pt; width:416pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(i)&nbsp;&nbsp;&nbsp;Minimum Standards: The ISO shall meet the minimum standards required of Non-Qualified Options, as described in Paragraph 6(a) above, except clause (i)&#160;and (v)&#160;thereunder. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-5</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:20pt; text-indent:20pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(ii)&nbsp;&nbsp;&nbsp;Exercise Price: Immediately before the ISO is granted, if the Participant owns, directly or by reason of the applicable attribution rules in Section&#160;424(d) of the Code: </font>
        </div>
        <div style="margin-left:40pt; text-indent:20pt; margin-top:8pt; width:416pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">A.&nbsp;&nbsp;&nbsp;10% or less of the total combined voting power of all classes of stock of the Company or an Affiliate, the exercise price per share of the Shares covered by each ISO shall not be less than 100% of the Fair Market Value per share of the Common Stock on the date of grant of the Option; or </font>
        </div>
        <div style="margin-left:40pt; text-indent:20pt; margin-top:8pt; width:416pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">B.&nbsp;&nbsp;&nbsp;More than 10% of the total combined voting power of all classes of stock of the Company or an Affiliate, the exercise price per share of the Shares covered by each ISO shall not be less than 110% of the Fair Market Value per share of the Common Stock on the date of grant of the Option. </font>
        </div>
        <div style="margin-left:40pt; margin-top:8pt; width:416pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(iii)&nbsp;&nbsp;&nbsp;Term of Option: For Participants who own: </font>
        </div>
        <div style="margin-left:40pt; text-indent:20pt; margin-top:8pt; width:416pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">A.&nbsp;&nbsp;&nbsp;10% or less of the total combined voting power of all classes of stock of the Company or an Affiliate, each ISO shall terminate not more than ten&#160;years from the date of the grant or at such earlier time as the Option Agreement may provide; or </font>
        </div>
        <div style="margin-left:40pt; text-indent:20pt; margin-top:8pt; width:416pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">B.&nbsp;&nbsp;&nbsp;More than 10% of the total combined voting power of all classes of stock of the Company or an Affiliate, each ISO shall terminate not more than five&#160;years from the date of the grant or at such earlier time as the Option Agreement may provide. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(iv)&nbsp;&nbsp;&nbsp;Limitation on Yearly Exercise: The Option Agreements shall restrict the amount of ISOs which may become exercisable in any calendar year (under this or any other ISO plan of the Company or an Affiliate) so that the aggregate Fair Market Value (determined on the date each ISO is granted) of the stock with respect to which ISOs are exercisable for the first time by the Participant in any calendar year does not exceed $100,000. </font>
        </div>
        <div style="margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">7.&nbsp;&nbsp;&nbsp;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">TERMS AND CONDITIONS OF STOCK GRANTS.</font><font style="letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Each Stock Grant to a Participant shall state the principal terms in an Agreement duly executed by the Company and, to the extent required by law or requested by the Company, by the Participant. The Agreement shall be in a form approved by the Administrator and shall contain terms and conditions which the Administrator determines to be appropriate and in the best interest of the Company, subject to the following minimum standards: </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(a)&nbsp;&nbsp;&nbsp;Each Agreement shall state the purchase price per share, if any, of the Shares covered by each Stock Grant, which purchase price shall be determined by the Administrator but shall not be less than the minimum consideration required by the Delaware General Corporation Law, if any, on the date of the grant of the Stock Grant; </font>
        </div>
        <div style="margin-left:40pt; margin-top:8pt; width:416pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(b)&nbsp;&nbsp;&nbsp;Each Agreement shall state the number of Shares to which the Stock Grant pertains; </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(c)&nbsp;&nbsp;&nbsp;Each Agreement shall include the terms of any right of the Company to restrict or reacquire the Shares subject to the Stock Grant, including the time period or attainment of Performance Goals or such other performance criteria upon which such rights shall accrue and the purchase price therefor, if any; and </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(d)&nbsp;&nbsp;&nbsp;Dividends (other than stock dividends to be issued pursuant to Section&#160;25 of the Plan) may accrue but shall not be paid prior to the time, and may be paid only to the extent that the restrictions or rights to reacquire the Shares subject to the Stock Grant lapse. </font>
        </div>
        <div style="margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">8.&nbsp;&nbsp;&nbsp;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">TERMS AND CONDITIONS OF OTHER STOCK-BASED AWARDS.</font><font style="letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The Administrator shall have the right to grant other Stock-Based Awards based upon the Common Stock having such terms and conditions as the Administrator may determine, including, without limitation, the grant of Shares based upon certain conditions, the grant of securities convertible into Shares and the grant of stock appreciation rights, phantom stock awards or stock&#160;units. The principal terms of each Stock-Based Award shall be set forth in an Agreement, duly executed by the Company and, to the extent required by law or requested by the Company, by the Participant. The Agreement shall be in a form approved by the </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-6</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Administrator and shall contain terms and conditions which the Administrator determines to be appropriate and in the best interest of the Company. Each Agreement shall include the terms of any right of the Company including the right to terminate the Stock-Based Award without the issuance of Shares, the terms of any vesting conditions, Performance Goals or events upon which Shares shall be issued, provided that dividends (other than stock dividends to be issued pursuant to Section&#160;25 of the Plan) or dividend equivalents may accrue but shall not be paid prior to and may be paid only to the extent that the Shares subject to the Stock-Based Award vest. Under no circumstances may the Agreement covering stock appreciation rights (a)&#160;have an exercise or base price (per share) that is less than the Fair Market Value per share of Common Stock on the date of grant or (b)&#160;expire more than ten&#160;years following the date of grant. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The Company intends that the Plan and any Stock-Based Awards granted hereunder be exempt from the application of Section&#160;409A of the Code or meet the requirements of paragraphs (2), (3)&#160;and (4)&#160;of subsection (a)&#160;of Section&#160;409A of the Code, to the extent applicable, and be operated in accordance with Section&#160;409A so that any compensation deferred under any Stock-Based Award (and applicable investment earnings) shall not be included in income under Section&#160;409A of the Code. Any ambiguities in the Plan shall be construed to effect the intent as described in this Paragraph 8. </font>
        </div>
        <div style="margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">9.&nbsp;&nbsp;&nbsp;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">PERFORMANCE-BASED AWARDS.</font><font style="letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The Committee shall determine whether, with respect to a performance period, the applicable Performance Goals have been met with respect to a given Participant and, if they have, to so certify and ascertain the amount of the applicable Performance-Based Award. No Performance-Based Awards will be issued for such performance period until such certification is made by the Committee. The number of Shares issued in respect of a Performance-Based Award determined by the Committee for a performance period shall be paid to the Participant at such time as determined by the Committee in its sole discretion after the end of such performance period, and any dividends (other than stock dividends to be issued pursuant to Section&#160;25 of the Plan) or dividend equivalents that accrue shall only be paid in respect of the number of Shares earned in respect of such Performance-Based Award. </font>
        </div>
        <div style="margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">10.&nbsp;&nbsp;&nbsp;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">EXERCISE OF OPTIONS AND ISSUE OF SHARES.</font><font style="letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">An Option (or any part or installment thereof) shall be exercised by giving written notice to the Company or its designee (in a form acceptable to the Administrator, which may include electronic notice), together with provision for payment of the aggregate exercise price in accordance with this Paragraph for the Shares as to which the Option is being exercised, and upon compliance with any other condition(s) set forth in the Option Agreement. Such notice shall be signed by the person exercising the Option (which signature may be provided electronically in a form acceptable to the Administrator), shall state the number of Shares with respect to which the Option is being exercised and shall contain any representation required by the Plan or the Option Agreement. Payment of the exercise price for the Shares as to which such Option is being exercised shall be made (a)&#160;in United States dollars in cash or by check; or (b)&#160;at the discretion of the Administrator, through delivery of shares of Common Stock held for at least six&#160;months (if required to avoid negative accounting treatment) having a Fair Market Value equal as of the date of the exercise to the aggregate cash exercise price for the number of Shares as to which the Option is being exercised; or (c)&#160;at the discretion of the Administrator, by having the Company retain from the Shares otherwise issuable upon exercise of the Option, a number of Shares having a Fair Market Value equal as of the date of exercise to the aggregate exercise price for the number of Shares as to which the Option is being exercised; or (d)&#160;at the discretion of the Administrator, in accordance with a cashless exercise program established with a securities brokerage firm, and approved by the Administrator; or (e)&#160;at the discretion of the Administrator, by any combination of (a), (b), (c)&#160;and (d)&#160;above or (f)&#160;at the discretion of the </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Administrator, by payment of such other lawful consideration as the Administrator may determine. Notwithstanding the foregoing, the Administrator shall accept only such payment on exercise of an ISO as is permitted by Section&#160;422 of the Code. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The Company shall then reasonably promptly deliver the Shares as to which such Option was exercised to the Participant (or to the Participant&#8217;s Survivors, as the case may be). In determining what constitutes &#8220;reasonably promptly,&#8221; it is expressly understood that the issuance and delivery of the Shares may be delayed by the Company in order to comply with any law or regulation (including, without limitation, state </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-7</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">securities or &#8220;blue sky&#8221; laws) which requires the Company to take any action with respect to the Shares prior to their issuance. The Shares shall, upon delivery, be fully paid, non-assessable Shares. </font>
        </div>
        <div style="margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">11.&nbsp;&nbsp;&nbsp;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">PAYMENT IN CONNECTION WITH THE ISSUANCE OF STOCK GRANTS AND STOCK-BASED AWARDS AND ISSUE OF SHARES.</font><font style="letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Any Stock Grant or Stock-Based Award requiring payment of a purchase price for the Shares as to which such Stock Grant or Stock-Based Award is being granted shall be made (a)&#160;in United States dollars in cash or by check; or (b)&#160;at the discretion of the Administrator, through delivery of shares of Common Stock held for at least six&#160;months (if required to avoid negative accounting treatment) and having a Fair Market Value equal as of the date of payment to the purchase price of the Stock Grant or Stock-Based Award; or (c)&#160;at the discretion of the Administrator, by any combination of (a)&#160;and (b)&#160;above; or (d)&#160;at the discretion of the Administrator, by payment of such other lawful consideration as the Administrator may determine. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The Company shall when required by the applicable Agreement, reasonably promptly deliver the Shares as to which such Stock Grant or Stock-Based Award was made to the Participant (or to the Participant&#8217;s Survivors, as the case may be), subject to any escrow provision set forth in the applicable Agreement. In determining what constitutes &#8220;reasonably promptly,&#8221; it is expressly understood that the issuance and delivery of the Shares may be delayed by the Company in order to comply with any law or regulation (including, without limitation, state securities or &#8220;blue sky&#8221; laws) which requires the Company to take any action with respect to the Shares prior to their issuance. </font>
        </div>
        <div style="margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">12.&nbsp;&nbsp;&nbsp;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">RIGHTS AS A SHAREHOLDER.</font><font style="letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">No Participant to whom a Stock Right has been granted shall have rights as a shareholder with respect to any Shares covered by such Stock Right except after due exercise of an Option or issuance of Shares as set forth in any Agreement, tender of the aggregate exercise or purchase price, if any, for the Shares being purchased and registration of the Shares in the Company&#8217;s share register in the name of the Participant. </font>
        </div>
        <div style="margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">13.&nbsp;&nbsp;&nbsp;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">ASSIGNABILITY AND TRANSFERABILITY OF STOCK RIGHTS.</font><font style="letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">By its terms, a Stock Right granted to a Participant shall not be transferable by the Participant other than (i)&#160;by will or by the laws of descent and distribution, or (ii)&#160;as approved by the Administrator in its discretion and set forth in the applicable Agreement provided that no Stock Right may be transferred by a Participant for value. Notwithstanding the foregoing, an ISO transferred except in compliance with clause (i)&#160;above shall no longer qualify as an ISO. The designation of a beneficiary of a Stock Right by a Participant, with the prior approval of the Administrator and in such form as the Administrator shall prescribe, shall not be deemed a transfer prohibited by this Paragraph. Except as provided above during the Participant&#8217;s lifetime a Stock Right shall only be exercisable by or issued to such Participant (or his or her legal representative) and shall not be assigned, pledged or hypothecated in any way (whether by operation of law or otherwise) and shall not be subject to execution, attachment or similar process. Any attempted transfer, assignment, pledge, hypothecation or other disposition of any Stock Right or of any rights granted thereunder contrary to the provisions of this Plan, or the levy of any attachment or similar process upon a Stock Right, shall be null and void. </font>
        </div>
        <div style="margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">14.&nbsp;&nbsp;&nbsp;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">EFFECT ON OPTIONS OF TERMINATION OF SERVICE OTHER THAN FOR CAUSE OR DEATH OR DISABILITY.</font><font style="letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Except as otherwise provided in a Participant&#8217;s Option Agreement, in the event of a termination of service (whether as an Employee, director or Consultant) with the Company or an Affiliate before the Participant has exercised an Option, the following rules apply: </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(a)&nbsp;&nbsp;&nbsp;A Participant who ceases to be an Employee, director or Consultant of the Company or of an Affiliate (for any reason other than termination for Cause, Disability, or death for which events there are special rules in Paragraphs 15, 16, and 17, respectively), may exercise any Option granted to him or her to the extent that the Option is exercisable on the date of such termination of service, but only within such term as the Administrator has designated in a Participant&#8217;s Option Agreement. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-8</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:20pt; text-indent:20pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(b)&nbsp;&nbsp;&nbsp;Except as provided in Subparagraph (c)&#160;below, or Paragraph 16 or 17, in no event may an Option intended to be an ISO, be exercised later than three&#160;months after the Participant&#8217;s termination of employment. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(c)&nbsp;&nbsp;&nbsp;The provisions of this Paragraph, and not the provisions of Paragraph 16 or 17, shall apply to a Participant who subsequently becomes Disabled or dies after the termination of employment, director status or consultancy; provided, however, in the case of a Participant&#8217;s Disability or death within three&#160;months after the termination of employment, director status or consultancy, the Participant or the Participant&#8217;s Survivors may exercise the Option within one year after the date of the Participant&#8217;s termination of service, but in no event after the date of expiration of the term of the Option. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(d)&nbsp;&nbsp;&nbsp;Notwithstanding anything herein to the contrary, if subsequent to a Participant&#8217;s termination of employment, termination of director status or termination of consultancy, but prior to the exercise of an Option, the Administrator determines that, either prior or subsequent to the Participant&#8217;s termination, the Participant engaged in conduct which would constitute Cause, then such Participant shall forthwith cease to have any right to exercise any Option. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(e)&nbsp;&nbsp;&nbsp;A Participant to whom an Option has been granted under the Plan who is absent from the Company or an Affiliate because of temporary disability (any disability other than a Disability as defined in Paragraph 1 hereof), or who is on leave of absence for any purpose, shall not, during the period of any such absence, be deemed, by virtue of such absence alone, to have terminated such Participant&#8217;s employment, director status or consultancy with the Company or with an Affiliate, except as the Administrator may otherwise expressly provide; provided, however, that, for ISOs, any leave of absence granted by the Administrator of greater than three&#160;months, unless pursuant to a contract or statute that guarantees the right to reemployment, shall cause such ISO to become a Non-Qualified Option on the date that is six&#160;months following the commencement of such leave of absence. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(f)&nbsp;&nbsp;&nbsp;Except as required by law or as set forth in a Participant&#8217;s Option Agreement, Options granted under the Plan shall not be affected by any change of a Participant&#8217;s status within or among the Company and any Affiliates, so long as the Participant continues to be an Employee, director or Consultant of the Company or any Affiliate. </font>
        </div>
        <div style="margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">15.&nbsp;&nbsp;&nbsp;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">EFFECT ON OPTIONS OF TERMINATION OF SERVICE FOR CAUSE.</font><font style="letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Except as otherwise provided in a Participant&#8217;s Option Agreement, the following rules apply if the Participant&#8217;s service (whether as an Employee, director or Consultant) with the Company or an Affiliate is terminated for Cause prior to the time that all his or her outstanding Options have been exercised: </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(a)&nbsp;&nbsp;&nbsp;All outstanding and unexercised Options as of the time the Participant is notified his or her service is terminated for Cause will immediately be forfeited. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(b)&nbsp;&nbsp;&nbsp;Cause is not limited to events which have occurred prior to a Participant&#8217;s termination of service, nor is it necessary that the Administrator&#8217;s finding of Cause occur prior to termination. If the Administrator determines, subsequent to a Participant&#8217;s termination of service but prior to the exercise of an Option, that either prior or subsequent to the Participant&#8217;s termination the Participant engaged in conduct which would constitute Cause, then the right to exercise any Option is forfeited. </font>
        </div>
        <div style="margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">16.&nbsp;&nbsp;&nbsp;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">EFFECT ON OPTIONS OF TERMINATION OF SERVICE FOR DISABILITY.</font><font style="letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Except as otherwise provided in a Participant&#8217;s Option Agreement: </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(a)&nbsp;&nbsp;&nbsp;A Participant who ceases to be an Employee, director or Consultant of the Company or of an Affiliate by reason of Disability may exercise any Option granted to such Participant to the extent that the Option has become exercisable but has not been exercised on the date of the Participant&#8217;s termination of service due to Disability; and in the event rights to exercise the Option accrue periodically, to the extent of a pro&#160;rata portion through the date of the Participant&#8217;s termination of service due to Disability of any additional vesting rights that would have accrued on the next vesting date had the Participant not become Disabled. The proration shall be based upon the number of days accrued in the current vesting period prior to the date of the Participant&#8217;s termination of service due to Disability. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-9</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:20pt; text-indent:20pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(b)&nbsp;&nbsp;&nbsp;A Disabled Participant may exercise the Option only within the period ending one year after the date of the Participant&#8217;s termination of service due to Disability, notwithstanding that the Participant might have been able to exercise the Option as to some or all of the Shares on a later date if the Participant had not been terminated due to Disability and had continued to be an Employee, director or Consultant or, if earlier, within the originally prescribed term of the Option. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(c)&nbsp;&nbsp;&nbsp;The Administrator shall make the determination both of whether Disability has occurred and the date of its occurrence (unless a procedure for such determination is set forth in another agreement between the Company and such Participant, in which case such procedure shall be used for such determination). If requested, the Participant shall be examined by a physician selected or approved by the Administrator, the cost of which examination shall be paid for by the Company. </font>
        </div>
        <div style="margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">17.&nbsp;&nbsp;&nbsp;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">EFFECT ON OPTIONS OF DEATH WHILE AN EMPLOYEE, DIRECTOR OR CONSULTANT.</font><font style="letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Except as otherwise provided in a Participant&#8217;s Option Agreement: </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(a)&nbsp;&nbsp;&nbsp;In the event of the death of a Participant while the Participant is an Employee, director or Consultant of the Company or of an Affiliate, such Option may be exercised by the Participant&#8217;s Survivors to the extent that the Option has become exercisable but has not been exercised on the date of death; and in the event rights to exercise the Option accrue periodically, to the extent of a pro&#160;rata portion through the date of death of any additional vesting rights that would have accrued on the next vesting date had the Participant not died. The proration shall be based upon the number of days accrued in the current vesting period prior to the Participant&#8217;s date of death. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(b)&nbsp;&nbsp;&nbsp;If the Participant&#8217;s Survivors wish to exercise the Option, they must take all necessary steps to exercise the Option within one year after the date of death of such Participant, notwithstanding that the decedent might have been able to exercise the Option as to some or all of the Shares on a later date if he or she had not died and had continued to be an Employee, director or Consultant or, if earlier, within the originally prescribed term of the Option. </font>
        </div>
        <div style="margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">18.&nbsp;&nbsp;&nbsp;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">EFFECT OF TERMINATION OF SERVICE ON UNACCEPTED STOCK GRANTS AND STOCK-BASED AWARDS.</font><font style="letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">In the event of a termination of service (whether as an Employee, director or Consultant) with the Company or an Affiliate for any reason before the Participant has accepted a Stock Grant or a Stock-Based Award and paid the purchase price, if required, such grant shall terminate. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">For purposes of this Paragraph 18 and Paragraph 19 below, a Participant to whom a Stock Grant or a Stock-Based Award has been issued under the Plan who is absent from work with the Company or with an Affiliate because of temporary disability (any disability other than a Disability as defined in Paragraph 1 hereof), or who is on leave of absence for any purpose, shall not, during the period of any such absence, be deemed, by virtue of such absence alone, to have terminated such Participant&#8217;s employment, director status or consultancy with the Company or with an Affiliate, except as the Administrator may otherwise expressly provide. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">In addition, for purposes of this Paragraph 18 and Paragraph 19 below, any change of employment or other service within or among the Company and any Affiliates shall not be treated as a termination of employment, director status or consultancy so long as the Participant continues to be an Employee, director or Consultant of the Company or any Affiliate. </font>
        </div>
        <div style="margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">19.&nbsp;&nbsp;&nbsp;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">EFFECT ON STOCK GRANTS AND STOCK-BASED AWARDS OF TERMINATION OF SERVICE OTHER THAN FOR CAUSE, DEATH OR DISABILITY.</font><font style="letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Except as otherwise provided in a Participant&#8217;s Agreement, in the event of a termination of service for any reason (whether as an Employee, director or Consultant), other than termination for Cause, death or Disability for which there are special rules in Paragraphs 20, 21, and 22 below, before all forfeiture provisions or Company rights of repurchase shall have lapsed, then the Company shall have the right to cancel or repurchase that number of Shares subject to a Stock Grant or Stock-Based Award as to which the Company&#8217;s forfeiture or repurchase rights have not lapsed. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-10</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">20.&nbsp;&nbsp;&nbsp;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">EFFECT ON STOCK GRANTS AND STOCK-BASED AWARDS OF TERMINATION OF SERVICE FOR CAUSE.</font><font style="letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Except as otherwise provided in a Participant&#8217;s Agreement, the following rules apply if the Participant&#8217;s service (whether as an Employee, director or Consultant) with the Company or an Affiliate is terminated for Cause: </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(a)&nbsp;&nbsp;&nbsp;All Shares subject to any Stock Grant or Stock-Based Award that remain subject to forfeiture provisions or as to which the Company shall have a repurchase right shall be immediately forfeited to the Company as of the time the Participant is notified his or her service is terminated for Cause. </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(b)&nbsp;&nbsp;&nbsp;Cause is not limited to events which have occurred prior to a Participant&#8217;s termination of service, nor is it necessary that the Administrator&#8217;s finding of Cause occur prior to termination. If the Administrator determines, subsequent to a Participant&#8217;s termination of service, that either prior or subsequent to the Participant&#8217;s termination the Participant engaged in conduct which would constitute Cause, then all Shares subject to any Stock Grant or Stock-Based Award that remained subject to forfeiture provisions or as to which the Company had a repurchase right on the date of termination shall be immediately forfeited to the Company. </font>
        </div>
        <div style="margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">21.&nbsp;&nbsp;&nbsp;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">EFFECT ON STOCK GRANTS AND STOCK-BASED AWARDS OF TERMINATION OF SERVICE FOR DISABILITY.</font><font style="letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Except as otherwise provided in a Participant&#8217;s Agreement, the following rules apply if a Participant ceases to be an Employee, director or Consultant of the Company or of an Affiliate by reason of Disability: to the extent the forfeiture provisions or the Company&#8217;s rights of repurchase have not lapsed on the date of Disability, they shall be exercisable; provided, however, that in the event such forfeiture provisions or rights of repurchase lapse periodically, such provisions or rights shall lapse to the extent of a pro&#160;rata portion of the Shares subject to such Stock Grant or Stock-Based Award through the date of Disability as would have lapsed had the Participant not become Disabled. The proration shall be based upon the number of days accrued prior to the date of Disability. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The Administrator shall make the determination both as to whether Disability has occurred and the date of its occurrence (unless a procedure for such determination is set forth in another agreement between the Company and such Participant, in which case such procedure shall be used for such determination). If requested, the Participant shall be examined by a physician selected or approved by the Administrator, the cost of which examination shall be paid for by the Company. </font>
        </div>
        <div style="margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">22.&nbsp;&nbsp;&nbsp;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">EFFECT ON STOCK GRANTS AND STOCK-BASED AWARDS OF DEATH WHILE AN EMPLOYEE, DIRECTOR OR CONSULTANT.</font><font style="letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Except as otherwise provided in a Participant&#8217;s Agreement, the following rules apply in the event of the death of a Participant while the Participant is an Employee, director or Consultant of the Company or of an Affiliate: to the extent the forfeiture provisions or the Company&#8217;s rights of repurchase have not lapsed on the date of death, they shall be exercisable; provided, however, that in the event such forfeiture provisions or rights of repurchase lapse periodically, such provisions or rights shall lapse to the extent of a pro&#160;rata portion of the Shares subject to such Stock Grant or Stock-Based Award through the date of death as would have lapsed had the Participant not died. The proration shall be based upon the number of days accrued prior to the Participant&#8217;s date of death. </font>
        </div>
        <div style="margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">23.&nbsp;&nbsp;&nbsp;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">PURCHASE FOR INVESTMENT.</font><font style="letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Unless the offering and sale of the Shares shall have been effectively registered under the Securities Act, the Company shall be under no obligation to issue Shares under the Plan unless and until the following conditions have been fulfilled: </font>
        </div>
        <div style="margin-left:20pt; text-indent:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(a)&nbsp;&nbsp;&nbsp;The person who receives a Stock Right shall warrant to the Company, prior to the receipt of Shares, that such person is acquiring such Shares for his or her own account, for investment, and not with a view to, or for sale in connection with, the distribution of any such Shares, in which event the person acquiring such Shares shall be bound by the provisions of the following legend (or a legend in </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-11</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-left:20pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">substantially similar form) which shall be endorsed upon the certificate evidencing the Shares issued pursuant to such exercise or such grant of a Stock Right: </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#8220;The shares represented by this certificate have been taken for investment and they may not be sold or otherwise transferred by any person, including a pledgee, unless (1)&#160;either (a)&#160;a Registration Statement with respect to such shares shall be effective under the Securities Act of 1933, as amended, or (b)&#160;the Company shall have received an opinion of counsel satisfactory to it that an exemption from registration under such Act is then available, and (2)&#160;there shall have been compliance with all applicable state securities laws.&#8221; </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(b)&nbsp;&nbsp;&nbsp;At the discretion of the Administrator, the Company shall have received an opinion of its counsel that the Shares may be issued in compliance with the Securities Act without registration thereunder. </font>
        </div>
        <div style="margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">24.&nbsp;&nbsp;&nbsp;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">DISSOLUTION OR LIQUIDATION OF THE COMPANY.</font><font style="letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Upon the dissolution or liquidation of the Company, all Options granted under this Plan which as of such date shall not have been exercised and all Stock Grants and Stock-Based Awards which have not been accepted, to the extent required under the applicable Agreement, will terminate and become null and void; provided, however, that if the rights of a Participant or a Participant&#8217;s Survivors have not otherwise terminated and expired, the Participant or the Participant&#8217;s Survivors will have the right immediately prior to such dissolution or liquidation to exercise or accept any Stock Right to the extent that the Stock Right is exercisable or subject to acceptance as of the date immediately prior to such dissolution or liquidation. Upon the dissolution or liquidation of the Company, any outstanding Stock-Based Awards shall immediately terminate unless otherwise determined by the Administrator or specifically provided in the applicable Agreement. </font>
        </div>
        <div style="margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">25.&nbsp;&nbsp;&nbsp;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">ADJUSTMENTS.</font><font style="letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Upon the occurrence of any of the following events, a Participant&#8217;s rights with respect to any Stock Right granted to him or her hereunder shall be adjusted as hereinafter provided, unless otherwise specifically provided in a Participant&#8217;s Agreement. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(a)&nbsp;&nbsp;&nbsp;Stock Dividends and Stock Splits. If (i)&#160;the shares of Common Stock shall be subdivided or combined into a greater or smaller number of shares or if the Company shall issue any shares of Common Stock as a stock dividend on its outstanding Common Stock, or (ii)&#160;additional shares or new or different shares or other securities of the Company or other non-cash assets are distributed with respect to such shares of Common Stock, each Stock Right and the number of shares of Common Stock deliverable thereunder shall be appropriately increased or decreased proportionately, and appropriate adjustments shall be made including, in the exercise, base or purchase price per share and in the Performance Goals applicable to outstanding Performance-Based Awards to reflect such events. The number of Shares subject to the limitations in Paragraph 3(a) and 4(c) shall also be proportionately adjusted upon the occurrence of such events. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">(b)&nbsp;&nbsp;&nbsp;Corporate Transactions. If the Company is to be consolidated with or acquired by another entity in a Corporate Transaction, the Administrator or the board of directors of any entity assuming the obligations of the Company hereunder (the &#8220;Successor Board&#8221;), shall, as to outstanding Options, either: (i)&#160;make appropriate provision for the continuation of such Options by substituting on an equitable basis for the Shares then subject to such Options either the consideration payable with respect to the outstanding shares of Common Stock in connection with the Corporate Transaction or securities of any successor or acquiring entity; or (ii)&#160;upon written notice to the Participants, provide that such Options must be exercised (either (A)&#160;to the extent then exercisable or (B)&#160;at the discretion of the Administrator, any such Options being made partially or fully exercisable for purposes of this Subparagraph), within a specified number of days of the date of such notice, at the end of which period such Options which have not been exercised shall terminate; or (iii)&#160;terminate such Options in exchange for payment of an amount equal to the consideration payable upon consummation of such Corporate Transaction to a holder of the number of shares of Common Stock into which such Option would have been exercisable (either (A)&#160;to the extent then exercisable or, (B)&#160;at the discretion of the Administrator, any such Options being made partially or fully exercisable for purposes of this Subparagraph) less the aggregate exercise price thereof. For purposes of determining the payments to be made pursuant to Subclause (iii)&#160;above, in the case of a Corporate Transaction the </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-12</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">consideration for which, in whole or in part, is other than cash, the consideration other than cash shall be valued at the fair value thereof as determined in good faith by the Board of Directors. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">With respect to outstanding Stock Grants, the Administrator or the Successor Board, shall make appropriate provision for the continuation of such Stock Grants on the same terms and conditions by substituting on an equitable basis for the Shares then subject to such Stock Grants either the consideration payable with respect to the outstanding Shares of Common Stock in connection with the Corporate Transaction or securities of any successor or acquiring entity. In lieu of the foregoing, in connection with any Corporate Transaction, the Administrator may provide that, upon consummation of the Corporate Transaction, each outstanding Stock Grant shall be terminated in exchange for payment of an amount equal to the consideration payable upon consummation of such Corporate Transaction to a holder of the number of shares of Common Stock comprising such Stock Grant (to the extent such Stock Grant is no longer subject to any forfeiture or repurchase rights then in effect or, at the discretion of the Administrator, all forfeiture and repurchase rights being waived upon such Corporate Transaction). </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">In taking any of the actions permitted under this Paragraph 25(b), the Administrator shall not be obligated by the Plan to treat all Stock Rights, all Stock Rights held by a Participant, or all Stock Rights of the same type, identically. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(c)&nbsp;&nbsp;&nbsp;Recapitalization or Reorganization. In the event of a recapitalization or reorganization of the Company other than a Corporate Transaction pursuant to which securities of the Company or of another corporation are issued with respect to the outstanding shares of Common Stock, a Participant upon exercising an Option or accepting a Stock Grant after the recapitalization or reorganization shall be entitled to receive for the price paid upon such exercise or acceptance if any, the number of replacement securities which would have been received if such Option had been exercised or Stock Grant accepted prior to such recapitalization or reorganization. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(d)&nbsp;&nbsp;&nbsp;Adjustments to Stock-Based Awards. Upon the happening of any of the events described in Subparagraphs (a), (b)&#160;or (c)&#160;above, any outstanding Stock-Based Award shall be appropriately adjusted to reflect the events described in such Subparagraphs. The Administrator or the Successor Board shall determine the specific adjustments to be made under this Paragraph 25, including, but not limited to the effect of any, Corporate Transaction and, subject to Paragraph 4, its determination shall be conclusive. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(e)&nbsp;&nbsp;&nbsp;Modification of Options. Notwithstanding the foregoing, any adjustments made pursuant to Subparagraph (a), (b)&#160;or (c)&#160;above with respect to Options shall be made only after the Administrator determines whether such adjustments would (i)&#160;constitute a &#8220;modification&#8221; of any ISOs (as that term is defined in Section&#160;424(h) of the Code) or (ii)&#160;cause any adverse tax consequences for the holders of Options, including, but not limited to, pursuant to Section&#160;409A of the Code. If the Administrator determines that such adjustments made with respect to Options would constitute a modification or other adverse tax consequence, it may in its discretion refrain from making such adjustments, unless the holder of an Option specifically agrees in writing that such adjustment be made and such writing indicates that the holder has full knowledge of the consequences of such &#8220;modification&#8221; on his or her income tax treatment with respect to the Option. This paragraph shall not apply to the acceleration of the vesting of any ISO that would cause any portion of the ISO to violate the annual vesting limitation contained in Section&#160;422(d) of the Code, as described in Paragraph 6(b)(iv). </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">(f)&nbsp;&nbsp;&nbsp;Change of Control. In the event that the successor corporation refuses to assume or substitute the Stock Right as set forth in this Paragraph 25, the Participant shall fully vest and become exercisable or earned, if applicable, in each outstanding Stock Right as to which it would not otherwise be vested, exercisable or earned. If a Stock Right becomes fully vested and exercisable or earned, as applicable in lieu of assumption or substitution in the event of a Corporate Transaction or Change of Control, the Administrator shall notify each Participant in writing or electronically that (i)&#160;the Stock Right shall be fully vested and exercisable for a period determined by the Administrator, and all outstanding Stock Rights shall terminate upon the expiration of such period and (ii)&#160;any Stock Rights to which shares or other payment shall be due shall be paid out immediately prior to the Corporate Transaction or Change of Control as if fully vested or earned. For the purposes of this paragraph, the Stock Right shall be considered assumed if, following the Corporate Transaction or Change of Control, the assumed Stock Right confers the right to purchase or receive, for each Share subject to a Stock Right immediately prior to the Corporate Transaction or Change of Control, </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-13</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">the consideration (whether stock, cash, or other securities or property) received in the Corporate Transaction or Change of Control by holders of Common Stock for each share of Common Stock they hold on the effective date of the transaction (and if holders are offered a choice of consideration, the type of consideration chosen by the holders of a majority of the outstanding shares of Common Stock); provided, however, that if such consideration received in the Corporate Transaction or Change of Control is not solely common stock of the successor corporation or its parent, the Administrator may, with the consent of the successor corporation, provide for the consideration to be received upon the exercise (or payout or vesting, as applicable) of the Stock Right, for each Share subject to the Stock Right, to be solely common stock of the successor corporation or its parent equal in Fair Market Value to the per share consideration received by holders of Common Stock in the Corporate Transaction or Change of Control. </font>
        </div>
        <div style="margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">26.&nbsp;&nbsp;&nbsp;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">ISSUANCES OF SECURITIES.</font><font style="letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Except as expressly provided herein, no issuance by the Company of shares of stock of any class, or securities convertible into shares of stock of any class, shall affect, and no adjustment by reason thereof shall be made with respect to, the number or price of shares subject to Stock Rights. Except as expressly provided herein, no adjustments shall be made for dividends paid in cash or in property (including without limitation, securities) of the Company prior to any issuance of Shares pursuant to a Stock Right. </font>
        </div>
        <div style="margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">27.&nbsp;&nbsp;&nbsp;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">FRACTIONAL SHARES.</font><font style="letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">No fractional shares shall be issued under the Plan and the person exercising a Stock Right shall receive from the Company cash in lieu of such fractional shares equal to the Fair Market Value thereof. </font>
        </div>
        <div style="margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">28.&nbsp;&nbsp;&nbsp;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">WITHHOLDING.</font><font style="letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">In the event that any federal, state, or local income taxes, employment taxes, Federal Insurance Contributions Act withholdings or other amounts are required by applicable law or governmental regulation to be withheld from the Participant&#8217;s salary, wages or other remuneration in connection with the issuance of a Stock Right or Shares under the Plan or for any other reason required by law, the Company may withhold from the Participant&#8217;s compensation, if any, or may require that the Participant advance in cash to the Company, or to any Affiliate of the Company which employs or employed the Participant, the statutory minimum amount of such withholdings unless a different withholding arrangement, including the use of shares of the Company&#8217;s Common Stock or a promissory note, is authorized by the Administrator (and permitted by law). For purposes hereof, the fair market value of the shares withheld for purposes of payroll withholding shall be determined in the manner set forth under the definition of Fair Market Value provided in Paragraph 1 above, as of the most recent practicable date prior to the date of exercise. If the Fair Market Value of the shares withheld is less than the amount of payroll withholdings required, the Participant may be required to advance the difference in cash to the Company or the Affiliate employer. </font>
        </div>
        <div style="margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">29.&nbsp;&nbsp;&nbsp;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">NOTICE TO COMPANY OF DISQUALIFYING DISPOSITION.</font><font style="letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Each Employee who receives an ISO must agree to notify the Company in writing immediately after the Employee makes a Disqualifying Disposition of any Shares acquired pursuant to the exercise of an ISO. A Disqualifying Disposition is defined in Section&#160;424(c) of the Code and includes any disposition (including any sale or gift) of such Shares before the later of (a)&#160;two&#160;years after the date the Employee was granted the ISO, or (b)&#160;one year after the date the Employee acquired Shares by exercising the ISO, except as otherwise provided in Section&#160;424(c) of the Code. If the Employee has died before such Shares are sold, these holding period requirements do not apply and no Disqualifying Disposition can occur thereafter. </font>
        </div>
        <div style="margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">30.&nbsp;&nbsp;&nbsp;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">TERMINATION OF THE PLAN.</font><font style="letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">The Plan will terminate on March&#160;29, 2028, the date which is ten&#160;years from the earlier of the date of its adoption by the Board of Directors and the date of its approval by the shareholders of the Company. The Plan may be terminated at an earlier date by vote of the shareholders or the Board of Directors of the Company; provided, however, that any such earlier termination shall not affect any Agreements executed prior to the effective date of such termination. Termination of the Plan shall not affect any Stock Rights theretofore granted. </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-14</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">31.&nbsp;&nbsp;&nbsp;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">AMENDMENT OF THE PLAN AND AGREEMENTS.</font><font style="letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The Plan may be amended by the shareholders of the Company. The Plan may also be amended by the Administrator; provided that any amendment approved by the Administrator which the Administrator determines is of a scope that requires shareholder approval shall be subject to obtaining such shareholder approval including, without limitation, to the extent necessary to qualify any or all outstanding Stock Rights granted under the Plan or Stock Rights to be granted under the Plan for favorable federal income tax treatment as may be afforded ISOs under Section&#160;422 of the Code and to the extent necessary to qualify the Shares issuable under the Plan for listing on any national securities exchange or quotation in any national automated quotation system of securities dealers. Other than as set forth in Paragraph 25 of the Plan, the Administrator may not without shareholder approval reduce the exercise price of an Option or cancel any outstanding Option in exchange for a replacement option having a lower exercise price, any Stock Grant, any other Stock-Based Award or for cash. In addition, the Administrator not take any other action that is considered a direct or indirect &#8220;repricing&#8221; for purposes of the shareholder approval rules of the applicable securities exchange or inter-dealer quotation system on which the Shares are listed, including any other action that is treated as a repricing under generally accepted accounting principles. Any modification or amendment of the Plan shall not, without the consent of a Participant, adversely affect his or her rights under a Stock Right previously granted to him or her, unless such amendment is required by applicable law or necessary to preserve the economic value of such Stock Right. With the consent of the Participant affected, the Administrator may amend outstanding Agreements in a manner which may be adverse to the Participant but which is not inconsistent with the Plan. In the discretion of the Administrator, outstanding Agreements may be amended by the Administrator in a manner which is not adverse to the Participant. Nothing in this Paragraph 31 shall limit the Administrator&#8217;s authority to take any action permitted pursuant to Paragraph 25. </font>
        </div>
        <div style="margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">32.&nbsp;&nbsp;&nbsp;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">EMPLOYMENT OR OTHER RELATIONSHIP.</font><font style="letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Nothing in this Plan or any Agreement shall be deemed to prevent the Company or an Affiliate from terminating the employment, consultancy or director status of a Participant, nor to prevent a Participant from terminating his or her own employment, consultancy or director status or to give any Participant a right to be retained in employment or other service by the Company or any Affiliate for any period of time. </font>
        </div>
        <div style="margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">33.&nbsp;&nbsp;&nbsp;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">SECTION 409A.</font><font style="letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">If a Participant is a &#8220;specified employee&#8221; as defined in Section&#160;409A of the Code (and as applied according to procedures of the Company and its Affiliates) as of his separation from service, to the extent any payment under this Plan or pursuant to the grant of a Stock-Based Award constitutes deferred compensation (after taking into account any applicable exemptions from Section&#160;409A of the Code), and to the extent required by Section&#160;409A of the Code, no payments due under this Plan or pursuant to a Stock-Based Award may be made until the earlier of: (i)&#160;the first day of the seventh month following the Participant&#8217;s separation from service, or (ii)&#160;the Participant&#8217;s date of death; provided, however, that any payments delayed during this six-month period shall be paid in the aggregate in a lump sum, without interest, on the first day of the seventh month following the Participant&#8217;s separation from service. </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">The Administrator shall administer the Plan with a view toward ensuring that Stock Rights under the Plan that are subject to Section&#160;409A of the Code comply with the requirements thereof and that Options under the Plan be exempt from the requirements of Section&#160;409A of the Code, but neither the Administrator nor any member of the Board, nor the Company nor any of its Affiliates, nor any other person acting hereunder on behalf of the Company, the Administrator or the Board shall be liable to a Participant or any Survivor by reason of the acceleration of any income, or the imposition of any additional tax or penalty, with respect to a Stock Right, whether by reason of a failure to satisfy the requirements of Section&#160;409A of the Code or otherwise. </font>
        </div>
        <div style="margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">34.&nbsp;&nbsp;&nbsp;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">INDEMNITY.</font><font style="letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:11.5pt;">
          <font style="letter-spacing:0.2pt;">Neither the Board nor the Administrator, nor any members of either, nor any employees of the Company or any parent, subsidiary, or other Affiliate, shall be liable for any act, omission, interpretation, construction or determination made in good faith in connection with their responsibilities with respect to this Plan, and the Company hereby agrees to indemnify the members of the Board, the members of the </font>
        </div>
      </div>
      <div style="margin-top:2.00000000000002pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-15</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.3pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Times New Roman, Times, serif ;font-size:10pt;">
      <div style="padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:15.85pt;height:24pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:17pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:6pt;margin-bottom:476pt;margin-left:69.66pt;width:456pt;">
        <div style="width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Committee, and the employees of the Company and its parent or subsidiaries in respect of any claim, loss, damage, or expense (including reasonable counsel fees) arising from any such act, omission, interpretation, construction or determination to the full extent permitted by law. </font>
        </div>
        <div style="margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">35.&nbsp;&nbsp;&nbsp;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">CLAWBACK.</font><font style="letter-spacing:0.2pt;"> </font>
        </div>
        <div style="text-indent:20pt; margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">Notwithstanding anything to the contrary contained in this Plan, the Company may recover from a Participant any compensation received from any Stock Right (whether or not settled) or cause a Participant to forfeit any Stock Right (whether or not vested) in the event that the Company&#8217;s Clawback Policy as then in effect is triggered. </font>
        </div>
        <div style="margin-top:8pt; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">36.&nbsp;&nbsp;&nbsp;</font><font style="font-weight:bold;letter-spacing:-0.2pt;">GOVERNING LAW.</font><font style="letter-spacing:0.2pt;"> </font>
        </div>
        <div style="margin-left:20pt; margin-top:8pt; width:436pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">This Plan shall be construed and enforced in accordance with the law of the State of Delaware.</font>
        </div>
      </div>
      <div style="margin-top:0pt;height:12pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">&#160;</font>
          <br >
        </div>
      </div>
      <div style="margin-top:2pt;margin-bottom:21.86pt;margin-left:69.66pt;width:456pt;">
        <div style="margin-top:5pt; text-align:center; width:456pt; line-height:12pt;">
          <font style="letter-spacing:0.2pt;">F-16</font>
          <br >
        </div>
      </div>
      <hr >
    </div>
    <div style="page-break-after:always; width:595.31pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Helvetica, Arial, sans-serif;font-size:9pt;">
      <div style="position:relative;padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:-8pt;margin-left:0pt;width:595.31pt;">
        <div style="position:relative;z-index:-1;text-align:center; width:595.31pt;">
          <img src="px_cyclacel25pg01-4c.jpg" alt="[MISSING IMAGE: px_cyclacel25pg01-4c.jpg]" height="1003" width="775" >
        </div>
        <div style="margin-top:5pt; width:595.31pt; line-height:1pt;color:#FFFFFF;font-family:Times New Roman, Times, serif ;font-size:1pt;">
          <font style="letter-spacing:0.02pt;">Cyclacel Pharmaceuticals, Inc. 200 Connell Drive Suite 1500 Berkeley Heights, NJ 07922 VOTE BY INTERNET Before the meeting &#8211; Go to www.proxyvote.com Use the Internet to transmit your voting instructions and for electronic delivery of information up until 11:59 P.M. Eastern Time the day before the cut-off date or meeting date. Have your proxy card in hand when you access the web site and follow the instructions to obtain your records and to create an electronic voting instruction form. During the meeting &#8211; Go to www.virtualshareholdermeeting.com/[ ] You may attend the meeting via the Internet and vote during the meeting. Have the information that is printed in the box marked by the arrow available and follow the instructions. VOTE BY PHONE - 1-800-690-6903 Use any touch-tone telephone to transmit your voting instructions up until 11:59 P.M. Eastern Time the day before the cut-off date or meeting date. Have your proxy card in hand when you call and then follow the instructions. VOTE BY MAIL Mark, sign and date your proxy card and return it in the postage-paid envelope we have provided or return it to . TO VOTE, MARK BLOCKS BELOW IN BLUE OR BLACK INK AS FOLLOWS: KEEP THIS PORTION FOR YOUR RECORDS THIS PROXY CARD IS VALID ONLY WHEN SIGNED AND DATED. DETACH AND RETURN THIS PORTION ONLY The Board of Directors recommends that you vote FOR the following: 1. The approval of (i) the issuance to Mr. Lazar, our interim Chief Executive Officer, of the Common Stock upon conversion of the Preferred Stock, and (ii) an amendment of the Series C Preferred Stock Certificate of Designations removing the Series C Ownership Limitation, for purposes of Nasdaq Listing Rules 5635(b), (c) and (d). For Against Abstain 2. The approval of the issuance of shares of Common Stock in connection with the Exchange Agreement, for purposes of Nasdaq Listing Rule 5635(d). The approval of an amendment to the Certificate to effect a reverse stock split at a ratio not less than 1:4 and not more than 1:16, or the &#8220;Reverse Stock Split,&#8221; such ratio and the implementation and timing of such Reverse Stock Split to be determined in the discretion of our Board of Directors. 4. The approval of an amendment to the Certificate to increase the number of authorized shares of Common Stock from 100,000,000 shares to 250,000,000 shares, which number would not be adjusted as a result of the Reverse Stock Split Amendment, if such amendment is approved. 5. The approval of an amendment to the Cyclacel Pharmaceuticals, Inc. 2018 Equity Incentive Plan, as amended to reserve an additional 500,000 shares of Common Stock for issuance thereunder, which number would not be adjusted as a result of the Reverse Stock Split Amendment, if such amendment is approved. 6. The approval of the adjournment of the Special Meeting, if necessary, if a quorum is present, to solicit additional proxies if there are not sufficient votes to approve any of the above Proposals. NOTE: The Company will transact any other business that may properly be presented before the Special Meeting or at any adjournment or postponement thereof. Please sign your name exactly as it appears hereon. When signing as attorney, executor, administrator, trustee or guardian, please add your title as such. When signing as joint tenants, all parties in the joint tenancy must sign. If a signer is a corporation, please sign in full corporate name by duly authorized officer. Signature [PLEASE SIGN WITHIN BOX] Date Signature (Joint Owners) Date</font><font style="color:#000000;letter-spacing:0.02pt;"> </font>
        </div>
      </div>
      <hr >
    </div>
    <div style=" width:595.31pt;margin-left:auto;margin-right:auto;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;color:#000000;font-family:Helvetica, Arial, sans-serif;font-size:9pt;">
      <div style="position:relative;padding:0pt;margin:0pt;font-family:calibri, arial, sans-serif;font-weight:normal;font-style:normal;font-size:8pt;line-height:8pt;">
        <a style="text-decoration:none;color:#003366;" href="#TOC2">TABLE OF CONTENTS</a>
      </div>
      <div style="margin-top:-8pt;margin-left:0pt;width:595.31pt;">
        <div style="position:relative;z-index:-1;margin-top:8pt; text-align:center; width:595.31pt;">
          <img src="px_cyclacel25pg02-4c.jpg" alt="[MISSING IMAGE: px_cyclacel25pg02-4c.jpg]" height="1003" width="775" >
        </div>
        <div style="margin-top:5pt; width:595.31pt; line-height:1pt;color:#FFFFFF;font-family:Times New Roman, Times, serif ;font-size:1pt;">
          <font style="letter-spacing:0.02pt;">Important Notice RegTHIS PROXY CARDaIS VALID ONLY WHEN SIG rding the Availability of Proxy Materials for the Special Meeting: The Notice &amp; Proxy Statement is available at www.proxyvote.com. CYCLACEL PHARMACEUTICALS, INC. SPECIAL MEETING OF STOCKHOLDERS [TIME/DATE] THIS PROXY IS SOLICITED ON BEHALF OF THE BOARD OF DIRECTORS The stockholder(s) hereby appoint(s) each of David Lazar and Dr. Samuel Barker, or either of them, as proxies, each with the power to appoint his substitute, and hereby authorizes them to represent and to vote, as designated on the reverse side of this ballot, all of the shares of Common Stock of Cyclacel Pharmaceuticals, Inc. that the stockholder(s) is/are entitled to vote at the Special Meeting of Stockholders to be held at [TIME] on [DATE], via live audio webcast at www.virtualshareholdermeeting.com/[ ], and any adjournment or postponement thereof. THIS PROXY, WHEN PROPERLY EXECUTED, WILL BE VOTED AS DIRECTED BY THE STOCKHOLDER(S). IF NO SUCH DIRECTIONS ARE MADE, THIS PROXY WILL BE VOTED &#8220;FOR&#8221; PROPOSALS 1, 2, 3, 4, 5 and 6. IF ANY OTHER MATTERS PROPERLY COME BEFORE THE MEETING, THE PERSONS NAMED IN THIS PROXY WILL VOTE IN THEIR DISCRETION. PLEASE MARK, SIGN, DATE AND RETURN THIS PROXY CARD PROMPTLY USING THE ENCLOSED REPLY ENVELOPE CONTINUED AND TO BE SIGNED ON REVERSE SIDE</font><font style="color:#000000;letter-spacing:0.02pt;"> </font>
        </div>
      </div>
      <hr >
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>lg_cyclacel-4clr.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 lg_cyclacel-4clr.jpg
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M%!04%!04%!04%/_  !$( *<!F ,!$0 "$0$#$0'_Q "S  $   <! 0
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M%I,JDPDKYF,>2R*@\^,6601BP$ ( 0 @! " $ ( 0 @! " $ ( 0 @! " $
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MW<G2OQ&[^R,GE19A_E->'R+YG-<R9EZ%[J&$\ %$D?<!I&I;P8R-NGU.4?\
M(R"S]X<\M+H+E9\^TD'<C:J9GYDRCGR])4NS^9U:_6Y1>,KY,VCC7U!VIY3;
M&04QHG%R!?\ ?!/L1,QRN3Z5*/0[W%]9C+26/D;FLF1VN]4C=3;JA%0TJ9FG
M0CR*3J(X-E+@]3TM-\;(Y3/6#R??(T'A&'*-J*+@K2-J3[RN C&T9RJ/QBJ1
M )E%R", ( 0 @! " $ ( 0 @! " $ ( 0 @! " $ ( 0 @! " $ ( 0 @! "
M $ ( 0 @"52MHG @\^KJ2DKU&U "AJ!K]L4=;E(I*Q1-4=P.\=KQAI3- 177
MD$I-.VH$"?LF-([/%X+EU]AY[F^IJO\ 3J]3G'(,MOF85;E7=*IQJGY425$
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M#\XL", ( 0 @! " $ ( 0 @! " $ ( 0 @! " $ ( 0 @! " $ ( 0 @! "
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MY35MZN.GA'.D=1LZ8IRYN+2U)4$'21F0//PBZT1"+V $ ( 0 @! " $ ( 0
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M;S4TN%85-1FG4#;,1B$W@^WE(RXVQ3)?U>0D)=6GXE!/.++H6CT+^! @! "
M$ ( 0 @! " $ ( 0 @! " $ ( 0 @! " $ ( 0 @! " $ ( 0 @#SJUWTT+
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M*"M6A/,B.);<VL'H^/Q(1>4O Y3[+_55FG<3N[_DW*:6G?Q+(''J5-&G<0A
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M="Y%0)T.HB2Y*M"5"12##+*[<E!QMK< 4G@(O%O!BE%9(A*?A$I<"8999;?
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M#Q\(QX9G6%[S.F:EK8%;Q+43\X@R1DBY#R5<#.?Y1!FP3@CE @35$D$%;CI
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M=(+<(ZC(17!N;M,%9.G.!0K SB"Y$B $ 0YS@", ( 0 &D ( 0 @! " $ (
M0 @! #V0!"7E  "4 0*08 ! $ 3:S\H 0 @! " (2$3DC!&()'V0 @! $-8
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=! " $ ( 0 @! " $ ( 0 @! " $ ( 0 @! '_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>lg_secretarysoffistamp-bwlr.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 lg_secretarysoffistamp-bwlr.jpg
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M%!04%!04%!04%/_  !$( +( M ,!$0 "$0$#$0'_Q ""   !! ,! 0
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MBE.'W/\  #7 QJUXS+1E69+<O&>SF^:$+)D-LK %$,-GEVP"0/;\- V7S)F
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M(T%UAA7* LDH4IMLI4T0I)!V4FOST 0\NQ[K95V?RK:$K&58%)3;+^RV*&9
MY(82\L? =QQ51\-!9G$\DMF8X[:\JM3H<A3FDOM\-Q^:D&A^RN@D.@T/.(;;
M7)4?RVD%P_"B02=!4K';A'RCROG'F.4MR7;+*%XUCJ4>YOZLKX%3?*GN2W)Y
M'Y:"P^)8Z[C.#)MY=[UP,=Q<I\#WN/J;I6OQJ-!S>,G(1QYQB.XVY.;DN?J*
M%D\TO%0"@KYU&@?LBN<>R6QV6Z J026H:5@%9?<V;2D&HH5:",X.Z];Y+ELR
M%OMY*^52TRNI=:=/<#8Y>J H).@'OF]G$+5D5ID3;)(GS939?NC4(DD0&UA+
MCS@*T@(0*!5-!W7#-;3XPQYSR!<L@;5ATQM$6RQ$J/%HE -5>VOM*%)ZZ!TQ
M[RK"NF+KO4TQ+BV^X.R(Q^^VH>G()-=!-9&6X[9D6Y#D4,KN "F6DAL+0#45
M6:_+XZ!GR;R+9[)>7<>RYIF'9'&"]^INJJQVB%;FA)KMM0: 1XYF'@ZYWBXR
M+;ET6Z&V+48UL9[@)0#1 /<0D>T[]=!.'9^(R<87GDJV.-M-2.#S,/M@/E2A
MQ5NL;5.@EK^:6:R6JR2H\)2+5=4I=;9;*"M*G DT7R52ONT$,O/FBQ8=E9BY
M?.MUOLLI+:(0 /U/=?2. JE!%23\=!S97A.07G&S>;KE*(++4EJX09(-28H2
MI0:-4'[_ "2=!/?&5BM-BQQJ3:[B;LQ,!<,\?Z?)*BE5.AZU]-!JRW]/L-W9
MNTAUD,7("-(@O#\IT'WU(H?=[1H)M&0.TA7"C) 4PW^) (Z?"F@B&7K-OON-
MSXX4Y.>?7'X( JZE+2E5_A6N@9_(6.6\W1]ZX2$1[;DT!ZR3>8_+2XZTM#3A
M%#OS=3O\M!"OVMRY&,PK_P"&[BKG-PN:]'BNK)Y/0T+[+;@!_"0W4?;H+%:"
M#>6<B;Q7QMDN0)<X?3PRA"O@MY0:'^:]!7GPO9GDX-X\Q":HLW7)'GL@O+@Z
MJ/9(37;U5'T%E\WRAK$[#)NY1WGB$-1F?YENJX#X="1H 1CF29%"OEQRE,%5
MOF-*2+U;4;HDQE$A#H%5;CW*.XT$TS2\W3)+E9;QB;P=M5E:3<KI&K5#K=$N
M@$#\382?\=!YD6573,[>X_A@;3;;8E,]<X!25"2A)6637^JJ>GIH&WR!CMIN
M$RU9%=\G%ANMYAMPY3*:D/-K2A*P $+VJG0!S]S&&V["O&<+Z2]IE,)G-+9A
M*)4VM*FG%?F!*:\237;0#FZVS'(%H8>MKCUI#K2%J:A'W..$#<=SEH.NTX#D
M>6ICNLY9<_KFOS(T7NQ^8;%?:045^.@Z)%JM][G.LY'&>GW2W 17_KE;?E'E
M_P!,I]3H.M^!B$Z/](;'"92K[AB=]*C]O<6=!R7&UTLWZ''N;]K@I(5VD*20
M!4?)72F@%609BQ&D_P!OHRBY79J(*!')JC9 H*>Q/2F@>[U!LZ,-ARXD-9N<
MV9%0Y.D*!4D*J"K8TVK7IH+@3<6G)P&WQK--<OT+_8R+A%!'MXL;CHG;?XZ!
MV\2S+IB&*Y#>LAA.6V '$KM4)W>J$I(52A/XOGH.N39?K,E:O7D*,'[5>$\;
M4I2B$P7B.20=QZ)4?7KH'G$<^M:+=?HEUN#JT8VYVG)RTG=/M2GC1-34K">F
M@B<',,@OWEM%JNL)AK&(\9+D"$FOU3:"I82\KWD54?:= 4/(EI8NF+RE*1[X
MBFYK:QU_(<2ZJG\$: $_JD?$_/>-YM$6$V7R';4M2$;T$EACFJOS*W1H+3:"
MOW[K[NQ \8.6!]5$9),9C.#_ *@+3K3U&_0?<'6NV@=?'T?CY"D6U,%*(N/6
M2/"B2G:$I=3(7R!H1N4K.@Q_<#?+);[;;&+@[,5(2Z2S&@$!8*BBBG:H7[1U
M'30#RTW6\85D\6]MW$Y-8;E"0Y<;:KEWVVI#9)W4$@4J:[:"?8E8(F'WV9DE
MF>3*P#*$-=VW(JKZ-QP'F%4VH2Y[OLT$@?AV%UI[&,+A(1 N;G*;(:![**D@
ME(._+W'0"'S+8+X_DG>&,R[@F)$;M]@?:=:2R5*0GFX$*/*J5IT$)_<=!QV#
MXNMK\*>\,D4^PF:PLUXD,JY(71.]"/0Z"$71NSS';7%GS'H*W6D(A3X_M =X
MUHX2E6W7I3005J-_9>1-YDYD4:?=(*N<MB"AY,AUP@I" 5 CM^X'[?70$6S9
M <N9=R&Z1>U>I;JGY-M*T<D\@#5(J>A^9T#FM#,IM3:7%MKE-50\D@*;<(/R
MZ5T'!C5F5>;-EV O0X[]]:A?7NY-+51$5EI#CB:U4FI7P(VT 8\08*F]7I^=
ME$"8[@]M>5&N=[AA(0HI44%P<DJ]OM*NG303_P E1<9M%E=B6689^*QY\5V)
M*40ITM**B02 !0;4''06<%SAQ/%;;.$7&1"D75$6-,D%5%,EQD@*;(2*;#YZ
M!\P6Z7S,;+?<.O,AN\W&T!IRUS5!1#GY8J'"H^XU5Z4T$ZN<''\\L,.VWZ68
M;L!T/2F@H-J"VT*12JP0=B.F@B:4-2+]DF3S$MIPJW1RU"B@%EJ2\@@I*NY3
ME_#X:"!XG,QZ\YCC&5VU[M>3+B\ZW=2:H"X8:4I+:^0%4A141OUT%H)[*9$&
M;&)"@\RX@I/]:2FG^>@J1YLMK]KPO#;RLM-OX[D?TR2D$!+3K\= !WK4A.@M
ME^H)^@_5J_[/Z;ZRM?P\.?7[-5%>/W=H;5%\?H4V'4.7M15RI_\ 1'QU%33Q
MV[+<\D>0@I9DA$Q26HRMDI2'$="=MM!EF>.W]>6N7>)-A-6F4TIE*IZT(5WJ
M*]J.:T$BJATT#1:O$%Y7:YDN=<&K9>'P2[+CFK9B$&@!03MQKZZ#O\1Y#@S$
M1S"8LEZ1.?>DMJ$IM:&G^P:+*5+2D'_'0%>VVZWV6*XQ:XJ(R 2XMA!'4DFN
MW2N@J]F.;9'/SQB9!N,UB:J<Q#LEL"70P4GV.*4*4IS2-]!%_P!UUPQ23@*?
MT^(J+D9FLJDOAM5#)#"@:BE:5J>N@C*X$)^#],ZE,B&A#9;"TFH46TUI7[=
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M\=-R;])N5T?9GV&4DI<@.I4LJ!_"2-J>N@$R_P!LF+Y!DEV#L5=ALX4I4 P
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M@% 6WP.:1TV!]!H )><2\W>*TJMZ&&?)GC1%$FWRU)_4&&J5)0XM,ATJ&]*
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@0+0+0+0+0+0+0+0+0+0+0+0+0+0+0+0+0+0+0+0?_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>px_cyclacel25pg01-4c.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 px_cyclacel25pg01-4c.jpg
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M_\0 SP !  (" P$!              4&! <! @,("0$! 0$! 0$!
M      $" P0%!A    8! P(# P4)# 8& P<5  $" P0%!A$2!R$3,2(4014(
M43+2(Q9A0G24U%97&!EQDC-3TR2DM%65%SA2<K66MCF!D6)#LS8T=3>AL8*R
M<Y/D)36E)F<)T6.#5&9VP?&CPT2$)^%W$0$  @$!!@0% P0#  ,      1$"
M R$Q05$2!&&1(A-Q@3)2%*&QT?!"8B/!X06",X/_V@ , P$  A$#$0 _ /OX
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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M>\$S96<UTBQ/&[O&B8=)E,;(HB(3[I&A*^XVE#KI&CS::Z^.H(M0
M
M
M
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MPA:WTN-H<4K5"C-1H+4NO@"1O?1\#4H$7=J2NRWJ1]#UVD",@
M
M
M
M
M
M
M
M
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M,@'8  1E+DF/9(U(?QVUAVS$1Y464[!?;DH:?01&IM:FE*)*R(R,TGU 28
M                                K%[R/Q[B]@53DN5U%/:*2EPH=A/C
M17MBS,DJV.K2>AZ=#T 61EYF2RW(CN)=CNI)QIULR4A:%%JE25%J1D9'J1D
MB[[*<;Q9F,_DEM$J69CR8L1<UY#!.R%_-;1O,MRCT\" 2X   ,"5=TT%)JFV
M,:.DI#4(S=>0C25)-*6F?,9?6.&M)(1XJU+3Q 9X      \Y$AB*RY)E.H8C
MM)-;KSJB0A*2\34I6A$0#&C7%3-GS:J'.CR+2M)E5A":=0M^.4E)K9[K:3-2
M.XE)J1N(M2ZD S0   8MC95U1!?L[:6S K8R>Y)F2G$,L-H+[Y:UF24E]TS
M16-9QAN9H>7B5_7WB8QD4CW=*:DFV9^&\FU*-.OLU 3X#S?D1XR4KDNH90I2
M6TJ<42"-;ADE*2,].JC/0B]H#T                 >;S[,9I3TAQ++*=-S
MCBB2DM3T+4ST+Q,6(F=P]!
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M1S:A:TH(D[M#ZZ%_[H^5_P"AI8:>I'1%1.,37Q>G0RG+';S;$'S7H
M
M             ?.EGP%R3C.:Y)E'"V<L8U79>Z<JYJI\1,M#<M9J4IU@U)66
MNY:E)+:G3734RTT+;M]F>-OAIXMR%><7;]C:9D<EN^NWFEN3+2?)8>5VD(3O
MVEHIPT]Q>FY2C4KJ!O1OP<\6V>-8@7(&7)=5DU]&:B53<K7N0Z)@]66DDKJ@
MGE?6[?#:2/;J!+T+X<>2*1R_Q;!>0DX_QIDEHNXF,,Q5%<1E/*0;C4>2E1&1
M&3:$[MR>A=2/S;A:^'PY,<YCQCD:1;^IIL2HSI:R!)[C\U;ZT.-KDO2%J/>M
M2'3W*,M3/J!;4KOPG<@-X=DG'=9G,"+B-M.]X-&=;NL)9F\APFYLDEDK:C82
MBV:[E%[$^4%ML7..$<EEY)B>?\;W\6@S7&:HJ%29L8Y-?(@DA1$G:1[DF@W%
MZ=#UU+PTZDMU+X>9%WQ5?X%GF8V.0WN1R?>4J]?-2FXDQ*R=;*)&4LTH92HC
MW((RW:G\WRDD6RL XMY,JLA@V^;Y562*VI:-J/5453'A(G.[#04B:XM!JWIZ
M*)+6TB5U(R+4E!+<'<4SN*Z:^8N;)JWOLAN)-U/G,-J909R"01((EJ4?0R4K
MQ^^ ETR+B6?D?.&*\IRK)DJ3%8#\:-3]M9NKER$O)-TU[MI$1.IZ:?> -H22
M?5'=3%4E$HT*)E;A&I!.:'M-1%H9D1^((T!3_#O?4O -]Q)%R".K(<BE.R["
M\4RYV5'(>:-SR$K<9J::)O77V@MN<H^'F_7;<=7^#7L"#:8+4-T*6K>$<V(M
MIMKM^I;:)1:/%N4?4^I[?,6G46C&?AIR]G >2,4>RZ/.ON0;-F?)R%Z(IIPV
M&WB=<2XTVK:2E^8M$>4MQZ>P"UXY/X;L,TX:@\28_:LU,>,W6Q'I3S*G$+B5
MI(T22$*(R,U-H5X^P"W>VX;?L^6L&SHK!EO%\&K78,"E-M1O*DN-N-$YW-Q)
M)))-O0MOBC[O06K;?PYSIE5R]&N;YOWIR?+)]J;%947HV&'%NQVE$I6JTI->
MU9$9;D@6B:#X=>0&[SC>URG*ZN75\?.GZ2@KZWTD;8A"$I=2M*B-;ZC0E2U+
M21$9%H7SM1;,ON N18649C8<89RSC>/\@O%)R%E^(;TV.^K?W7(CR5$9&ON+
M,NJ#3KT/4B4!::SC@&3=U.$R,=R%PLVP(EE77&0(]ZHGHD)23Z)J7#,U;]-2
M47S.I)+P,A;T@\,YA8X1F5#F>5L2+C+8;D%A-57LPZVL;6DR)+#:22ZXE1Z&
MYO66XON^8Q:F5/PU<@2'>-6,QS*#-QWCR4T]&H8,!3++B(IH4TM3AKW..J-!
M)6:TZ$7@6JE&H6O%_P 0Y=)YYJN8*"_AL06H+-39UDZ,I]TH:'3<=3&61D25
M.$>A*/3:9F?F(] $/0_#8@N.N0<+RVY3,L<_M7[>5:PVE([#BEMOL>1Q1FOM
MO(-P_,6XCV_= MDX)P_RG R+'[3D#D)=C2XE%*'3T=*VY7L2B2@FTN3S)1=T
MR)*3V&1EJ1=?G$H*-*^%;D!NAS/"Z7.($+$\GGKLS6NM[MI(-QU#GIY4G<2B
M:3L(_J^JE?(E2DF+;(1PE-7R3QYF,FRC'1X!1%4Q:EME9*7,-A<<WDJ-6B4;
M5(VITU+;_P!0M3\O^'WE;*X5CA]IG5=>8782>^Q8W]84R_@-*4E1MQWDFE&I
M;=-Q;?N$G70"UMI:O,*+E'$<&Q2QEIXKP_'$Q;R._$VMO2VV^S$(YCB/K7%I
M4EQ2&#(D=L]WSB2 MW,F#VW)/'-UA%-8-5<NW2RTN:^A3J$LH>0ZXG:DR/S)
M1M_Z0(4Y7 \A68<4VQ6K/V9XRK#A-5O:5WI$OTY,D\2]VU);D-+/4C/RG\O0
M6SJ;A9Q/)/(N=9-8MV$;-X+=-&@L(4TN-7$T3+B%+,SU-1(1\TO'4P+4C&?A
MWY1IHU'A$CDIQCBW'9JIL*+4L+K[>0VIQ;I1WI+2R,D:N*UT4K]SHG:+;EHZ
M/.HN<9#>7F1HG8A-0RW08\U'0WZ(T)23BUNZ;EJ6:3/JK3J?W 1<
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MH.VGW^AAJ1J>O++&*BYC^&,M'.<9QV1$K'88KRS;4RL>LU8;+HU(;:57NP+
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MGX !'KU+P
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M MH#C4NG7Q\/N@.0
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M67.^TAU:"-24.:)WI(ST)6TM2ZZ C*
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M6CZ76Y!./$@B-9NM*4A9J+11J2HR,^I RM@
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M14.$TM6JC,]4:*,SW:ZF"VVDTTTPTAEE"6V6TDAMM!$E*4I+0B(BZ$1$".X
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MO.2:BCS[ \@R1BQ]5ADG)HUG$@(AN151Y2(\B$A!+5N:=0YHAU2NXCJ?F/0
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MMRES$J"D<KC4VE)7S%>F3)?)XEJ5VW%IV())>"M=0&P\"NLQBYSDV 9=;L9
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M?<7T./;?S2/Z1EAF:PVZA@D[UFHT$KJLSZF?@1: B\
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M4"T^I\2O4Y1BM'DR6C83<U\6Q)@SU-LI;*'MNNA:Z;M 93
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MIBLP8+)J4LT1XS:6FT[E&:CT2DBU,]01G@
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M,D1%\[:9%J9IW%?>-161:2I@4T%)IA5T=F'&2?B34=!-H+_J20,LP
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M>[JM"4-I)F.5?$>-O5!$:C)QQ9F:C,_9]P!L$$
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MH?W !4V&F4F"J0T4U:36B,:TDZI!>*B1KJ9?=T >X
M                *X6!8>42'!]T,>DK[0[^&UYC)JT4ZMXY*>OS][JU?)U
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MS2DSU,DZEKIX /4
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M"Q697E565CVE3S9LH#<I3;RV6VDKV+-6Q6S=H>AF>@#: (
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M;?SVGLER*8J7,MU0S6DWFV5FTVE*=I&:4$1$:M->A%H6WUL#(
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MT!$?9<6\>V^2MY?98[#D9&VIISURV_,MR/\ P3CB2,D.+;^\6XE2DZ%H9:$
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M3*[26VDB<D*C-DRT;A^W8@B2G[@"0
M                       $+CV(8IB2)+>+4<"E;F+)V6FNBM12=66NBE]I
M*=QEJ>FH":     8UA75]M">K;6(S.KI"=DB)*;2\RXG771:%D:5%T]I (G'
M,'PS#^\>*8]6T9R/X=5;#8B&X7CHHVD),R_= 3X   .-"UUTZET(_P!T!R
M                                                /DO'<OY#MYT3
M,I-JNMM'\K74269^0LLU:4-V*HAU'N7L*4ETXZ?(?\.;AD[OV'H#3QCVN1-%
M2X?0NR2J;O)\Z?FQXEHBADRGX%L9,1BF[5+1Y'''5-MF2EDGQVI41A-T%[E=
M\[A>#93EZV**QL<B8=M:BQ-R?(34E'5!KI%HPADC?2EU[O*9T-WL_.UW@CG9
M7_XD83:0,OGY(5939C#@7+\DVO4.U<B.28ZB22$R5-$XI#CJ2/O=M*SUV /#
M'BOW:CB*NN\VOBK^2X:K7);=Z>MIXYD>N9?C5\1].THJ'C=6I1-Z+<[7SM34
M9AD1+7(+FWJ<$C9G:NX^UG%CC[%]%E$F?+JXU"JP7'7)(C-Q3,@E,&_\_I\[
M>6H#-Q[(LHK+FOQI-[/LH=3R%;4$;U;YNR9-<QCKMBS%DO*\SNU]1$E3FJM"
M3KX )#BVPC3(W'N:6?)-A)RK,4/G8X\Z^4J#-E*C./R(C4,DF43T*T&7<:)&
MFS8X9FL!>.7+:TQ)C',]BS76*/'[1I.5126HH[M-8EZ1YYQM!&:SBK<;D)^0
MD*^4!K&GM<ERNUQ&ORO)+6AHN057V3L(8E^B?4RTY'155<>0UM6T@H:O5N(0
MHE+7NZZ:@*_2RIN1<@\9G<7LVRK\>S/)Z.@R!4DVU6%?"K3>84ZXC:A]9NDJ
M(MQ)?7)0HCUW&"I/C^=DW(\G!Z2ZRVZ8A3JC*K"S773%1'Y3D"_1$CI6\T1+
M23:'-"[9I/1))UTU(R.F(Y-=9BK"\9SG,K"IHO==_)1<QIJ:J5;6%-=+KVVW
MI2-IJ-B,@GEMH,NXH]Z]4I,@&VN ;F??\80+.QN'<@>7.MVFKI\R-R5'CVDI
MEASRD22(VT(T))::> $M6QKO*,GR^)BK^4VD.OG\@Y352'($GL2"KJZL.2U%
M0LB,T(2M'0T^9)&>TR/J08:K?-),)_#X63O6/N3,[FFBTTJW<I[FYK8<)E]J
M.BW2E:^['7([ADLTFZA.AJZ=0YQZ=$R+D?AN=(M[IR77%E]5(.XEL^J]95N1
MTG'6[$/L2=-QMFZT9]]"$FKJ1@.<'M<DKL6X?S2WS.VFOYM>,-7Z[&=_,=AP
M; V8[31Z(0E2D((R+JXM)&>J@$C)S6SNKJWIDY=(A8M:\BECK]U#E)2J+":H
MVY2(<9_KV3?EH[.Y!DHE&9$>XP'E.K:?_%/C&#$S2QR*)0Y5>0/52)BC=@NE
M2IEE6N22T.29+T2:EJ4O8LV%F>AD PL!R&_Y E8EC&79;9UU-(J;ZW1.A355
MTNSL8M](B=E4IO:HT0XZ4J[+:BUW$:M4H 9V+661<B6F$X]/S"U.C>C9<A=I
M52BA/74*DM(T.OE+=CDDT[VUFHUM&DUZ'UVJ/4-K\'6UM<<<PGKN>[:3XDVV
MK3L9.TY#[5;9R8C*W30224OMM)W*T\Q]0):-Q]+] [<T\3(K*HILGY/LJ.\N
MCG+-UAAF.Y(;;:=69]EZ6\2&5/%Y]-"(]=H*R[F[R6'<6/'--F%JYC,;,\:I
MX60E+-ZR;;N(SZ["N]:HE&Z;.U"DFO<MON$2C,TD".<Q5DM4CER1 S2_:/C"
M%3N8TUZ]2]7RK6Y*W)N\E>I[JNCB7M4F1F>FX]2*V%BTJ7AO+5QC-AD\VQQQ
MW%8N23';V63_ &)AS7X[KK:U[4L-*0@MS:=&TF70B!&YD+0XA+C:B6VLB4E2
M3U(R/J1D9 CL
M
M
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ME*4I+0B(BZ$1$ [
M
M
M
M
M
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MFMON^?:KL[O-UZC@VN8
M
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M,=MQMW9YM=^G4"4O$XA=B2F)1\@YC([#B'38?M&EM.;%$K:M)1BU2>FBBU\
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MJ1D?RD/RKZ<MH@@
M
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MB;'T _(U?NGSD]O'E!]C,/\ S?K?Q-CZ ?D:OW3YR>WCR@^QF'_F_6_B;'T
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M(8802C-1[4-DE):F9F>A#BVRP
M
M
M
M
M
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M:$A:DFE"E'IJ*;%!
M
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ME/,);K"4AAF61[24]O4VG0U)29GM(6^D@0
M
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MT&25*679U+;(:1(*/*)79?;6PX\TZTLT+3N;</:I)I5H9 BV
M
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M32$((OOE&9@-G @
M
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M25:&1E[2,$=P
M
M
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MO)Q^.VI$EZ4Z:C0LW3)"BVH3H>[774$6
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M            '"5)41*29&D_ RZD ZK>9;;-UQQ*6B\5J,B27L\3Z .=Z-I+
MW%L/J2M>AZ_= "<;/P61Z=3ZD $XV9Z$M)F?LU(!RI:$_.41?NGH &M)::J(
MMW1/7Q,_D #4E.FXR+4]"UZ=3]@#@UH2>BE$1_(9Z .3,BT(STU\ #4M=NOF
M\=/: ZD\T;ILDXDWDEN4V1EN(C]IEX@.VI:F6O4O$@'!K01:FHM-=-=?: )6
MA71*B,_N'J [ &I%IK[?   <$9*+5)ZE\I .2,C\.H 1D?@ X,R26JCT+Y3
M<F9%X] '!F1%J9Z%\I@.0'&I:[=?-XZ>W0 U+737KXZ &I:[=?-XZ>W0 U+7
M;KU\=/;H Y
M
M
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M$U%?:902\@Y#58^OD&[-6\@J,XB#02(9FA#9N:*[9=/$NH?6(,@
M
M
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M83WMU\/N: 6VH"   \GI$>/V_4.H:[JR::[BB3O<5X)3J?51^PB >H
M  #R<D1V5M-NNH;<>5VV4+4236LDFK:DC\3T(ST+V /4  >3DF.TZTPZZA#[
MYJ)AI2B);AH+<K:1GJ>A=3T >H      \CD1R?3%-U!25I4XEG<7<-"#)*E$
MG770C,B,P'J          ,=RP@-*6AV4RA;7;[B5.)(T]]1I;U(SZ;S+1/RG
MX ,@
M
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M3?Y)6Y%59&['?O\ %+J5CTFTAM]IB9Z=IE]J3V34HFUJ;?03C9+425DK0]-
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M00
M
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M+A*H:X<F+(ED\U4,2'Y,N0Z^ZG'I"Y4$W'%+W*4VXXHS49ZJ+HK4B 7@
M
M
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M9F1LX$
M
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M3IIIT 7$
M
M                      ?,O';7+JH/()X9)QEK'3R_)MZ;EBP<F$YZUSN:
MG&=0C;_H^74%16)6MW)P/CG%*.UR%"V<0AVDJHQ=JOANM=U:FVI<RSLU]I+)
M]MQ*&$(-1F2E+U(B(%9M+S9F5%B>/9UE,QN?%RW$9!U<3M;$.Y=5NF3#*.VD
MM#L&W2\B>FYHS21$8)3F9=<MOW=WB1VUPY98%3U2G;2J>IHL9^UFPERGYU@5
MF;7<C$X7;0VWH@DH7N/=X!L;*\IS&-Q-C?)$9YMJRJRJKS*(56;4R+,K%)25
MBVRX1K2;9-.+?:6A9_P:=#/VA2RSG+\QR"MC0;Z33XAG^1V5;26T(XZC9IL<
MA+3K$6XRLDNV,EMU:7%[M&DELZZ ,JKS',:W.*W"7LA?MJFHS0\?<N)"(Y.S
MH4G'7+-$:2MM"4*>CO>12T$E2M$[BW:ZABS<MS7(;J5C5=E4BK:E\DS,9]X0
MFXSKS%5'Q\IBX[7<;6E*R=2K19D:D*^730!=N1G<BBW?&N%UF43*B/=RI<"W
MMD%'5,E-1*UQXB)3C1H0\ZIOHM"2T,S-)>! *&C(,ZM[VMXVCYO+998R^WQI
M[)(C415C(K8=&FT2VXI;2V_4,K7Z=;R6T]4[C3NU >5KEV;1\+R[EMC,)+4[
M#;J740L46F,=<['JYJ()19J":-U<N87UG<0XDTJ=1L222T,)9G,,L>YC+BD\
MG<^R[=@[:?:!+9%)6Z3!2?LSWNQVNXV2O4J62C<..1(U)6I@/7#<WS:^R/&N
M,)MHM63XM86SN?6"4-LNR:VJ435<9H-!DE,_U4=[R[3,FUZ:=0$C?V.293G.
M?5R<TD8/58!!@2:]V,B,;"W)D1R6N=/*2VKNQFS3V^T2T)^K7J9'U(*%R-R/
ME15V59OA^37%@UB:8Q)E5S5;7XI'DICL+=8D%-6N5-4ZITE:-EY2<0A'F(S,
M)O-,MSNF=Y5S&#D\EN)B%C"IZ2E6U'.NCIM8E<EZ9)/M&XZ4<Y:I"$FLDIV'
MNU29@)C%:&7CGQ%E7S<BF9*Z>#N.(E69L*FLI5;-[DJ5'::(T.*U4WJGRZ&1
M=-- P++)<RL\DD8W79 ]3-S>1G\?<F0X\4WTU2,:;G*92;C2BWFX1FEU9*4D
MS+Q(B(!<^-K*[=JL_P <O;5^\+%;B74P+*83:9CL/T$:6A+ZFDH2M:#D*1OV
MEN(BU+4!K#C*=D6#8UPW;2,MDR:'):M]BWJIK4<JV'$A4LBQ8<CI:;0XA3!,
M$EQ1N*-TM3/0]- ]<2S3-$9A@DI5WD%A19NU9&]+O4542'.:CU;\YF360(RG
M)$9&J&S(W3^8HB5JH]0';&<JY#I*3C/.9V3S\GEYI5SGK:AD,QD1%N1:239Q
MBBH890MMPEQTMK5N5W-QGH730.*9F[FY1P-F%WE[]_*RAR=:2:U],8H[,B30
M/NJ.$3+;:VV6=W:4A1JUU29Z*\0FN4,MY#J<IR7CW&;@VLER]BIE<=J6TV91
M3;-Y%J@E*09*)"(J73W:[>]KX$ I]YFE[RO'H\DAS_0X^_E^)56/J;;0M42Q
M1%<DV4A*74&E:TN2?3%O)2"4SX'UU*EK[-\^Q27=<<P+V=;FG+:3'X-R^<$K
MQN#<U:[%UIMY]+,8WC6V;+#CR>F_[Y1)!'#^5<I5G;Q)R[E5AGEF/54&=82*
MFRR!F#<1WE26)J(G=9+0T;X[CB"6I*BUUV]0V7QC-OF\DY!P"VNY=W"QB5 1
M56LXVCL29LX")*D.N,MMI7VUJ5L4:-=.AZZ -=L\J9VW7LXZ<PK#,>.HF26F
M>);;-IR<B@:6U5MFDD*VIL3>9D^4B4:6U;>@#).\S7&8&%W2,[D9!)Y K+!V
M="D-Q%,MOHI'[-J76):;;4TVRXTEM2%&XE27$[O-H9A,T6=9-,F?#ZP];*<5
MEM+)FY(UHUNF.M4C4@G%D2=4[7E;O)H6IZ?< >MY8Y+E.:\AQ49N_A-9Q[&@
M.5_ID1E1S5*@G.<G6*9#:C=8(]S7;2M"=&U]=W4@H?)7).4M0<KSO#<DN9T;
M%7XS*),-JM@XG&=2B.3T9]$I:Y<U:UN:F;9%IW$H1H:=3#+@I)/*,<B_2Q:'
M_P!>(MF N/*=W>3LNDT&.W60)53U3<^=78TBM@M0W7ENFU)L+*T7L[:TMJV1
MT(\$*6K4M- K>*7_ "!RG84,*3F$W'HTG :K(YAT[,5MUVWDRI+7>-3S+FUO
M1HC6T@B2OH70BZAZ8KD^8\K1X2++,'L4]!A51D*UP6XB$S9]JF4E^7()]M9*
MBL'')*V4DE.Y1ZJ+RZ!!Y%#];\$M"COO14HK:%:NR:2W%ZZ,G16Y*O+YM_[I
M$"\67?0LEJ+GG+*:'+)]7*P]FLL8K3+<5PITN!CS#IJGFZTHW4N)22#0C81=
M5>.FA'OE&:\F7=WG%C0R[" SA:(Y53<*331*=IQ=6S/6_;>\74O.,NJ=V[D[
M4H:3JGZS4P';(,BY%M&N5<H9RZ52?8.# M:6DKD1'X7JE43-B^W(<<96J0RM
M:C2DB4DBU-1:ZEH%FYLAO9)$XCF*L)5:Y*RNK-28*FR)+DF)(<)PNZVYYVS1
M]69]"W'J1]-!"MIS+-G,-_QI^TLQ-F61^Z"P(D1O=WHRNO=7H3;[1O\ JC;^
MN[O<W;OO=G0!5/?,K#9+.2U:$OS\>+EV?";=+<A;L2R84C>23(S26FY6A^!&
M"KADS_(V,KI*3&\ZGY-<YY26TIA]Y$)1,6=; 3/CRX1,QR2W&><(HZFE;TZ.
MIT/=U,B#G<]97:2;6ZQV61T>6U::'C^,A"34C*T-PM_52#U,G)ZR\QFD_3*Z
M?*6FP^6:64K(>&([EQ.)R)D:6'I+:FD'(<1625FZZ1MF6]7:4GRZ%M<61%U(
MR(U_@[^3XMBN$Y=5Y)*17W&;RJ%[%U-Q_=2:ZQNYK+B4EV^]WR<+O)>-W_L:
M;0'MB&><J7:<=Y"4].9CWMZFOFP+"72Q\=*O<GNQ#B165NHFE,;))&E1ZN+=
M2I)I-)Z +MS)F.18U=7)4LSTI0^/LBNHRDM-*6BP@R826'26M"E>4G%>37:?
MM(^@$(6UM>0<+M9U2QG93)-UALV^:L<E3$8@0+F+)AQTNMK0VVAF.LI1EVW-
MZ4J))F9]=0U_R'9W$KC;.,*RBVR2#>QF:*V+'\B]W29*&5V[<=V0Q8P"-I^,
MM9I\BT)4VXCIY3T!5RS2WY A.<PVE=F5DQ$X[KXK=#6M-Q#2X\_2,R'9$M:F
M%*<5O7W$DDTI2K4^I'H")CE'D_*,0N);U)+3*3#X]L,@3 T0XUZ]$Z$PS+<)
M)&HT(2ZXK0CVJ(E?] 5?FZCL*G [2BF<ES,@]<U2VAU<PHGK^X5[!CKFL.,-
MH),0^\G1DVU)2XE!I7IN28A8++)\K5FEC@4;(':J%9Y="QX[U+47UD>&UC#5
MDMMMQ3>TY,MU)H0XXE>W4]A?-(@C;+*L_@9 KC&ORV6IF#F-/2HRIUJ,_8+K
MK6HE37XCAFR3*GV5-)VN]O4B4@U$9EU#WL+?D>-&R# ZC(9MQ)H\HCU[#ZY=
M?7Y%85,BF;L5Q8DB0T3"Y#3CF\U&@EJ92K0R,!LSAS*"R'%Y*)5M/L;&JM)=
M3+1>1&8%K&>8,G$Q9*8ZC9==;:6C5YKRN%YM-=0);%!
M
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MZEPMJWR1KL)Y1=%.DG>?M,!+6^*8W?.O/W-8Q->D07ZA];R-QKKY:D+>8/\
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M*U$I:C,SUZ@+*
M
M                                                      
M
M
M
M
M
M
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M/4!V8L:^4X3,:6R\\II,A+;;B5J-ESYKA$1F>U7L5X& R0
M
M
M
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M=/\ W 27U,"
M
M
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M:%%M4D^I'X@/9;S31H2XXE"G5;&R49$:E:&K1.OB>A&>@#N
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MY#B6F6VTEJ:EK69)2DOE,P'NE25I):#)2%$1I41ZD9'X&1@.0
M
M
M 'R1B64%Q5:9QD[*DK:S"7EQQ8:R49.Y-0W#S4-A!%TW2V9*4Z%U4;0-/?#$
MSN-L4RS&*>]F1K=[/"KG9-=7E;6]B^JFARIJ(33I]M#KBR<<[\@C;:;U,RUT
M 9J.0^3?2RL49NIU=9,YM2XY&M;F+6O6S5=<02DN)DMQ4KBJ<0:M6S3YOF[]
M#U($>+]YDF*<Q9#B[%F]$BW<O%JS(N1'6&'G&7$USG9:-DD$TA^<LNT3RF^R
MUN+R[U) ?5"2T(BUUTZ:GX@C4_+]MFT.SI8F,/6)U'IYDJYBXO[M=R+5LVD,
M.M1[,E)<C)4LR>[2=^XT%X:ZE:XN>8[VM@1LLI;&+D:VL"LIR;-RL* IRRC7
M$. IYYLR6\RADUK4^PES9JD_D(R";R._Y"X]MKZJ7F[F2-L\?WV3Q3F1(+4A
MFUKUQTM/?S9I!=A1N*[;:DGIHHC-730)S#[?.JG-\.K,AR=S(X>:8_,M9D=^
M)%BMPYL#T2M8IQVT*)I:91I-#IK/RDK=J9@+7R[D<O'<:B^[[9ZIL;.PCUT9
M<""5I92%.DM:H\)A?U??6EM6UQXC;0DE*41Z --M<C<EQX648TU;SH=E6Y'B
MM556-_$KGK:/&R-3*74RVH7\V7M)9K;TVKVF1*T,!*W&;<B8E<9'Q\WD:[-U
M5MBE;49//BQCF5[63N/MR%NH9::8=-LX_P!1N;+S.$E6XB 6/C"LLJ?F?DJ!
M:W:\@D-U>-&W/D-,-2B:,K#:W(],AMM3A:&>XD)U2:=2]H"=SRUR2PY Q;CR
MENW,9A6D&RMY]K&:CNS'_=RH[:(L8Y2'6TGK([KI]I2MB="TU,P&H,6N<@I<
M>+&XN061W-GE^6JGGC%5'DV]KZ.<:7'XQR35$ALI6XE3JG"5XI0CQU!2FM\M
MS?*.+SOKB=%LZ3,<II3=-N$F2ZU5P91I.4EIMQCOFV@X[IL'LT4HT^;11!G8
M=R7RKD:,=SQM-BJOO;I,274RD4T?'6ZIV:N'VX[RGVYIS&MI+\^IK<)2.WII
MH1O[.8^2R</NVL-E^ARLHCKE-(V-N%ZQM.]I"DNI4C:M220K5/@9^T$:+L^<
M\ENZ.WSK$9+$+':NEHH:F9;:7([61Y-,80ZMYTNIE6,N)[C>I$:UF2O#H6G'
M).7\B\61LIHHF8.7LPL3D9-765A&A%/@RX4^+%<+8PRVTIAY,@S03C1FE2#T
M,R\ L/+'(F6XOE>55]+8I8AU?'=ADD2/V67#1:,3.TT^9K2HS+:1IV'Y3^0!
MM#!JV_K<?93DM^[D=K*/U3LYV.Q$2CO(2?::;82DB;2>NW=N5UZJ,$:BRK(N
M0CF\NW]9F7NR%QWVI-+1E$B.LN]JH8L'435.-FZMI]2E-HV+0I.IJ)1Z$1%1
MEUR7R%'7R1GS%FXS281!KI%7AIQF#;<D6M-'D*.8_P!OOFAAU_N;6UH/RGJ>
MAZ$%CE/Y[B^6TN$RL]D7#.9TUL^=X_"@-NU%A5MLN%-92TTELXR^[M[+Q*T,
MDZ.=3 5W#\_Y3Y.Q/-+NDNHT#)<<KV(=)308Z'FI\UA!2SL])3*7/3V6PV8A
M:[4M[CZKZD%^XTY!G\GY/99!3/J;X]@5=;&CQ30TKO7,]I,^2:G2+>2HK+C#
M"D:Z$M2]>I= R>1+C(9.:8;Q[1W*L=8R)JTG3[>.AER<;=2A@RC1O4H=;)3A
MR-ZU&VHR0@]/'4@IMUE61^IIL'C9O87V0L>\?>7V+KJ]VU?1$E^F;<ENS-8<
M4F5?52")*36[\W:DC(!$8IFW)?(<'BZN3E9TDJ_B9,]D-C!A0W'I!X_8,1&#
M03B76FUK)1FZ;9&@]5;2TVF01-O9Y?FV)8=R+<Y";<&SSVJ93AZHT9,:*Q#O
MCB,M-.]LI!R4FUW'E*<,E>9.TB(@'T=FETUCF)7=Z]8,5*:^$^^5E,:7(CQU
MH;/:XXTT9+<2E6A[$'N5X%U,$?/\+D+D.CLYD2987[[,W$;RZ0O**^LKWT6-
M2VRI#\2/$(W&FE&Z>K4M)Z=-#,R4"LQ.?\B83$QC)+:]7E191A]OD4NH?C1H
MS+,ZHKH\YI,0XS2'"2YW#;6EQ2]?G%H?0!TKHF1N<D<'9%D>4GDKE]&N+%#2
MF(K+49^33DZLX:H[:%''VJ)!$X:S^:>[4P&T^:K_ "'&^/Y-EBLY-;>N3ZF#
M%G.,HDH:]?9QHJU*:<Z*+8ZKH!#6]Q=\F-YA,X[K[O(IWV9JHDMRZJ(-(Y-F
MS[1V2IMV6F:;#7IV4LDV34=LC6>N]9&1:A7CO,RFYW79W/G'79.SQ5;6C\&"
MJ)+K_61Y+*=&UI2\2FENFE_RNF>J4IW&G<2@O,;D#*W)/"J%61*;RW'+&SR
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M3T49F ^DZO3W9"T+0NPUH1^)>0@1E@
M
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MQK-A+Y^UU+9+UZZZ@+1;>]2K)9T91SN>ROT!33644W]I["=-LC62-?G;2UT
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M]=NFI@C'XRP=OC[$8V/FZW)L%O29]I+8:)AIZ=/>7(>4ALOFH)2]C:?8A*2
M9F8XOA^5Q(<#+XS+[2)*%UJUO+BOHEZ*)/IWFEMN)<-.XOJUD9EJ7@ B'^&N
M,GX-57?9UAF)2M.QJ],5Q^*I+$A?<=;6MAQ"G4.+\ZTNFHE*U4>IGJ"VEJ;
M,-QXZLZ.FCP$TB9K=0A@C0B,W:.I>E):21[4I<6E*C+30O9H"(M_A[C23D"L
MH>QV.JZ5-1:][<Z396+2DK*4EDEDTEXS0DU.I1N5]\9ZF GKR3BTY,G%<A>A
MO(GP9#\NJF*09.US>UM]Q:%GU:3W$I6H^A:D K53PYQ; 2<JNHF7528;T Y;
MLB1+<<KYC1-.,=UYUQ1LJ06B4;MI>*=-06T[$Q?#GG::5"A17G,4:?JZ9QM7
M<]$TMM$=YA.BC(O(TA"DJZ] 1%4'#_&N+V\:]H<>8A6D)3RH#Z5O**,4E*D.
M(CH6M26FU$M7U;:4HZ^ %K/=453D<#W9=Q438!NL2#8<UV]V*\A]I70RZI<0
ME1?N (/+N,\&SI]F5E-.B=+897%1(2X]&>5&=/5;"UQUMJ6TH^IMK,T?< >[
MW'^&/3Z.R.FCMR\;9<B4AL$;"(\5YOM+8)MHTH4T:2T[:TFDO$BU 15#PUQE
MC%@U:T>.L1;".3R(S_<><-EN2@VW&VB<<43;9I,R[:-$%["(%M.1\*Q:)$H(
M,>L:;B8NI*Z!HMVD1265QR-&I^QM:D^;7Q!&=64533OV4FLBHC/V\HY]DM&N
MKTHVT,FXK4SZ[&T)Z?( C;G!,0R$[=5U4L33OH;5;;F[N/U$2,M;C3:M#+38
MIQ2DFG0R,]=? !,5M=$J*Z)4UZ#;@066XL5M2UNJ2TRDD((UN&I2C(B+JI1F
M?M,!$5>#8E2NUK]75,Q7:=,Y-8I&[ZA-J\4B62=3/^%<22E:_P#0 D::BJ<>
MB.0:6*B'$=??F.--ZZ'(ENJ>>7U,^JUK4H_W0$'=<98)D-K,NKFD9EV5C&9@
MSW5J<)+\>*^B2REQ"5DA1MN-H4A1IW)TT(]-2 9]IA>*7<N=.MZF/.DV<!-/
M/7(1W">KT.+=2PI*M4FDEN*5X:ZF Q<2X[PW!ERWL8JTPY4XFTRY:W7I4EQ#
M);6T*>D+<<V(+YJ-VTO80"+Y'XXB\BR<5;L^TY3T=FJRGPWNX1OI]'(CH)M;
M2DJ0M#CJ7$K(R,C3T!69_A9Q_P#9?[&^X8YX]ZCUOIS-PW?6;]_J>_N[W?W=
M>]W.Y_V@1X'Q%QPK&TXDK'V#I$S/>J4&MWU!6.NOJ_4[^_W_ &=[N;]OEUTZ
M /3_  HX]]PQ,:*B:*HA3TW$9LG'B>*R29GZHWR7WE.GN,C6I9F:3VGJ70!B
M_P""_&'O([4\=8.84LK)G5Q\VF)I.D_WX[/<[;+AK3N4II*3/KKXGJ6VO9O
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M .P
M
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M01LD$    =5K0VDUN*)*$EJI2CT(B+VF9@.Q&1EJ74C\#
M
M
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MEN.P@FV&4I;:;3T)*$EH1%^X1 CT
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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MJ+:ZDNNGREJ$G#SS&)V:V/'L69ORNJAM6,V%L41(COF1)/?IM,_,G4B/4MQ
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MX^U85;B6+:IL([L&QANN)WH2_'?2A:-Z?,A6FU1>!GH8(LX
M
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MNCN;22[M,DFHT@/H@$
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MISNIE14.,M,-R4-;$'W4MEM4HT&9Z=!*N\JY\W1\N(QO(^0IN"XG]FX]C&5
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M4S;ZVKKZR=;6:[NE/6#,;)Q1-/(+P2I;9)-Q*?*E>XD]- 1:
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MR9K*V/"36L0V&JY):)B(:0EDBUW:$@BV^/7P 90
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M-SFX=;;1E1<PIG$*-N:XRG^:3&C29$B0WIVEJ41DMKIT-)&"+%E5.[D.+W=
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MO'8[>+)Q,I<PXB*\JLIZGU'/-LF>QW3?^=WM/-W/'=U :5+X1\5(B+_$#/\
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M4Z;ODU+V@.W)7"=-R?:0K6RR7):-V%'.*AC'[5=<PXDUFO<XA*%$I>IZ;OD
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M>P!I^3\)^+29+\E6>YZVI]Q;IMMY$ZE"36HU&22[9Z$6O0!Y_JD8K^D#/_\
M>-W^2 6OCS@6CXXR \BK\JRJYD''<B^CO;=RPA[7329K[2D)+>6WH>O3J DN
M3>'ZGE)VL=L\AR&B.K2\EI..V2ZU+O?-!F;Q)2K>:=GE^34_E 4+]4C%?T@9
M_P#[QN_R0#@_A(Q4RT_Q S_K_P#I&[_) -U-X[';Q9.)E+F'$17E5E/4^HYY
MMDSV.Z;_ ,[O:>;N>.[J TJ7PCXJ1$7^(&?]/_TC=_D@'/ZI&*_I S__ 'C=
M_D@%[XRX<J.+I-C*K<BR*\59(:;<1D-FNR0T3)J,C:)24[3/=YC]O0!@\B\$
M4G)-^WD-CE.4TLAN,B&42AMW*^(:6UK62S:2A1&L]^AJUZD1?( J7ZI&*_I
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M/=U3I\GR -5?JD8K^D#/_P#>-W^2 /U2,5_2!G_^\;O\D VW@6%0^/L:CXQ
MLK*VC1UNN)G74I4Z:HWEFLR4\HDF9%KHDM.A -8W'PMXS=6]A<O9SG,9ZQDO
M3'(T2_=9CMJ?<-PT--DV>U"3/1*?870!A?JD8K^D#/\ _>-W^2 6/!/AZH,!
MR:+E,'+LNMI41#J$0;JZ<G05]]LVS-;)H22C(E:IU/H>A^P!8N3>*JOE&-71
MK.]O:--:XXZVYCU@NM6Z;J229.FE*MY%M\OR=?E :Z_5(Q7](&?_ .\;O\D
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M;DZ"LWV5LGW6301*VDYN3J?16A^P!N(
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MIKI%@^U$?[A&9E'EI)++AJ+1#I(/4B48#*X,W_:+B<C,]?\ #.6:B/7Q]X0
M)6CDM.1\795]K<!:9>/D=^/CDZMDNFW%CY'(2;5?:[=J]4DE)MRD(VFX24'U
M41F VA@6%U^ XS%QZ ZY+=0IR38V4@S5)G3Y*C=DRGE&9F:W7%&H^O3HDNA$
M"+*
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M_NF"K5(QG,</M?AIQ_"$U[>9-4]M+C-W?>] F58,>KDI>['UG0G7"+;]]I[
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M;Z*^2A*3U-*B,T*^357B>P@%]J6&9-7\)S$AI#S#CM@3C3B26A1;&?%*B,C
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M5NM=YY7F<0DUF6Q73;H7L!%U
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MPVU?ZJDFG[@%MAJP#&59XCDDX[GVL17^YTR>ZYV_1]PW=O:UV:[C^=IJ"+.
M
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M\_I"JOW[GT #]:CX>?TA57[]SZ !^M1\//Z0JK]^Y]  _6H^'G](55^_<^@
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M//Z0JK]^Y]  _6H^'G](55^_<^@ ?K4?#S^D*J_?N?0 /UJ/AY_2%5?OW/H
M'ZU'P\_I"JOW[GT #]:CX>?TA57[]SZ !^M1\//Z0JK]^Y]  _6H^'G](55^
M_<^@ ?K4?#S^D*J_?N?0 /UJ/AY_2%5?OW/H 'ZU'P\_I"JOW[GT #]:CX>?
MTA57[]SZ !^M1\//Z0JK]^Y]  _6H^'G](55^_<^@ ?K4?#S^D*J_?N?0 /U
MJ/AY_2%5?OW/H 'ZU'P\_I"JOW[GT #]:CX>?TA57[]SZ !^M1\//Z0JK]^Y
M]  _6H^'G](55^_<^@ ?K4?#S^D*J_?N?0 /UJ/AY_2%5?OW/H 'ZU'P\_I"
MJOW[GT #]:CX>?TA57[]SZ !^M1\//Z0JK]^Y]  _6H^'G](55^_<^@ ?K4?
M#S^D*J_?N?0 /UJ/AY_2%5?OW/H 'ZU'P\_I"JOW[GT #]:CX>?TA57[]SZ
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MM/7Y5+21%_TF VK!G0;.&S85LEJ9 DH)R/*CK2ZRXA7@I"T&:5$?RD8#(
M        !KCGOD*9Q7Q!EF>5K27;.JB)* ES0T)E2WFXK*U$?SDH<=2LT_?$
M6@#X@^&CX4H?Q 4ECR]RY>V4I%Q,D(AM1GDE*DNM*VO29#[J'3TWZH2@B(_+
MKKIH0#?'[/7@/^/O_P ?9_)@#]GKP'_'W_X^S^3 '[/7@/\ C[_\?9_)@#]G
MKP'_ !]_^/L_DP!^SUX#_C[_ /'V?R8 _9Z\!_Q]_P#C[/Y, ?L]> _X^_\
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M^_\ Q]G\F /V>O ?\??_ (^S^3 '[/7@/^/O_P ?9_)@#]GKP'_'W_X^S^3
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MF /V>O ?\??_ (^S^3 '[/7@/^/O_P ?9_)@#]GKP'_'W_X^S^3 '[/7@/\
MC[_\?9_)@#]GKP'_ !]_^/L_DP!^SUX#_C[_ /'V?R8 _9Z\!_Q]_P#C[/Y,
M ?L]> _X^_\ Q]G\F /V>O ?\??_ (^S^3 '[/7@/^/O_P ?9_)@#]GKP'_'
MW_X^S^3 '[/7@/\ C[_\?9_)@#]GKP'_ !]_^/L_DP!^SUX#_C[_ /'V?R8
M_9Z\!_Q]_P#C[/Y, ?L]> _X^_\ Q]G\F /V>O ?\??_ (^S^3 '[/7@/^/O
M_P ?9_)@#]GKP'_'W_X^S^3 '[/7@/\ C[_\?9_)@#]GKP'_ !]_^/L_DP!^
MSUX#_C[_ /'V?R8 _9Z\!_Q]_P#C[/Y, ?L]> _X^_\ Q]G\F /V>O ?\??_
M (^S^3 '[/7@/^/O_P ?9_)@#]GKP'_'W_X^S^3 '[/7@/\ C[_\?9_)@#]G
MKP'_ !]_^/L_DP!^SUX#_C[_ /'V?R8 _9Z\!_Q]_P#C[/Y, ?L]> _X^_\
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M]6L_VM# 17P)_P"6_'OPRS_KKH#Z1
M
M
M                                              ?GE0_\RN3^$S?^
M'' 'Z&@           T'\:O^63.O]6L_VM# 17P)_P"6_'OPRS_KKH#Z1
M
M
M
M              ?GE0?\RN3^%3?^'' 'Z&@           T'\:O^63.O]6L_
MVM# 17P)_P"6_'OPRS_KKH#Z1
M
M
M                                          ?GE0?\RN3^%3?^'' '
MZ&@           T'\:O^63.O]6L_VM# 17P)_P"6_'OPRS_KKH#Z1
M
M
M                                                      ?/WQ,_
M$V7PZJQA/V9^T1Y&4X__ $WT/8]!Z?\ _$/[MW?^YII]T!H']IE_]S/_ .S?
M_P!  /VF7_W,_P#[-_\ T  _:9?_ ',__LW_ /0 #]IE_P#<S_\ LW_]  /V
MF7_W,_\ [-__ $  _:9?_<S_ /LW_P#0 #]IE_\ <S_^S?\ ]  ?5'P\\T_X
M\8"YF_N7W#LL'Z[T/J?6:^G0TO?W.TSX]S33;[ &UP   ?GE0?\ ,KD_A4W_
M (<< ?H:           #0?QJ_P"63.O]6L_VM# 17P)_Y;\>_#+/^NN@/I$
M
M
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M& BO@3_RWX]^&6?]== ?2(
M
M
M                                T_\ %1_EYY"_]5+_ /$0 UC_ />]
M?_8&_P#^OY__ (,8!]7    _/*@_YE<G\*F_\.. /T-           !H/XU?
M\LF=?ZM9_M:& BO@3_RWX]^&6?\ 770'TB
M
M
M                                            -/\ Q4?Y>>0O_52_
M_$0 UC_][U_]@;__ *_G_P#@Q@'U<   #\\J#_F5R?PJ;_PXX _0T
M    &@_C5_RR9U_JUG^UH8"*^!/_ "WX]^&6?]== ?2(
M
M
M                                                      T_\5'^
M7GD+_P!5+_\ $0 UC_\ >]?_ &!O_P#K^?\ ^#& ?5P   /SRH/^97)_"IO_
M  XX _0T           &@_C5_P LF=?ZM9_M:& BO@3_ ,M^/?AEG_770'TB
M
M
M
M          -/_%1_EYY"_P#52_\ Q$ -8_\ WO7_ -@;_P#Z_G_^#& ?5P
M /SRH/\ F5R?PJ;_ ,.. /T-           !H/XU?\LF=?ZM9_M:& BO@3_R
MWX]^&6?]== ?2(
M
M
M                        T_\ %1_EYY"_]5+_ /$0 UC_ />]?_8&_P#^
MOY__ (,8!]7    _/*@_YE<G\*F_\.. /T-           !H/XU?\LF=?ZM9
M_M:& BO@3_RWX]^&6?\ 770'TB
M
M
M                                    -/\ Q4?Y>>0O_52__$0 UC_]
M[T_]@C_W+^?_ .#& ?5P   /SRH/^97)_"IO_#C@#]#0           :#^-7
M_+)G7^K6?[6A@(KX$_\ +?CWX99_UUT!](@
M
M
M                                            #JXVVZA3;J26VHM%
M(41&1E]TC =66&8Z.VPVEI&NNU"226I^W0@'H   #\\J#_F5R?PJ;_PXX _0
MT           &@_C5_RR9U_JUG^UH8"*^!/_ "WX]^&6?]== ?2(
M
M
M
M        #\\J#_F5R?PJ;_PXX _0T           &@_C5_RR9U_JUG^UH8"*
M^!/_ "WX]^&6?]== ?2(
M
M
M                                    #\\J#_F5R?PJ;_PXX _0T
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M0B+J9]"Z@,BNGQ+6OB6D!?=@S66Y,9S0T[FGDDM"M%$1EJ1ET,M0&2
M
M
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M $
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M _7"^&_\^6?Q&Q_)0#]<+X;_ ,^6?Q&Q_)0#]<+X;_SY9_$;'\E /UPOAO\
MSY9_$;'\E /UPOAO_/EG\1L?R4 _7"^&_P#/EG\1L?R4 _7"^&_\^6?Q&Q_)
M0#]<+X;_ ,^6?Q&Q_)0#]<+X;_SY9_$;'\E /UPOAO\ SY9_$;'\E /UPOAO
M_/EG\1L?R4 _7"^&_P#/EG\1L?R4 _7"^&_\^6?Q&Q_)0#]<+X;_ ,^6?Q&Q
M_)0#]<+X;_SY9_$;'\E 6#"_B,X8Y#R&/BN&Y2W:7\I#KC$),6:R:D,(-Q9[
MGF$(+1):]5 -H@             #\\J#_F5R?PJ;_P .. /T-
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MT]@"$Q_@_B7%9,2;08C7PIL$Y)QI*6S6\7K6C9>)2UFI2TJ;,T;5F9$1F1:
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M5K\RDFO0_D!;7RHIZK'ZR+2TD-FOJ82":B0XR$M,MH+V)2DB(OE!&:
M
M
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MKI_[W@"+,
M
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M,K*
M
M                                                 /SRH/\ F5R?
MPJ;_ ,.. /T-           !H/XU?\LF=?ZM9_M:& BO@3_RWX]^&6?]== ?
M2(
M
M
M                  #\\J#_ )E<G\*F_P##C@#]#0           :#^-7_+
M)G7^K6?[6A@(KX$_\M^/?AEG_770'TB
M
M
M                    C,@R.BQ2J>O,EL6*JGCFA+\V6LFF4&XHD)(U*Z%J
MHR(@$+C'*''>:6#E5B63UUS9-,JDN184A#SB64*2@UFE)F>TE+26OW0%M
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M0P$5\"?^6_'OPRS_ *ZZ ^D0
M
M
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MY&X8AR%W+]BB3+F[*]U3:FX/;F/H-+9)\Q=TR[JMY^*NG3Q)+Z&!'RA\25U
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M]OB?4$EM@$?GE0?\RN3^%3?^'' 'Z&@           T'\:O^63.O]6L_VM#
M17P)_P"6_'OPRS_KKH#Z1
M
M
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M9+[24D1([R?*LD^) C(9P7#H\>CB,4D1N-C2S=H&DM)),)9D:34S_HF9&8#
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M"?\ EOQ[\,L_ZZZ ^D0
M
M
M                                   'YY4'_,KD_A4W_AQP!^AH
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MU[4J*XAYE>T]#VK09I/0RTZ& R@   ?GE0?\RN3^%3?^'' 'Z&@
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MG(X5E7D:Y^VN83\AM+&EEXU!G+CQ8B8,"P)/J%-LL()"GW30CN.J\221$22
MM:O\/X7VO^U_K7_5?9_[,^ET1VNQW^_WM=-V_7IXZ:>P$0E)PU4TD%<!BRDN
M(7B43"-ZDMDHHL+U.U_H7\(?J5:E\WH0+9)X7QZPJ\>I;.7(E5E#C4O$%LGL
M0<J%.8BL+<6I):I<(HJ5)-&FBC M'KX2?MVI19IE]ADDE-/84%')?8BQUP(]
MJQZ=]_ZI!=Z2ILDI-U?337R^8P+6B/QW CVV%VY37U.X56RJF(V9(VR&YC49
ME2W>FI*(HR3+;H74P1C9EQP]D%[#S#&L@E8KF4.*JM.UB-,2VY%>MPGCCOQY
M*%H6E*]5(46U23,^H*KTG@F-+I)"'\DG.YU+N(.2R,Q<9BG(59U:4MQC],3:
M6.RVVG8EK;II[3 MWF\',3'IU2K)9S?'-K8G<VF&I:CFP[+<?*4ZVF2I!O-Q
MG7B[KC"3\341*2E6T"V8?$#C-U+<K,JLJ_#K*U+(;/&&"9V.V)O)D.;)9I[[
M3#SJ$N.LH5YC-1$:4J,@'>EX<J\?D8U8U5I)8N<=DV:U3TH;)4V!=S'9LF%(
M0DB2IHG7$K;]J%()1=3/46E<UP&3D]O29+27TC',FHDRH\:?'98E(<B3^WWV
M7&9"5)5J;+:D*^],O:"-;R.&LCH,@X^KL-O+%B)2)RF5+RE],:4\B1=/1Y"6
MY+*TI0\EU1N>""/5!*U(%6A/";-=$J9>-9).J\UJW[&6[DRFX\ER<[=N(=G^
MKC*0EI:75MH4A*23VS0G:?0]1;*H.&*>@ML>O46DR7<4TNVM;&9()K?9V-ZR
MEF0^^2$)2C:2$DVAHDI2DB3[ +6;#<-B88U=M1)3LHKNYGWSQO$DC;=LG.ZI
MM&TB\B3Z)UZ_*"*A3\*,5+D2G^TEA(XXK'GY-7ABTLHCMG)2Z1L/24))Y^,C
MON=MAQ6A>4E&HD)(%MVQ[AMRHG4)6F4S[O',0,U8C22F8R$0W"87&:6\ZV@E
MR%,-+4VR:]-I'J>Y74"TA4\35=33<?TS5A(<9X^>)^ XI+>Z290WX>CNA:$6
MU\U>7VD \J[A7$(-OG-D\3TR/GC:XUA7O+^ICQY).'+;CFG12"D.NN/.:'\\
M]?8!;%K>(K9F.NOO,[N+FGCULFFJ(+B8\9#3$MGT_=E&PA/K'T-D26UO%H1Z
MJV[E:@,V;QC8(QO%Z/&LKG4S^+U[=2AXVV9D2=%0PVP93(;I=IQ6C1*0HM#0
M9JTZ*,@$+"^'C#V*IFDERI4RJ3166/R&%$RSW/>]@BS?DI[3:$MN)?1N:2A)
M(1["Z 6]G>%I-TQ:_;7+IV1V$RDGXU63'8\6-Z"#:MI;DN(;9025R'"0C>ZK
MQ).A)(M0+6Y&#0D9/091ZMTY./U4FE88,D]MQJ6J,I2UGIKN+TR=-.G4P1%9
M1QO/L\C=RS$\GEXG=SXC=;<NQ6(\MJ7%CJ<4RHVY"5$AYHW5]MTO E:&2BT!
M3%.(\=PN\I[>B>D-1Z6@<QJ-!<-*T+:>EHF+D.+T)1O+<09J/P/<9Z &9<71
MLNR-K(TVTBM?72V.,V;#+;3J)5;9I(S3JXDS;6VZE#J5H\=-I]#,!Y3.'Z&R
M:Q*)9RGY5=BU+.QU4->Q*)T.SALPG>^:2(R/8SJ6PRZF8!B/&=QC=E6O6.;6
MMW34,=4.BJ'DL1FD-*;)E*IBXZ$',<0V1)0IWPZJT-9[@$\O"X:^0F.1#DN^
MO8IGJ!,/1/9-E^4U+-S73=N)31)\=- 1WRK$(N5R<<DR9+L=6-V[5Y')HDF3
MKK+#[!-KW$?E,GS/IUZ$ JMSQ),E7%S,QO+[+&*C)W4R<CK:YN.:W9)-(86]
M%D.(-R*ZZVVE#BV]=="46U74%>MMPU0W$G+),FPFMNY0JH?;=96E+U?*H$D4
M1^.XI*C-9+2E9]S=J9:'T,R MASN';'(:&YJLRS6SNIMQ[O1ZE+4>'&C,UDM
M$U!,0VD]HEN+3]:ZK<M1:$6A)(@%L<P>N?S2?F<EU;SEC2M8](KEDDXYQF9#
M\C=X;C4KOJ29:Z: BM8SQ)-QZ1607LPL['"J%"FJ7&'4,--)8-E3#;,M]M!.
M2FF6U&EIMS0NB35N-) K!I^$':JPQ@G<PLYN,X5*]5B] \W&[;#?8=CI:>>)
M'<>)IMW8RI1D:$]/-KJ!:T9UQ\G,)-1=UMQ+QS+J!3YT]W!)ITT-S$I0^R\P
M^E;3S3A(09I6G4E)29&7M(K$O@UJ[H<DB97E%A=93DK<%J1D:VHT=<9NHD>K
MA-QHS2":0VV]]8I.AFX9GN/KT+;BQX2E3BMH;&83X%'E:4*S:MC1HJ4V4DXZ
M(TE]I9H-454EMLDO$WJ1_>[3Z@6R[?AQ4FQLU8YE-CC./9 B.C(J6N2SM?*(
MPW$2J,^M)N15+8:0RXIOYR4EIM5Y@+=U<+U*9;]M%LY,;(/M,[EM?:H0UW8K
MLEEF-(B%HDM\=YEKMN)4>JM=3/5*=!:VXG"R:$S;?:><4YR1:S9%7H2"-BM=
M=UC,*-"4D9H3[>IZ::F9Z@C7$#X?DUS<:JCY;8)Q:MO&<FJZA,>(2RG,SO7Z
M2Y7;-Z4C>:B22U$9=-35M(%M9E\45JJ"10)L9*&I&3'EW?(F]Z9)VI6O:+II
ML)PMFOCM 0=EP8<YQZMCY;8PL)=N$9&C&&FHRF46!34SUI)Y2#<],MXE.=CP
M2L]2/0M +7[.9TNKPG)+*O=-B?#JITB*\DB,T/,QUK0HB/4NBB(P1H;B3X:^
M$,IXOP_*,FQ)FZR.\IX5G;VUB_)D2I,R:PE]YUQPW"U-2UF?[@*N7ZIOPZ?H
M_KOWTC^5 M1LEXPP7AGE?B.TXPJ4XU(O[J72W;4)UXF)D%V \[VWFUK4E6Q;
M:5H/V'U ?3X(  "OYW,EUV#Y-80'E1YT2JG/QGT?.;=:C.+0HM?:1D1@-(\.
M?#SPE?\ %&%W]YA-=:7=O2P+&TLIZ#DRI,R9'0\^ZXXLS49K6I2ON +M^K'\
M/WZ.Z7\6+_\ " U[E_&^#\3<L\/V_&U*QC,RYNIE-;E6[F&ID!Z \Z;3[9'M
M7HMM*T&HO*9:@/IH   &B_B:@QKN'QEC%HDY&/WV=U$&ZKC4I+,N)V93W9>)
M)EN;-;:%&D^AFD@%Q_P&X1_1UC?]TP_Y( _P&X1_1UC?]TP_Y(!1^%Z6JP_F
MKF3#<8BHJ\4BECEE#IHQ;(C$NPAO^I6RT7E1W.TC<22(N@#?8   /SRH/^97
M)_"IO_#C@#]#0           :#^-7_+)G7^K6?[6A@(KX$_\M^/?AEG_ %UT
M!](@        /*3)8AQGI<E9-QHZ%.O.'X)0@C4HS_<(@&DL4S6WFPN/KW(Y
MUFF=R!)MK>% AN1DPH\%5:])B1726UO4AN,VVM.Q1&<C52C-)[05DT>;3HY<
M3Y,U83I6)YQ#122F+9;+DE,YZ(N?!E+-AM"3>63+S+VW1*MR#T+;U"[9[FUM
MB28;5-CCU[)E)>==D+DL5E9%:8V$9R9DD]J%+-9$TA*5*5HH^A),P14&.>?>
M\'$CQC%)EO>Y<FW3%K4RHC34=^@=0S*)Z5O6T;>Y1['6]Y+Z:%Y@6E\P+,F,
M[QU%XW!>K);<B57V57*-"WHLZ ^N/(94MLU(5M6@]%)/0RT/[@(H\?G%]O+*
M:AO<3ETE9D4TZRGERY<7WB;YH<6VJ16)5WV&G":5M6K735.XD[@6F!!^(&PL
M(]38QL"LET^0RY5+C\Q,N$:I-Q%6^CLJ;[FYME7IG3]0KH6T]4Z:&8IEKY^@
MMTK7=HG6<W<N)F.'C4B9%CMHGUK)29"E3G5)9)A#)I<[GBK<24H-1Z 4Y:YZ
M9E5,!VMQJ589++NUXN]1Q941PF;-,)<Y)^J)?:7'4TDE]Y)]$F>J=R32!3W:
MYM<>K$1D8M+/D%RZ?QE&)>ICD9V$6*F<ZLI9F3?ITQE)=-W;KUTVZ@4J]!S+
MDM6YDDB_H;*=:SLV:Q2DQDG8O>B.NU+4I*>]N2V;!K0M9.;OF*W?< 33//-D
MEIR798-.AUM/;M8]ETSUD1U%=/E/LL,]I*5;I39^I96M2$I-*5^!F1D0IS:_
M$31U-U8)DUAIPRHLSH[7(USH;;K4U$@HCBTUZUE(<CMO*)M;J2U\5)2I);@*
M>D[GEV#)MYB\0G'AV.WIXU?Y%ZF*26)"GV8Z'6HV[NO-[GV^YM(C3KT)6AZ"
MDMQ9F>793D7(4'(H"8]=07SE94OH>961,MQH[A,FAM)*,]'.\:U&?\)L^\,!
MA77-_NR3>6,'%YUG@.*S'*W)\I8>924:1&-)239B*/O/MQC61/+3IH9*VDO:
M8%,; +C,LEYASUV[.9%Q_'G&:NI@-SHSM;L=BQI*'%,-MDXIUY+O?)Q2]$)5
MV]-4F J.9<I\AQ'.46TQW8D+%;[&X5,J$Y&>DK9F2*_NQT(VD9KE-OJ61N*T
M3OV=#29@+RYS<BF@Y,K-,;ET-YC95[GNI,B-,]8W=/+C0>P^A:6R4MYM3;A+
MVDWIJ:C3U I*<?\ *L?,K>=C%G7HILI@Q6K+T+,^+:L/0'W%LI=;D1%&6J7$
M&AQ"TI4D]#ZI41@*+RI>75?G4EK,K[)L1XW9A1G**ZQ2*<B.N89N>J]Y/(BR
MUMFD^V32%))M2=3/KJ E&.7I>-8EB4*5.K\]S&^8E/Q+.ODQJBME0H3I(.6Z
M](5VVE;5M)6V@CU>-1)222/:'JKG]FP8QZ/B>+S+[)K^1;5ZJ5J7":]'.H=G
MJVWY)NJ9V$2]R'6UJ2LMNGSB IBIYJB4,1V'&BS[G)+3(KZNKZ^VFP832"IY
M&V6KU9DVTW%9-24,DHENJU27FZF0IW?^(ZF74U#E54G(R*SLIU(_62Y\2%$B
M6%4A*Y+3M@I2V%:DXA3';-7=)1&1%HK04V;5Y.N9B?VILZF93+;COR)E5-2C
MU3)Q362TGVUK0HCV&:%)5HI)D?M!&J<8Q[DO/\,KN3&L\G5&7W<1NWIZ5@HZ
ML<C,R$]V/%?CFPIQU)MJ2EYTW.YNU-.FA$"K?S-=Y#C?#.4WU?)*%DL"J4^B
M5$ZI:D)).Y3?<(ST(]=NXO "&KL=S5A&:XI7<8<DV_(R[*>3&3U%D3,N+&J.
MPZIV9WV84?L+;6ELD)4Y]8:MNA@+1 ^(@YN+Q<K<Q&5"@WDEN!B#<N="95:2
M?K^^9F:]L9EDHZEFZ\9;DZ;2,S(C%*WG_-.1Y'B\:GPZ$]5Y4K(ZO'LD9@64
M%R1&19&AYGT<Q)/,J*4VK:A[;JV9*WH(RT I8E_$'24$ER++@NO8=13&Z"WR
MF58PSEIG-.HAN.G"4I+[S2'U$AU]"2U/<M*%(+4"F79\^.5C&86ZL.L'L8PR
M<[43K9N1%UD6#<F/'0S'8-?<7O*0E6XR))'Y?$"GK9\W6U9*B4+V'FC,CC>\
M;:CD7-;%3#B./NLQ_P"=.N$TZ\^32EH:0>B2^>I/344R"YO:OFZM7'6-SLL]
M=4,Y%-[#K$-42ODN.,MI^N5M7)4MEU*6$GXH/51%IJ*2/#E[D60<+XS?S9!6
M>3S:HI"I$DR03THR5M[AH(M",]"5H0#4^&Y3>>_,=9O\_O:+E&9+CHR#$<OA
M)BT4Q*E$F5&K5(C);(_'TCC4E2EZ%N(]Q@++B_-66H^UK614*[&V3F$C&,-J
MH+T<G)#C;/>..M?1*$L-MJ>=D.'IHK0NJ=#%+"OG%N+"EU]CC,V/R+$LH=&G
M#FWF'EO3;-E<B*IJ6E1,G'6RVXXIY6W83:R4G<G0Q2%RKEVSHIN'VV9QI& U
M<2ZGPLJCSW&GXLB.W32);"X\AHE%(;4YVTH[9$ONEVS3N+0!M?&K^?<XZU?W
M%+)QYQY+CZ:N:IM<QN.1F;9O):-24.*1HI36XS09[3ZD8(U)B5/R+RAAL3D]
MO.;&@R.Z:788]1P_3*HH<=2E'%8DLJCJ7(W)VF^M2]VIGLVZ$"IC)>;W<6LG
M<<.F:N[^A@Q9N9+C3XM='C+DM&[VX:9[B')+BDH6XELM-$[=RR4HB IVG<U3
M[*<JNP#%)60M*I(61^^%28T"&S M67G(RW/4*)>\S:/ZLD:Z:G[ *4J+RYF"
MN/:O)7VY:L[?P"SR1N(3\/W2[Z543^>N(2V1]PB=[J&241)1N;41J,C(4R\(
MY%D892/3LQD9%;6[6.U%O(@2I$.Q2])O+!^)%1%[#32B=?<)*22I6Q"#273:
MI1A?F^2\L8J[1=SQU;1,A@JB)B5L=Z-,BRTSU*0A:)R5)90EDT&<HW-.TG17
MF)2=0H>2<^9)+Q.X/&Z-,/,Z"[HJVVBHL(4V*F+<R4)0IF61*:6;G5A2=I*:
M4K>HM$@4L%_\04"BL+1KW(<FGQI26,JGIL833T60EE#[[<:*XM+LKTZ'$FX:
M"3KU)&]1: 4OV89U58AC3>1N-N629CL6)3PH>Q3TZ98.):C,LFM24ZN*6752
MB(BU,_ $:CY,YHS&NP;*ZQC'W<8Y(K(T*3V%3(LI"*RRD^E*=&?(MCAH61M&
MA2"-"S(^J06EAY-L<HPCX>K*?#L)\/*8$&+K.F2&IT]IYZ2TAS>^AM+;BDDM
M2=Z4$7R /"[A9=Q-:XO;Q<QMLIQ^YO(&/W51D)PWE)3;.E'9DQGX\=A:%M.J
M1N0>Y*TF?@9$8#W:^(*G=NVVRJ],->L_<;61'80NZ<PY7H2<.!W.^48Y!=OO
M'U^^V;/,!20QCF1W*LLD4E9C;SM'&L)50_;,S8CTJ-*A+6VM4VO2OOQF5+:4
M2%KZGJ@S21+(! X;S#,GT&+5>)T-SE][/K%7<\[.5!CRH]8<MV,AV1()+3#C
MSBVUI9:;26I(,U&G34Q3*K>>Y>2Q\>3A^%SK:XR2LEW,6 [+BPR8CP)I0W"D
MNN*,D*W&G0DI5YCV].ID*9RN:W[+%:/)L3Q299MV[$B1)5/DQJB% ]$]Z9YJ
M3+D*-'>[I*2AM!*W$E2NB2U I"P.9KW+,MXV7C-8XWAV55UU)LR>>C$^A^K>
M:C.D719J*,O<9&VK1XED9=$F!3(QOEVRF8_C5=A>.6V9W<JCBWT\["9"B/LP
M):UML*D2#2VRN0\II>QM"$D9),S-) 4RV^=_?\FJ@\>XK-R:;;TJL@8;7(C5
MJ6669:H3[$A4A7D>;=2:-I;B-6I:Z$:@*8CWQ$U\Y.,MXGC[]O89+5>_684J
M9%JG"CDZ;!QV3DJVORB<2I/9;/V:FHB4G44V)D.9Q\=P&?GTROE(C5]8JW?K
M'DI9F)0AGO*96DS-*72+RJ+=T5[010IO.=E#17U[^'.0\MM6GK*)1V5K70B;
MIFE-MHE2)"W#;;6ZMPD(CIWKW$K=HDC4"T]D<Y^^&<;1A>+3+ZUR6-9OQX1R
M8L1,9VDD-QI;4EY2UH3M6O:E:-Z5GIIT42@*=<7YX;R)_')LG%IU/A^4%+:K
M+^8_&\LVN8?D2&GHZ%J6VA*8SY(=ZDK9KH23(P*>M1S9*L':29-Q&968QERC
M:PVZD2HQE.D.,+D1FWV4J-<;U*&S4R:MVO3=M,] *=G^:J.UQ/';&#&G-O9=
M7VTOMQMB95:W31'%S5+4XDT$XP^28Y;DZ=U1>P"D3"YKLFJJ%#QW$[7*%U^,
MU.26D^3+A,/%!GQEN$;JB)*7)9]E1]MM"4K/=H:2T("DM*YN3--#N#8Q.RJ'
M'J(617;S#T>(N)!LV52(S:6WUDIZ2MI"E]E.FA::JU,B I+7F?6$KA*;R9B\
M0T3Y&.*OJR-(4@S9-V)ZA!N:^57:(]RD_?;=/: UO1\I\GN9'4=O'I.0S9N"
M5EW,H8\J'&8;DN3)*')7?624]R0VE';91^X>W34!:;'G^M<;H4XE3+N9UW41
M\C./,G0Z9,>NEJ4AHE.RUDA;ZUH6E+2#,O*9J4E.AF*7S&,R@9YA$3,\,44J
M-:Q%R*Q$GZKZY.Y/:>VFK::7$FVYH9Z&1Z&8(T)AN4WOOS'6;W/KVCY3F2XZ
M+_$,OA)BT4Q*E$F5&K5(C);(_'TCC,E2EZ%N)6XP5>;/XBZ&KN)_?K#+"JFR
M]R6F2*G0VW6IB9"8BUHKUK*0Y';>43:W4EKXJ2E22W 4Q,JYDES*S+R9H;JM
MQ[%[1%+,R>MEP&Y"[!JPB,I9C-/DX9H<2^7<6IO0D[DEYNI"F7>_$714EQ;(
M]UJ?Q#'IYU-_D'K8C3K$MM:6WC9@+64A]IA:TI=<2DO!6Q*]H%)*'S0NTSFP
MQ.HQF3/@5%DFFM)S,N*4YAY6PCDG7+6E\X:3<3K(+V:J2DTEJ!22Y6R2_K"Q
MC%L6DIK[S,;9-2BV6A+IPHK<=Z5)?;0LE(4Z3;)I:2LMNY6IZZ:&'?&\)S'$
MLBCN1LPG9%B,EETK6%D:VY,UJ2DD]EV&\PRUHE1ZDZVYY?:G3P 1F<VN0Y'R
M)5<3T%P_C<1VHD9%?W$%+1SUQ6Y#<-F-%6\EQ+2EN+4MQSMJ,DI(DZ:@*U:Y
MCD?!]Y,J;F?89QB;E'+R&O<FJ8.YB^ZI$=$YM3J&V4/-)9D>H2:RWEL4C4]2
M 62]YWQF@MLXIY,20N3A5=&L]R#2:; Y:4[68QEKJHEO,-'K]\X0%,"RYY>K
M'KJ8YB$UW$\8MT462WS<J,:8TAPXZ26U'U[KR$'(1W-"3M+J6[KH*=,B^(BD
MH;BX;15*EXKC4OW;D=X4V(R\Q)1L[WIX#BRD2$,=Q/=6A)==Q()>TP*9-YSF
MJBE9B\]B5@]C&$*6Q<7S;T;M*E&PP\RRRUO[BMY2$;UF24-%YE'IX"D+EW+6
M4RN,[3(HE+)H[&!84)Q)-;+AV\6RBS[1AEQJ#*95L<<4G>TXA:4[=Q=3(]0$
MA?<LRCH\DK\EIK7$LAH'Z-UUBNEPI+[L.YL41H[C+YI<:T4M"VWT*1J2=Q)/
M4R40>TWGA<!V]LG\2G%A&+7+M%D62%(CFF.MIQMLY#<8C-UUE!NH-U2=#06O
M16U6@I/<S7MOC^-5,REEKA27\BHH3SK>W54:78LLO-GN(^BT*-)@0E>1+IJC
MK:9YU^='*9?4]<E=:ME#AKFSFF$I=-Y"R-E1JT=))$HT:[3(^H(H\KGN5'F.
M*;PFR?H$Y!)PYFT1)B$I^Z8D.16D-LK6E79=<02.\I220H^I:$9@M/17*KMH
M[4P+BLL\:R>%EC&/6%-$E1)#:Y#]8]/8)Y_:M+D5UHT*/9L<)>G@1'J$1@',
M6?6'&=?D=QBKMQD-A96L5E;$F+$KD18,MY'=DRE$349#>STZ-VY3JD;BUW:D
M'7_'&_R6;@"L4I^W'M<DL,?RB(N7$7L>KHKKBVV7]%H=;T+OI=9/S$C9T4L"
MDGC_ "X\[34U1B-59YCE5FJYF)B64N'$>:@5MH]#<?DR"2AM*.YHU'0AM2C3
MH2OFJ4 S%<XKGEC\+%\3G6V1WY6[1U#K\:&J!,Q]YIB:Q,=6I24;%.Z$I&_=
MTT+S$!2\8'F,;.\:CY#'AO5SJG9,.;72MAO1ID%]<:0THVS4E6UQM1$I)Z&6
MA_<!&O>9+S,TYMQYAF/JEPJ6_FR7+:?6S(\*6M$&.MXVB6\VYM0@B[SFA:K(
MMA&1F"LRGYQ]YR*2SE8M.@<?91.;J\;RMUUE12),E2D1E/0TGWF&9"DFEEQ>
MOBC<2-Q 4R,:YBEY!BF0YR]B<NNQ2DASY4:<_*BK5-<JEOMR&VVFU&I!$;!D
ME;FA&!3$B\Y.M,,RLEQ*=11[:EEY!BYO2(SZY[5?%*8]'<0THSCR.THEI0YJ
M1IW>8C2:0*2C_,,!AG!WCJ9!EG%/-O8Q=QHO2MP(#4]33IF?52DN["-/34OD
M 0$#G:ZLXF,.Q>/[ I>;$\]BL1V;"0J1%8AHEG(>42U$PV:5Z>;57AY=5$0%
M,UOG),Z) KJ?&)LSD29/GU#V(K>98.+*ITH<FJ?F*,V280AUI2'4[NYW&]J=
M5'H*8=A\0<2'75[98\^QETNVE8_+I+.7&KHT.QKV$2'4.SW#4P:5MN-KCFC=
MWB46A%YMHI(7/-:ZR-20V\:?;S.YCR9KF/6LZ%6%#C0GRC.NO2G'%M&E;BDD
MQVMYNI/=H2=3(4P)GQ"5SL''3QRE]?=Y#[P2BMG6,&J0R]3OIC2H_J7G%-.O
MDZLB;;:-6]'UFI(Z@4V.>708F&.9O>QI5)718#EG8Q)[>V7%:8;-QQ+C:#7J
MM))/HDSU]FH(U\CF?(-&8MG@TRELK^!+GX4B7,BK3/5#8]2IB0;9J](_VOK=
MCFJ3)*BW;DF0+1Q)892YP>G*\BG6$G(+:M<N_53Y,>4HE2(:74JCDPTVAEDS
M\S;)I,T:Z*,S :OC\QYVU\/]Y'O[!43E"OQR#DM-<L;#584U@;*FY:"-.A.,
MFX<:26WHHB5KYR!:;;Y#YEG8!+L''<2DRL;ID(<L[F1.AUQ.H-I+SGN]F2M*
MI9MH5YB2:?/Y$[E= 2G%ES7VLUEXC0XX_>)JRAJM7(\R(U/)$]E$A#D6O=63
MTAM#;B5.++;IYB+<:3 I4.6^9,G5BN4N8)43HM326<>D>S=#T9"6K!FPCM2D
MHBNZN+93N4PMXD_/UT(R+<!$+3F_.#^#64I=GB<M.)5\EJ',NWY<6+(=4X:$
MJ<@P'%=Z4T@W"(UHTU,E;25M IY9=SNK&V<HN:W$YM[B&'/G7WEW&DQFMM@@
MF^ZTS'<43CB&3=0EUWH23W:$HDF8%-Q BL\C)4OCW+4(2:UJIK$DI21J49G%
M<T(B+J9@*[\/TJ++X/X[<AR&I+2<>JVE.,K2XDG&XC:5H,TF>BD*(TJ3XD9&
M1]0&R &B^;WV'>4^#*UMQ*[$\EE2BB),C=..S62.XYM\=J=>I@-Z    K7(C
M;CO'^5M,H4XZNFL4MMH(U*4I45PB(B+J9F?@0"G<!9)CCW"7'W8N(3O9Q^L8
M>V2&SV/-1&T.-J+74EH41I4D^I&0#8WOZC_M.)_\^W](!I+F2VJK3E?@ZHK9
MS$RT3D<N<J&PZAUTHK%9([CII29F2$ZEJ9@-^@   T;\2<N+6'Q/;6+R(E5
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M2EIVC-;<&O8;C,DM7SE;&R(MQ^T_$P$L   #\\J#_F5R?PJ;_P .. /T-
M        !H/XU?\ +)G7^K6?[6A@(KX$_P#+?CWX99_UUT!](@        ,>
M<ZMB#)?:/1QIIQ:#,M2W)29ET 4SB[*+7*.)L<RZ[>2JWL:EN=,?:;)*>ZML
MU&I+9:%_T *[4\TU[%%1(.'=9=9OT,+(+6=5UK;:FX,TE);DNQB?\IN&VM1,
M1S=61)/IX:EI#Y1S/91K;D2L+U-'0XQ2U%K79*W7)G&2K):MQJ8=>;-?<+:A
ME&U/S'#4?0B,4LE[SOBN/V5S#F5=R[7XW+:@Y'>,0R775ZGTM+0MUPW"4I&C
MJ35VD+4DNJB(M#,4YROG7%<2DWA2:NXL*C&32UD%[6PRD5\.4MM+A1UN=Q*E
M.$EQ!K[:%);W)WFD"F;S?EEUA?%=[E..2&X=M#3$]/*?:2^VRF1,89<6I"C)
M)[4.*/J>@$-=U'(M_$S'%JR@Y+K.5(UW/]#;T]?#A(D081M+6N?WZ]Q1-H94
ME)*2\GS[M$GJ V3&Y@Q.7C>/92TB9[LR:Z3C=:1L%W2G*EO0B-Q)*/:WW&%^
M;7PTZ 4J^'<QRE8A3OWL*;D.97,^\9AU-'%0I]<.HLWXAO*):VFFFFTI:0I;
MCB=RE$1:J,"D\[S3CJXE*Y2U=O=VEVF<IFCA1$HL(_NAQ+,Y,EN4XPEI;#JB
M:4A2]QK/1)*+J!2VQ,IK9N+%ES27VJOTBYRFY3+D:0AMI)J6EQITDJ0M.TR,
MC+Q!&B.,^7KR?7)RG+LW;GN?9^3D;N&MX\]5J<;98[ZTPYTA1%)['S%=HE:G
MU\ 5)<8<GY3E5[5FO+:>Y=N(#]A.Q?T3]:451-$XTBKFFA:)I-+,F9)[U;?G
MEI\T!G8OG.=P.4:_",FR"MR";,K95GEE1 BE#1CAM(;=8[3ZEFJ0TLW>SHLC
M<\'/*6J0$/PQRG?9U=4DR^SEEM=ZS,FQ,,50/0DNLM[]K<:S>-*7U,)V..DT
M2CZ'[-3 EF?XQY,FGPW-C:=DT.:9-*C5U-!AD_..E1$EIA-H2:B,W7W(Z)*W
M%*(D)7H9DE("RY!RNX[@=EG6.,2H<C#9Z/M?C=E&2W.1$CFDYC"D[C)*RCNE
M*9=:6I"]J>II48#:S3K;S:'FE$MIQ)+0M)ZDI*BU(R/[I C7+_(9,9IEZK"8
MW78'Q_6L+O)#C>Y3UC-;]8>BBU/9'C$WY$%N6M[3[TB,KR;Y&L<QKK>DQBKM
M<6SI-8=M1,Y% 2TW);2HB0KHMU!)4LTM.MK4AY!+UVEX@+'CN?TU]QW!Y)5O
MC4LFL3;R4$E<AQA"6NX\WM:2I2UMF2D:(29F9="!%>A\V42US&KNAO<<=C5,
MO(8K=S#1'5,KZ]*52%,DEU>CC9+1N:=V++<6I>.A:<T?.&)V\A+<V%9X_!D5
M;]_66=U%*)$FUD1*%OOLK):S(FDN(6I+B4*VF2B(R I 0^9++)>2<!HZ6LL:
MC&<@C6\R0NY@I8.PC1XS;D5Z*YW%FDB4K<I"B2O:I)J21&0%+EE&36R,ZQ/!
M:%Q+,BQ*5<WDE24N*:J*WMH4A*5>"I#[[+1+^]3O,O-H"*'D'.KEG8X8Q@\2
M<W27F4Q*A61RX23JK&#]>F2B(]W#42C4V7;6M"=Y)4:-Q=06E\P7*+*POLPP
MV^=2_<XO.;-J4A!-D_56C7J82U$6A;T%W(Z]"ZJ:W?? B\
M
M
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M :VY\A!M)4:M79$EID_FJ4T1F>T]0&X00
M
M
M  ?GE0?\RN3^%3?^'' 'Z&@           T'\:O^63.O]6L_VM# 17P)_P"6
M_'OPRS_KKH#Z1               !QH1F2M/,70C]O4!R             XT
M(C-6G4_$_;T #(C,C,M3+P/Y '(#@R(S(S+4R\#^0 ,B/H9:EX]?E+J Y
M  <&1&6AEJ7CH?W '(#@B))$E)$22Z$1="(@'(
M
M
M        _/*@_P"97)_"IO\ PXX _0T           &@_C5_RR9U_JUG^UH8
M"*^!/_+?CWX99_UUT!](@
M
M
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MDK.&R\BKV,J?VDU3N26TRE*<+<A/;-6NY9=4I\5%U(@%<POE./G6<Y3C=,F
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MY%U3]]H [56?83>7DO&J?(:^??P=WJJZ/);=?1VSVK\J5&9[#/:O3YI]%:&
MZT7(.#Y/9RZ7'<BK[.V@[O50XDEMUU)(5L4K:DS,TI5Y5*3J1'T/J ]LHS?$
M,)CQY677D*E8E+-N,N<^ACN+3H:B02C(SVD>JC+P+Q 5+)>7(%=G&)8'C[E;
M8663-*L%2)4_T[**Y*FR0ICMM/=]U\EJ-A!;4JV*\Q$"NV<<PU6 YYBN'W4-
M::W)6WS<O"6?9@N(=:89[Z-AZ-NNO(:[AK(DJ4G7H>I"DO&Y"@GF.6XS9MM5
MM?B<&ML9-Q)D)0RINR*2:MY+)*6TME'ZJ-9ZZ^S3J1DT_)7']_56%W3Y-6RZ
MFI+6TF-R6^U%3H9[GC,RV$9$9D:M"/V .T#D; K.@F95 R2N>QVOU*PLDR6R
M8CF6G1Y1F6PSU+0E:&>I:>) *]CO,^*9!:Y@E$R$QB>*,5DD\G.:TJ$^BS:<
M<5N,R2EHVE(V&2EF>I^!'T!:6&KY%P.ZHIF3U>25TG'Z[<5C8HDMDQ&-)$9D
M\HS+MGH9'Y].A@C)QO-<1S!+JL6NX=OZ=#;DA$-Y#JVDO&HD=Q*3W(-1H5H2
MB(^@# QS-?M!F.:8GZ'T_P!D'Z^/ZON[_4^\(+<S79M3LV;]GSE:^/3P ).>
MU%/)R1S)IU94TU ]%8]:NP:<=,Y4=#Q%(9VI..LU+VMMFI1N)T47CH BKKF?
M!*D\07'M(UC#S.Q.KK)L60TIA*D(4I:U*(S^:LD-&GYQ+6DCT!:9J>3<9JZ1
MNVS2WJ:$W7I[32"LF9+3B*Z4J,LT.$2-ZTGL[K:4F;:SV'U(!FS^2./ZNNJK
M>QR>LC5=X9)IYCDME+,KPU-I>[11%J6Y1=$^W0$2B,@JYE"[D51)9LZQ++S[
M,B*ZEUETF-Q*)#B-4GU2:=2 :A3S7R!$P.%RE<8)"1@TB''M9:X=YWK%BODI
M2ON$P]"8;<4E*B4;9/$9^!'J"TVVYE6-LLVLA^UBM,T2$N72G'4H]$A;*9"3
MD;C+MZM*)SSZ>4]016J_E&G>R#.*RV-BJI<*36N/7LF4A,=YJTB%))9[B239
M)U)!:J/=_P"X LV.91CN7UJ;C%[2-;5BEJ:]3#<2Z@G$:;D*VGY5%J6J5=0&
MO;7EC)CSVUPG%,6A6J:=V)&E39UVU5N.2)4=$M:(\=4=Y3O::<0I1D9=3T!7
MK=\LWC5W<P<1Q161U>-OHA6SR)[,:;(F$TB1(8K8JTJ]2Y'9<0MPEN-:F>Q.
MJB <YORMD&&O75JO#WG<%QI44KB\D2D1'WRE$A3BJZ,MM12$L$XDE[W6]R]R
M$;E) >>1\L9%%SF=A&'XS"NY58S"5,D6%TW3FJ38)<<;88;7&>-U1-M[U;3Z
M;BZ +7]LN[G!X;%BI7[OK$V^0SU.$34-,E:FXC):%YG'3:?6>NTDH;U^^($5
MYCF;'K_+H&(X+*K\C>GU]G-]=&G(6RQ(K382VTZEI+A['3>Z.$?@D]I*]A:2
MD/D)%QQ=,Y"K(AM28U=-E.5DHSW,3ZY+J7XKII(CU;>:6THR\=-2!&IL"XTY
M%Y!PC'L[M^9\IB6>2U\6XDQ*Q,"+"85.:2_V66E1UF2&]^PC-7737IKH L/^
M F9_INS7_P"<K_R0!!286>\.<E<=Q'.0;C,L>S2QDT=K5Y F*X;:DQ'9+,B.
MXPTT:%(4WHHCU)1'_P!0?1H   -><ZYG<\?<1Y;F./=HKNKA&N M].]M#SJT
M-)6:?!6S?N(CZ&9=>@"G1^",Y>CM.R.<<R<D.(2IYQDZ]EM2U%J9H;],K8DS
M\$[CT^4!Z?X"9G^F[-?_ )RO_) &!B:LVXWYPJN.+7,['-,9RBAFVC:KQ$<Y
MD*;6O,HU;=8;:U;<0Z9&A2>AD1Z^.H;_      &@6,RY[Y%R#+%\:/8O1XIC
M%U+QI";^/.F3Y,JN)!/OF<9UM"&U*7HVGJ>A:F SO=?Q<_G%@7]V6OY2"H++
M\P^)+B>A?Y S:5A][A],Y'7>5M3%L(=@N&\^AA:X[CSSC>]'<WZ++0R(R ?1
MA&2B)1=2,M2/[A@CD  ?GE0?\RN3^%3?^'' 'Z&@           T'\:O^63.
MO]6L_P!K0P$5\"?^6_'OPRS_ *ZZ ^D0     !J?FOF6!QBS54L>3"C97DBG
MFZR3;+4U60VF$D;LJ6M!&K8C4B0VGS.+,DEIU,BQ# XPR?B?%,)M[Z#FC.1%
MZ]N1F&6.:J7)MK%;;2%+0VDR;29FAMII!;6TD1?*9AN<$:ZSRDM[+D/B^S@0
MW'Z^GLK-^TDHTV1VWJF2PVI>IZZ*6M*2^Z"HR=B4V9R=G5W)IRDP)^)0:FNE
MNMH<2ZYW9ZI$=!J]BM[6]/@?34!JJNP_-,3*AM+*!DG8F8-C^/J8QR#5V,EF
M36,.)E5\INP9?[:'5.)4E:=K9GN)SP2"MNQ,:OL<X$+%JBC18W\.@7#BXW<R
M6[!M;ALFDH<AY"66WDD1]H]"0A1%IJ1=01I2SJ\OE-SK^RBY =+78'D]6]8W
M=; I8\9UR(RXVPQ#@DE;;24M*T4M3B3/HA70S!4A)AV648OC=I5XQ-Q2HPK"
M+EJWG36VV&'DV%,3+,2(;2U'(;)9>H4O;M3L3]^K0@]:FMO,VHL 5CN'3Z6/
MB&)V+<Z5)0W':EJLZ7TK$*"I#BO4)=>4F0:ST2G8DU>=6A$6*)C%QAD#AK)G
ML5DV5=BU NONJ6N8;>GP+.=#AH*6F.1EW5I-EUETT*-:27J6I&H!%IPW.*C&
MI/)^/8LMO+8.7S\HQO$75(3+]S6\=NODQ'"2HT,K>+6:XV@U;5D1?/U 9$C%
M<UX]=P>D@0Y[E?!IWTVV68]7Q+>[>O)TDI$U@U3DK3&CON*4_P!W8>JM$J-)
M)Z@X3P7+\=L^/UW='(K45--E<2R)TVEDP_.O6Y+"%K:/8HW&R-9&@MI^S0N@
M$K7D3=CB'*5]F%AB=AEU-D-'!JJURJC-37XBX3DE3\-QMQ:30U)-Y#F\S[>Y
M.B]-" 0?#W'>7X;E>(-Y!"5V:S")5=*FH6EZ/'ER+AN4U!)S<9J-ED]A&7ET
M1T,"6?RGCV2/<AOV]73R[&'<8)?8U'DPD)6EBR>6W*9)\S4DVTN$V:$+\-YD
M7M 0EUQMD\ZHXSIZ*J55S8V$7U'.F)T8173I]3%982^IH]Q?7I5\S=YB,_'J
M \N+\7O7<GP0K6GRB*[A,&1&>5;MU$"J@&Y#](N-%7"BI<G-N*21I,G-I$E+
MBCW>4!:N5\0M<ARZ2^C'GL@I'<)NJN1#;D)A>HDR9T!UN,B09*[;JDM+6A1I
MVZIZ@*+'ILTR"HS)FUQZ_P BQIR'4G$FVT6!09FJ3!G$_P!IAYE*422AH+U+
M1OH(G'M6R,R49@/!5#R+9U\G(9='87$*BRO&\@B3)M5#J\JM(E7O1+2^RP;9
M/G';-LHZEH;6OS)+7H9A[6T+/[&TSS,ZO"YD>+>W.+RHOO.OC3;*/ KX2FGI
MT6"XXI*Y3+B4[&W/,C7=M-1;0&&Q@N9WMGEL^RH[>?!O;_!)B9%_'A-2IT&M
MDZ35O1XI(;0EI*3)32FR5LT-6NNA%67/>/\ )9^89S=UM$Y-JE3,)MW*]LFD
MINF*%^2[,C()Q24+<2CMZ)<T)1I2GY 1BYO59%FMA%SNCPFSH*ZHNX$^<\S&
MAHR2T*+!E1DRBA2VW4&<);R.R3VY:T[C0232C4-@<,4<V&[E>1S(EW%/(9[+
MY.9&<-B7*.+&0PJ3Z&"RRW&W[=FBOK'"02U:&8$M9WV+94>*9OQ,UATV7E64
MY#,M*W+FT-E5&U.G%*8L'YA*)33L1HB1VMIKW-I2C4E$8#<'&]-9U=[R-*L(
M2XC%KDJIM<M9)(GXWNR SW$F7BDUM++K[2,!JFPQ_*JWD*6QBV-VK"9^4L7,
MNJL(L*WQ267=:-RV1-=2A^#)2VA3I(0I2DO)2E*3(]0$DUQ_<(PF'%11.)M?
M\3$Y \HVFRD^B+)%/^M4KQU])IYO'9T\ %5M:?DBWF)KY./VT5R'F<2ZDT]5
M6UT3'VHC%NATYJ9AD<F:^ZUHZLTN)5O4K<DDIT 3=IQADLSCO,HT*G<9MI6?
M3,C?B-(C%+M*IFW3*(FSD$MI:EM(2II+Y&A1I2E2= 'B[BEGD,#,LDF4.8VQ
MRX]+&-V>NKI;F4JLG*EE(A1(\9I)O025W&E2?X<]6B\I$9A?N$FLP]3E<S)(
M;YULJ3$54WEO6Q:B_L.VQVW?7-1222R9VMMLNK0E:DZ]-"(P):ZOL6RH\4S?
MB9K#ILO*LIR&9:5N7-H;*J-J=.*4Q8/S"42FG8C1$CM;37N;2E&I*(P&X.-Z
M:SJ[WD:580EQ&+7)53:Y:R21/QO=D!GN),O%)K:677VD8"IU\N^X?R;,X[V)
MW&28UE-NYDE198^RW.=1)F,,MR8DEDW&U-&EQG<TX>J%)5U4DTZ ,22>>Q<G
MQ#E3-\3>L/3PKJ [0TB$3Y=*JQE,.PW=F\S>=..R<>2XQX&KH6S4!"83QYD\
M;.,*R"SQ]V)2.7&8W[5<Z32O<C%PB/Z-EU*%J0AU9I<7M:-1(4M2?8 ]*GC[
M((&)<?QF<>7'L*_D67<V;;3;;;C->Y,L]DAS:9>3M.,IZ:^4TEIH Z8MQS=L
M8;Q/$L,;-%C59E86]XT\TTIUAAQ5JIN0Z>I]#-<=1'J?WGR%H&-'Q'*L9S9>
M=R<7FV&.U6:9).<JH+:'I:V;F!#9BV<>-O(G20XVZA1%]81.*61'H8#.Q_";
MZ?E5%DDG%'*R@LLZL,G14R6VNY!B'0+B-2)+23,FW7Y:"?VD9FE2B,_-J V/
MQ306%#.Y#.; 5 CVF6S+*O(TI2E^._#AI[Z"29]%N(<U/Q-6IF U)FE#(GV%
MV[9<973'+ZG)#=!FF$K5!A2]RE%!D/RTRD$V:$]M,@I:%:;3-)*+1)!ZYG@7
M)%P]E=))@.3\BRG#:".Y=1B2U62;.D?>=L(;CVJ#9]62]C>Y))-*^IEH R<R
MQS).6W;>7BF)S\3)C#K3'E.7#+5:_.D3WHKK$!*4+5]2TF.Z1N[NV1NZ)U+<
M8#OG<:YY$QZQ:QGC>PQV9'@U%<BXDL,0K9KM74*0<2&T6Y*V8S;;C_=W]M*D
MEL)74!L+AZEN<,C76 6M<[Z>GFKDUF4*)"BN8M@I3Q/R'"/<J:A6YN4:TEN,
MDK+4E=!*A5&!Y&K.XLVQH7%5+?)-W?*<?0VMKT3E$;,:7IJ?0WR22%::DHO8
M V+Q306%#.Y#.; 5 CVF6S+*O(TI2E^._#AI[Z"29]%N(<U/Q-6IF USCE)D
M-52,<7S<'D6.3LY!.M%9C);:*L;]5,D26[EN7JM2I3;;J4I:T)W>6T]J.H#&
MQK',CFU?%6 ,8;-QVYX^L(DR^OWFFFZWM0([C4HXLEM>KZK!2]32A)]%J-S0
MT@/;$, R*LXZX6AKQ]V'=T>2%/O6B0VE^,P\S8I>==4E7@LW&]_4]=2 =,9P
M')*_CCB&&O'7H]W49A[SNV22VE^-&=<L>X^ZI*NJ3)QO=H9ZD9= $#@N 9;7
MEAN"Y#6Y/*GXO?(M9+Y)JX^.H7'DN/JL&K HJI3_ 'TN'N8-SNJ-:D+-)%J
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M >T"##JX,:MKV41H$-IN/%CMEM0VRRDD(0DO824D1$ R
M
M         %0R'BSCS++AJ_R+'8=C;M$VDY#R#^M2RK<VE])&27DH/YJ74J(O
M8 MY$1$1$6A%X$   "GU'%?'=!D*\JI\<AP[Y9NJ3+;0?U:I'\*IE!F:&E+^
M_4VE)JU/7Q,!<        >;[#$EI3,EI#S*M-S;B26D]#U+4CU+H9:@/0
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M'TB
M
M
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MU/H7B9Z .U1<MW'K^W$F1/03'H"_71W(O=4QIJZQW"+N,JU\CB?*KKH D@
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MX<< ?H:           #0?QJ_Y9,Z_P!6L_VM# 17P)_Y;\>_#+/^NN@/I$
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MS*K&9%IU=R2MM1084))+DSBT+<9.$I"3022U4!"I\64L?DRQX_J,_5+NH/V
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M .W'X:)QKJ[!MR?B<A3%9:NKDV/<1#6;).NF25NK4I*5$LR)2^AF6IZ C5^
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ME319?D;U?FDC*N):VCCV=GDMI*39)K[9U\TFPW,0DC-+K&UUQGJ31D6FW?M
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M?^'' 'Z&@           T'\:O^63.O\ 5K/]K0P$5\"?^6_'OPRS_KKH#Z1
M     %3RANA>NJI#;E8UR0B-8*PYVS1W5MFIM"92VT)6A:D[=G=)"B,T^T@%
M'X'.56S^0\5O-C^95^0JL<BM(NJ8$QZWC-/L+CMF1&UL82VVMHS69*3N-1[@
M66Y 11LMY@XXPBS.HR6Y*/9,M)D2668TJ:<9E>NUR2<5ITF$F1:DITTEIU\
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MB^4!!6V;8Q29#58M83=N179*57P&F7I#JFFU$E3CG90LFFR49)[CII3KTUU
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MK0MFS33;IX::>P!!UV"X34)V56-U<%&KBML:%'9+5]!MN?,07STF:5?*GIX
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MM1:_(9_* R:_&\=J'">JJB%!>)3[A.18S3*B7+4E3ZM4)(]730DW#^^,BU\
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MIT]G0!EMU-6U*9G-08Z)T9@X<>2EI!.MQ5&E1LH61:I;,T)/81Z="^0!F
M                          /SRH/^97)_"IO_  XX _0T           &
M@_C5_P LF=?ZM9_M:& BO@3_ ,M^/?AEG_770'TB
M
M
M                              .INMI/12TD9>PS(C <=YG^,3_UD Y2
MM"]=BB5IXZ'J [     *1R'RY@/%K<$\TM3B2;12TUT&.P_-F2.R1&XIMB*V
MXX:4$9;E;=I:^/4!1OUM>%O_ ,]N/]W[G\D!:<'\6_"J2-2IUN22ZF9T%P1$
M7R_^B 4VYC62T.8T,#)\8GM6=#9M$_!G,&9MN(,S(_$B,C(R-*DJ(C29&1D1
MD")4   &J,M^(_B3"\AEXM;V\EZ[K]A6$>MKI]DF.MQ.Y+;KD1AU"5Z'KL-6
MI>T!#?K:\+?_ )[<?[OW/Y("TRZGXIN%[>U@T[=Q,A2;%Y$6([955E C*?=/
M:A"GY,=MM)J/HG<HNH(W*   #\\J#_F5R?PJ;_PXX _0T           &@_C
M5_RR9U_JUG^UH8"*^!/_ "WX]^&6?]== ?2(          QEV5<VI2');*5H
M/1:5.((TG]TC/H ]6WV7B(V7$N$:261H42M4GKH?3V'H ]          !U-:
M"639J(G%$9I3KU,B\3(@'8!Y/28T<VRD/(:-Y9-,DXHD[W%>"4ZF6IG\A /4
M          =4K0O78HE;3-*M#UT47B1_= =@       =5+0C3>HD[C)*=3TU
M,_ B_= =@ !X2ID2$A+DV0W';4HD)6\M+:36KP21J,NI_( ]P !U4XVC;O42
M=QDE.ID6JC\"+7V@/-,R(J0N(E]LY3>F]@EI-Q.XMQ:IUU+4NI /8
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MU]@ EUI3BVDK2IUO0W$$9&I)*\-2\2UTZ #KK3+:G7EI;:26JEK,DI(ONF8
MMUIILWG%I0TDMRG%&1)(OE,SZ .5.-H;-Y2TI92G>IPS(DDDBUU,_#30!RE2
M5I):#)2%$1I41ZD9'X&1@.0'5"T.));:B6@_!23U(_\ I(!V
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M^1<C708-#D5M=ETVSR2MMLE],M^,4?%)"(ZG8\)3R?K)"GFO*MTTH+>?7RD
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M&1]2 ;& :,YP<;<Y0X+@H6E4U632I"8Q&1N&RS62.XX2?':G4MQ^P!O,
M!H'DF_B<;\]X[R1E<::U@S^+S<?<NX<1Z<S&L5SF92$R4QTK6VE;:%;5;3U5
MT^4R"9_6KX'_ #G=_NFW_(P'5SXK>"4-J6C(Y#JTD9I:;J+=2UG[$I+T9:F?
ML =_AAJ+>KXM*5<0'ZMZ[N+B[C0)J#:E-Q+&<Z\QW6SZI4ILTJVGX:@-R
M ^9,$Y4Q'AO(>2<6Y-7.Q^QL,PM;^K=<KILJ+,KK/M+8=8>BLO)5T29++H:3
MZ>)& NWZU? _YSO?W3;_ )& UWSES1@7+7&=QQEQK(G9)F>4*BP*VOBU=@T2
M5'*:6IUYR1':0VTA*34M:E="!7U.A.Q"4>.TB+7]P$=@ !^>5!_S*Y/X5-_X
M<< ?H:           #0?QJ_Y9,Z_U:S_ &M# 17P)_Y;\>_#+/\ KKH#Z1
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MK&91R*JRG7<5V1+>D+.?:QSC27'%.J4:]Z%*/S&?F/4!E_X88EZ/T/8>]/\
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MWY6 LF$\%\4<=VZK_$,;9@W:FE1RL'7I,Q]#2]-R6URG7302M.NS34!L,
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M9OBEG PZ\;QNHS%^$N[FRY;U@]4LP7'U1XT=!LL]UR0M2%]Q6U+:"3J6[<1
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MF1B[G&U99RX<AUY;JWW7#;5(]J5/&X1)-2C_ (+_ +0$MFY-F><2\SE8-QQ
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M;&##I\(R3)(LJK1#E/G8IC/5\U<=F:G0FG"?09.GL/1LTDD]WB ^D 0
M                            ?GE0?\RN3^%3?^'' 'Z&@
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MB&HL)%I8QK6PKKN==M9-!LXBVTO0;%F"W7_5)4VI"VG&4&AUIY*TK2I1'[-
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MZGU!$D                                 _/*@_YE<G\*F_\.. /T-
M          !H/XU?\LF=?ZM9_M:& BO@3_RWX]^&6?\ 770'TB
M
M
M
M       _/*@_YE<G\*F_\.. /T-           !H/XU?\LF=?ZM9_M:& BO@
M3_RWX]^&6?\ 770'TB
M
M
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M )DJ\?G7#'N.VM*G%DM'EU[7LLN0ZU3K27U$HENH=>-II:77RCMN=M!ZGUZ
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MS'SY@]_QV<FVQO#:J\.^O3B2(T%MZU3'9CQT+D-MFMTS:4HTI+HG_IT#Z+
M !\PX'RUA'#F0<EXKR=+D8W:SLRMKVM.3!ENL3*ZR[2V'F'H[3B%D9)\Q:ZI
M/H8*N_ZV'P_?GBC\0LOR4$:ZYTYOXXY8XPNN->-;&1DV:Y.J)7U=7"@3B5O5
M+96IQQ;K#:$-(2DU+6I6A$"OJIM.Q"4GU-)$6O[A CL  /SRH/\ F5R?PJ;_
M ,.. /T-           !H/XU?\LF=?ZM9_M:& BO@3_RWX]^&6?]== ?2(
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M=[EZAM*N6[4S7:.VJ[6JK;6!>5DM$MGWI);;92J-]6X7J4JT9=ZH(SU/YJB
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MT:<SDMGC;-@Q!DE5-O1YJV(<9Z69*:3(=;V'INT-1D7E,R2!2R.\PX2UD"Z
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MMN8TXY!DQ*V;+982N<U!>>3M=["MVXB6?0M2-1$9@4VP"
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MU5EO<QF-0V4[&K*AKG)F06%]*>F61(WFV[)<4VS%/9U(V^ZH]#/;IH867E'
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MO";,DH^[ HBV+_1W719TCE>79\OG^M5]SR]0&WP0
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M::5;R+!I3B'6W8TJ.PA':6A)]MQ+QK2YX*T\NI M-G@@
M                                          !D1D9&6I'T,C >$2'$
MKXS<.!';BQ&2VM1V$);;06NNB4I(B+J?L >X
M                  Z(:::-9MH2@W%;W#21%N49$6IZ>)Z%X@.X
M                                            #\\J#_F5R?PJ;_PX
MX _0T           &@_C5_RR9U_JUG^UH8"*^!/_ "WX]^&6?]== ?2(
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M*^7)8:>D0'E(6['<<02E-+4V:D&I!GM,TJ,NG0] 1E@
M
M
M                    #\\J#_F5R?PJ;_PXX _0T           &@_C5_RR
M9U_JUG^UH8"*^!/_ "WX]^&6?]== ?2(                           ,
M6/6UT27,G1(C+$VP4AR?):;2AU];2":0IU1$1K-*$DE)J\"+0!Q'K*V),F6,
M6&RQ/L3;5/E-MI0[(4R@FVS=61$:S2DMJ=Q]"Z ,L
M
M
M                           ?GE0?\RN3^%3?^'' 'Z&@           T
M'\:O^63.O]6L_P!K0P$5\"?^6_'OPRS_ *ZZ ^D0
M
M
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MXMFF[=KTT\==0$#C>85.4N7S5:3R%8Y:/4EB<A!-EZJ.TT\LT=3U1M>3HH]
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MG7=?*XON:H3IU)*OD 2"5)5KM41[3T5H>NAE[# $K0O78HE;3-*M#UT,O$C
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M?-W_ .NKO^SX@#> #5_Q'_\ L$Y'_P#U?L/_  % +A@G_D?&?_54'^K-@+
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MB6OM_P"H!R   #@B(C,R+J?B?R@!D1^):Z=2U^4@')D1^):@*%EU9B&-7?\
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M_P#4 Y <&1'T,M2\>OW.H#G0CTU]G@   #@B(NA%H7CT^[U -"UUTZ^&H#D
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M@1L $
M
M                     ?GE0?\ ,KD_A4W_ (<< ?H:           #0?QJ
M_P"63.O]6L_VM# 17P)_Y;\>_#+/^NN@/I$          >2HT9<A$M3*%2FD
MJ;;?-)&XE"S(U))6FI$9I+4ON ,0Z&C5;)OU5D0[U*.TFT-AOU9-Z:;2>V[]
MNAZ:;@'+U%22')KS];%=>LFTL6+BV&U*DLH(R2AXS3JM)$9D25:D \VL<QYB
MH50,U,)NA61I75HC-)B&E1[C(V23L,C/J?E 95?75]3#:KZJ(S!@,$9,18S:
M664$9FHR2A!$DNIF?0@&,]CU!(3/1(JH;J+7;[S2Y':44K86B>^1I^LT+PWZ
M@,J# @U<1JOK(K4* P6UB+&;2RRVG771*$$22+K[" 82L8QI<V39JIH*K&82
M4S)AQ63?>2@TJ23B]NY1$:4F6X_87R (/$N-L?Q2;9V:&T3[:QMK&Y;L93+)
MR8QVKG<<89=))*)LM="Z]2\0'&*\:X]B]C;7!-(L+:SMYUTU/E,,JDQ%6.WN
M,L.DG<ELMORZGKU 6MN'#:2^AJ.VA,E:G)*4H2DG%K(B4I>A>8S(B(S,!CU-
M'24$=42BK8M7$6LW5L0F&XS:G#(B-1I:2DC,]/$![MU\!J(JO:BLH@+):5Q4
MMI)DR=,S61H(MIDHU'NZ==0'E54U111/04E?&K8)*-91H;+<=K>KQ5L;)):G
MIU/0!XRL<QZ;8%;3:F%(M2:5'*<]&:<D$RLC2ION*2:MIDHR-.NG4P&0FKK$
M-OM)A,):E()J4@FD$EUM*.VE*RTT4DD>4B/V= %:/ D2<]BYM9V3DMBGC.1<
M9I.RRU%KERT(;DO)4A)+<<<2V2$[U:(2:B27F 6Q]AB4PY&DMH>C/(4V\RXD
MEH6A9:*2I)ZD9&1Z&1@,*)C]#7UQ5$"JAQ:DE$X4!B.TU')9*)9*[:4DG7<1
M*UT\>H#,DQ8TV.[$F,HD1'TFV\P\DG&UH46AI4E1&1D?R& QVZ>H9C.PF8$9
MN&\A+3T=#+:6EMH0324J21:&DD))!$?WI:> #SF8_0V$R)83ZN'*GUYD<"4_
M':=>CF1ZD;2U)-2.I?>F0#,D1X\R.[$EM(?BOH4V\PZDEMK0LM%)4E1&1D9=
M#(P$?%QC&H,9,.%308T1"%,ICLQF6VR;6LG%()*4D6TUD2C+Y>OB ]ZVEIJ=
MM]JHKHT!J2XI^2B(RVPEQY?SEK)M);E'[5'U =:FAHZ!IUBBK(E8R\ONO-PF
M&XR5N'TW*)M*2,_NF R6X4-F.N(U':;BN;S6PE"4MJ-TS4O5)%H>XS,U?+J
MQZFDIJ&,<*BKHM9#4LW51X3#<9HW%:$:C2VE):GH74!DMQ8K3[TIIAM$F1M*
M0\E"2<<[9:)WJ(M5;2/IKX .51HRWVY2V4*E,I4AI\TD;B$N:;B2K34B5M+7
M3QT 8A4-&5L=^59$*]4CM*M"8;]6;>FFTWMN_;ITTW ('$>.L?Q)R7+88:F6
MLFPL;%-F^PSZMHK64Y*<90ZE)*)M*G#(BU\/$!/'0T:K9-^JLB'>I1VDVAL-
M^K)O33:3VW?MT/33< X*@HBMSR JN(5\I';.T*.UZLT:;=IO;=^FG33< Z-8
MUCC$R18LT\)NPEN(?E2T1FDO.NM*):%N+).Y2DJ(E$9GJ1]0'$_&<;M(2*ZS
MIX,VO;<-]N))C,O,I>49F:R0M)I)1FI1FK37J8#-3 @H?;DHC-)DLM''9>)M
M)+0R9D9MI5IJ2=4EY2Z= &0
M
M                                        _/*@_P"97)_"IO\ PXX
M_0T           &@_C5_RR9U_JUG^UH8"*^!/_+?CWX99_UUT!](@
M
M
M
M         /SRH/\ F5R?PJ;_ ,.. /T-           !H/XU?\LF=?ZM9_M:
M& BO@3_RWX]^&6?]== ?2(
M
M
M                                      #\\J#_ )E<G\*F_P##C@#]
M#0           :#^-7_+)G7^K6?[6A@(KX$_\M^/?AEG_770'TB
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M9V(<M8AG5S*I,:.=*=A$^4N8J!)9A-OQ7B9=8.0XVEONI,R5L(]=IZ@B\@
M                   #\\J#_F5R?PJ;_P .. /T-           !H/XU?\
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M-Q>KQR#;P+Z'C]C[ZM+R/@;L5^TB6MK8G,8A+>=VJ1$;969*5&5H;W4SV[3
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MI*/?IH V5PK26N/X(F#=P55]DY:W<MV,YMW[)=M*?:4>TS+S-K09?< EL($
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MJ'+=LHL9I;Z*^"ZNNK8RFW#CIDOH233!.)94323/KII\@"X@
M    *]98/BUODU9F%G7)E9#3(4W6277'5(8WZZJ2SO[6\MRM'#1O+7H9 +"
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M           T'\:O^63.O]6L_P!K0P$5\"?^6_'OPRS_ *ZZ ^D0
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MVHM&DK(R:Z[-NH$OHD$
M
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M3,.*TAB.TG71#3222E):_(1: /<
M
M
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M/:A)F1&I6FNA%[3T =P
M
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M:2,]2_=!&2
M
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MU2I*BU(R,CU(R >@
M
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MBT(B\ 9>H
M
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M(6>U"M%*+1*C\J5'T4?0NH"R@
M
M                                _/*@_P"97)_"IO\ PXX _0T
M      &@_C5_RR9U_JUG^UH8"*^!/_+?CWX99_UUT!](@   ^0N3S>Q_ .9L
M>L*%5^5S=2;5K*&'(SU>PE]<;M,RG3=[K,F'Y6VV.WN5Y-GSM2-+-R14YA$;
MYEQ6LQ&VNI&?)9E4%A!0RJ":"K(\1U+SJG$]I;:V5F2%%N66FW74$8'*%)R#
M:+Y#QVNHK9";N W'J6:.LK4Q;=MNN0VE^SLY.]WN-K);783VU$E"2;-1JW +
M OCG)[X^86V:Y=?9Y+CU/6X]9RR2@W'$5+C+S)+W*4@B<5VW?DU]H".LH%YE
MU[22:?CRSQUBDQ#(**8<J-'CI.3)B,(C0630Y]8TVIM9-K(NV>[R_? (PZ;D
MF!7UF/JQ^SKV7<)IZ=AR@KZZ1+L):(1MOP[.?-2X41MAP]J4D1),E+5N,^@"
MV<<8+;Q9U;)O<?4CT_&%#CBE2FD*-$V.N64N)YC/Y6]Y>"BT 6OB.SE8YC.
M\:7M9,B9"C%FI;SCJ6S8:57]B,['6HG#63I&ZDR+9MV_?:] $CSMUX8STM=/
M_J%8=3\/X!?3_I AJK):6_SZ#-F8YA,_&6*? +_'#BRF&8[DR5:1F$Q*^,E"
MS[C+"F5+)POJ]5%M\3 1MWAV7U%YD[DZKR275YE2U$*)$QV/5S&G4Q:U,)^N
MG+L&'U12)PUN$M)DT9.*5\](#(R#'>0JUR9BD2CM8\!W%:^EK9%)&KK&3;.M
M0ELN1[:VF-:-(9</8DR;;)25*674]I!'6F,9C38W1,U6-7\/)7\+IJ9]$*)!
MNJ6T?@QU-KK;>%-2?ITMK6:2>)PDJ;<7YM4@K-R+$\XK\CRN7=U%X\QF]/51
MDUV'L5DZO4N/7E#E5C[EC'>7%:2Z:UMN%HV:'#4?G28(^BL.JG:+$:"D>2XA
MZMKHD-Q#[Q2G4JCL(;,EO$ALG%$:=#7L3N\="!'S-R?0\DWT3D3&X^.6;:K"
MS*76U%'75S518Q&'X[B)TRQ>U>=DJ;;U-I#B%DI*4$6GF!IF\@XQE,?%.5<#
M3A5CDE[F%N]>T5U%::<A+CO]A3).R''"4R]#)I3:6S21GM3LU)1Z$>O(F,Y-
M&QWES"/L58Y1<9O8.7%!<QF678:F76(Z&4NON.$;3D(V5$A"B+=HGM_./0/I
M]DC)ILE?.))$>OCKH"/GM>+3#YW7@3#3?V)=GL\JR]BU$I$Y+:H"8RDETT=F
MMIGENZ&I"M.I&"HJHQ?*FL2Q_B23B4X\OI\FCW$O-7&FE5FR-;^\7+-J6:U*
M6\^QJUVM"<W+4E1$DM0!51F#,2NX\:PZV4_5\BLY%(N2;9*J]SN7ZK!,AI[N
MZK,FG$DII*=Z=%;B(BZAM/A_&)./,9B_8U?N^?:99?6"'EH23LB+)F*4P[N+
M4S2ILD[=?81 ,;G"LMY=;A]O4U<FX3CF4UEU80H"">EG#CI>;<4TV9IWJ2;B
M3VD>N@$-?Q\3RRGR&'D#^/37X</DZXM76HS;;SYUMI7N1&9B4;RU:)Q:=Y_.
M(M3TZ (G[#9O0LX?D#L"YCM4%KF*)A4,>%-M(YW=H;L68U'F-/I<;6TE2%*0
MGN)2LC+H:@&X>%*"30XG,5*@V5:Y;VLZW*)=O17)I%,<)7<6U#::9CFZ9&Z<
M=LC)LU&6NNN@E7^3CS"-R+33:JLGLT1U;D=618Y60;.Z5*7((U05N326F-&4
M@DN=S9HI?SE%M+4-54>%97BN%X8N1CN24>40*RXJGK6@9A73J$R+1V1Z"=7/
MH6TZPZG:ZA]M24Z]#VIT!7TIQNQ>QL#QZ-DU9#IKYF"RW-JJQ*6X<9:$Z$TT
MA!FE))(B+:@S2D^B3,M 9:3Y0Q_*V\QR9[$<<M7+/(%5RO2NQ(-[B5^<5IIM
M"K!$HD*@J9-!-J4EU/E0EQ.Y1Z J/Y'HLR9Q[F'C^KP^WN+#-;(KFDLX;;!U
MJH[T:"VXE;RW4['&EQW/JU)W*\NW774@L]I7VM!<<C4EAQZ_F[V<V3$^IE&T
MRJLDQO1QHS<:?(69G'3$6RM9;TGY3U;U48"+R/ <DE\=\PQF,???O[S+BL*=
M!(;]3*B,NURFGFE&KYJ.VZ:-5$9:'T ?0$"U=FV-I 772XB*UQIIN;(0A,>6
M3K2737'-*U*4E!J[:]R4^8C\2Z@C4')6"Y)<<J4"ZF#W\0RA-<UFDG0NVPC%
M9RK6+W"\3.2I9Q_W"!77&>.KN!SG:V,F$I&#UCL_(J"8:M4KM\D9C,2T$6O_
M '?8D+\/^_,!"8=@60U?'7"\1W'W8MW29)ZZ^:)#:9$9E]BR2\\ZI*O!2G6M
M_4]=2 5W ,!RN$6#X/?5N3N3L2N464MXBJXF/,N1G''%S69Z(OJ9)22</5@U
M]Q?<43AEMU!4[28!DD3C?C&&K'GF+VMSOWQ;M$AM+\>*NQGJ7)=42OFFRXWK
MHHSVF1 C;?+M+]H./;BJ.FE7Y.^G=.MKY2(4Y7IY+3Q.QG7"-'>9-'>;0ORK
M4@D'T4"-.5M#GMRS+DRZJPGPBRG#YL.YMZJ'4Y!*8K)Z')9S4QC1WFHK*4=I
MUQM"CU66AD6H*A)ZGZ3$:;"YV/.6$MGD&)/1G#2HCU?)7)R4W"D-/(=4XN6:
M5G%=9V;T:+U\B05;7N/[U.!99'8H%IO9W(YWT;:V@I#L1.1,/IEI5KKH49*M
M%:D>SH",;',"R=OD2AGV5 \53%SK-+AY]U+:FD1IT590I)EN/HXLR[9Z:Z_(
M CHV/WF(9I#RF;0/3($#,LNEQ<;CJ8.QDQK5B/V;*!%<=03Q,FAPEI2>]*'5
M+(O$!?\ X>'4OP.09"*_W4EW-;=?NW5"C85VHQ*0HVE*;W[B,W"0HR2O<G74
MC E5>4Z[/I^59M5UU)8M5MY3(@U#^/5]<Z=RM<1U"F[2QFI<..AIQ1MH01(\
MBC4DS4K0!5[;%<PIZ>$W28M=Q\EL<5HJZ3&:APKN@N9%?$[10KB+,+^:=E:C
M;4ZE[3MF:M346@*^K*[UGN^)[P;:9G]EOU34<S4RA[86]+9F1&:25J2=?8#+
M)
M
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M/OB(!Y8_RSQ=E60)J<?O(LZ]=:>**M#;J4RF8IZNE%D+;2W(2@_,HF5KT\?
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M+Q^_R*/#M639*6T:77&XIR=.UZIUM"FX^_4C3WUHU(R/P,$I=R/7J7@
M
M
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M89SR=D^-428TFV/#*:4U%E*T8=<K\C7.*,Z9:[2?2SV]5=/-J?0!QR!B>?\
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ME&JB*^D*U"VZZ(AU!MN)9;2MM6FY*B01&1[3,M2^X8(R@
M
M                                                  !^>5!_S*Y/
MX5-_X<< ?H:           #0?QJ_Y9,Z_P!6L_VM# 17P)_Y;\>_#+/^NN@/
MI$   &L:SD+B_$[96$8_!7 @LV154J965CJ:5BZEJ0917I+#?:3(6;J-VO0C
M41*42N@*Y;Y=H:J))5;3U75F]>VM-4U5)6RUSW55CJB=83'^L6ZJ.A/USZ=K
M1^)::D1AW_QVX\7 ASXLB=,3939E571HU=,<ER)]<@EO,(8)KN$LM=/,DBU(
M_D IE%S-@[F.1<BC/3)2ILQZJBTK$*0NX791=W?B'")'=2ZUL4;A*21)(MQG
MMT,"GE,YOP"%20KM<B8ZF?->IV:YB!+=LDVL9!K<A.1$-FZA\MOS%I+V'KH9
M&!2;R?)RK*6EM6)B*M-K954-'KX;[JUE92&VBCFT@T+;=<W["4OHVKJHM",$
M1\'ES#['(6L>CG.(I,MZL@7"X$E%3+L(IN$]&8F&CM+<0;+I?.VF:%$DS,@$
MGF&>T.%% 9LRE2[2U6XW4T]9%=G3Y:F$=QWM,LI4>UM'F6I6B4^T^I ,O$\M
MI,UJ"NJ)UQ<9+SL22Q(9<C28TN,LVWF'V7DI6VZVHC2I*B_]P!787,>#S\A;
MQ^._+TD2W:N%<KAR$5$FRC[S<B,S31VENI[:^A*T,TF23,RT <8_S'@^2W,6
MHK7)B?>9NHH[23!DQZZS5&)2G2A2G$);>VDE2O*?F(C4G<74%143XAN-IU6S
M=17K)VIF2V:RKF)JIW:GSY*7C1'AGV?KE[F%MJV:D2]",^H%)8N8\(+'5Y$Z
M]+9-$\J15,Y#D%;^]U)):810R0;JGE)/>24D9&CSZ[/,",=_G# (F/ED,U^;
M&05BBC?K'8$HK1FT>;-UN*Y#)LW2<<(BV:),E:EH9D8+3"L^9..:RQ*SF5]B
M<^%"95<V;=-*=730YR$2DM6#J6C5'U3M<<:5U3H2EI+H8%(B^YL=C7_(&/-;
M*2+B$.GF1LDF094^$OWFZ25[T1S0:B42DI8V*\Q[U>"#("EJN>9\$H;J33V$
MB43%<^U#N+IJ'(=J*^5(V=IF7-0@VFEJ[B-=RM$;BWFG4"F/<\Y<?T-K855B
M].3[FEM0;Z>BOE+@5KD@D&RJ7)2WVVT.=Q))5NT^70NH%-D C7E]S7@N.7=I
M0SW)SDN@..>1/Q8$J3%K69;27F7Y3S;9H0VI*OG:GIH9F1$1F"TC6.78U;DW
M(<;)WF6L?QB;30:0XC+K\R6[<5[,A+*&VC<4^ZXZ[M:2TC73]PS 2[7,>$'2
M3;F6],@OUTJ/73:27"DM7#<Z=M.+']%L-U2WR6DV=B5$LCU(^AZ$8[/-V"KJ
MK"PE*GU\ZLE1:Z5038$ABX];8]8;"(9H[CBI'_=;",E=>O16A:9">8L+^SSN
M0O+G1C9GII5TS\"2BV.V6A+B(:(9H[BW5(42TD@C2:?-KM(S()[$LRI<TA2)
M=0;[3\)XXEE73F'(<Z)))*5]I]ATDJ0HTJ2HO8I)D:3,@1!4?,.%Y%>QZ*K<
MF+3/>D1:FW7!DHJI\B"3AR&HLLT=IQ3?:<U\VBMI[35H"JOC?)O'M/6U5X:6
MK7+,OAIM[6=C-'*)^3"CJ['KY3"$.OML-GY"-Y1GKKMUZZ!-.<[X"J+5R*Y5
ME;.W<!=M4PJRLF3)4B$T\;"W$MMMF9$DRU/?IT_=(@*7?'<BILLHH.2X]+1.
MI;)E,B%+01D2VU?<41*(R/HI*B(R/H?4$:XJN<L98HJ,[&7)R+(+6K*Z91C]
M//6<J'WE,K?:C:.K;2@R\R7%Z_\ 61 M-AUN3TUWC3.6T;RK2DE1?70W8C:W
M''V=AK(FV]"6:STTV:;MW334$:PX6Y>F9M75,K*WR8N,O583,?IVJY^(W'A5
MBD)=3ZAQ:R?T)UL^[H@C5N(B\H++SS#FQ^-95B,--B562*_,G)BY;+I+388H
MVT24)\R/)W362^A[BTT,@*;&P_)%VW'U!E]ZXQ$7.IH=M9ND?:C-&]%0^\K5
M9GM0G4S\RNA>)@BO5/.7'MHW+DKERZR!&KW;IB=:P94"/,JF-I+EQ%O-I[S9
M;T?-\Q[DF2=#(%IPQS'@-I6WIVB9M<FHK7+:SJKFNDPY3E/HI*I3<=]LE.L'
MH:3-)'H?11$9D1A&U7+_ !I1U-/4XY4V4:-.:DJQJAKJ.6RY*BQ%(4X[%C)9
M1]49.DXE9DDE%J?B FI?,F#M4]+<5CTN\+(D.NT\"GA2)T]YN*K9(4<=M&]!
M,J\CO<).U7E/S= *>%ASCQ[!K:"R8ER[-.4)DG0Q*R!+FS)*X"DIDME':;-Q
M*V=WUB5I2:=JM>I 4]#YGPDKY-(1SU,*G^Y??J8$DZ8K0W.R44YNSM=SN'V_
M';O\N[7H!2#Q;G>JL:W*K3)8,FI:H\DD8U61T19#LFP=2OML-,-$@UNR7#2K
M<TVD]A::]-3 I?<1S2DS2))D57J&)4![TMG63X[D.=$?-"7"0^P\25),T*2I
M)_-4D]4F9 BL6G.?']/:S:J:].255.15W=BBOEKKZ^2\:$LE*E$WVFTN*<2E
M*MVG7KH0+2(S_-^&)-LY79S1E>Q\??1&LKN12N6-54OR";43<B6IE;;6I+;-
M9$9DG4M^@"5N^;^.L5LI])8O2XZ*%^/"NY;5?*77UARFVU1CDR$-FTVAWN)2
M@]=-?D IF0N9<%DUU]9S),JG9QHF'+5FVA284E#,PS3%=0RZV3CB9"B-+.Q)
MJ4KRZ;N@%)7$<_HLR>F0H34VNN*\FW)E1;Q'JZ<VR_N[3O:?2DS;7L5M6G4M
M2,CT41D"*9;<TQL5Y"RK&\FCR%T=/ J[&*]65\J<ZQ&D)D'-DRU,)<)#+7;;
MZZ$?4^BM#T+2VM\GX2['R26W9I5$Q2&Q9W#Z4+4V4"7%.8S(:4DC)UMQHE;5
M-ZZFDT^) BS5TYJSKXEDPEQ#$QEN0TAY"FG4H=22R):%$1I41'U2?4C 9(
M
M
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M$"
M
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M$2VE*61+3]8CJG4O,7R@+  Z)::0M;B$)2XZ9&XLB(C49%H6I^W0N@#N
M   #$GU57:DTFSA1YJ6%DZP4EI#Q-N%X*3O(]%%\I ,L           '0VFC
M=)XT)-Y*30ES0MQ),R,R(_'0S(@'<              >"(<-N4[.;CMHFOI2
MAZ2E"2=6AO78E2R+4R3J>A&?34![@
M
M                                    _/*@_P"97)_"IO\ PXX _0T
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M+?MWIT4?E,C^X")8
M
M
M   'YY4'_,KD_A4W_AQP!^AH           -!_&K_EDSK_5K/]K0P$5\"?\
MEOQ[\,L_ZZZ ^D0     !"9/B&-YI"CUN4US=G7QI+4YJ*^:NR;[&NPUH29$
MM):GJA>J3]I )L
M
M
M                      !^>5!_S*Y/X5-_X<< ?H:           #0?QJ_
MY9,Z_P!6L_VM# 17P)_Y;\>_#+/^NN@/I$
M
M
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M[>1?[#O?[JD_1 >]?FM9/LH]2N'8P)<LG#B^O@OQFW#:3O4E*UIV[B26NAF
ML@                               /SRH/\ F5R?PJ;_ ,.. /T-
M       !H/XU?\LF=?ZM9_M:& BO@3_RWX]^&6?]== ?2(   *U5_P#GC(_P
M*J_^-, 64                                                !6\
ME_\ KSB?_K-S^H2@%D          $-EW_E.]_P#5TO\ \!8#WQ[_ .L%5^!Q
M_P#PD@)(                               %:X\_\CT'X$S_ /% 64
M                                              !5,<_\W9G^%0?Z
M@R M8          JF0_^<<._^5L/ZFH!:P
M     ?GE0?\ ,KD_A4W_ (<< ?H:           #0?QJ_P"63.O]6L_VM# 1
M7P)_Y;\>_#+/^NN@/I$   %:J_\ SQD?X%5?_&F +*
M                               K>2__ %YQ/_UFY_4)0"R
M "&R[_RG>_\ JZ7_ . L![X]_P#6"J_ X_\ X20$D
M            "M<>?^1Z#\"9_P#B@+*
M                    JF.?^;LS_"H/]09 6L          53(?_..'?_*V
M']34 M8                               /SRH/^97)_"IO_  XX _0T
M           &@_C5_P LF=?ZM9_M:& BO@3_ ,M^/?AEG_770'TB   "M5?_
M )XR/\"JO_C3 %E
M    5O)?_KSB?_K-S^H2@%D          $-EW_E.]_\ 5TO_ ,!8#WQ[_P"L
M%5^!Q_\ PD@)(                               %:X\_P#(]!^!,_\
MQ0%E                                                 53'/_-V
M9_A4'^H,@+6          *ID/_G'#O\ Y6P_J:@%K
M            !^>5!_S*Y/X5-_X<< ?H:           #0?QJ_Y9,Z_U:S_:
MT,!%? G_ );\>_#+/^NN@/I$   %:J__ #QD?X%5?_&F +*
M                                    K>2__7G$_P#UFY_4)0"R
M      "&R[_RG>_^KI?_ ("P'OCW_P!8*K\#C_\ A) 20
M                *UQY_P"1Z#\"9_\ B@+*
M                         JF.?^;LS_"H/]09 6L          53(?_..
M'?\ RMA_4U +6                               #\\J#_F5R?PJ;_PX
MX _0T           &@_C5_RR9U_JUG^UH8"*^!/_ "WX]^&6?]== ?2(   *
MU5_^>,C_  *J_P#C3 %E
M         5S)$J5<8H:2,R*S<U,B\/\ ZGRP%C          $-EQ&>*7I%U,
MZ^7_ . L![X]_P#6"J_ X_\ X20$D
M"M<>D98/CY&6A^A9/K]U)& LH
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MF8H__>= =OU2\P_3UFW3Q_G:OY4!T/X4<J)XHY\_9H3YIWDUZP]YI^73NZZ
M.5?"AEB#T7S[FJ3^0YBB_P#YH#E/PF9>HB4GGO-E)/P,I:C+_P 4!U+X4<J4
M\J.7/V:&^DB4IHIA[R2?@9EW== '?]4S,#U(N>LVU+Q_G:OY4!T;^%+*G5N-
MM<_9HM;1[74IF&9I,_8HB=Z .Y?"7F!]2YZS8_\ ^[5[/_RH#C]4W+R3N/GO
M-MOR^K5I_P"* Y_5+S M"/GK-M3\/YVK^5 <?JFY>1Z'SWFVO3IZM7M\/^]
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MXD ^EZJ$NMK(5<Y(7+<B,-1U2G223CIM()!K422(B-6FIZ%H RP
M                      ?+UQ\+EO"<F6/^.F5T-,IYQUJ*B84>'%;><-26
MD:NI2E"=VU) /(OA6R933+Z?B!S(V)!I*.X4TS2X:RU3L/O:*U]F@#W_ %2\
MQ_3SF_XVK^5 /U2\Q_3SF_XVK^5 /U2\Q_3SF_XVK^5 /U2\Q_3SF_XVK^5
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MG5^4G1S\=9<<6XIMV&Y'GF9FXWHE:5MJ-*D*T/123U#:8(
M                        #2_+N-/9-FF/.5T2BS"?20)DJ1QWD+_9;?CR
M7&FDV#!&V\CNM*0;)*>94C1P]#2K34JD5-OC](W78Y3XNF@MF.0*=N\PVX)F
MQBTSUG'4\EZJ4PKMMI<2GNM*0?E6I>B$ZZ )6MY-Y.L*7">22LJQ&+YQD4"K
M3C/HS-Z#6S92V&S1+)[5R0:4%WB4WM29JVD6WJ'K6\B\I>FHLVG6=9(QRSR]
M>(KQYN"IIWT;EN]6(E'*-U1]]!H)6PD;%)+_ $C 8]KRYFT#*FIT*W8M\?\
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MFID6T                                      ?GE0?\RN3^%3?^''
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M$)LVV186=W>SVVHS]M=S%S9)18YJ4VPWJ24(;2I:EZ(06Y2C-1F8(MP
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M<M:-=I'MZ(;1J>QM/0O$]5&9F&TP
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
2                    '__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>px_cyclacel25pg02-4c.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 px_cyclacel25pg02-4c.jpg
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M_\0 P  !  (" P$!              4&! <" P@!"0$! 0$! 0$!
M      $" P0%!A    8! P($! ,""04)#@(+  $" P0%!A$2!R$3,2(4"$%1
M,A5A(Q9Q0H%2,],D5)47&)%BTI16<H*20Y.S=+0WH;'1LF-S--0E-65U=CA3
M1%6UP<2%-F8HPF1'$0$! 0 ! P(%! $# P4     $0$"(4$#,1)189$3%"(R
M4@1Q@:'1\,%"L>'Q!17_V@ , P$  A$#$0 _ /?P
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M                   (C*I,B%B]W,B.&S*CP)3S#J=-R'&V5J2HM=2U(RU
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MQ)W)6HV"61(,C^.@Z_\ YV[RSCG/C>67CZ_JSZ=/]>[/Y&2S>GK\FTQ\EZ@
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MW@O).&\B<<VME>R(;[D'*&<CLO4NKJ9"=I]E:T$?Y>Y:R09]5;3+30P*YR>
M,A=YY1D:9+7]T*[-&92*?>1*_4S3"F$K)O;J>J]'S5KIU,@*K?*/"W+&;9-F
M[,ZIA9377*#/#+FSN9,6'1M$T9*:16MD:5OJ/0D.F6A*(EJ/0U$"U<,?XHS>
M'G7'>13(D9FOQO!BQFT),@EK38);4C1!$GS(UT\WX_@"*1$X2Y?HN*..\2:A
MHM8=%+M5YGA\2Z<J$6C4Z0MV*9S&2+R-:[E(UZGIT/X%K!_PX<EIXRSS#(E7
M35DV_P AK[FF8A2UK@LQ6C(UM$IULEZ,DDBU4G5?7I\Q6QZO!N6<QY;I.0>0
MZVKHHV%5LZ#5LULM4PK&;8,K8<?+<E*FF=JS-*'/.GH77J9$57$N!^0Z;#^&
M:69'B>MPC))-O?$F21I3$>E+=2;9DGSJVJ^D%KYE' /(-U@G,E$PW$199?E/
MW_'T'(+8]%1)2Z27%;?RUF@CT(_WNAGIU!*@?<E,NGJ7CZR9?@T'/.]['SQ:
M#,1-DJ@W[+L,R+0MQIZ)V+4G:E2ST4:B(S+CU3@V*0L&PZCQ"OT.+30F89.$
M6G<6V@B6X9?-:]RS_$P9>>U\6\V8;69YQIA%=46V%YW-GRXN0S9:H[]8U<-D
MS(0^QM4ITT(+1!HUZ^8_'815JI.%K[%N0^*IU:MJ9B^$8]+IK&<XX3;ZY#S2
MTDM#.A]%+/73=Y2/\.HJ>]R''N1\F\;*Q?%V6'[-5A#E&U*=)AHV6%FI>JC)
M7^30#%[Q[ L'Q)YV3BN-55)(>3L>>K84>(M:-==JE,H29EJ7@"-/X/P??IX.
MS#C#*ELUUED4ZTD1I$=?J6VREJ0XPXO0DZZ*26Y/R(%J"B\9\U9PUQ]A7(-;
M44F)<?38-C(N8$LY3]HY4-]F.EEDDI-DE),^YOT\=2(M"2 QK_B+FV[Y =YU
MC+KX.=TT]B-C6+*=;<AN8^VA;;S<B22->\Z3RS-7[OFVG]&T*Y[C*TLIY2Q&
MCQ"WCP\WS>$6)9Q2176Y4J+6&ZQ.4MXF]=O;3O,U*(C4A);=4Z@N/8-? B54
M"+5U[26($)EN-%81]*&64DA"2_ DD1 R\93O:SR3;<?X%CKZHT*SJ+.T8R$F
M)>B54MM*:D*(EI26_;L/R?B#57VWXCY?9KN7E8A,9I[7++N'84+L:6<=UZNC
M:I<9[S:2..M2-"(R_P!SJ1=01'X'P9F-=GEUDJL5K</H<@Q*;CQ0&+9ZYEQY
MLEQ*R?EOO)U><7MZJ;/0D;2ZF1ZBH0N N3[7B_":.ZHH/WSC:Q?.)5)M7&6K
MFLF'O?TDQMJXSNXB)![O#4ST\ 6I*5P'F=GQ'R'3P<5JL9R7+G:M-;5LVDRR
M?*)6S&G])TZ6ZZAQ9$2]AMI3TZ?(B%;0Y.XZR?*9?%#U.RPI&(WT"SNNZ\3>
MR-&2E+AM^4]YEH>A?$$:2Y$X!YCS?]95]K40;ZXG63DW'LTLKN02(M6;R%MP
M(=:25-LN$1*)2U$2=JE)U/H8+6TWN+<ZD<CY=E;,&H*#>X=&HH<:U,YD)4YL
MVC<8E,-DE2F#(E(4I)^'70_ $5'BCA7/\;Y(ILBAX\QQSC\%$@\I@UMX_:0;
MMYUHD([,-9'V$)7JLDN+5M+33JD@*VGS_@>1\A8M25.,-LNS(-_76D@I#O92
M4:(;AK,C,CU5YBZ 8K6083RK@W+.2<E<955?D\+-(D2/:U5A+] ]$F0&TLM/
M(<41DMK:6JD$>XS,RZ:$8"LTWMZS6AK.,F5/0["SJ,M=RW+G4.=EAM4HT;DQ
MDJ3JLD$GIT+4R^!'T%>FIT;UD&3#)6PY#3C6_P =.XDTZ_P:@CR-5<'\Q?W-
M8[QA/IZZ/+Q/*HEM%G-V!+3,A$[+??<TV>0T*>0E"3ZJ+KH1EU-5L?,^&<AS
M'E;+[MU;4;%LCP1_%&)I.;GFI[TE#J5&R6AFA.W4^O7P!*I/%? V64V2XE^I
M,)J*^/B9$N;DKEY96KLZ1'026'8$,WTMQ3U21N$XC:9>"2T)(+6[^7:#D:[Q
M^(_Q=>(I\IJIK4]$>3TASV6M=\5\R(S)*^A_CIH>FNXB-5XOQ=R/D_,F.\GY
MGC%'@T?&&99*9I74R)EH_+:6R1O.-$2>VDEF9;O-XIZ[M4AJGC3'.7<^X0MN
M/,6@5+V(9)=S&W\AD2E-R*UMN6AQY*XVS\W?L)3:FU'IJ9&7@9%7C.?;QDT+
M.KC(<>QN-FU3?5M?"89EW4RC773*V(B&EYY,9QLI+*DH):F]=W4R+:7U"K#,
MX>Y P:PX\S;CVKJ+&ZQ6JD4MUBK,AZ%!=;FK6^M4-^6;JT[775G^:K4RTZ>)
M E9&5\><TY]B>)JS!58_DE?F\+)'Z^&LF8\&EC$Z7IR=V_G.)W_5\==-3TU,
M*3R9P5R[FUOG4:PJX62G:RG96(9-:74AMBJKS42T0H]8E)MD\2?RR>,B+751
MJ/4]2UM#%.,\NKN9:+/;"-'8IHN"1,<EMMODXXW9-/)<6VDB(MR"(CT7\01*
M\F<=WN6\I<99-#88?QW&SNF[]+SA(7V;2(W'22$&7FUT5K\@&A\;]KO)='@L
MRK?5%F9$]E--*;6Y+U05#1I<[6BC2>A[G3T;T\ 6IS./;YE[>>9E<4F+0,PK
M,R?*9!DS[N=4MU<EU)D^4N+%=;*6RHSZ)+KIT^9 5F9Q[>\ABY-C^3T6.0\K
MKHF-Q<<L,:8N)V/)CR89D:)$:0AWN*8+P[3KBCT^:C(TDKMM^#<^J,%XW=Q6
MDIE97B&0?J.SQ^!)D1X#JUGNVMOS7'E[B)""69JT,]327P K.R?AGD&]M>:[
M1N)$;5R!44\6F:.41D4J'%:;D(6>TMJ4K)1)49>;^$!8)W%N92++@64VS&[7
M'\9363:OEY%J@1HVC/E_,+<VOKT^'S ><<CNIN)\1\B\;T&68Q.PE-E+6T\^
M^\SDFYR4@S@E7.H;7W#<3YGM#02"69&>A;2O8>+*Y @KPFI:K(184W0QT7DQ
M]U:+)BP;CDE#;;7TFG4DDK7KU/PTZD;#!&O>/\0NL=S#D6YLT-)@Y+;1YU6I
MMS>I3+4)IA1K3H6T]R#Z JAVW%&9RN <EX^C,1E9/:6TR=%:5()+"F9%[Z])
MJ=VGH?9^&GCT 1>9<,V;6<Y1?0\$K\YB90\U/@3)5J]5/5LPH[<=QN2@E:/1
MS-LG4&U^86JDF1]#(5O3":%6+XG44#C$**]!C(;?CU+2X\!#Q^9PF&W%+42-
MQGMW*U^8(U)C_"M^G@G%L0F/MT_)F([Y^/V\9SNIB63;[KC9&LD^=EU"^V^@
MTFDTJ/H9D0+4;B'&/(G&U9@&2T]5%N\DH,?DXOD6/G-3&-R-)EHEH=BR5I-O
M>VXWYDKT)23T(R,@'VUXNY'LJJTSAZ!!5GUEEU'EQXPW,VQT0\?)EIB%ZQ3>
MTWE-MZK=V;-Q]"^89UYQ/F=I+R/(H:(K-TWEM-FN.0I#WY+[E=6L17HK[B$J
M[>[\YM*R2?717@ YYMA/)_+^/STY+4U]%'KY-;88YBLF7ZLI4RN?4Z^<V7%2
MG8T^VHV$(:,S3]9F1] &7Q/QU,I<L?R-_C^IPBO9A*B1T)G.7-N[)=6E2UE(
M)?::C[4Z=O::U*\Q[? !,<C8MEJ<\QSDG%ZB+E2J:#.JG\<FR$0U(*P-LSEP
MWG4K;2]H@VG-_P!39[2,!5^#^*\UX_S&WNKJLKXU%?0MM? B3WY:J!IJ4Z^B
ML:[J$I<97WU.FILDI2LC(BVZ :M^7\=.95RQBF2V5;"L\4J:JTASF9R6W]),
MM;"F32RXE1'_ ":O-\ &5R=Q^5QQ+E&#X/6PX$JUAN,0XC*&X48WG#3J9]M)
M)+H7CH Q,\QG+HF78QR1A5?'NK&DAS*>UQ]^04)<F#/-E9+COK2IM#C+C*5;
M7"T6DS+<D] %1<P#E2PBYE;HC0:?)N4)L&#;ME(3+:HZ"%%.*I9&;9%*E*;-
MPMJ=$;ED>[1(#*A<=)Q?CC,N)LSF0X_%"8SK6+9'+?9;>CQ9B5.&U)0M*$]R
M(_YVW=Q]PMNNAD D_;C O96"'R#F&U>99VZW<63R6R:_HS;#<6"E)%UV>G90
MZ6OQ<,#4GEB.6:#*Y5[B<"/FF)6D5EB3BTN8W6OPI3&XC>BNN-K;6V\E7YK;
MG7<1&1Z= &NY/#&:V.#<BR8]96T&0YG.IK2OPR%(W5L15'(8?5N?0VVCU$KM
M'W5H;).NW4_$P*[\KP#D++,MDW&38DWDE9:PX!TE5-R!V-4X[**.2);4F+&V
ME+)3WYANH0M2TZ)+;H0#GB7&/(.*0^'S75QI[F*PK6@R:.B<EI3,>U=8(I;"
MS1HX2$,FLV^BNI)+KU(*SC_M[MJ1B!AKO']#:>ADI;7G=C.D/PGZU#N\EKJ4
MK2OU7;\NS=VNYY]^G0%K8%MQEE<S".9J-EIC[EF]E-E41&\1)6P_ B1D=Q6G
MD/<ROH8(E,XXRM\QOZM"UHC43F)7V,VDM*B4\R[<MQ6T*;;,BW:$TL_$@%!P
M;ABYJ[K&(TWCF@K7<>D,/VN7/6$BS1+."1=MVNA;D*9><625DM_0FBU(B7T
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MKTV!'.)'.)82H2":-9N=4,.((SU/Q/J I7^"_@K^H6W]M6/\\ ^'[+^"3_\
MR%M_;5C_ #P#=5UC-3?XQ-Q"Q0XJEGPUULE#;JVW3CN-]I1$ZDR62MO[Q'J
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M+EUVL>S6/,?74I>1"]'.DP2(I!H->XHZT;OY-.FO@ H7^"_@K^H6W]M6/\\
M^'[+^"3+3T%MU_\ C5C_ #P#=3>,U3>+)PY*7?LB*\JA*#><-[TI,^GT[V[N
M;MG[^[=KUUU :5+V7\$D1%Z"VZ?_ !JQ_G@'W_!?P5_4+;^VK'^> 7OC+@_
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M_A/MBXFX^R>#E^-1+%J[KN[Z5<BTFR6B[[2V5[FG75(5Y5JTU+QZ^(#<0
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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M;=;=2GZ'3)HU(0I1?4E*C+4M2T(]",KF
M
M
M       #2GN>XUR'D7 (JL00E[*\:L6+NLBJ,D^H-A*T+:(U&1;C)>].I]33
MI\07%)LN?^7,V:JL5XTXYN:+.W)+*;V;D$(T5,%I)_F_F*T-23/]Y24*V_21
MJ,@(OON?HI]_P-D];$KUW%SVX2XT>+'4\\I]$QC<MIM)+41DG>?EZDG7X 8S
M(7'_ .I_;G7\=FR51)L<6BP>VXT;7IYJX:#U=;(B,C2]YG"^K77X@-,XIS'R
M5QEQTQQ-,XRR"1R92QEU5)+B1?55+^W<F/(-Y.NJ4$:=Q()25;?J3KY2QV<W
M1.4#Q+AF^S"EDW^74MZS;Y)#QV&M\VT,K0]VR2UO22R0DD&K78:]=.@&-B0?
M<FY:%.:8XRS.$_&A2YC#EA4J:9<=C,J<;9U0M:MSJB)M)$7U&"1IGCSVW<QY
M3Q_9V%GG2\7/D!R189)CDNI2\\XX\XO13[CCB'$J67GVD1;=WS!:X1<%Y/SK
MV_UV,N4\J-R5Q'>DY619S+C*;&%%-?;2PMTD)622/:C:>ADT1?O$ O\ 8<_<
MM9VJHQ;C#CRXQ_,')3)7]AD<(TU4%A/1U)N*VFHM3UW&2%[2T2DU&6A(J?,%
M<S7^Y0\FR[CRVSS$"Q]B(IJNJEV#)S#-6BR)6C>J=#U\^I:@N+?C-YB-SB'(
MV.X%Q'>8-,FXS8NNNRZ<J]N:XTPXTRP@VU*-QW5]1H1I_&!$#PWS?8\<<98]
MA5MQ;G$JQJ&'&I#\6G6;"E+?<=(T&M:%::++Q20+N/2F4NO7''=T]&BOID3Z
M64MF"M!^I);\11I:-!:GOU/;M^8,O-?MV]L7&MUQG29!R+ASYYDX[*.8U9.S
MHJM&I3J6MT;N-I(C;)'12/-X_$&MU/<[8"G(>9N&:].-*LL+A'+C63#4-3M;
M'C?E$A#I(3VVT$2?*E6A= 3&%G_$]3C//G#\[C_#T5U.U)ENW<RJA*1'1MV=
MLY#C:=B="W;=QE\0%>PSC;F7E'.\VYCK,DE<;O6LQRHKHUA4=Z6]41R:-K\N
M4;>Q&U#>NB?,LE?PE1%#A_(& \;\T<$3ZR?;QX\3[KB]M&@O^FFI?[*7D,F1
M+3NT-M7:0I1DKN?(P&1<^W+L\,83R3@F-HA\J8Y!B6%M328JGRLB0V1OMOPY
M!*)3Q'YR3M(U>9.FXT;15URN==\D9G[?<O;Q>RAQN_:MY% ?A/I*O6XU'9=;
M?W(+8V9DOMJ61;T=01I/%N*N1X&,<MLW-59R%XO1N8CBC;D5XU28\BV5)<.(
M6S\U/D4K<WKY7/D"MA9+A7(_*>0\3<?4Y3<6K<'QFNN)F02Z]UR.S<ICL;6R
M2YL;<=:VMEL-6J34O4O*8"0AX'RMPWSSC&>WMO*SZ#F"5T>46D&L4PJ,T26F
MV%R$1S<22$&32^X>GE;47[0[<4MLH]KF3YECMSAESDF#Y#9NW6.7./Q_6&2G
MRV]A].J22HDDA)ZF1ZI,R)25$9#U9^33.:N0O;YR799K0N0E7#C2L/Q=F*L[
M9F"4MM6CZ$%N6>W:1:MI7Y%*,M%)!%,PZ]XNH\:H(5U[=LDF9'6P8C5A9)QQ
M"^]-CM(2X\2UJ)1[EI->JBU!5TY%?R; .=Z#G=K$[6]PVUQ]%;8QZU@WK""\
MO5>CC)'T,B-'U*).NXM=2+4C+XF3DW)7N$N^:'<;LL;PQFD32UI73/II4ETU
MMJU2V>OE+:X9FE2B+REKJ9Z!+9)1WCWO&PZ_9K);E#'QA]A^U0PXJ&V\9S]&
MU/$6PE>9/E,]>I?,#L9W17<KW;<9W;%5*D4,6EL&)MDAAQ<1E3K$]))<=(MB
M3/>DB)1_$OF!V4?CG)<N]KC%]QMDV#7F1T:K%^=B=Y01O6-2FWTI2EIWJ1-G
MY$F?BHC-7E,M#,OJS\SRGGZS]O\ ;M9-C[_ZUSBP.JI:6LAN*DP*>5U<.9VR
M,DZH);6JR29$I)JZZD057/O;%S!1<9140,^/(&<()%I08U#JDL.(D,JW+..\
MVM3BEI)2UI(TF:S+PU/H*F,VR[)?[U.'^8Y&$9!818N/R3NJVLK7W),>;(;D
M1W&30M*=NUQ>I;S+5'4O$!LY',V;<A8]DD'CK";[&\TKH'KZE[*ZTHT*2XV\
MV2HZ#-W0W5H-1(W&1:]3Z$"1YRSY%7R9C4>DI^$+NFYY=7&3+M(5<JK@-2FU
MI[[YK0I*30YHK3O(+;KKO\NIE>M:C/["BS/%>(<AK9<J[F4*)KV4&?\ 0I$J
M$V2)24J41&M9*(E*TZEO3J74$43WBT=Y?X%C$6AK)=K)9R>"^\S!8<DN(91'
MDD;BDMDHR21F1&H^G4@,8;G'AYC[BN4JW)JB4K#,AQ:' ]>IE:8SCI%%T[+R
MDF@W6U)WITU-*DZ_ !KW@KB[D*#REGF$\A,S'*MK$9&)U^0KC+3$?K^ZPU'[
M+NA(7HRK5*=QJ21;3^D%U+<=<E\@<!88KB3)^.+VZR&F=E-XS/IXRI5;/;D/
M+>0:GD]4EO</Z$J42="4E*BT ]6UZ3/>4\.XSQNZY+QR3D&:75DW#E5U%'(G
M84:22U-N24M[TEL)'YAEH1&HD_#4$;J!
M
M
M                                                        $1^F
M*/\ 4IY>J+OR+T95J)BUK7VXG<[JD-H4HT(W*T-9H21JT3N,]I:!+@
M
M
M
M
M
M
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M:R)*S(MQ$>I$?QZ] 9?0
M
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M]XKG8$3%UG/%TAZ?(KC5VFK I[Q2I;;:U;==JT[$$>TU(,_WM",M6*'GW/\
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MR_*5KN=<;025+/77JHRU!EF
M
M
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M4M)$HOF6I]0'>
M
M
M                          \PT&'XYDGO#SVUNX)2Y^/0*6?3O&XZCL23
MBLHWDE"DDKI\%D9?@"]FM^9O;YQ1B')_$6-T-*Y&J,KM)$2]85,E.F^RVY$2
ME)*<=4I&A.KZH,O$%S5I]T_'F)\9^WF-C.&PU0:;]1Q9784\Z^?=>:>)1[WE
MK5UVETU Q5?>-26%QRC1R*IXV+&DQ.1>L+3U/_V7(=D*T_$D)4K^ #%3]T^1
M/\M.PLFK5E]AQ7%ZBTDI2>XDS<E?;/MG\C[9HU^.J0,7_P!UC6-N\G<2MY?5
MS+K&U0916%76$M4Q]OR:):)M;:C/=H?E470#%R]O]+P3^O%R^/<"R;&LAAP'
MW2L+YJ4U%-E:VVEMI-V2\DUGO(R+;X$9_ $U%VZ2R3'?<UR(HC6T\4C%JY:O
M!+%!#[;IMG_%<=7N,_ S(%5?'?;GQY8^VZ+R75M2ZCD&-1/WC-W%F2"5ZN$A
MQXORS6:$DKM[?(DC+Q+J!6XL3YJF1?:S%Y<R%TGKJ+5/MJ<<+3U-C'?7!8-1
M=.KKJ4&K3YF"3JTO[?F;KA;DS$6,DL%2*[F2E3,E*=4G5F[WKD-(7H9F:]CB
M4]>IJ>T_=!=;!]VW#7'K^!YERR[6+/.FV8)HL?4R"01I?CQ"_))SM?R7E^C\
M?$$S4OQWP[Q]@_#DK-,:K%Q,BO\ "M;24J3(>)SU,!,AS1#CBD)U66OE26@%
M>8.)X'M^?P*M>SKCK++_ "?=)];:T[,MR"Z1/K[9-J:E-)\J-J5>7ZB,&F[/
M=%Q_@+?M_HLHIZ9Z')I8]7"QY4MR0B5$KY:T*-EUM;AD:R(]%=PE*2?Q!,>O
M&OY)'^Y+_O RY@
M
M
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M2/\ <E_W@9<P
M
M
M                       5^3@N$S+]&52\<K'\G:4AQNZ=AL+G)6TDDH43
MZD&LC2DB))[NA +                  K^08+A.62&)>4XY674J*DVXS]C#
M8EN-H4>II0IU"C21GUT(!8"(B+0NA%X
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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M%'H S@
M                                                   !Q<;0\VMI
MPMS;B32LOF2BT,!X=Y@X"XFQ7E_B/%J*@.+1Y1-E,WD7UDQSOMM*CD@M[CRE
MHTWJ^A2?$&JF?<?BF(\/Q^'X6)4[[-#5Y2=E]LB+=F275DY&=<2UWW%J4M>W
M1*35XZ$!B)YDY>A<F9OQ%%C8KD6/*K\IAN*=R& 4%MTG),=.UHR<<W*+351
M8L.,UF0W',ON1JL2D^BR:97-,54K=VS1)<9,D&2R^@S/H2_W3Z_ !IQBLXLQ
M^AK<2Y1PW(^,>1(;[2O[Q(Y2)2%RD+W*>/5Q'E66IEV$KVGU2?3J'NS,5H>X
M?OW$SBM6W,:F**S3MVRB5 6?>+9Y='/K\O3KT!E^>%,?MV?X5:B+@6,CGI;;
MR8RZ_P!<:CF'*<]-TW''-)-=O<24[O'3S VV7RY$)%KP'$YK@S;3;2O(R: R
M3SE@[H2=J%=E2'3=+R=S16[4E:@B1XOJ,/ON<\5N_;91V])BE-W49Y-FN/%#
M4VXE6UA27WG5FM1$I.TS^K:HDEL-0"S\3X%C_N-S//\ D/E9#MXU5W#U)04B
MWWFHD.*QJHM$LK09GM4@O$BW;E&1J/4AZ)'CJBA\;>X')N X*G+#BO)*-5HS
M0SU*E-17'2)+K9&YKY%I[B5:]5$:-QF:=3#4=Y695C6<3/9_29/&8P/(KJ/)
M8GNN[I4.#+2;ZH*C,]"6OR?E=.XO3P)U1 -[<X\-IQ+%L9Y$XCB)@97Q6RVJ
M(RV6JIE/'(S?9=,M#<,B4MQ6IZK2ITNJED"9K"X8A3.?.29/N'R>$N+C-0DJ
MO *:09.$VMHM)$H]-$J-*U+)*M#\YG_^$D#6?[EDD?+' !F6IEDJ]/\ EX!_
M_L QJWDG'H^*\M9KD?./'5MGF)W;R5X_D=8\^IJOKR)6C)-M+;0E24FE/YBT
M&1H,TZDK4%;Z]K'Z31QF<7"LKF91CS$UXHJ+-HF)=:2DH4<-:",^A'^81EY3
MWGMZ FM)<NXXYCG,^2YCR_Q]:<B<?VK4=&/V-:Z^INK80@B6V;+2DI2>NOUK
M1U+<6IJ,%?(6<47'_MBS&VX;R^PLXKUBU$KXMDCLSJ#[@M*%M)T4H]>WJ;;B
M#V[]5)\VX#NO4;VB\6.<6(=<9D*SAVN*R5E?JG_4E9*9[W<)&_M]O?\ N[-=
MO[V[S E:DFYQ=Y_Q)P9:Y$^N7<0LW9K'YKIF;CZ8SB2;6LSZJ5L-*5*/JHR,
MSZF"O=UY_P"Y++_HK_\ S:@9?GYCF37E=[7\.PRAFN5;F<9:_36%@R9I<1#6
MM).(2HC(RWFI&[KU22D^!F#7=Z,LO:%@$,J*?QO-F81E%%(;?3?Q7')DB0A!
M>9+J'G2;,U'UU).WQ2:32>@)589QNFRWW?\ (V-Y!&]936F',1I\?>MKN-*5
M6F9;FU)4GJDNJ5$8+V4B+P%Q,Y[J)O&RZ SPUG'4V3==ZR86DLU-%O[O>[O@
MH_+OT O1@<U47'U+[B*+&LCQ.TR;"JC$8<&#C]'WWYJ&XQO(8,C0^TXI+9%Y
MC4YK\]0%_P )J>)$8#RK.X\X\R#"I[>,3X\U_(FY+1267XKZB0SWY4@CVFWJ
MO0B\2!%7XR]N/&&8>W"%F[T!^'G3E=836KV-+DI6B5#?D$RKM&X;6A=M!&1(
M(]/ R/J"UOSVPYM<9[POC]WD#RY5RSWX$J8YJ:W_ $;RFT.*,^JE&@D[U']2
MM3!-:8X+XWQOW$KRWEKEMIW(9LFXDU=55NR'FHL"(PAMQ*&TLK09:$Z2"+7I
MMW?4HS!=8M(Q(XTRGG'@NMFR)F",8?87U)%E+4\J"IR&C>TE1^"3]29?CM2?
MU&>H5?@O,+S"< M>+LN<2NASG%[.]P282C-LI"H[Z),+<HB(E*-!JV:]%?,W
M2 UZ8]K!$7 &$Z?U5_\ [LQ\$UXWP)GB-QW-RY!XUR/,[--]-.+94+4A;##!
M'T:6MF2P25;MRCU2?0R!I:6G'%^R#*D*N$6$5-VP<"L[QOOU,4Y\79#>,R2:
M5ZDIW0BTT7T^1$[L["*7VYSRQR))X6S15M*]"T[;+8G%!.0[L2;YJ*>1=HU'
MOU)&FWX? !:LJSV-QS[P\@OY-';7Z'<:8BE"H8Q3):5.%&5W%-FM'D(D:&>O
MB9 =G?Q/F;&?>[Z]R2/465&V]BW;]!=QRB34FTY#3N4V2EZ)5XI/7J0'90N6
MYEQR+G6?\RX[9DPCB"56PL8C[D;92X,DUS5EJHM2;5O=U+ZD&1=0&T_=;D]=
MFWMIILLJSUK[F;5364ZZJ1WD.&I"C+]Y!F:%?B0)GJ]4-?R2/]R7_>!'YO8/
M&X7=OL\5R9@>0999)R&<4*51-2W&66.ZK\M?IY3!$K=J?4CZ T]Q8\>.X'PT
MW8X34/5F/5E+(N:NFF]TGVB<:<G=I[NK<62S6L]Y&L]#U($:#X$X)PCE_C[^
M]'E=M_*<NRY^8Z[,D2GVCC-LR'(Z4-$RM!%U;-1=-$EHE)$D@7=4*;86U)P[
MS_P[-L'[6DP6;7(Q^3*4;CK<219)(F5*\-$]I!D1=-35ITZ );B&A]N-Q*PJ
M"KC'*$9;(1 -=Z^U/16G8(;2XJ1O*;L[2G$FHC[>W3X: :]8\A\48#RK&@Q,
M[J?NK%:MQV$GU$B,;:W2)*SUCN-F>I)+Q!EY>]H_#7&^11[S+KBF.1D&+Y6Z
MW1R_52D$PB"EA]@NVAU*%[%GNU<2K7X@UNL3AWE^'QKG'+T>7BN19$Y8Y5,=
M)['H"9S;7;DR"VNF;C>U1ZZD0&JMC]BW=<+>Y2X;C/1&["[:EHB2T=N2TEZ>
M;A-NH(SVK3NT46O0P'9@]1[=9N/8XQ=<,9I/N9,.$W/N([$XX3\IQM!.2&U-
MST%VEK,UI-*"\O@0#U?[CVD-<"YNRV6C;=6I*$_(DK01 F/#M@WQ 7#M>] X
MVR6MY *%$).;N)DQZ@IAJ1OE=[U"T&VH]33HR7X:>(--[\EO6^?7O"/!]CDR
MK#',AK&K'*+JM>/;;G$CFHS)W0C4A?8<,M2ZJ62C+5):$=?/O$^*<!X_3\N\
M0-.XUD=#81H[[34F0]'FQ7]24V\EYQ9GJ9%NZZ*3NU(ST,ABS^YFZ//G./>%
M:Z5Z!6=RF;2\>-24JC4\0NZ9J)9I(S,R4XDC\5,Z?$$QE>VC))/]W67\5W3Q
M.WW'4F=5&K<2^Y 7W3CK)1'H:=4N(3ITVI2!KROQF][;(G&Z5\FXM<V6:27I
M34:; .6VTZ?@RVTLI"&-Y:_O(/K]1&#2_P#(&.9QC7LVHJCD%#[-HC(V5PX4
MM1G(C05H?[33FIF:3UWJ))GY4J(NFFA$[KGSUPQA?!N'0N6>(VI.,Y516$0R
M6U+DR6I#3Z]BFW4R'%ZD9F6I$9)4G5*B/7H,UO7F3/[3&N![S/J+6+;*JX[L
M)?BIAVQ4TRE9:EIN;[VXM2\2Z@F-7X![4.+\GXJJK/)FI5AFN2US%M+RA4M\
MY;4N>T3Y*;+N;%$V:]/.D]^FJ@*T=EF8W>7>TN!&RJ0Y9S<:S=NC.:LU+=?C
MQX;KB-5GU4HDO=LC\="+7KU!>[<G#E#[=)W(58K#>,\FQ_)(1.S8-K<-3VHC
M:F4:'J;LUU)F9*/:2D&0(S/>)50+RXX?IK5KOUECDR(<UDE*0:X\AR.VXG<@
MR46J3,M2/4@,5SEKCO&/;;D^ <A<4(DTOK+IJHNZI,F1)C3(CY&I25D^MQ7T
MI46FNFIDHB)2=07U1DPB+./=;_\ (%_]V*LP&IJEGV\2>*J^G5B%[+YHMH*V
M*J5%*8EN1:N+4AA;1*D=E:"4:-Q):/4NA%N!6P>;*>XI^._;[4<K0Y=S81IC
MS5_61U*>GOQ3=CGZ5"D+2:GNP:6NB]=_[WQ!&PN%J;@=WD6K=Q#B;+,6R.*F
M0_"N;MJ:U":,F5I62C<FO)U4A2DIW(/J?S!$9PCQUC'N-<S/E3EAEZ^F2+F3
M45%<[(?:8KX;#;;B4M)96@R,B>)):_Q=WU*,P7>C:F.>V+$86%R..\RL)>88
M:U:';4-=,6[%57'M<;2VAV,ZE:BV.'J6I(-6JB01F"5I/V_<$\5Y3GG*D2\H
MCE1\1R14/'D'+EH].PU(DDA)FV\GN:$TCJYN/H"[J?P3"Z;W%\N\DY)R@3MO
M3XC9JH,=Q]3[K45AIIQU!N&EI2#U,FDJZ'H:E*,]?+H/1SHJ9OA/W#S>*L2D
MOEQ_F6.2K9ND?=6^U!EM-R#W-FLU*+_T99:F?4ED2M=J0'G[C-[VV1.-TKY-
MQ:YLLTDO2FHTV <MMIT_!EMI92$,;RU_>0?7ZB,%;L+C/G"3[2(>)OQY;N0,
MVA2Y&.+=-$Y['TJ5_0C,SU(]YDZ3>NNPMNFOE!.Z!P&5PH?*>&JIZJ]X4SN#
M)0PY5S&W7H=JEQ:4G$<=DN;T]S136Y3:=V[^,2= ]W R
M
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MSG6N,9 3J6V9BE*4IQA3.WRZK49>=&A'M,E;2,!(8%P]R1C=GEG+>4V-=?\
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M1M)/Y"^N\S\.@#Y&XLR5KW)3.6E.Q/TN_1%4H:)Q?K/4$;9ZFC9MV^4^N_\
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MS(M ]/@@
M
M
M
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MHUZ&K:2W5)(ST(STU =='E.,9.VZ[C5U N6F#)+ZZZ4S+2@S\"4;*E:&>GQ
M2P  KQ9[@QWQXJ6351Y,2NV=-ZZ/Z[N?Q>QOW[OPVZ@+"      ,=Z?!CRHT
M*1)::FS-Y0X[CB4NO&TG>OMH,]5;4]5;? @&+=9%C^-1D3,BMH=1$<5VT2+"
M0U%;4O0SVDIU22,]"UT <:3)<<R9AR5C=O"N(K2MCKU?):EMI7_%4IE2B(_P
M 2@#HFSH5;$=GV,EJ'!CIWOR9"TM--I+Q-2UF1$7XF8#O(R,M2ZD?@8
M     Q(-I66D6/.K)K$V%+(U19,9U#S3J2UU-M:#,E$6GP,!S@SX-G%1-K9+
M4R$YN)N1'<2ZTHT*-"M%H,R/11&1_B R     $7$R3'9]O,Q^#;0Y5[7)2NP
MK&9#3DN.E>FTW6DJ-:"/4M-Q$ DE+0DTDI1$:SVI(STU/0ST+^ @'3#G0;%D
MY%?):EQR6MHW6%I=03C2C0M.Y)F6J5$:5%\#Z ,@              8TRQKZ
MXF#L);,0I3R(L;ON):[LAT]$-(W&6Y:M/*DNI@,D        !CPYT&Q9.17R
M6I<<EK:-UA:74$XTHT+3N29EJE1&E1? ^@#(  &-)L($)V,Q,E,QWIKG8AMO
M.);4\]M4O8V2C(U*VI4K:GKH1F ^2+.MB&T4J8PP<A],1CNNH1W)*]32TG<9
M:K/0]$EU 90#BM:&T[EJ)*=2+51Z%J9Z%X_,P'3'G093TF/%DM/R(:R:EM-+
M2M;+BDDLDN)29FDS2HE:*^!Z@,@           '%"T.H)QM1+;46J5),C(R_
M R <@     !TRY<2OBOSI[[<6%&;4])DOK2VTVTV1J4M:U&1)2DBU,S/0@'-
MIUM]M#S*TN,N));;B#)25)46I&1ET,C(!]4M"5)0I1$M>I(29D1F9%J>A?'H
M Z9<^# )DYTEJ,4EU$:/WG$M]Q]WHAM&XRW+5^ZDNI@$^? JX;UA9RF85?'2
M;DB5)<2RRV@O%2UK,DI+\3,!D$9&6I=2/P,    !CQ)\&>3QP9+4DHSJXTCL
MN)<[;[71;:]IGM6G]Y)]2 9 #J>E1HR%N2'FV4--J>=4XHD$EI'52U&9EHDO
MB8#C%FPIS$>5"DM28LMI,B*^RM+C;K*R)27&U),R4DR41DHNG4!W@.)+0HU)
M2HC4@]%D1ZF1Z:Z'\NA@.0               .M]AF2RY&DMI>CO)4V\RXDE
MH6A9:*2I)ZD9&1Z&1@- HP3"/\3CU5^F:K[66!M22A>AC=COG<.(-SM]O;OV
MEMW::Z= 5&%"SIODSFF1@5W#QJ)3_992R=KT3CDO,431HCZ*6A+3!(26IH2:
M]5=#(BT,.5MS?DM\[B-77SG<43:XI RVXM:ZDE9(_P!^R4;;41EAE#B6VR-#
MBUNND>I;4IT/4P(VQQ+E>19?BBYN45ST&UAS9-?ZEZ'(K46#$=1=F<S&E$3K
M;;[:DJVK\%;B^ (I7,^<YKB^308C-G)Q' E5ZI+V7Q:160M_<NZI/II3:#,V
M&DMDE>[9Y]QD2D[3!<5^9*RC*.4^#;_]35KI3*BZ?D.4K!2ZYY<<HBI9L.O&
ME9)D(4ELMQ;F32>FIF8#X7)?*LGC9SW QK."G%4&Y/;P)<-'GIFI)LGNGDX;
MA2S;(W2,D]O=Y=@"UR[CE7.<JS&)@=] QVKPQ]FM@QI<$IJK2R7#:F.>J6M2
M5,,%WD-)[)&L_,O7H20%!N.0;_$.6LD@)B,0\TRVLQ& =DXEV10U4ITIJ'79
M#Y)09I):R1'2K8;JM"/:6N@3K%)R+.YFS:MQ;*8U/.9H,;.XNWJQN8])EMIF
MI:V,*<0VTVL^XITBU/HDDZ=3 <<4Y8SWE>-@^/8],BXM>7>.OY/D-SZ4IVQN
M+,*O)J(PZO82G7=RS-S=L1TZF C;O*,CNK+$,6S%R-,R7#N3ZVLD6<-HV&)L
M=VHERX\CLFI1-.*0Z1.-I4HDJ+H>A] @N2+[/^1^"\DY&<MX;6"6,A<=C$3@
MD;J:V';)BI?.6;F_U)J:[IIVFWIY=NO4BK7EO+.7SLXRBEQZ\=QVNQ1YJ!"9
M8QJ?D164]4=$AWU3T9M:6&DFM+24-GW#ZKUTT($9S&=<LYSEN+XU2OLX*Y:8
MHC);UBSJU3)D64U.3&<80VZZR9$LU:%W"U)):_48#A2W67JQ?ESD_$JPKG.Y
M%[+JJ:'HIPRK*%U,!E"&C4G<:"]1*[233W'%FGQ/4!+\/YK-S"TN\=N,MB99
M#:AH5)J[*H<H;Z*ZXHVWFGX+B";=C&DR+N)\%'L5KX@);V_S7CPJPQ=UUR0W
MA5[;XK$D/*W.+AU4I2(VI_YC)MM_[T#59RBNRZV]QTF%A]TSCTI6#PU3+9V&
MFQ<0VFWE=MMIIQ:$:K49[U+UZ)T(M3U((-_G+,96+8+7.2$5619'(OH]WD-?
M52;GL,XS)5%6Y&@,I<4:Y*^WU7JAHC49D?0".UWEKE!O$IC$)/=NH^1TE)1Y
M3;TLNIB6L6Z<0T:E0Y':6EQA:E-NFWHGH1I\0'9DV?Y_09+%XSFY@XU85=65
MO>9?78N_:/RGILEUN+&;@Q2?;CMH;09N.K4HUF1$G:>H"(LK_/<[N>(7S06.
M9NW=9'7-6T^MD,1WHS%8\E5@Q"E&VZ1/,>=I#IZ$YT5JD@$Y:\H<C8C&RVNL
MYL>XE\:6='87]HU!)M=GB]P2C?(F&U[6I,=*7%J6CR&ELO+U,!LO&,JNLGY'
MR^%&6V6$XPW#JFU)0E:I-R\V4R2HG25J266G6&S1I]2C/7H QN8LMGXG2USD
M+(ZW%FITPH\NVGQWK&836Q2ME?!92HY$A2B+HKRI1N5HKH0&-21^:>1&L0Y
M:KYS-Q?8M8XY'H+FWJGJ94QG(9+#>V5!7L4@D[U)2XDD[TZ*(B BU7^9\D<:
M3[2DR6^BY$=CB]Y?T-HBO1"<B6-&RAQ;*V6W%)<8-+J5H-2M^I;3,]=0'RIS
M/D_'4<=Y3F=S!MJ;/Y,*LFTD2 47[;)LX:Y,=R,\3BUN))3>UXG====4Z%T
M1']Y?*B.-D^X)RR@_I4S*>K BAHU^S*D=GI/-SN>K[?YNNWM[O+L =V2Y_EU
M%;Y?&Q1JIA7#F=8_CL>2["(T/-V\**1KEFTI"W5)-PBWZ[B2DDD C^0+?D:#
M0<J\9Y'D[%P]&PIS)85\U6M1'BC.G*CR83C*'#0?<)DR;=3YD$K7S&1 )O'6
MY]MR'QGAN03?NC6+8J]EYN]AN,R_/DNHKH9J82:DD<9EQ\D&1_4>[QT 1K'*
MF>1>0&ZS*LAC8M+?NS@1\2O*=Z/52JOOFVA<*Z;WD[)<:(G$;E)0;A[-A$6H
M"]5[BZ'W#6M/#+;69;C+=[-:U5H5G4RT03=2G7:1NL/M(69%U[2=0$-RKR==
MUF>Q./*6RD8\RBH*^LKZ'2R,BE*)Z2J*Q&:CL(<2V1FVXMQUU)ET2E.AF BW
M>6<S7Q[&GWEG$PN<F[?II&16M5.1)L8+"=[$RJIW$&\MR02D:H<U2WHX>BM"
M(!$4_..;,U&74J)"+V_@6]!2XM>6E8_1F\O)S2EMR9!5L6E+![E$I)))TM.A
M:@1W\U5?)M/Q'GD#,[J#EF..5L21!L4Q$UL]NP3/9)49<=HUM+846U27-Y+2
M>J3)710&+M1WG(V,\H4^&9I>P\B@Y363[%@XL J\Z^56K8W--F3BS<94E_1)
MN:KU3X@)'D'),O?S/&^-<)G,4MA<Q9MM:7\F.4U<:#7J:;)$=A:DMK==<>2G
M<X>B$D9[5'H TYR;=YOD&,Y+QWD-U$<M<.R3&(\^R;K67(UK"NI<5Z(IV,ZL
MTMN,KU-U"?(YMVZ;5 K</+=>Y5< 9C6O.MOO1,9G,NOLLHBMN.(B*)2TLM^5
MLE'JK:GH0(IN;\=8'_A\E7[-' J[ZGQI-U5W4".U#G1[&#"*2PZV^RE+B5=Q
M"2/17F\ &/D')F5O%C<-S-(N*V-A0U]C]JJZ23DM[(L);1+=[\5IM28\=)F2
M6RZ*6>[S)T(!G<>\OY=?%QED&2(CL8YG,"QKIJ&6R;1%OZQ;KK;ANK49DB2Q
M'?(F3+RJ3X@1&5')F0V=MQSEV1182ZC)9>66M4AVO1]QA4,. IR$EETU&I+C
MS;?==6G3>E9)T(B 0N03.3LHQ#CC/\CN8#U#DN48O8_IIB%V_MT:5/:=BFS+
M)>]U9$:$O=U&A[CV[=OF#9/N@(E<)9 E1:D<JE(R/P_]\P@,;/OIK];1V=C%
M7%;E1(K[[#EBZ<:$EQIM2DG(=(E&VT1EYUZ'M3J8(\[X=S!E+F:8?!=RYO,:
MK*9+U?9IC8_*JZR'(*(Y)0J!8/)04A)*;VD2S6:T>;H"IV#8<N/\F1L,I\Z8
MR"'4K:E9K*521HT>#&7YVXB7&W5&J4^1=$_\6CSG\",*CGO-^88T[D-_69A
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MI49Z>.@+5RPW$H>%TJ:>),F6+BG794RQLGSDRY,J0K<XZXHR(B-1_NH2E)?
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M6ECC,)G$XU?&R"N**XA<D[*0X]&=:E-O)7^6I"TZH\I]2/X J9=X0QZ/28_
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MI)$;);DJ,M7",C1_&^ !2Y)CN2-//X[;PK=F.OM2'*^2U*2VX7[BS:4HDJ_
MP'179GA]N],C5.05L^17I4Y8,Q9C#ZXZ$'HI3J4+,T$1^)JT 0F$\J8AG.(N
MYK GL0Z6.]*9EKER&$''*+(<8);YI6I+9.$@G$;E=4*2?Q 6:OO:.WK?O-39
MQ)].9*5]PBOMO1MK?U'W4*-.B=.O7H J]=R?17><0,1H'8UO!G5,RW3=P);4
MF.E4&5'C*8T:W$:M7]QGOZ:::?(+;9VM72PG;.YFQZZM8(C?F2W41V$$9Z$:
MG'#2DNI_$P'3&R"AFUS%O#M(DBIE*2B+/9D-.1W5K5L2E#B5&E1FKRD1'X]
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M39;%J2?;W:DC0%6J;D^-5EI%I+&Y@P[J=IZ*ND2F6I3^X]I=II:B6O4RT\I
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MV?5O92LUIT^.J>@#G(RC&8EPQCLJZ@,9!)(E1JIV4RB8X1ZZ&AE2B6HNGP2
M^R\HQJOMHU#/N8,6\FZ'#K'Y3+<M[<>A=ME2B6K4R_=(!%UV9IL,_O<%*$;:
MZ2OK[$YQN$HG2L5R$$@F]I;=G8\=QZZ^!:=0M(
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M<O9(S/??E3F\1Q9$J7+;)F0\\DYQ+6Z@C425J/JI)*/0_B"-T @
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M4/+;2IYO7MN&DC4G=T/0_$M0'/0M==.I_$!]
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M[]/*"N&7V\YS/>&*'*I=;^O46TR=95M4XXMI,=59/;2\VEXB<[>I$G<LOJU
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MA)K6EB,V;JS))=3,DI/H R84Z//KX]G&,U1)3*)+*C(R4;;B26DS(^I'H?@
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MKT[R4+:4E:B+H8"W  #I<B1'GFI+K#;DAC7LO+0E2T;O':HRU+7\ '<
M                             /BDI46U1$:3\2/J0 1$DB2DM$ET(BZ$
M1 /H    #B2$),U)21*5U49%H9_M <@   <30@U$LTD:R\%:=2_A <@
M!QV(-6_:6_33=IUT_: Y
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MIK;BUM[[,L?MYN2QILN1+CV,N-3)L&-D92C;9VO%M;2PA&B#V@(' G>0'8>
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MR#3<58]8,S<AC66.3[:PAQ[D\>=MI<&:F&DGYB2[CO9:_-6TVM*E*5O5J2=
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M:DMZI3U)LBW'JH]3U,#6ZP0
M
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M!'KJIS1Q6JU&9GKU 9JL/QA;]_*55L'(RAI#&0N&GK-::8.,A+OS(FC-!?@
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MWN.=YLM>BMSSBOVJ 68
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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MZ;JX@8_36%]:N=FLJXSTZ:]H9[&(S9N.*T+J>B4F"/-RO=5FC= GD5?$T_\
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M:(7[I<NH8E3E>?<73:#C>[<91#R%J>U-<;:DIWM..QD-I41&CSZ'H>GT[CZ
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MPY1KM;+D-U/+KW'1-Y/-3]N:D1F$R/.H^\9/NH,S_=Z=.@+K8GN*:9B^U>3
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MX]S\B;8-I=6I:OCM(R0G_-26O74P-9_N)_[#L\_^42/^\0&(GA[_ .VG'?\
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M4RT!K6K8K#\SVT\YY<PVMO',CR9B32&M)MDXRBT8-3B4GIT\Z4?M29? !M7
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M<(D1W91+:(S41[730:E=/WC!6^/:%_\ ;UB'_P#$?_UE)!-;O!
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MR,SZ+-Q6[]H#)QO&J'$*:-CV,P&JRDB;_30F",FT=U:G5Z$9GXJ4I1_M 2H
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MU+L,?PVS^^Y!?N1GHT5I#3C#J6B-U*5;U=G:6J2ZJ3I^\9#T4Y\R_3ONW_\
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M&TR<AN;F?&DV$OTK\>- C,&9FIY3R$&6AF1FHB-))(^NNA N+A[TXB*_@!B
MVHUHBV-<PA2O$R;0XDC/_("8S/>)_P#;M)_Z35_\ZD#&H,0L?8W0SJ&]C39[
M625KL.:TLTW"TIG1S0X1FG8:#(G"ZE])_L!>JRKY1PKBGW<\F6^<V"JZ!-JZ
MZ+&<1'?D[GCBP7=-&$+,O*DSU,M .RR<-./\I^X7*^<*F#*B8$W5-4E-,F-*
M85.>_)W.(2KQ0GM+U_:C7KJ1$UZA4RRM9.K;2IPB-)+-)&HDGXEK\@1Y)YRP
MO'\X]TG&N'7S+GV.=23.\U$<5&7^2F:\G:MO0T^9!:Z>(-9Z+UE_MRHJ;AG/
M,)XU9DE8Y"PS)0Q+E.2#=D5[B7VVT&ZK1)KV;-?#4RU/0@2JA@ONUX\Q+C&K
MH,I8GP>0<;KV:A_%E0Y"9#\J$TEA!(6:-B"<VD9DXHC3J9:'TU$:<RO![_$?
M:?6KRN*Y M,GSAJ[<@+)3;S#,F(ZTA*D'U0I26M^A]2)1$?7H"]URY0XJH_;
M_P @8KR3-A2LPXI]4W&LX5N\].=J92E$:9+?4B61DG<E+B5$:DF@S(U(,@]J
M0Y%=:P6;""MJ77SVD2&9#>BVWFG$DI"R,NBB-.FA@RZ[S_W)9?\ 17_^;4 \
M2>VSV]T/*/$[-M?Y1D<6!(FR6)%!7SDQZQ:65I^IE32]35^\>H-;JW>X[ <9
M@WW /'%;'7 Q?[N]6-L1'%MNH8==A(4:7>JMY[C4:S/<:NOB!B#/#J+VV\_T
M=GED==]@&1GZ?',GMG7)$FDF]2-"E*/MZ$:R\ZD$9(5N2>J%ZCU3.,YK7>V[
MF;DB!R8S)@8IG-A]]H,E;8=D15&XX\ZII792M1F7>V'HG5)HZEM42@/5DXO=
MKYS]QK/*V*0I*..\(HY-<Q<R6EL(G2WVY"-K:5D1G_Z2H]#+RDC56TU)(!1_
M;/[?J/E+BH[6]RG(X<!Z?)BR**MG)CUKB&NV9FMI33FIJU\QZ@;K8/.V"JXK
MD<49]A%&[+PSC20ZS:54,E.OM0I"FUJ?+4]5&>CAK6H_K4DU>)F"8A^<^<,4
MYTPMGB;A]$O)<IR>3$[K:(C\=N&Q'>0^I3RWD((M%(22C+5"4[E&HM"U+F._
MER7QI39/1<:\]XJ2,'@4<:-C/(4;U2I*I##33;C2SC)W)22DN:H\^GE4:=%Z
MD%8X:SR+QJYRKD&$V5I:\#8]5D]C[MR2R:7>.*;0PRQO2@R):U+0K1"3V[#6
M6NA@:@Z#A+W!Y'PG.@,Q\=D468N%EDA4PY!W[LAPD/MJ2LFS0E:TH\J?DXHC
M,MQ@5FYYRI$S'ASA/,[M]12*'*(T/)GMJG'$/U:4FZXHB+4U+:)+VA?QM 'I
M#'_<WQ7G-HG%\!MCMLQFLR54]<_%F0V7Y$:.Y()"WG622@C)L]5'_P!\$CRC
MD]S[=,GH+F]R>HL...=8:Y6^DID2T&NS0M1LFE*D&RG<>WN?R2B/=^"C*]D\
M R,TE\/XK(Y -\\J<BK.4J61E)4SWG/3*>W>;N&QVS5N\VOU==036LO=ZA#<
M/C(D)))*S. M1)+351I7J9Z?$#&Y[KDK%Z#.:#CRP6^G),E;>>JT(94IE28Z
M5J7O<\$GH@^@(A^<.6:_AK I>6RF"F3UN)A5$$S-*7YKR5*0E1EX(2E"EK_!
M.A=3(%QH+VQYOQSD&=*R#(,ED9+SKF#+O=WPY#42NBLMJD*AQU+02")*&_,K
M73RDE/Q-9=>EN.>2,9Y3QT\HQ-;[E44AR(:I+*F%]UDDFKRJ^'F+J#+2O.G)
M/$ME/O>+N<::?5UM:P5MCED2WS;L7^RXVE<4XQ$7<1W#2DG3-&[7=IIU+C,X
M7Y4GX?Q7QS Y<.6UD.63%5..ZQE=U;!O(;B>H))))!&E:-JC+JC177J8&MG<
MT4V=9%QO=4/'+[47)[)M,5N0^YV21'=629&U9$>U1MFHDJ\2UU+KH8&/)U-3
M\PX=SQQAC!T..P+2GI'HE5 B/2%0U5>Y[U3SJU*W')5JZO4OJ7U,CU,%>P,)
MY*Q?D"7D,+'7'UOXQ/756I/LJ9),EM2DJ)!G]1:H/J#+4'-%MP?5<KTSG,^)
M+<:?JELUF73B>E5.C:W%G%5';-2>XDU*/<;9F6Y/P,C(N./L]@S(^-9A.KV)
M,3CJQR"5(P:+,)9+*N,S(EH)SKL,MB?Q4E7QU U3N4,_CL<U9=C<R55<>JCU
ML9"<B50INK^_:?91_1XYO$;9I/7M)3M49FG3KIH@K4,:-&F^W7B>KG-D\P>?
MN1)L5PM=$K6YO;6D_#5*NI?B"M]9O4MQ?=QB</'66JZ;,PV>TTN.@F4]TFYR
M&35L(B\FU.GR(B^1 SV:1K<EX\I/:]DW%EY5*;Y:B2Y1SJE<%Q4U,EJ23B9:
MG"09(0RR6U2S66A),OWBU+W>V.'4)?X;P1LS,D.8W5I,RZ'HJ$T73Y CP/$H
M^/</XUS7 <LJI3?N#@7*(^,DVS*5-6E+K/85#6V1H)LS)U?^>2B,MVJ=#3W;
MBW(L*/<XYQ9DSKZN3'<>BVUFGM&;)J2V3;ZC=+R[NZA?0&47[G?^P7./^@I_
MY]H#'FG,L>K,M9]JN-727%U5I5)C2TLK4RX;:V8)'M6GJ1_B0*]6\:\*8+Q/
M)L96'LRVG;1#34OU4MV41I9-2D[2<,].JC!*U][NLHL(V"5W&V.GOROD2P9I
M8+)'M4<;N(-\]?@DS4VTK_-<,#&D,_P_G?BJ%@G)61Q<=52\6KBPHY8Z<A,M
M=>ZIMA:)!O(22D+T-"E:D>YU1Z>8P5L+(J['>3?<[&K9)%-Q;+.-S)+I)+5<
M66^ZXVZV:B/:LO*M"O@H@.RC\(0LSQWW/56 YNOU$W"J&;1U4_::?45*%+D1
M%EJ9D:20]HC^*G1!]4@;Z+O[G\3QJWYNX2595S4A5U8NP+;<1Z28D:1%4VTX
M1=#2DWG/VDHR\ ,>LB(B+0NA%X$#+RCF]TO@OW,S>5,JA2'..LTJ&:M^ZC,J
M?1!E,$PG:X2",_\ \LD]--5)7JG<:3(%[(W*,RK?<KS)QQ6\:,RI^*818??+
M_)%L.QHR=CC+J6D]U*%$H^SL+4M5&OH6U)J!?19?=?\ _P V<)?_ %;'_P"?
MC F.WWS:'PM')7@=Y"(]/EVI &-5^Z#V]\6<8<9QLGP^LD1+==I$BFZ[+D2$
M]IUMU2BV.*474T%UT!<UV>XDN,5>YFE+EU;K>%_I=GU"F/4;^_W9?:_]%(W/
MJ^7\(&>B_P##EG[:(B<NIN%)4I=Y/I9$B>S(38&DXT1*B(R5+222,E/? ]3U
M :5P'@%W//;<6:8G*GJS.+(F.+I/4N*K[&/&>,EQ^PDT[5J07EVGYE%M/ZM4
MBO6WMNS3#\SXKJG</K&*)FLW0;*@C:DF'-0>]PBW&:E$X:NZE:C,SW>8]VX$
MUHOF?&6LQYTY(H%M=Z2YQJY*@-Z:F<R#*8DLZ?B:F]O\(*U6B3;9;QS'Y9R(
MB._RKD3'ZTW$I,M\6FKG6D&GQZ&H]#_%(#;O(#W(O+7N24GBTJM]/$D=*$N7
MANG7E932,G5:-)4HW2/1*?#13&NO0!D<&O9IQ-SW?<>\D)@1W^1F%Y%7_:#<
M.N^X(6ZM:&"=2DT;DDZ2DG\4((NAD!JT9H?_ />KQN7_ /34W_Q+$$[-J\Z_
M]C&?_P#R"R_ZLL#%*X6/_P#M4J#_ /Z>G_\ [P!OJ\D<2-^T96"P#Y7?F-YQ
MW)'KDL?<]A-]Y79T],DV_P"3V^'Q\0:ZMO\ /CF%9GCO $3%7GW\$G73%5 =
M2IYB2<%I<>$9$MXNXE9$@R):BUUZ]03&%<X/0^V[G3&\HR>.YD/&5TX4>JO+
M=UR5(H;#777<:MADDS)9*6G=LU-/G;,U#U3?,M]P_<<G6>,>X7%OL<%F,TYB
M6<P3EJ<FQNJC2M49![MIK,B2:5I2HE>&I&837L\?M%R<YBT<VTLN'(LMEK"Y
MET1DZ9I[A/$UJ1>7;LW$1$7@>U*C40)KU,"
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M\R)1& [T(0VA+;:22A)$E*4EH1$7@1$0#BVPRTI:FFTH4X>YPTI(C4?S/3Q
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MPO#:K!J==15N/2%2)4BQL)\M25RI<Z:X;K[[RD)0DUK4?[J4D1:$1$1 )J5
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M>;2X@M/#1*B,@'>VVVRVEIE"6VD%HA"")*2(O@1%X .0
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MW#<;67('*G$N_'WKO$(4J8C(U)2:H[4=]<;3O*2:3(C)"C\?@"XW%A_%W'F
M/2)&&XY!IY4I)-R)$9HB>6V1D>PW%:JVZEKMUTUZ@CS=QC[<(.7T7*%7R3C!
MUEI;7TM['KR1'2F<RRX9J;=8<Z*-LE^8T;MJO P:J8QC"N3.0N%,KX(Y*K':
MN^IB3'Q[)5,DBNFM1'B<BF2VR(CVK:)*U;-QM*)6AKW CJJ>4O<'C>#Q^.U\
M2V<O/*Z&53"OF5I74+[*"9:DK=(C1J22)2D]PDJ/KJDCT(*UG' &98O[6ZCC
MZIKG;_+WKYFXN8U<GNDA;K;I*)/AJEM)-MFKXJZ^ +>KTGBO"G%.&6#-UC6(
MU]=;LI,F9B&C<>;W%H>Q;AK-)F1Z:EUTZ E>?<GILHQOW'9UFDOBB9GV,V\.
M#%KE)CLO,$ZU%BDMQ)OH<+H;:D'H6H*N,F=>9GQ3R/C-3Q',P65(J'BA129C
MM?<)+[:VR0A#"&]5I(B\?F"*8[[;Y4G@K$\@Q>C;QWG#%HR+!HTQVFI,N0PM
M2EL24J(T..*(B-LW2/S$23T2I0+6?R\KDSD/ N+,G5@MH>5T-\Q/R*@;9-MU
M*X22-:V]V[1MTTZMF>NFNA]2 QM;#.7LXR?)H5';\4WF.5LKN]ZZG+;..QVV
MEN)WD22/S&DD%U\3!%9YCPO(KWGCA_(ZNE>GTU*_)5;V#;1+:CI-3:FS=4?A
MH9&I/R/PZ@8]!@CS7F^-Y_Q7S?.YJPG&WLQQS)Z]NOR6E@*),]AYA+:4/-(T
M,UD9,H/H1^*R/;JE0*L?&EMS3R!FEUD695+N(<6.0RA5N*6"&E3Y#ZBT4^M6
MQ+K?0U;B,R+Z4D1Z&H!KGCY[EOVT,6_'KF 6.=XBJ<]-QF[HS):^V_H7;D(2
ME>SZ24>I%M4:M-Z329%]61B?%W)%CCW,W*&;57HLYY IIT&GQF.9.OL1_2K;
M::49'H:U[64)3X^756AJT(-:Y/P1R7>P>((D>GGL1K*FAXSG+*4[2BQ(-DF2
M2I1:ZD1$LEE\?R_X *VE%P3-":]S2%T,M'ZH;4C&B-LB*<11I;:28T/S?4@O
MX2!%:XYFW.'X/2XS>>W*;=VU:P;,NT=APE*?7O4K<9N,J5X'IU,%>N,;L)-K
M05EE,K'::5+C-//5,C3NQ5K01FRO;H6J/I/0&7D*EK,HPCDWE*SO.%IV<5V1
MWKTJHF*BQW4(CH?D'N0;Z'/*Z3B5>73PZ@TSL%XOY!9PCG"X<Q9>*5^:P)+6
M,X$PM+JT.]AY.Y+:=$H-1K2A)$2=>OE))( 8W',VYP_!Z7&;SVY3;NVK6#9E
MVCL.$I3Z]ZE;C-QE2O ].I@+=R)A]_R'RQPODLW"WSQIF(\O(JZ8PW(CP#?0
M2B8DI,MFJ3Z=4_ $;MLN,,+D8KD6*4]- H8N2P7J^>[5Q&(JE)>:6TE:B:2C
M<;?<,T[@1Y]P#+^<.$,43Q=;<76&62:93S&/7M.O? D,.+4XWWEDA>PDFKH9
M[3V]#21EJ9I&_P!RG(E=[>>3I-W 5/Y0Y$G1[>930"2ZMK^G-/=HMJC(U)WN
MN*VJ,B+H6IEU%2&7\ 655QW@O(O%5$S2\P8G7U\B?7,1FDJGK],VF2V\SIL6
M^E9J5N^I7F3J:C3H*Y<XQ,VSF7PQGK/'=E:?:'IDS)L66PE;C*]\0E,.)<)2
M32LVU]M2DZ*3UT+P Q=N/LPEO9=7Q&>!9>')EFMA[(?30V$QVS0:CWJ:90K:
MHTD6FX$;]!&@N L3R?'N2N:K.]J9-=77E^B53RI"22W*8)Z:>]H]3U+1:#_W
MQ NHO%.,I4WW,<F9'EN*HF8G90X15$^RBM2(KCS;,9"NT;I*+<6U1'H7P 8N
M'\=7M!SGS!9PL;76XG:TC<:B=CL(8AO.E&8)3;)(VIU-9*UT+QUU :ZX?:R/
MCW!8F,9-[?)V26S#TAUVT>AQ%*6EYPUI3J\TM7E(]O4P77KW [63=8C5V$O'
M7L3>6VILL>DDA+D1MAQ33:-&R)))-"$J21$6B3(&7F#/^*<XR/)^?W(E+*)J
MYBT<[&)I(+23,IR9=-#"C\5GL6WT^8-(G$>)N1:VOX7LK2CG/7SN8V.2YHXM
M!&Y%7)?8;2[)/7IN;:)?^7X@)*RI\HQ3GWD7*[#B2;GF/WGI6ZMTHS#S*399
M:W+2;Z'"ZZ&GI\@%RN9%_G/"_(V-4_$\W!YBX;?H*TF6&SL'Y"M%FVAA#9&I
M"6T[C/X&0(J&#6UMBV'T-!:>VZ;:6M5"8BRK-<.$:WWF4$2G=5L*5JHRW=3U
M!6YN=*_(<WX OH=52RCR*XKX;J*(B2Y+;><>8=6RHDGH:FRW$K3Y'H"8P[3&
M<@>]JY8BW6OJR?\ 1K%=]J).LCU:8*&S:V_QB46F@'=K N/LY+%?;=#_ $_-
M]5C%NP_D+7;+=!:2\V9K>+7RD1$:OX 5%\C\$YI0\\XI>8/"E3>-K;):_)+6
M!%+='KK)F2V4IY2-?*A2#[A*+_.3IHE(%7?+L8Y"XEYJM>8<%QMS,<5RV&W&
MR2C@K)$^/)82A*7F4&1FLC[9*Z$K4U+(R3Y5 BB<=\77N1<X8WR%C_%SG&N&
MT*I#UB=H^OU<UZ0VZ1*)ASS),E+T(DIVD74U>! KTEQWR)99K=9G26N/N4,G
M$K,JTB=?[YRFG&^\T^1=M!()QI2'"3JKHHNH(R.8:NPN^*<TIZF,N9:3Z6?&
MAQ62W..O.QUI0A)?$S,]"!,5CA['KVE]O5-CEM7O0[]BGE1W:YY.U]+JS>VI
M-.OB>I:?M!5"]O\ Q$S6<$N5^:X5&1F)?<]C=C 87-/>:^SYG$FKKJ6WJ!K6
M4OBOD=?L^@82C&)ZLL;OU25U!-?TE+!NNJ[AHUUVZ&0+W;+I\VG0IT!R+[:I
MT*6RXUVY[<6 VXRHC(NXE:6$F1I\==2!'HK(F7I./VL>.@W7W8<AMIM/52EJ
M:41)+\3,P1YJ]N7MSP\N-H$CD_ V"S),J2;Y6K2C>-I+IFUN0I1IV[?AMZ@N
MZD_=/B&06R^,Y.+8F_DM;C=P4VPJ(+*%-^CC]@^R:3(TDE:4&@B-)I_ #&?A
M.9S#RNK9C^WV9BZI+Q1W+],:$SZ1I[RK<4IMI"MI%]1$KJ0"K8+P'7Y?F7-Z
M.3,3-N!>W*W,:NI3"$R"9=>EF;\)[JI.FK2^G0_*2B/J0%2?%<'G?&\)R[A]
M^,J!D6.M.%@&9KBM*K);#:BV-*-1*3N46FTUI49)4>[JWU#6N=Q,^Y2P].(7
M_!$DN77B9CR,W[#$2+WFW$[Y/JFT(2?<(CW-]SMEN,RZ%H"MB\A<6<FXI-XO
MY2PIE.5YE@-1'HL@JS<-#EA&0P;3KC2E]3,^X]KKJKS)41'H9 B(SE'*ON;E
M4&$R,"L,%P&%/;LLCM+P^V^Z3!*1VF&S2@U>5:MNA'JHR,S223U+Z+FWQS.O
M/<=GDG(*)YSC^_Q%JF.:M&V*\M2HQ+:0LCU)9$2C+3JG;K\@11. >(^3./><
M<CBY"4R1C==C\BDQG)WDDY'5%]5'=B(3KTW)1N,V_!)D:? B!=8U[/Y.DTUM
MAG,?##G(^7(7(9I\N@1&"BNLN$?94;\=HE,D@SU(TFE6G11$HC,PWC[;\'R;
MCOB&CQC+E:73)R'W8A+)THJ)+RG4L;B,R,TDK56WH2C,B,RZ@FJFGCJ??>X_
M/9>14;[V Y!B+5.J>XG2*^M:HQ+:0LCUWD1*,M.I&G7Y -=\'\9\F<3\Q9;,
MR&OL;W&L?QF778U9(22RFQ6)$>1$BL'KIW5()22;_=5J7@1 NOG&OMMY'RBA
MO<KR[,K?"[[.9<Q_(J"*RG1UEQQU!)D$I9:DHG'-J#Z$A1 5@L8%RK"]M_)'
M"DW'Y\Z;0V<=.*2D->2QKG;-MU1Q]%'KL-MQY1?!+A%\# 9<SAC.YWN+Q"W7
M72TX+,119%?/:%Z1FUHH"F4(=T/^4WM[=/CW0*Q3XUY$=]K_ "%BR\;G%E%I
MECD^%6&W_2'XRI4)SNH21GJG1"^OX&!W6;'LKLJ.LJ8RO;5.=LJV/&;.>F)!
M2ZI^.A*>Z2NQN)6Y.XCUU!';G".0,4]RQ<GT^!6V3TJL>:KMM>24Z/N&:E$:
MS(R\FFAD"]DUQ[BG(7(/.!\X9]CBL/K*:K.GQNDD.I>FN&X;A*==VD6TB)YW
MQ2GZDD6I$9F19_=7C.09?PO<46,5S]K</R(*VH<5.]U26I*%J,B_ BU Q6G,
M(R23SKQ?<2J)]W&J_#G:RZE.MI7%9?<COH-A[4S+4]Q)-.G74!1L"X0SGC;W
M-4C42+,G<35:;1^@GF?<C0&+**^9QUJ,S-*B>/9_G=%_O&"U['!EY^X=Q')Z
M7G?F'(;:IDPJ2[?B*J9[R-K,E+9N;C;5KUTU(%UAP^-YMK[K\LR7)<73/PJ5
MCS$>#86$5J1"7,1Z(M&^X2BWD27"\->A@=G7C/'5M0>Y_-+ZLQHZS"96+IAU
M\R+';CP7)1^B4IMLF]$[C-"]>GP,!4>+\0YYPOVW>BPN&NESZOO'Y[U-8QV5
M.3JXTI);*"?(TI-1Z*(]2,R2:2/4R!4#E&+9+S%E&)?I?AB3QQ?UUK&L+W+Y
M#:8*&VV#W+2@VT-$_P";SI7IOU2DBT(S >R\B9>DX_:QXZ#=?=AR&VFT]5*6
MII1$DOQ,S!EYJ]N7MSP\N-H$CD_ V"S),J2;Y6K2C>-I+IFUN0I1IV[?AMZ@
MNZG?<I@%OEMKQ/"H\>5;4-5?LKN(K+"7(C%<2XZ5)=;^DFMB5%IIIH6@&(?*
MN-,AX2Y6J^3>&L:588A=&4',\3JF&U+:06I]^(WTV%IYB2@TI):=IGM<T(._
M*\=Y%XFYKM.8\(QI_,L1R^&S'R&EA*V6,:0RA!)<;;,C4K^2)1=#^I:3)/E4
M QZFCY)YNYEQGD?+\4D85@>"(<?JJ^RZV,R:Z6[7MZ$I)$I+:CU3IHC0C,U'
MM"#N.'<X]R>5Y9E>?Q9V)4-9$<K..*N9JP\B29DXB8^VG=Y3,B-TO$]VTE?E
M$"^C=/ -]R'984BEY1I9E7EU HH#\Z6G\NP91J3<AMPC,EJT3M</7J?F_>T(
MFJGP1AF0X[RWS3=7%*]6UMY;,/4LUYI*$262>F*6II1>*3WH4?[2UZ@:]! C
MQGQAP?F=-[F;&;:5LIGC6@L+>^Q]]TM(2Y%FE#;9-'\5DE2/^2!J]'9A'".9
MU7NDE3)M=*3QA2V-IDE+)67]!]5:L-^5H_XR5*06G_D@+T7#'L)R^+S1SC>O
MTLI%/?U"6*68I&C4MTHR4;&CUZGJ6@(K7"6;<J<4<;5.#2^',BLI-<N4MR8T
MI#2%^IDN/EHE2#,M"7M_@!=2_)3O(,;FOCKENHX_M[F)"QM:;&JBDCO1I4]$
MA*H[B^J26UWBW=-#^ (V[QQR3EF:V<N#D''EMAT:,QWVIUFMM33R]Y)[222E
M)[M#W?L(!SYWP$^2N*<DQ5AKNVCL8Y52GH2O71#)YE)&?AO4GMF?R48&-8>U
M;!<\B2\JY*Y4@O0\TN?1U$9N6V33Q5];';02]I>!.&E"3U\3;U^/4:A:&%R?
M[;LTS"-4X3.SGC?*9Z[BL>I3[DR(^Z9[FG&B)2CT(R09F6A[241]5)(OJL?$
M.%<@93R]=\\\CTWZ9]1!*HQK''%D[*:C:IU=>,B+:>B3Z*(C,UJ\J4DG4C+M
ML1R=[W=T.9M5,E>*,8TN$_;I1_1D2#.49-J5K]7G3T_$#LKWN'QS)WN9>/LS
MKL&EYOCU%#EE9U\=EMYI:GC6E*%=PE)U(U$OS)^ &+?QAELR5EC%<UP?+P5B
M8TZB3D!QXC#3:&T&ZE#ALM-J,EJ2E)%K]6G0!V>['%\BS#ANPH\7K7[:W=F0
MG$0XJ>XZ:&WB4I6GR(@,0DG!\@G>X' [B;1/OXG&PE=3<2G6TKB(?=3(2J.]
MJ9EJ9*(C29==P"A<;\)9UQI[E:QAJ+,G<5U3-FO';-7YD>'&L677/3J69ZDI
M+JC29?O'Y]/,"U['!EY^X3Q')Z+FKF:^N:F3!I[R=%<J)KZ-K4E#:Y)J4V>O
M4B)23_A!=8=5QM+M/=5G.2Y1BR9V&3*.(U6V-A%:D0G);;<%)DWW"46\B2X7
MA\#_ (1V<</X]ML>]S/(-W78TJKPJ;CC,2KEQH[<>"[)V0C6AHF]"W&I+FO3
MQ(P&J.&(F3\<X4G&\I]O\_)K5,I^0=F]#BK4;;NW:C5YI:O+I\P75]Y5I\QY
M#H^'[*FP*=0E4Y*V_/H";1NKX<9Y"$K6ELDI2@THW)T3H1 B0+B%O+?<]GMM
MG.(IM,$L***Q76$]A#D54M#4)M78<,]R'2(G4DI&BBT/J0'9E\&XYG_#F<W?
M$T^KE6?%KZW)^)9,VRA3<;N:N&Q)<01'J9:I,U?\8GH6U9:#4K[O,3R7,^(C
MI<4JY%O:G9Q'O21$=QSMMDYN5I\BU(#%#Y%E<Q<^8]!XM@\;3L.I)<F*N[R"
M[?;-#,:*HE?EMD2#6>I$KRZF>FFA:F9%6R?@5_"]TN"WE94REX52XHJI7;$D
MCCM.-IFH0VM?3S:*1\/WB!.REW-GRC'1=8AS1Q"YRQ.1(>3CF35\*.EAR*LO
MRTJ6PT:HY$?FW$9++<9'X:F5TUGMNSZ?[8HF%S5HAY[76ZLGHJYUU)IC*ZI3
M$4YJI*34E2W/':3BBW?$P+U6.SY/]R><PJO$<4X]G81EBI#'WS*;$FUU;#;1
MZNJ8[S:DN)69:Z%O,D^4MQGN(C.S_C*QRSW+X'99!CGZBP>)CK\2ZL)<5IZO
M]629JD]Q"]4DK>IM22TZ&HM/P#'PK!\PX'YGD4N*4LBTX3S-7?UB-$\JFG+,
MDEW%GY^TD^GF/3MJ(^JD*U"@X?5Y3@.8\C.Y!PE.S5B]R&9.JYZHL9U"8QR'
MC(T&^VX>BR42BV@KTWQ->2KO'7S?P1_CYJ))6S'II"&FB6A24N&\A#*$)(E*
M49'T\2,$:[]KV(Y/B?\ >-^I:F35_<\EDS:_U2-G>CKUT<1\TG\P-53&N'<E
MR>X]Q=#>P)%-69K,9.@LY*-&7E,O2W6W4:&9J0E9MJ5I^Z?S KCB/)//G'6$
MQ.-IW$ME<Y71QBJZ>ZB+)RH>98+MQW'7$D9$24$G4MY;M.NPS/0*_D' ><8S
M[6K/$T0G+OD+(+IB\MX< B?4AQQQLC;(TZ$K8ALC6:>FXU::EU!;U=ONMX*S
M*[6QF_'$.7-L+Z/'K,TIHFJERO2['8\E:-?,:#:2A?RVH,OWC S7HUO)LHK,
MJQ3#6<3DRL?GUINV>4)=)+%>^PRLTLN-[#U4M2$I^LOJ+QZ@B^ @
M
M                           "-I<?I,=9DQZ."S :F2GY\LF4DDWI<I>]
MUYP_%2U'XJ/\"\"(!)
M
M
M
M
M
M
M
M
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MG$'MW;NO@".2^2,*;RR?@R[5)93603MIU?VGM6X2229N&O9L/0EI/:2MW7P
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MKY%X /07'']\"\G;/-\ QO'Z1++I_<ZE]#LM+VA$E*2(S/16IDH$;D!
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MOH>IM[3_  ,!@7W%T&^XD+B5ZQ?:@%5Q*<[-*$&^;<)+22<-)EMW*[74OQZ
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M#Q+A?+\;R.!>6'*^27T.&M2W:B>XDXL@E(4G:X6I]",]W\ %;B!
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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M\$Y*PCDR!*M,'MDVT"&]Z:2\AI]G8]M)>W1]MLS\JB/4BT!%K
M
M
M    !Y;X1@5V2>XKFN\R=AJ9DE1/CP:?U22<6Q7DM]LC:)6NFJ&62U+P+_=&
M"ZE^2*3C;",9YCN.,W(T'DJ14+5D4*OE*)^.T\V@S=](E>UKR.&YW$H(]RC/
M7J G/;K@N!O<"8U%;J(,Z'>UQ/71NLMO>JDO&HGR>4HC-6U6YLB/Z23I\ ->
M3%/J+VS9]11W5R,3J<Z9CTCF_>11UJ(U(;4>O33:O]JS/X@UW2'*-G9<:<8Y
MC[<LNF+D*J9D"VP&P<0K^G4\B3N6WJ1:$;1ZJ_W7<271"01Z)]VU;7)]O-[9
M%#8^XK*I)4SM(-\_Z9&3_*:;O M/'PZ F,?FBLK8?M'LI,.$Q&D/T=)WG66D
M-K7^?#/S&DB,^I@9ZM.<AX'.Y'RKA[&JB8Y OSXYBS:22VHF]+"#'7(82I?B
MA*E(V[RZIUU^ *L''_)J^4.?^)+*T3Z?,:FGN:G*:Y2#:<9L8K,E*U&DR(DD
MZ7GVE])ZI^ "^>T@C*WYA(^AEETK4C\?K=!-:=CJ)? WN/4GJE65F9'^!V+
M*VEQT?.Z\5Q)$?C+$I% JOKB:L'I*"DN0S9;T>6G4]%FCS&6GB",E$*'.][=
ME'FQFI3'Z20KMOMI=21DIG0R)9&1'^('9U1:^#BOO88K\3BM0*^[QA3]_$AI
M2VR;I&Z9+4V@B2E1FRR?AU,]?WCU'9-^\O/$8OQ<C%F):8EEFDI%9WE&9=J
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M);>1ZK-MLT)GI0E*U%IH7;<>/Q^&OP ;\]REGB&-5+5)D?#KF1\?5+,:85W
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MS;!I7"=CKCDA&QQ1E^^9[B,M3Z$0,KJ
M
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M7-6VMEVX4E2HY-DHC2WIJ>BM2,^OP 7D$
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
@                                       !_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>sg_jeffreywbullock-bw.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 sg_jeffreywbullock-bw.jpg
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M%!04%!04%!04%/_  !$( (\!'P,!$0 "$0$#$0'_Q !\  $  @,! 0$!
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M<MD]S=,?&\A24_F3%8)<*=?SGW:% -!-_$\4L.#XY;<4QB$W L5J93'AQF@
M E/JI1'YEJ.JEJ/52B2>IHC,T"@4'GG3X-LC+FW*4U#AM]7)$AQ+321^*ED
M4' N1O-+@K (TE,2]C*KVPYV4VNQ#ZC58UU)DJVL! (ZE+BC\@:"+MY\F_)[
MR+FR<7X:QU^RV1Y[M_4V="S+;:/HF5<W2EEG74$J0&OEJ?B5VWQL\++9QE<8
MF?\ )$EN^YZUMD08+>JH-ND'J7-ZNK[Z?@L@)0>J03M6")=4"@4%;'W#^,;[
M;\ZMO*C+7>QJ\QF;7)>:2K6/.B!6U+Q]!W6S^V1Z[%#3H-0U3QVY>OWC9R!:
MK%D-Q%PXCS%IF6)+:G#"#,P]M%RCI5H4+:6VIF4@IU&Q:% J0G0JU$$$ @Z@
M]011']H%!IO)_*.&\08H_F&;33$MC2@S'9;3W),J2M*E(88;U&YQ02?B  "I
M1"02 @3>9'D;YQW9*;+#.+</LO.F&J2MQFV'M':5/.(253'P?: A&Q!U'M]Q
M)6R9G]N)%MPZ5<,/RV1=,PA1E/IM\J*AJ-->;&Y3310HJ:*@"&]V_P!V@) .
MH(VSP,YUN5_M=RX>S66I5VQACZJPO2R0]_&M*[;T=Q2]#K&44[-W4(5IT2@4
M'-N;^0,B\ON8[7POQ7-[G'MN=[KUR;0X(SJVP!)N#X)&YIC7ML @;E'H?>FB
MIP\0\-X3PIBZ<:PV(4%TI=NES?(7,G2$IV]QY?\ G:A.B$ZG:!J=2(?_ ''>
M/(T96*<I6N"6I;[CMFOD]K1(4I"$NPBO3KOT2\D+^02GX)H./2,RRKS+Y:XW
MP&XR78-KAP8T*:'7"L*=B1S(ND[0:#NOAI0;_H@'XFBK3L=QVQXE8X.-XW!:
MMEBMC28\&#'3M;;;3\!\22=2I1U*B22231&3H(^<J>9?"O&)D0&[H<IR-D[#
M:K'MD)2O0']V22&4@:Z*"5J4#^G6@B[??+?R5YR6[8>&,4D6:$7"EV19F7+A
M-2A1&U+LQQ :9'S4E"#_ +M**]<7PL\CN5[O'N/->9IBQ6D@=R7,<O4UM)U)
M0TTE093^.CP']:"0W&O@]PA@0:E7>WN9C>D$+,J]D+C)4DZ^R(C:UM_!WN?U
MHC@WW%[KNO/'/&]J2F+!C1GYJ830#4=/?<1$C (2 D!L,N)3IZ FBIWX1BEM
MP7#['AUH1LMUDA,06/FH,("2M7S4L@J4?B31'#?-7ER+QMP[<+)"FEC+<O2;
M5:VFEA+Z8RM/JW_F$):);W#]3B:#3O 'AYS#L F<E7ED(O69AL6U*TC>U:(Y
M44$'U'U"SW"/BE+9H.2< +CGR[Y>SU<T3[;C+637@N1E%0DMF7L"4'H%#8HZ
M?#4"BOOP4MEPY)YTSGF2^A*Y,1M^0K_;<+\^M6J.GY4M-O(Z>@4*"QFB.>YU
MSGQ'QL>WFF70+=*W*;^B2X9,L*0-2"Q'#CB=/FI(%!'K*_N*<86V8F%AN/77
M)U$A(D*V6YE:B= $!P..DG\6A0:5<N<?.'D^4VSQ[@#^)V6X@B!*5;R%!E9Z
M+<F7/1G73]26T?@**\,#P?YSY/G*O7-_(/T[RST:[CMZE:)&@&BELLMI^6Q2
MOZ4'=^,_!_A+ #'G7: YF%]8(7]7>2%10L*U&V&C1K3TZ.ARB)$6RU6RRPV[
M=9X3%OM[6O:B1&D,,HW'4[4-A*1J?D*#UT"@4"@U#E#CNQ\K8)><$R! ,&ZL
M%#4@#5<>2GW,2$:$>YIP)6!KH=-#T)H*@^2;9FG%\:X<'9W:V5/V>YF[6BX*
M"BXRF2V&W5Q'00%QI:4-*6DCHML?E6%@E3Q\$><UY_@[O&^1S._EN(MCZ%3F
MI<D60%+;2BKT)84H,J_V]OU.IHB75!C[Y?+1C5GG9!?IC<"S6UE<J=,>.UMI
MEH;E*/Q]!Z#J?04%>N,VK)O.CFZ3E60]R%PMASP:C0O<A+D<N;D14D::OR0G
M?)6#JA&@!_[=%6%6*Q6;&+/#L&/06;;9;>V&(4&*@-LM-I^"4CYGJ3ZD]3UH
MC(4%.?-;N4\,<^\EP,??5:7+N]<6"MH(43:+]I)V(4H**=S;B4[DZ*3\Z*GK
MX9\#1N)^/&,GO$53>>Y8PW)N7?2 Y$AD[V(B1U*?:4N.@]=YT/Y!1$EZ"*_W
M!6D.< %2QJIJ]P%H.OHHI>3K_A1H(5^&TN;CWD)@ESD6^0Y O#L^W19 ;6$+
M4Y$<;6I"M-%!HK27-/RCJ:*M\HB%?W$.0,OQG$\8Q*P/28%ER5V9_-3(ZNV'
MT14M!$52TG<$J[BE+3T"@ .HU%!Y?$?QDX*O.%6[/[I*A\@9%+;;=EPWM%0K
M4\H!1BN1"25.H4"%*?&BAU0D)ZJ":ENMEML\-NWVB&Q @,]&HL5I##* ?]*&
MP$C^PH/50*"N+[A+C9YFP!D(T>3:VEJ<Z=4KN#H2/[%)_P T5/G/<\QGC3%+
MCF>7S!"L=M1O>6!N<<6H[4--(]5.+40E*?G\AJ:(IUYXY.RKF3.'^1;_  Y$
M&SW+?&QJ,X%F.U;XBR@-,N* 2LI42IY2.G<4KH/0!:_;;S$XR\?;9>;NZB"Q
MC.)Q%OJ W)0Y%@(2E*4C3<2L!*4_$G2BH6^'^)SW^">><O<0MIV[6F5:X-Q"
M07"N- E/OA!/4ZE]K7YG\1093[=V4VO&,?Y7NF03&8%@M+5LN,Z8Z3^VTVB9
MO40-21HGH$I))Z#J0*(P^8^1G/GDYF,S N!HLNSXL"HH5#4(LU<30ME^?,W
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MU=K7"NK T8G1VI30)!T0\@+'4=#T/PH/700T^X]?3#XJQG'TIU5=+X)"EZ=
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M3W78[*=0L]]U81J/RA6OH *"WV/'8B1VHD5I#$5A"6F&6TA"$-H&U*4I&@
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MGM]G8_[%OC,Q&^@3[&&TMCH.@Z"@]U!7[]RV\J+O'F/I20@)N<]Q?Z228[2
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M>M$=.H%!6IYK2[9E'DQBF-X=&^HS"$U;H-T5';U6Y-D2.]';5M&JU(:6@Z_
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,@4"@4"@4"@4"@__9

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
